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BRIEF ABSTRACT 
 
Understanding how organisms deal with potentially toxic or fitness-reducing 
allelochemicals is important for understanding patterns of predation and herbivory in the 
marine environment.  The ability of marine consumers to tolerate dietary toxins may 
involve biochemical resistance mechanisms, which increase the hydrophilicity of 
compounds and facilitate their active efflux out of sensitive cells and tissues.  While 
several allelochemical-responsive detoxification enzymes have been sequenced and 
functionally characterized in terrestrial invertebrates feeding on chemically defended host 
plants, there is virtually no information concerning the role of these biotransformation 
enzymes that may mediate feeding tolerance in marine invertebrates.  The objective of 
this research was to assess the diversity and dietary regulation of cytochrome P450s 
(CYP), glutathione S-transferases (GST) and ABC transporters in the generalist marine 
gastropod Cyphoma gibbosum feeding on a variety of chemically defended gorgonian 
corals, and to identify those dietary natural products that act as substrates for these 
proteins.   
Molecular and proteomic techniques identified both allelochemically-responsive 
CYPs, and constitutively expressed GSTs and transporters in Cyphoma digestive glands.  
Inhibition of Cyphoma GST activity by gorgonian extracts and selected allelochemicals 
(i.e., prostaglandins) indicated that gorgonian diets are likely to contain substrates for 
molluscan detoxification enzymes.  In vitro metabolism studies with recombinant CYPs 
suggested those Cyphoma enzymes most closely related to vertebrate fatty acid 
hydroxylating enzymes may contribute to the detoxification of ichthyodeterrent 
cyclopentenone prostaglandins found in abundance in selected gorgonian species.  
Finally, the presence and activity of multixenobiotic resistance transporters in Cyphoma 
and the co-occuring specialist nudibranch, Tritonia hamnerorum, suggests these efflux 
transporters could function as a first line of defense against dietary intoxication.  
Together, these results suggest marine consumers that regularly exploit allelochemical-
rich prey have evolved both general (GST and ABC transporters) and allelochemical-
specific (CYP) detoxification mechanisms to tolerate prey chemical defenses.   
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COMPLETE ABSTRACT 
 
Intense consumer pressure in tropical marine ecosystems not only structures the 
organization and functioning of marine communities, but has a profound effect on the 
phenotype of resident organisms.  In order to persist in the midst of extreme predation 
and herbivory, sessile benthic marine organisms, afforded with no means of escape, often 
produce chemical defenses, termed allelochemicals, which render their tissues 
unpalatable or toxic to most potential consumers.  Despite the fitness-reducing 
consequences of consuming noxious/toxic prey, less mobile consumers, frequently drawn 
to their hosts by the chemical refugia they provide, are able to tolerate the toxicological 
challenges posed by their prey/hosts.  The processes underlying dietary allelochemical 
tolerance are likely mediated, in part, by biochemical resistance mechanisms that have 
evolved under the selective pressure of host chemical defenses.  Although many have 
invoked this hypothesis to explain the variation in marine consumer tolerance, few 
studies have examined the enzymatic diversity and corresponding metabolism of dietary 
allelochemicals.   
The shallow Caribbean reefs of the western Atlantic provide an ideal model 
system with which to investigate marine consumer detoxification and transport-mediated 
resistance to dietary allelochemicals.  The ovulid gastropod Cyphoma gibbosum is 
considered a trophic generalist, feeding upon at least three families of allelochemically-
rich gorgonian corals.  By virtue of its polyphagous diet, C. gibbosum is exposed to a 
broad and unpredictable array of gorgonian defenses likely necessitating an equally 
diverse set of counterdefense mechanisms.  Using a combination of molecular, proteomic 
and biochemical approaches, I characterized the diversity and dietary regulation of three 
families of xenobiotic resistance proteins and examined the potential of gorgonian natural 
products as substrates for these proteins. 
Cloning of multiple cytochrome P450 monooxygenases (CYP4) cDNAs revealed 
that Cyphoma digestive gland tissues expressed a total of twelve new molluscan CYPs 
grouped within three subfamilies, designated CYP4V10, CYP4BK, and CYP4BL.  
Expression of CYP4BK and CYP4BL group transcripts was significantly induced in 
snails feeding on the gorgonian diet Plexaura homomalla, (known to contain high 
concentrations of ichthyodeterrent cyclopentenone prostaglandins), compared to a control 
diet devoid of gorgonian chemistry.  Both CYP4BK and CYP4BL subfamilies form a 
monophyletic clade sharing extensive sequence identity, and in some cases key active 
residues, with vertebrate prostaglandin-hydroxylating CYP4A and CYP4F subfamilies, 
suggesting that allelochemically responsive Cyphoma CYP4s may have evolved from an 
ancestral gene encoding an eicosanoid-metabolizing enzyme.  Heterologous expression of 
select Cyphoma CYP4s indicated a possible role in eicosanoid metabolism, providing 
further evidence of the putative role of Cyphoma P450s in the detoxification of dietary 
prostaglandins and supporting the hypothesis that interactions between Cyphoma and its 
allelochemical-rich prey have contributed to the diversification of some P450 families. 
Enzymatic analysis provided evidence for high, constitutive expression of 
glutathione S-transferase (GST) activity in the digestive gland homogenates from snails 
feeding on all seven allelochemically diverse gorgonian diets.  A proteomic approach 
(HPLC coupled with LC-MS/MS) identified two major GST mu forms and one minor 
GST theta form – the latter being the first identified from a molluscan source - that were 
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consistently expressed in the same relative proportion in all snail digestive glands 
examined.  Gorgonian extracts were screened using a bioassay-guided fractionation 
approach for their ability to inhibit GST activity; all moderately hydrophobic extracts 
contained putative substrates or inhibitors for Cyphoma GSTs, suggesting that the 
constitutive expression of catalytically versatile enzymes may provide a competitive 
advantage for generalists that encounter a tremendous diversity of gorgonian defense 
compounds.   
To further determine whether specific gorgonian allelochemicals could be 
substrates for consumer GSTs, I examined the prostaglandin-mediated inhibition of 
Cyphoma CDNB-conjugating GST activity.  Enzymatic analysis indicated that 
prostaglandin A2, the series found in the highest concentration (ave. 2% dry weight) in 
gorgonian tissues, is a competitive inhibitor – and therefore likely a substrate – of 
affinity-purified Cyphoma GSTs.  Conservative estimates of the in vivo concentration of 
prostaglandins indicate that GSTs would be operating at or near their physiological 
capacity in Cyphoma digestive gland tissues, and thus may represent effective 
mechanisms for prostaglandin deactivation and metabolism. 
Finally, the presence and function of multixenobiotic resistance (MXR) 
mechanisms were demonstrated in the generalist Cyphoma gibbosum, and a co-occurring 
specialist nudibranch, Tritonia hamnerorum, which consumes a single species of 
gorgonian coral and sequesters its host’s dietary defenses for its own protection.  MXR 
expression was compared between consumers using immunochemical approaches and 
this analysis revealed that P-glycoprotein was expressed in the nudibranch tissues 
localized to areas with the highest exposure to gorgonian allelochemicals (i.e., gut lumen 
and epidermis) - consistent with a role in dietary xenobiotic efflux, while comparable 
expression was absent in Cyphoma.  A competitive-based dye efflux assay demonstrated 
significant MXR-mediated efflux activity in live Tritonia, suggesting that the use of 
transport mechanisms may provide protection against dietary toxins.  In the present study, 
eight partial sequences belonging to both ABCB and ABCC subfamilies were cloned and 
characterized from Cyphoma and Tritonia tissues.  Predicted protein structure and 
phylogenetic analyses indicate shared homologies and possible shared function with 
characterized vertebrate xenobiotic resistance efflux proteins.  Quantitative estimates of 
the expression of the putative glutathione-conjugate efflux protein, MRP-1, indicated 
constitutive expression of this transcript in the digestive gland of Cyphoma individuals 
feeding on multiple gorgonian diets.  The universal expression of MRP transporters in 
Cyphoma digestive tissues may facilitate the efflux of putative glutathione-conjugates of 
prostaglandin and other lipophilic gorgonian compounds.   
The studies described in this thesis provide the most comprehensive investigation 
thus far of the three phases of detoxification and transport that may protect marine 
consumers from their chemically defended prey.  These data indicate that both general 
and allelochemical-specific multixenobiotic resistance mechanisms operate in marine 
consumers to confer resistance to gorgonian allelochemicals.  These findings will 
undoubtedly help provide a framework for understanding the profound variation of 
consumer tolerance for their chemically rich prey, and more broadly, hold great 
significance for understanding patterns of predation and herbivory in marine ecosystems.  
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Background 
In marine communities, predation plays a pivotal role in affecting the phenotype 
of organisms as well as community organization (Duffy & Hay 2001).  The intensity of 
consumer pressure on coral reefs exerts strong selection on prey to avoid being eaten.  
Prey species unable to physically escape or tolerate consumers often produce noxious 
compounds, termed allelochemicals, as a mechanism of defense against predation (Paul 
1992).  Chemically defended prey are often noxious or toxic to most large, mobile 
consumers, yet appear to be the target of evolutionary opportunity for smaller, more 
specialized consumers (Hay 1991, Faulkner 1992).  However, the physiological and 
biochemical mechanisms that allow these more specialized marine consumers to tolerate 
(i.e., consume, manipulate, and/or detoxify) dietary allelochemicals are largely unknown 
(Sotka & Whalen 2008).   
In the field of chemical ecology, rarely have specific adaptive traits been 
identified down to the biochemical or genetic level (Berenbaum 2002).  Examining how 
chemical interactions at the cellular and molecular level shape the behavior of organisms 
is paramount in ultimately understanding how chemicals affect the distribution and 
abundance of organisms in communities.  In terrestrial ecology the success of insects is 
due, in part, to their use of sophisticated detoxification systems to overcome the chemical 
defenses of their plants (Li et al. 2007).  Chemical defenses in general are thought to be 
an evolutionary driving force behind the development of detoxification genes (Gonzalez 
& Nebert 1990).  Therefore, understanding the role of these genes in allelochemical 
resistance in marine organisms holds potential significance for understanding patterns of 
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 predation and herbivory in marine systems.  While several allelochemical-responsive 
CYPs and GSTs genes have been sequenced and functionally characterized in insects 
feeding on chemically defended plants, there is virtually no information concerning the 
role of these biotransformation enzymes and multixenobiotic transporters in marine 
invertebrates that also feed on allelochemically-rich prey.   
 
Introduction 
Marine Chemical Ecology 
The field of marine chemical ecology examines the role chemicals play in 
mediating a diverse array of interactions among marine organisms.  With well over 7,000 
natural products, termed secondary metabolites, isolated thus far from marine species 
(Harper et al. 2001), chemical ecologists are working to elucidate the ecological roles of 
these compounds in marine systems.  Taking cues from their terrestrial counterparts, 
which had laid the groundwork some thirty years before, marine chemists and ecologists 
entered into productive collaborations and began exploring how secondary metabolites 
mediated marine consumer-prey interactions (Pawlik 2000).  Research in this field has 
advanced significantly since the early studies in the 1980’s.  Laboratory and field based 
behavioral studies have begun to classify compounds as attractants, protectants or 
deterrents; however, more recently others have begun to address the physiological and 
biochemical mechanisms underlying these responses (Targett & Arnold 2001). 
Chemical defenses against predation have been a major focus in marine chemical 
ecology, as evidenced by the number of pertinent reviews (Bakus et al. 1986, Hay & 
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 Fenical 1988, Pawlik et al. 1995, Hay 1996, Paul et al. 2001, Paul & Puglisi 2004).  The 
existence of chemical defenses in marine organisms and their importance in mediating 
predator-prey and plant-herbivore interactions have been well established.  Many sessile 
benthic invertebrates lack the means to escape consumers and, therefore, have evolved 
chemical deterrents to ensure their survival (Faulkner & Ghiselin 1983, Faulkner 1992, 
Stachowicz 2001, O'Neal & Pawlik 2002).  Although chemical defenses limit predation 
and herbivory in tropical marine ecosystems, some consumers still regularly feed on 
allelochemically rich organisms.  The consequences of consuming defensive metabolites 
can be severe and range from reduced growth and reproductive fitness to decreased 
survival (Hay 1992, Targett & Arnold 2001).  However, for those consumers that 
consistently feed on chemically defended prey, behavioral adaptations (e.g. avoidance), 
physiological tolerance (e.g. sequestration, membrane impermeability, rapid excretion) 
and biochemical resistance mechanisms (e.g. detoxification enzymes) may explain the 
ability of these consumers to tolerate dietary allelochemicals (Brattsten 1992a).  While 
the first two strategies have been documented in the marine environment (Targett 1979, 
Targett et al. 1986, Gerhart 1991, Slattery et al. 1998), few studies have investigated 
natural product detoxification mechanisms in marine invertebrates as a means of coping 
with noxious dietary compounds.   
 
Gorgonian chemical defenses 
Gorgonian corals (Phylum: Cnidaria; Subclass: Octocorallia; Order: Gorgonacea)  
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 are the most conspicuous group of invertebrates on Caribbean coral reefs (Lasker & 
Coffroth 1983), reaching densities of up to 25 colonies m-2 (Goldberg 1973); however, 
they are consumed by only a limited number of specialized grazers despite their 
abundance and the intense predation in these ecosystems (O'Neal & Pawlik 2002).  
Gorgonians, also referred to as octocorals, of the West Indian region (Gulf of Mexico, 
Antilles, Bahamas, Florida Keys, Bermuda, South America, Caribbean) represent 38% of 
the known fauna with over 195 species documented (Bayer 1961).  The dominance of 
these invertebrates can be attributed, in part, to the variety of metabolites they produce, 
collectively known as allelochemicals, which are known potent feeding deterrents 
(Rodriguez 1995).  Numerous feeding studies (Fenical & Pawlik 1991, Pawlik & Fenical 
1992, Paul & Puglisi 2004) with crude organic extracts and pure compounds from 
gorgonians have shown that, with the exception of a few, small mesograzers (Lasker 
1985, Lasker et al. 1988, Vreeland & Lasker 1989), more mobile, larger grazers, such as 
fishes and invertebrates, do not readily consume octocorals.  Field-based surveys 
assessing the palatability of gorgonians found that the majority of lipid-soluble gorgonian 
extracts deterred reef fish at concentrations an order of magnitude lower than those found 
in the soft tissues of the corresponding gorgonians (Pawlik et al. 1987). 
As of 2001, the subclass Octocorallia accounted for 87% (~1300 compounds) of 
all reported cnidarian metabolites, with nearly 500 coming from the order Gorgonacea 
alone (Harper et al. 2001).  The majority of these compounds are terpenoids, representing 
over twenty different skeletal classes with unique substitution patterns and functionalities 
(Rodriguez 1995).  Diterpenoid metabolites (C20 compounds) represent the largest 
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 percentage of natural products isolated from gorgonians (~ 73%), while sesquiterpenoids 
(C15 compounds) rank second (14%).  Two sesquiterpenes - curcuhydroquinone and 
curcuquinone - isolated from the octocoral Pseudopterogorgia rigida, are extremely 
active as fish feeding deterrents at low concentrations (Harvell et al. 1988).  Similar 
compounds are well known as secondary metabolites of terrestrial plants and as defensive 
compounds of insects in terrestrial systems (Aneshansley et al. 1969, Eisner 1970, 
Thomson 1971).  The ubiquity of these terpenoid compounds, coupled with their 
demonstration of potent feeding deterrence in the marine environment, make them 
interesting targets for further investigation (Harvell et al. 1988, Coll 1992).   
Acetogenins, prostanoids, and highly functionalized steroids have also been 
reported from gorgonians (Rodriguez 1995).  Among the most interesting are the 
prostanoids, which are produced in large quantities solely in the Caribbean octocoral 
Plexaura homomalla (Gerhart 1984, 1986).  Feeding assays in the laboratory and on the 
reef with prostaglandins isolated from P. homomalla (e.g. 15-PGA2 and their hydrolyzed 
derivatives), resulted in vomiting or learned aversion to these compounds in fish (Gerhart 
1984).  Additionally, many interesting sterols have been isolated from gorgonians; 
however, information on their defensive function is lacking. 
Although these chemical defenses limit predation by most potential consumers, 
some relatively sedentary species such as the ovulid gastropod Cyphoma gibbosum, 
regularly feed on allelochemically rich octocorals (Harvell & Suchanek 1987, Lasker et 
al. 1988, Ruesink & Harvell 1990, Nowlis 1993).  Cyphoma gibbosum exclusively feeds 
on gorgonians and is considered a trophic generalist, because most available species in 
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 several gorgonian families are included in its diet (Lasker et al. 1988).  Additionally, it 
appears that C. gibbosum’s tissues do not mirror the chemical composition of its 
octocoral prey (Cronin et al. 1995), suggesting the possibility that C. gibbosum can either 
efficiently excrete these compounds or biotransform their dietary allelochemicals to less  
toxic metabolites. 
 
Allelochemical biotransformation and transport 
  Little is known about the role of allelochemical biotransformation in marine 
organisms (Kuhajek & Schlenk 2003).  In comparison, insect-plant allelochemical 
interactions are well understood and may provide a conceptual framework for research to 
elucidate the role of biotransformation enzymes in the chemical ecology of marine 
invertebrates.  In both systems, terrestrial and marine invertebrates must contend with 
dietary allelochemicals that can have deleterious effects on their growth, reproduction 
and survival (Feeny 1992).  Insects that feed on toxin-containing plants possess 
biotransformation mechanisms that allow them to exploit a specific subset of chemically 
defended plants.  Berenbaum and colleagues (Berenbaum 1978, Berenbaum & Feeny 
1981) were the first to report that xanthotoxin, a linear furanocoumarin produced from 
umbelliferous plants, was toxic to southern armyworms but harmless to the larvae of 
black swallowtails.  Cohen et al. (Cohen et al. 1989, 1990) later demonstrated that 
xanthotoxin resistance in swallowtail larvae was conferred by a suite of cytochrome P450 
monooxygenases selectively induced upon exposure to xanthotoxin, and responsible for 
the subsequent oxidation of the furanocoumarin.  While the dietary allelochemicals may 
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 be quite different between terrestrial and marine systems, Cyphoma gibbosum may have 
similar detoxification mechanisms to that of insects, allowing this molluscan predator to 
take advantage of an abundant, energy-rich food source not available to most other 
consumers likely lacking such biochemical resistance mechanisms.  Despite the 
significance of allelochemicals in the evolution of biotransformation enzymes (Gonzalez 
& Nebert 1990) and the importance of these enzymes in the detoxification of 
anthropogenic xenobiotics (Omura 1999), little attention has been paid to the role of 
biotransformation enzymes in the metabolism of the wealth of dietary allelochemicals 
from marine organisms.  
       Biotransformation reactions are just one mechanism by which marine organisms can 
defend themselves against allelochemicals.  A second approach involves multixenobiotic 
transporters (MXT) that may prevent putative toxins from accumulating in the cell in the 
first place (Epel 1998).  The ability of marine natural products to modulate transporter 
activity has been assessed only recently using invertebrate models.  Several extracts from 
seaweed and phytoplankton species were found to contain potent substrates/modulators 
of mussel and sea urchin multixenobiotic transporter activity (Eufemia et al. 2002).  
Subsequent crude fractionation of the extracts traced the compounds responsible for the 
inhibition of transporter activity in mussel cells to the moderately hydrophobic fractions.  
Interestingly, most known substrates for xenobiotic transporters are moderately 
hydrophobic, amphipathic, low molecular weight, planar molecules (Bard 2000).  
Exposure to these compounds would most likely occur via ingestion as the mussels 
actively filter particulate matter from the water column.  To combat compound 
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 accumulation, MXT are highly expressed in the gills of bivalves (Minier et al. 1993, 
Smital & Kurelec 1997), one of the primary routes of tissue exposure to dietary 
compounds.  The tissue distribution (e.g. liver, kidney, digestive tract) of these proteins in 
other marine organisms also suggests a parallel role in protection from diet-derived toxins 
(Bard 2000).  Marine consumers may use similar multixenobiotic transporters to prevent 
dietary accumulation of noxious gorgonian compounds in concert with other 
detoxification enzymes. 
       Much of the diversity of biotransformation enzymes in insects may be the result of 
co-evolution of prey chemical defenses and predator detoxification mechanisms 
(Gonzalez & Nebert 1990, Li et al. 2003).  I hypothesize that some marine invertebrates 
may have undergone a similar diversification of detoxification enzymes to combat the 
continuous barrage of defensive compounds produced by their prey (David et al. 2003).  
Marine generalists, like Cyphoma gibbosum, may have evolved an array of functional 
enzymes based on different selective forces associated with the biochemical defense 
profiles of their hosts.  Alternatively, selection for resistance to diverse metabolites 
among marine generalists may have resulted in the development of an enzyme/transporter 
with broad substrate specificities (Li et al. 2003, Smital et al. 2004).  Consequently, 
understanding the role of allelochemical detoxification and transport in marine organisms 
will allow us to determine how predators respond biochemically to dietary metabolites, 
and will contribute to a more general understanding of dietary preferences and patterns of 
predation on the reef.   
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 Mechanisms of detoxification and transport 
       The detoxification and excretion of xenobiotics, which can broadly be described by 
three phases, involve highly complex processes that are able to respond to an organism’s 
chemical environment.  Biotransformation is the process by which nonpolar compounds 
are converted to more water-soluble chemicals that are more easily excreted from the 
body (Figure 1).   
 
Figure 1. Overview of allelochemical metabolism and transport (reproduced from 
Sotka & Whalen 2008) 
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In general, the biotransformation of xenobiotic compounds is accomplished by a limited 
number of enzymes with broad substrate specificities.  The reactions catalyzed by these 
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 enzymes can be divided into phase I and phase II (Williams 1959).  Phase III processes 
involve the energy-dependent transport of multiple structurally and functionally unrelated 
xenobiotics across a variety of cellular membranes (Litman et al. 2001).  Select phase III 
transport proteins prevent the retention of toxicants in cells and tissues and are 
complementary to both phase I and II reactions in minimizing xenobiotic toxicity.  All 
three phases have previously been studied in marine invertebrates; however, these studies 
have focused primarily on their role in the metabolism and transport of anthropogenic 
compounds (e.g. polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls 
(PCBs), pesticides; reviewed in (Galgani et al. 1996, Eufemia & Epel 2000, Snyder 
2000).  The participation of detoxification enzymes in the metabolism of dietary 
allelochemicals in terrestrial systems has been extensively documented (Scott et al. 1998, 
Li et al. 2007) and I hypothesize that these enzymes may have similar functions in marine 
organisms. 
 
Phase I – Cytochrome P450 
The most familiar phase I reactions involve the addition of a polar functional 
group (e.g. hydroxyl) onto a compound to increase its hydrophilicity and facilitate 
excretion.  These reactions are accomplished primarily by a suite of inducible enzymes 
collectively termed cytochrome P450 monooxygenases (CYPs) (Parkinson 2001) found 
in terrestrial and aquatic organisms ranging from bacteria to vertebrates (Omura 1999).  
CYPs comprise a large superfamily of heme-thiolate proteins that metabolize a wide 
range of endogenous and exogenous hydrophobic compounds.  Embedded in the 
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 endoplasmic reticulum (ER), the cytochrome P450 enzyme can insert one oxygen atom 
from molecular oxygen, O2, onto the substrate as it is held at the active site by lipid 
interaction.  The combination of a relatively non-specific and loose lipid interaction to 
bind a substrate and an activated oxygen radical to oxidize it makes the reaction 
mechanism of cytochrome P450 extremely powerful (Brattsten 1992a).  In addition to 
hydroxylation reactions, CYPs catalyze several other  types of oxidation reactions 
including: epoxidation of double bonds, heteroatom (S-, N-, and I-) oxygenation and N-
hydroxylation; heteroatom (O-, S-, and N-) dealkylation; ester cleavage; and 
dehydrogenation (Parkinson 2001). 
Each functional gene appears to encode a unique enzyme (Nelson et al. 1993) 
roughly 500 amino acid residues in length (Omura 1999).  Different cytochrome P450 
genes are assigned to different families according to their degree of sequence identity 
(families share > 40% identity; subfamilies share > 55% identity) (Nelson et al. 1993).  A 
comparison of all eukaryotic CYPs found minimal conservation of residues with the 
exception of amino acids involved in structural conservation in the core of the protein 
around the heme (Werck-Reichhart & Feyereisen 2000).  The heme binding loop, 
considered to be the “P450 fingerprint region”, contains the most characteristic P450 
consensus sequence, including the absolutely conserved cysteine that serves as the fifth 
coordinating ligand to the heme iron.  Other conserved sequences include the Glu-X-X-
Arg motif in helix K, which participates in core structure stabilization, and the oxygen 
binding pocket in the I helix involved in oxygen activation and transfer of protons to the 
active site (Werck-Reichhart & Feyereisen 2000).  Microsomal P450 binding and 
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 insertion into the membrane is mediated by a hydrophobic amino-terminal sequence 
(“signal anchor sequence”), leaving the bulk of the enzyme exposed to the cytoplasmic 
side of the ER.  Adjacent and down stream to the anchor sequence is a proline-rich/basic 
region that may serve to join the membrane-binding N-terminus to the globular region of 
the P450 (Graham-Lorence & Peterson 1996).  Variable regions throughout the gene are 
associated with substrate binding and recognition and are often referred to as substrate-
recognition sites or SRSs (Werck-Reichhart & Feyereisen 2000).  The flexibility of SRS 
regions allows for structurally variable substrate binding and catalysis. 
  As of February 2008, there are a total of 7232 known CYP sequences, excluding 
variants and pseudogenes, representing 781 families (designated by number) 
(http://drnelson.utmem.edu/CytochromeP450.html).  In animals alone, 110 P450 families 
have been described encompassing 2565 named sequences.  The broad substrate 
specificity and inducible nature of many CYPs are consistent with their proposed central 
role in feeding habits, since generalist consumers can be expected to encounter a broad 
array of allelochemicals in their diet.  The enormous metabolic diversity of the P450-
dependent monooxygenase system provides a comprehensive protective mechanism 
against a wide variety of xenobiotics (e.g. chemical defenses, hydrocarbons, etc) for 
organisms challenged with these compounds on a daily basis (Simpson 1997, Mansuy 
1998). 
For many invertebrates, the true number of P450 genes is unknown.  However, 
sequencing of insect genomes shows extensive proliferation and divergence in both 
Drosophila melanogaster and Anopheles gambiae resulting in 90 and 100 annotated P450 
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 genes (http://p450.antibes.inra.fr/) representing 5 families: CYP4, CYP6, CYP9, CYP18 
and CYP 28.  The extreme diversification of P450 forms and the acquisition of new gene 
functions are believed to have occurred via gene duplication events (Berenbaum 2002).  
To fully understand the evolutionary diversification of P450s, research has focused on 
identifying individual isoforms that metabolize specific dietary compounds (Berenbaum 
1983, 1991, Cohen et al. 1992, Petersen et al. 2001), which may have acted as selective 
agents to promote P450 diversification.  For example, furanocoumarin-containing host 
plants are all but ignored except by a few lepidopterans in the genus Papilio.  The 
molecular basis of furanocoumarin resistance in P. polyxenes has been attributed to the 
constitutive expression of CYP6B1v1 and CYP6B1v2, which encode furanocoumarin-
metabolizing P450s (Cohen et al. 1992, Ma et al. 1994) and contain a highly conserved 
furanocoumarin-responsive xenobiotic response element required for basal transcription 
and inducibility (Petersen et al. 2003).  Additionally, specific expression of 
furanocoumarin-metabolizing CYPs is only detected in larval feeding stages and not in 
adults, eggs, or pupae, suggesting a function consistent with the dietary metabolism of 
toxic furanocoumarins (Harrison et al. 2001). 
  The polyphagous lepidopteran Helicoverpa zea also feeds on furanocoumarin-
containing plants, but consumes more than 100 different host plant families with vastly 
different chemistry (Kogan et al. 1978).  It has been suggested that this insect generalist 
can cope with a variety of plant chemical defenses because of the greater diversity, 
structural flexibility and functional versatility of its CYP6B genes in comparison to the 
specialist P. polyxenes (Li et al. 2004).  The cost of increased flexibility, resulting in a 
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 less efficient metabolism of furanocoumarins, is balanced by the acceptance of a wider 
variety of allelochemicals at the catalytic site.  C. gibbosum’s CYPs may have similar 
biochemical traits which may allow this consumer to be an equally successful marine 
generalist. 
Many terpenoids isolated from plants, including monoterpenes from Eucalyptus 
spp., have been shown to limit feeding by herbivores (Boyle et al. 1999).  Marsupials that 
fed exclusively on eucalypt leaves containing the monoterpenes p-cymene and 1,8-
cineole use CYP2 and/or CYP3 enzymes to detoxify these natural products (Pass & 
McLean 2002).  Inhibition of 1,8-cineole metabolism by p-cymene metabolites and other 
plant secondary metabolites may impose a significant constraint on foliage consumption 
in these generalist marsupials.  Inhibitory interactions among dietary compounds may 
explain obligatory browsing by generalist herbivores.  Likewise, C. gibbosum feeds on 
many gorgonians that contain high concentrations of terpenoid compounds, and the 
production of these compounds is further increased in response to elevated predation by 
this mollusc (Thornton & Kerr 2002).  The mobility of C. gibbosum (Birkeland & 
Gregory 1975) and the variety of gorgonian corals included in its diet may be explained 
by the need for diet mixing in this species (Harvell & Suchanek 1987).  It is believed that 
consumers are better able to tolerate particular compounds by limiting their residence 
time on any one species (Snyder et al. 1998).  This mollusc may use similar strategies and 
CYPs to detoxify the range of gorgonian terpenes.  
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 Molluscan Cytochrome P450s 
Among eukaryotes the phylum Mollusca ranks second in species diversity after 
Arthropoda, yet the diversity of molluscan CYP isoforms is poorly understood in 
comparison to that of insects.  This discrepancy results in part from the lack of a fully 
sequenced molluscan genome, although there are species in the pipeline.  Nevertheless, 
biochemical and molecular studies have provided some information about the diversity of 
molluscan CYPs. 
There is biochemical evidence suggesting that some of the P450s responsible for 
biotransformation in mammals are present in marine invertebrates in general and 
molluscs in particular (Snyder 2000).  Northern, Southern and Western blot techniques 
suggest that multiple CYPs (i.e., 1A, 2B, 2E, and 3A-like enzymes) may be expressed in 
the digestive glands of some molluscs after treatment with prototypical inducers of 
vertebrate CYPs (Wootton et al. 1995, Wootton et al. 1996, Peters et al. 1998b, a) (Table 
1).  However, some of this biochemical evidence is equivocal, and the presence of these 
CYPs has yet to be confirmed with a gene or cDNA sequence. 
  A few molluscan CYP cDNAs have been cloned and sequenced (Table 1).  Both 
arthropods and molluscs share the CYP4 gene family and in both phyla this family 
accounts for the majority of known P450s (Rewitz et al. 2006, Strode et al. 2008).  To 
date, multiple CYP4 isoforms have been identified in both freshwater and marine 
molluscs including Mytilus galloprovincialis (Mediterranean mussel), Haliotis rufescens 
(red abalone), Unio tumidus (freshwater mussel), Mytella strigata (mussel) and Perna 
viridis (Asian green mussel) (Snyder 1998, Chaty et al. 2004).  A CYP4 sequence 
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 identified from U. tumidus shares high amino acid sequence identity with CYP4C 
sequences in lobster and Anopheles (59-61%) and CYP4V sequences in mouse and trout 
(54% identity) (Chaty et al. 2004).  The ubiquity of CYP4 genes in mammals, bony fishes 
and invertebrates (Nelson 1998) suggests this gene family arose at least 1.25 billion years 
ago (Simpson 1997).  While substantial information is lacking as to the physiological role 
and substrate specificity of these CYP4 enzymes in marine invertebrate systems, studies  
 
Table 1. Biochemical and molecular evidence for molluscan CYPs 
 
Proposed CYP Classificationa Species Evidence Literature or GenBank Reference
CYP1A Crassostrea gigas Sequence Boutet et al. 2004
Mytilus edulis Western blot Peters et al. 1998a, Shaw et al. 2000
Mytilus galloprovincialis Western blot
Livingstone et al. 1997, Canova et al. 1998, 
Peters et al. 1998a,b
Mytilus edulis Northern blot Wootton et al. 1995, Wootton et al. 1996
CYP2 Crassostrea rhizophorae Sequence Rebelo & Moreira 2003
Mytilus edulis Western blot Jonsson et al. 2004
CYP2B Mytilus galloprovincialis Western blot Peters et al. 1998a
CYP2E Mytilus edulis Western blot Shaw et al. 2000
Mytilus galloprovincialis Western blot Peters et al. 1998b
CYP3A Cryptochiton stelleri Western blot DeBusk et al. 2000
Mytilus edulis Southern Wootton et al. 1995
Mytilus galloprovincialis Western blot Peters et al. 1998a
CYP4 Mytella strigata Sequence GenBank # DQ310714
Mytilus edulis Western blot Jonsson et al. 2004
Perna viridis Sequence GenBank # EU429566
Unio tumidus Sequence Chaty et al. 2004
CYP4A Mytilus edulis Northern blot Wootton et al. 1995
Mytilus edulis Semi-quantitative RT-PCR Luedeking & Kohler 2002
Mytilus galloprovincialis Western blot Peters et al. 1998a, b
CYP4V13 (previously CYP4C17) Haliotis rufescens Sequence Snyder 1998
CYP4Y1 Mytilus galloprovincialis Sequence Snyder 1998
CYP10 Lymnaea stagnalis Sequence Teunissen et al. 1992
CYP11A Mytilus edulis Southern blot Wootton et al. 1995
CYP30 Mercenaria mercenaria Sequence Brown et al. 1998
CYP320A1 Biomphalaria glabrata Sequence GenBank # AY922309
CYP322A1 Perna canaliculus Sequence
K. Herron (submitted to P450 nomenclature 
committee in 2001)
CYP356A1 Crassostrea gigas Sequence Toledo-Silva et al. 2008
a The CYP family designation as defined in the above table is based on the cited author(s) assignment.  
  For some P450 families, caution must be taken when identifiying the presence of specific CYP families in molluscs when substantial sequence information is lacking.
  For example, significant genomic evidence suggests the CYP1 family is deuterostome specific (Rewitz et al. 2006; Goldstone et al. 2007).  
in vertebrate systems indicate these enzymes regulate the biosynthesis and metabolism of 
fatty acids involved in cell signaling processes (Okita & Okita 2001 , Kikuta et al. 2002).   
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 CYP4 genes encode several P450 enzymes capable of hydroxylating saturated and 
unsaturated fatty acids (e.g. palmitate, arachidonic acid and various prostaglandins) 
(Yamamoto et al. 1984, Matsubara et al. 1987, Sharma et al. 1989) in vertebrates.  
Prostaglandins are unsaturated carboxylic acids consisting of a twenty carbon skeleton, 
including a five membered ring, and are synthesized from the precursor arachidonic acid.   
Surprisingly, the highest concentrations of prostaglandins in nature have been isolated 
from the Caribbean gorgonians (Weinheimer & Spraggins 1969), where they function as 
feeding deterrents (Gerhart 1986, Pawlik & Fenical 1989, Gerhart 1991).  Prostaglandin 
esters comprise up to 3% of the dry weight of the gorgonian Plexaura homomalla 
(Weinheimer & Spraggins 1969), with the hydroxy-methyl ester and hydroxy acid of 
15(R)-prostaglandin A2 contributing to the bulk of the chemical defense (Pawlik & 
Fenical 1989).  Cyphoma gibbosum can tolerate prostaglandins produced by Plexaura 
homomalla (Gerhart 1986) and actually prefers to reside on this species of gorgonian 
(Chiappone et al. 2003).  It seems plausible – even likely – that Cyphoma may use 
members of the CYP4 family to detoxify the prostaglandins it encounters in its diet.   
While the role of the CYP4 family in fatty acid metabolism in vertebrates has 
been studied extensively (reviewed in Simpson 1997), additional work in terrestrial 
invertebrates has suggested that CYP4 isoforms may contribute to toxin metabolism.  
Drosophilid CYP4 isoforms have been shown to be involved in the metabolism of 
defensive alkaloid plant compounds (Danielson et al. 1997), illustrating that CYP4 gene 
functions are more diverse than mammalian functions would suggest.  In contrast to most 
housekeeping genes, P450s involved in xenobiotic metabolism are often transcriptionally 
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 inducible by substrates upon which they act (Whitlock 1986).  Detoxification enzymes 
involved in allelochemical resistance should, therefore, exhibit a marked increase in 
expression following toxin exposure.  Using a PCR-based cloning strategy, Danielson et 
al. (1997) was able to identify 15 novel CYPs from an isoquinoline alkaloid-resistant 
drosophilid.  Six of these sequences displayed increased mRNA levels following 
exposure to isoquinoline alkaloids, while CYP4D10 was the only P450 that was strongly 
and specifically induced following exposure to primary host plant alkaloids but not to 
similar alkaloids of a rarely utilized host plant.  The substrate specificity and induction 
response of CYP4D10 makes this detoxification enzyme the primary candidate for the 
observed alkaloid resistance in Drosophila mettleri.  Other P450s that were induced to a 
lesser degree may still aid in allelochemical resistance through a cooperative action 
among multiple P450s (possibly within the same family), by allowing this generalist 
drosophilid to exploit a broader range of plants with chemically similar compounds.  
Although C. gibbosum is carnivorous, the association with its prey is analogous to plant-
insect interactions.  A generalist like C. gibbosum may possess an assortment of CYPs, 
whose expression may depend on the presence of inducers (e.g. gorgonian species-
specific suite of allelochemicals) specific to each of those CYPs.  
  Exclusive to the molluscan genome are the CYP30 and CYP10 families 
(Teunissen et al. 1992, Brown et al. 1998).  CYP30, originally isolated in Mercenaria 
mercenaria, is most closely related to the CYP3 family, followed by the insect CYP6, 
CYP9 and CYP25 families (Brown et al. 1998, Nelson 1998).  While the substrate 
specificity of the CYP30 protein is unknown, members of the closely-related CYP3 
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 family are involved in steroid metabolism.  Steroids have consistently been isolated from 
many gorgonian species (Block 1974, Cimino et al. 1979, Cimino et al. 1984, Coll 1992, 
Rodriguez 1995, Rho et al. 2000, Tanaka et al. 2002) and may have influenced the 
evolution of CYPs responsible for their metabolism in molluscs.  CYP10 is most closely 
related to mitochondrial CYP families involved in steroid synthesis (CYP24, CYP11, 
CYP27) (Teunissen et al. 1992).  The physiological functions of CYP10 are unknown; 
however, it is expressed exclusively in the female gonadotropic hormone producing 
dorsal bodies of Lynmaea stagnalis (Teunissen et al. 1992). 
The importance of cytochrome P450 enzymes in the metabolism of dietary plant 
compounds and other xenobiotics has been studied for over thirty years (Gonzalez 1989).  
While the primary function of P450 enzymes is to convert hydrophobic, lipid-soluble 
organic xenobiotics to water-soluble excretable metabolites, the phase II 
biotransformation enzymes such as the glutathione S-transferases also facilitate the 
elimination of dietary compounds from the body.  Studies investigating specific activities 
of phase I enzymes have noted that in fish and crustaceans total P450 content is an order 
of magnitude greater than in molluscs.  However, this trend is reversed when examining 
glutathione S-transferases (reviewed in Livingstone 1998).  Glutathione S-transferases, in 
addition to P450s, have increasingly been identified in molluscs (Lee 1988, Lee et al. 
1988, Fitzpatrick et al. 1995, Fitzpatrick et al. 1997, Stien et al. 1998, Kaaya et al. 1999, 
Vidal & Narbonne 2000, Hoarau et al. 2001, Khessiba et al. 2001, Hoarau et al. 2002, 
Petushok et al. 2002, Yang et al. 2002, Blanchette & Singh 2003, Le Pennec & Le 
Pennec 2003, Yang et al. 2004, Doyen et al. 2005, Hoarau et al. 2006, Blanchette et al. 
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 2007, Myrnes & Nilsen 2007, Vasconcelos et al. 2007, Doyen et al. 2008) and may prove 
to be an equally vital adaptive response mechanism against allelochemicals in the marine 
environment. 
 
Phase II – Glutathione S-transferase 
Phase II biotransformation reactions involve the conjugation of a hydrophobic 
compound or modified metabolite from phase I with a cofactor that increases the 
molecular weight and polarity of the compound and facilitates excretion (Parkinson 
2001).  Glutathione S-transferases (GSTs) aid in this process by catalyzing the 
nucleophilic attack of reduced glutathione (GSH: γ-Glu-Cys-Gly) on nonpolar 
compounds that contain an electrophilic carbon, nitrogen, or sulphur atom, including 
those metabolites formed by P450 oxidation (Hayes et al. 2005).  GSTs form a multi-
gene family that encode cytosolic enzymes that are found in most aerobic eukaryotes and 
some prokaryotes and exhibit differing, but often overlapping, substrate specificities for 
both endogenous and exogenous compounds.  Possible GST substrates include 
chemotherapeutic agents, insecticides, carcinogens, oxidative stress by-products and 
natural products (Sheehan et al. 2001, Hayes et al. 2005).  Large scale genome 
sequencing projects have estimated the total number of GST genes for Caenorhabditis 
elegans (57), Drosophila melanogaster (43), and Homo sapiens (40) (Ding et al. 2003).  
To date, seven soluble cytosolic GST classes, encoding proteins of approximately 200 
amino acids in length, have been identified in metazoans (e.g. Alpha, Mu, Pi, Theta, 
Sigma, Zeta and Omega) (Sheehan et al. 2001).  Beta-class GSTs have only been 
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 described in bacteria (Vuilleumier 1997), while the delta and epsilon classes remain 
insect-specific (Zhou & Syvanen 1997, Sheehan et al. 2001, Sawicki et al. 2003).  GSTs 
within the same class share greater than 40-60% amino acid identity while those between 
classes typically share less than 25% identity, with the majority of the similarity at the N-
terminus (Sheehan et al. 2001).  In the past, various mammalian GSTs have been 
classified based on substrate specificity and inhibitor sensitivity; however, these 
techniques tend to result in overlapping values between GST classes and have proven less 
effective for classifying non-mammalian GSTs (Francis et al. 2001, Sheehan et al. 2001).  
Thus, to avoid confusion, amino acid sequences should be used for comparison between 
GST classes. 
Each functional GST is composed of two subunits, either identical (homodimeric) 
or non-identical (heterodimeric) (Doyen et al. 2005).  GST subunits in mammalian 
systems range from 199-244 amino acids in length (Hayes et al. 2005) and are also 
known to have two distinct binding sites: an N-terminal G site which binds glutathione, 
and a C-terminal H site which binds the substrate.  The highly conserved N-terminal 
region contains a catalytically essential tyrosine, serine or cysteine residue that interacts 
with the thiol group of GSH.  In contrast, the H site has a highly variable structure which 
can accommodate a wide range of substrates (Ortelli et al. 2003).  The detection of 
alternative spliced products and the formation of heterodimers allows for the 
development of novel GST enzymes, which presumably increases the pool of potential 
substrates (Sheehan et al. 2001).   
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   GSTs involvement in the detoxification of dietary secondary metabolites in 
invertebrates has been known for some time (Yu 1982, 1989, Brattsten 1992b).  Many 
plant allelochemicals and marine natural products contain the appropriate functional 
groups that can be directly conjugated with GSH (Schlenk & Buhler 1988, Brattsten 
1992b).  Overexpression of GSTs has been suggested as a protective mechanism that 
invertebrates use to cope with, and adapt to, dietary allelochemicals.  Various species of 
insects have shown 2 to 40-fold induction of GSTs upon changes in host plant diet or 
when exposed to plant compounds in artificial diets (Yu 1982, Brattsten et al. 1984, Yu 
1984, Snyder et al. 1995).  Allelochemicals such as xanthotoxin, indole derivatives, 
flavones, and allyl glucosinolates that induce cytochrome P450s in insects often also 
induce GST activity (Yu 1983, 1984, 1986, 1992).  However, GSTs and P450s are not 
always coordinately induced.  For example, plant monoterpene menthols and pinenes are 
known P450 inducers in the fall armyworm, yet they do not induce GST activity (Yu 
1982).  In contrast, in the southern armyworm coumarin is a weak P450 inducer, but 
strongly induces GST activity (Brattsten et al. 1984).  Thus, studies intent on 
characterizing the responses of a single type of detoxification enzyme may miss critical 
information.  Additionally, studies investigating GST isoforms in five different species of 
lepidoptera established that the degree of polyphagy was positively correlated with the 
number of GST isoforms found.  Specialist species had only one isoform, while 
generalist species showed multiple forms, presumably to detoxify a broader range of 
metabolites (Yu 1989).  In light of the variety of compounds to which Cyphoma can be 
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 exposed, it will be interesting to characterize both the overall GST diversity and the 
differences in expression patterns among animals feeding on different gorgonian species. 
 
Molluscan Glutathione S-transferases  
  GSTs have been identified with some frequency in many molluscan species 
(Fitzpatrick & Sheehan 1993, Fitzpatrick et al. 1995, Blanchette & Singh 1999, Vidal & 
Narbonne 2000, Yang et al. 2004, Doyen et al. 2005, Blanchette et al. 2007, Doyen et al. 
2008).  Immunoblot analysis has suggested the presence of alpha, mu and pi GST-like 
classes from the clam Ruditapes decussatus (Hoarau et al. 2002).  It is now accepted that 
mu, alpha, and pi mammalian GST classes have a common precursor, the alpha/pi/mu 
class, which probably arose from theta gene duplication (Pemble & Taylor 1992).  
Recently, four complete cDNA sequences encoding GSTs from the pi, mu, omega, and 
sigma classes have been cloned from the Pacific oyster, Crassostrea gigas (Boutet et al. 
2004).  The expression of select oyster GST classes was found to be tissue-specific, as 
well as time- and treatment- (hydrocarbon or pesticide) dependent.  Currently, many of 
the known molluscan GST enzymes are found within the pi class with representatives 
from squid, octopus, and five species of bivalves (Tomarev et al. 1991, Tomarev et al. 
1993, Doyen et al. 2005); GenBank Accession # AF527010, AF227977 and EF520700).   
  The endogenous function of pi GSTs in molluscs has yet to be defined; however, 
studies in mammalian systems indicate that pi GSTs (GSTP1) are effective in the 
detoxification of electrophilic α, β-unsaturated carbonyl compounds produced by radical 
reactions, lipid peroxidation and metabolism of drugs (Berhane et al. 1994).  
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 Additionally, prostaglandins have been found to substantially induce mammalian GST pi 
(GSTP1) gene transcription, mediated by a prostaglandin response element localized in 
the enhancer region of GSTP1 (Kawamoto et al. 2000).  The cyclopentenone-type 
prostaglandins (e.g. PGA2, PGJ2) and metabolites of PGD2, including 15-deoxy-Δ12,14-
prostaglandin J2 are potent inducers of GSTP1.  Both the prostaglandin A and J series 
contain α,β-unsaturated ketones, which are very susceptible to nucleophilic addition 
reactions with thiols like GSH.  Similar studies have confirmed the role of pi GSTs in 
prostaglandin conjugation (Bogaards et al. 1997).  It is possible that upon ingestion of 
PGA2 from its gorgonian diet, Cyphoma gibbosum may experience a related induction of 
putative prostaglandin conjugating GSTs.   
While considerable attention has been focused on the role of GST in the 
detoxification of anthropogenic xenobiotics (Cheung et al. 2001, Hoarau et al. 2001, 
Blanchette & Singh 2002, Gowlan et al. 2002), there is increasing interest in molluscan 
detoxification of plant chemical defenses (DeBusk et al. 2000, Kuhajek & Schlenk 2003).  
The red alga Odonthalia floccossa contains a suite of brominated phenolics capable of 
deterring feeding in several molluscan herbivores (Kurata & Taniguchii 1997), yet it is a 
staple in the diet of the marine chiton, Cryptochiton stelleri.  Biotransformation enzymes, 
including GSTs, were hypothesized to aid this herbivorous mollusc in utilizing O. 
floccossa as a food source despite the high concentration of brominated aromatic 
compounds (DeBusk et al. 2000).  The elevated presence of GST in C. stelleri may 
protect the chiton against dietary metabolites while also conferring a selective advantage 
over other herbivores that avoid chemically defended algae.  
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 Phase III – ABC transporters 
       Originally discovered for their role in chemotherapeutic drug resistance in tumor 
cells, the ATP Binding Cassette (ABC) transporters affect the adsorption, distribution and 
excretion of numerous xenobiotics.  ABC transporters are a large superfamily of proteins 
found in bacteria to humans and are involved in the trafficking of molecules across cell 
membranes (Litman et al. 2001).  This ATP-dependent process involves the 
unidirectional translocation of sugars, lipids, amino acids, peptides, metals, inorganic 
ions, natural products, glutathione conjugates and toxins (Croop 1998).  In eukaryotes the 
typical structure of an ABC protein consists of two membrane-embedded transmembrane 
domains (TMD) and two highly conserved ATP binding domains (NBD: nucleotide 
binding domain) consisting of the Walker A and Walker B motifs and a signature C 
domain (Allikmets & Dean 1998).  Sequence similarity surrounding the ATP binding site 
can range as high as 30% identical residues between prokaryotic and eukaryotes (Croop 
1998).  The TMDs contain 6 -11 membrane spanning α-helices and determine substrate 
specificity, while the NBDs transfer the energy released during ATP hydrolysis to the 
transport of the substrate across the membrane (Dean 2002).  ABC transporters can be 
divided into seven subfamilies based on gene structure, domain order and sequence 
homology.  Below I will describe two of these subfamilies (ABCB, ABCC) and present 
evidence for their involvement in xenobiotic resistance. 
  The first ABC transporter, permeability-glycoprotein or Pgp (a.k.a., ABCB, 
MDR), was identified in Chinese hamster ovary cells and has subsequently been linked to 
the multi-drug resistance phenotype (Juliano & Ling 1976).  Since this time, P-gp-like 
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 proteins have been described in a variety of invertebrates including sponges, mussels, 
oysters, clams, worms, and insects (Bard 2000).  The full length P-gp gene is 
approximately 1280 amino acids.  Each protein has two TMD consisting of six 
transmembrane regions and two cytoplasmic ATP binding sites (Croop 1998).  P-
glycoproteins are expressed in tissues instrumental in xenobiotic disposition (liver and 
kidney), in tissues acting as xenobiotic barriers (colon, pancreas, blood-brain barrier) and 
in hormone producing tissues in vertebrates (Endicott & Ling 1989).  Localization of P-
gp to the apical (luminal) surface of epithelial cells in various tissues support the 
involvement of this protein in the transport and secretion of xenobiotics (Thiebaut et al. 
1987).  P-glycoprotein mRNA and protein expression has been shown to increase in 
animals and cell cultures dosed with substrate (e.g. verapamil) (Collett et al. 2004), 
suggesting that this pump can act as an inducible defense and therefore aid in the 
protection of cells, tissues, and organisms against toxic chemicals. 
  Substrates for P-gp are diverse but are generally moderately hydrophobic, low 
molecular weight molecules with a basic nitrogen atom, cationic or neutral but never 
anionic.  This list includes natural products, colchicines, vinca alkaloids (e.g. vinblastine, 
vincristine), anthracyclines (e.g. doxorubicin), verapamil, steroids (cortisol, aldosterone) 
and many many more (see Litman et al. 2001).  Interestingly, many P-gp substrates are 
also substrates for cytochrome P450 and both proteins have been found to be coexpressed 
in tissues involved in xenobiotic absorption, such as the small intestine and liver 
(Watkins 1997).  Several marine natural products from algae (okadaic acid, calyculin A, 
caulerpin), tunicates (patellamide D, lamelarins), sea hares (dolastatins), and gorgonians 
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 (polyoxygenated steroids) have also been identified as putative substrates for P-gp 
(Suganuma et al. 1988, Chambers et al. 1993, Williams & Jacobs 1993, Aherne et al. 
1996, Quesada et al. 1996, Schroder et al. 1998, Tanaka et al. 2002).  The original role of 
multixenobiotic transport proteins remains unclear; however, the expression of P-gp in 
non-cancerous tissues and its distribution in vertebrate systems suggests a protective role 
against dietary secondary metabolites and environmental xenobiotics (Epel 1998). 
For several years, P-gp was considered the only ABC transport protein associated 
with xenobiotic resistance.  This all changed when a second drug-resistance-related ABC 
transporter, the multidrug resistance-associated protein (MRP; family ABCC), was 
discovered and found to share 15% amino acid identity to P-gp.  In addition to the 12 
transmembrane segments characterizing P-gp, the majority of MRP proteins have an 
additional N-terminal transmembrane domain composed of five helices and an 
intracellular loop making MRP roughly 1500 amino acids in length.  Therefore, MRP can 
be thought of as having an N-terminal hydrophobic domain linked to a P-gp-like core.  
The tissue distribution of MRP is similar to that of P-gp, with protein expression found in 
the liver, kidney, gut, pancreas, bladder and tumor cell lines (Borst et al. 2000).  
However, unlike P-gp, the majority of MRP proteins are basolateral transporters whose 
operation results in the movement of compounds away from luminal surfaces into tissues 
or blood vessels  that lie beneath the basement membrane (Evers et al. 1996).  
Despite the overlap of drug resistance profiles between both transporters, the 
substrate selectivities of the pumps differ markedly, in that P-gp substrates are neutral or 
mildly positive lipophilic compounds, while MRP is able to transport neutral and anionic 
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 lipophilic compounds and products of phase II cellular detoxification processes including 
glutathione conjugated compounds (Litman et al. 2001).  The actual mechanism of 
transport, as with all ABC transporters, is not fully understood.  Studies able to block 
intracellular GSH synthesis with BSO (buthionine sulfoximine) were able to sensitize 
cells to natural product anticancer compounds; however, the formation of glutathione 
conjugates was never detected, suggesting that conjugation may not be required to 
transport compounds.  This led some to hypothesize a model for MRP which includes 
cotransport of GSH without actual GSH conjugation.  Support for this model is 
convincing; however, it is not known to what extent MRP substrates are conjugated or 
cotransported (Rappa et al. 1997, Loe et al. 1998, Hipfner et al. 1999). 
 
ABC transporter-mediated sequestration 
For the most part, multixenobiotic transporters (MXT), P-gp and MRP, have been 
described with respect to their role in transporting compounds from the inside of the cell 
to the outside.  However, some reports suggest that both transporters may concentrate 
large amounts of compounds within the cytoplasmic compartment in endocytic vesicles, 
effectively sequestering rather than excreting toxic compounds.  The ability to sequester 
xenobiotics may be an alternative protective mechanism that organisms use to partition 
compounds away from the rest of the cell.  One study investigating P-gp-mediated 
okadaic acid (OA) resistance in the common mussel, Mytilus edulis, found mussel blood 
cells to be highly resistant to the cytotoxic effects of OA (Svensson et al. 2003).  The 
authors immediately suspected P-gp’s involvement because of earlier reports that had 
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 provided convincing evidence that OA was a P-gp substrate in a MDR cell line (Tohda et 
al. 1994, Ritz et al. 1997).  However, upon measuring the accumulation in mussel blood 
cells of a well described P-gp substrate (vincristine) in the presence of a P-gp inhibitor 
(verapamil), the authors found a puzzling result.  Instead of increasing the concentration 
of vincristine (i.e. preventing P-gp-mediated cell efflux of vincristine) as seen in gill 
tissue, the inhibitor actually reduced the accumulation of vincristine in mussel blood 
cells.  Microscopy studies with the fluorescent P-gp substrate Rhodamine B confirmed 
the accumulation of the fluorescent dye within lysosomes and the subsequent decrease in 
lysosome fluorescence when incubated with verapamil.  When blood cells were exposed 
to OA, vincristine accumulation was not significantly affected.  Nevertheless, when the 
volume of the lysosomal compartment was measured in cells pre-exposed to OA, a 
significant increase was detected compared with control cells, suggesting OA 
sequestration within lysosomes.  P-gp lysosomal sequestration of toxic pollutants has also 
been confirmed in F/B cells of the digestive gland in the crab Carcinus maenas (Kohler 
et al. 1998).   
Sequestration of xenobiotics by ABC transporters may function as a protective 
mechanism against cytotoxicity; but more than this, accumulation of toxic compounds 
may provide protection against predation.  Sequestration of dietary allelochemicals in 
marine invertebrates has been extensively documented (Faulkner 1992, Pennings & Paul 
1993, Proksch 1994).  Specialist molluscan predators, such as nudibranchs, actively take 
up defensive compounds from their diet (sponges or gorgonians) and use these chemicals 
for their own protection (Cronin et al. 1995, Avila & Paul 1997).  It is not unreasonable 
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 to hypothesize that P-gp and/or MRP may be involved in the accumulation of dietary 
allelochemicals in these marine predators. 
 
Molluscan ABC transporters 
For many years, molluscs (bivalves in particular) have been used in studies as 
indicator species to assess the health of the aquatic environment (O'Connor 2002). 
Research soon focused on the role of ABC transporters and their function in mediating 
xenobiotic resistance in marine invertebrates.  Immunohistochemical studies, isolation of 
homologous genes, and in vivo/membrane vesicle activity assays all confirmed the 
presence of ABC transporters in molluscs (Table 2).  MXT expression and activity has 
been detected in the gills, hepatopancreas, intestine and other tissues of aquatic 
invertebrates exposed to environmental chemicals (Smital et al. 2004).  In addition, 
significant induction and subsequent return to basal levels of P-gp transport activity in 
bivalves exposed to pollutants in the field has been shown to occur within a 4-day period 
(Smital et al. 2003).  This suggests that the induction of these energy-requiring defense 
mechanisms is tightly controlled.   
Natural products of a marine origin have also been shown to modulate 
multixenobiotic transport activity in molluscs.  A study in Mytilus californianus found 
several extracts from seaweed and phytoplankton species, mainly those of a moderately 
hydrophobic nature, enhanced the accumulation of a known fluorescent P-gp substrate, 
suggesting algal secondary metabolites may act as P-gp substrates (Eufemia et al. 2002).  
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 Additionally, extracts from an invasive green alga species, Caulerpa taxifolia, caused the 
accumulation of fluorescent MXT substrates in the gills of exposed bivalves and  
Table 2.  Biochemical and molecular evidence for molluscan ABC transporters 
ABC subfamily designation Species Evidence Reference
ABCB subfamily or Anodonta cygnea Western blot, Fluorescent dye assay Smital et al. 2000
P-glycoprotein (Pgp) Brachidontes pharaonis Sequence GenBank # AJ972911, Feldstein et al. 2006
Corbicula fluminea
Western blot, 3H-vincristine accumulation 
assay Waldmann et al. 1995, Achard et al. 2004
Crassostrea gigas Sequence, Western blot, Southern blot
GenBank # AJ422120; EU073425, Minier et al. 
1993
Crassostrea virginica
Fluorescent dye assay, Western blot, 
Sequence
GenBank # AY319412, Keppler & Ringwood 
2001
Dreissena polymorpha Sequence, Fluorescent dye assay
GenBank # AJ506742, Smital et al. 2000, Smital 
et al. 2003
Monodonta turbinata Western blot, Fluorescent dye assay Smital et al. 2000
Mytilus californianus
Western blot, Fluorescent dye assay, 
Sequence
Cronwall et al. 1995, Eufemia & Epel 2000, 
Luckenbach & Epel 2008
Mytilus edulis
Western blot, Sequence, Fluorescent dye 
assay
GenBank # AF159717, Minier et al. 1993, Minier 
& Moore 1996, Luedeking & Kohler 2002, 
Svensson et al. 2003
Mytilus galloprovincialis
Western blot, Fluorescent dye assay, 3H-
vincristine accumulation assay, Sequence
Kurelec 1995, Galgani et al. 1996, Smital et al. 
2000, Smital et al. 2003, Franzellitti & Fabbri 
2006
Patella lusitanica Fluorescent dye assay Smital et al. 2000
Perna perna
Fluorescent dye assay, Western blot, 
Sequence GenBank # AF150878, Franco et al. 2006
Saccostrea forskali
Western blot, Fluorescent dye assay, 
Sequence Kingtong et al. 2007
Viviparus viviparus Fluorescent dye assay Smital et al. 2000
Unio pictorum Sequence GenBank # AY857552
ABCC subfamily or Crassostrea gigas Sequence GenBank # AJ438990
Multidrug resistance-
associated protein (MRP) Mytilus californianus Fluorescent dye assay, Sequence Luckenbach & Epel 2008
Mytilus edulis Sequence, Northern blot GenBank # AF397142-3, Luedeking et al. 2005
Mytilus galloprovincialis Sequence Franzellitti & Fabbri 2006
Saccostrea forskali
Western blot, Fluorescent dye assay, 
Sequence Kingtong et al. 2007  
subsequent inhibition of multixenobiotic resistance (Smital et al. 2004).  Evidence also 
suggests that glutathione-conjugated natural products may be transported by molluscan 
MRPs.  Human MRP1 is known to transport the glutathione conjugate of prostaglandin 
A2 (GS-PGA2) (Evers et al. 1997, Ishikawa et al. 1998).  In gorgonians, PGA2 and 
derivatives are potent feeding deterrents and have been isolated in high concentrations 
(Gerhart 1984).  Upon their ingestion these compounds may inhibit the inherent 
multixenobiotic transporter defenses of potential consumers and make them more 
susceptible to these and other gorgonian chemical defenses.  Interestingly, molluscan 
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 predators like C. gibbosum, which feed exclusively on gorgonians, do not seem affected 
by gorgonian chemistry and may have evolved sophisticated MXT to avoid cytotoxicity 
and exploit an abundant food source untouched by other reef predators.   
 
Rationale 
Understanding how organisms deal with potentially toxic or fitness-reducing 
allelochemicals has significance for understanding patterns of predation and herbivory in 
the marine environment.  Cytochrome P450 and glutathione S-transferase enzymatic 
activity has been extensively documented in many marine invertebrates (Snyder 2000, Le 
Pennec & Le Pennec 2003, Rewitz et al. 2006); however, as yet, no genes specifically 
involved in the detoxification of dietary allelochemicals have been sequenced.  Similarly, 
little is known about dietary allelochemicals that act as substrates for P-glycoprotein or 
multidrug resistance protein in marine invertebrates.  The focus of this research was to 
characterize the diversity and dietary regulation of cytochrome P450s, glutathione S-
transferases, and multixenobiotic transporters in two marine molluscs and to identify 
dietary natural products that act as substrates for these proteins.  
Chapter 2 describes a proteomic approach used to identify the diversity and 
phylogenetic relatedness of GSTs in Cyphoma.  Chapter 3 investigates the diversity of 
putative CYP allelochemical metabolizing genes, their transcriptional responsiveness to 
host-gorgonian allelochemicals and their enzymatic activity toward allelochemical 
analogs.  Chapter 4 explores the biochemical interactions among gorgonian extracts/pure 
compounds with Cyphoma GSTs, further relating physiological enzyme activity with 
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 ecologically relevant concentrations of gorgonian natural products.  Finally, Chapter 5 
examines the distribution and activity of two diverse subfamilies of multixenobiotic 
resistance proteins in both generalist and specialist molluscs to assess the potential 
importance of these efflux proteins in mediating allelochemical transport.  
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 Abstract 
Glutathione S-transferases (GST) are key detoxification enzymes involved in the 
biotransformation and excretion of reactive electrophilic compounds including natural 
products.  GSTs were characterized from the digestive gland of the tropical gastropod, 
Cyphoma gibbosum, to investigate the possible role of these enzymes in conferring 
resistance to allelochemicals present in this consumer’s gorgonian coral diet.  I identified 
the collection of expressed cytosolic GST classes in C. gibbosum using a proteomic 
approach involving affinity chromatography, high performance liquid chromatography, 
electrophoresis, nanospray liquid chromatography-tandem mass spectrometry (LC-
MS/MS) and MS/MS sequencing.  Two major GST subunits, constitutively expressed in 
digestive gland tissues, were identified as putative mu-class GSTs most closely related to 
GSTs from abalone and oyster.  One minor GST subunit was identified as a putative 
theta-class GST, apparently the first theta-class GST identified from a molluscan source.  
Two mu-class GST cDNAs, CgGSTM1 and CgGSTM2, were isolated by RT-PCR using 
primers derived from peptide sequences.  The full-length cDNA sequences encode 
proteins of 215 amino acids in length that share 78% amino acid identity.  Phylogenetic 
analysis establishes these as mu-class GSTs and reveals a mollusc-specific subclass of the 
GST-mu clade.  Homology of C. gibbosum digestive gland GSTs to mammalian and 
bacterial isoforms suggests a possible role in the biotransformation of gorgonian natural 
products such as organohalogens and prostaglandins.  These results provide new insights 
into metazoan GST diversity and the biochemical mechanisms used by marine animals to 
cope with their chemically defended prey. 
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 Introduction 
Glutathione S-transferases (GSTs, EC 2.5.1.18) form a large superfamily of 
multifunctional enzymes capable of conjugating a broad range of toxic electrophilic 
xenobiotics with glutathione (Sheehan et al. 2001).  GSTs function primarily as 
detoxification enzymes, generally rendering the resultant products more water soluble 
(nonreactive conjugate), thereby facilitating excretion.  The catalytic versatility and 
diversity of GSTs can be attributed to the nonspecific nature of the hydrophobic substrate 
binding site (H-site) and the extensive gene duplication and divergence that have 
occurred in this superfamily (Ivarsson et al. 2003, Pearson 2005).  The soluble GSTs in 
metazoans are divided into seven classes (alpha, mu, pi, theta, sigma, zeta, and omega) 
based on sequence identity, immunological and kinetic properties (Sheehan et al. 2001, 
Nebert & Vasiliou 2004, Hayes et al. 2005).  While the majority of GST enzymatic 
characterization has focused on mammalian forms, non-vertebrate models offer an 
exciting opportunity to examine the evolution of GSTs and their adaptive responses to 
environmental chemicals, including natural products. 
 Biochemical adaptations involving xenobiotic response genes, such as GSTs, may 
help explain consumer resistance to dietary chemical threats, providing insight into 
enzymatic mechanisms underlying consumer foraging patterns.  For example, the ability 
of terrestrial invertebrates (insects) to tolerate naturally occurring dietary toxins (i.e. 
allelochemicals in their host plants) has been linked in part to high constitutive activity of 
GSTs (reviewed in Li et al. 2007).  The induction of GSTs in response to dietary host 
allelochemicals may serve as an additional adaptive mechanism to protect against 
toxicity.  While the role of GSTs in plant-herbivore interactions has clearly influenced the 
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 ecology of terrestrial consumers, far less is known about the detoxification enzymes that 
allow marine invertebrates to exploit allelochemically defended prey.   
 Only a few studies have addressed the induction of GSTs upon exposure to 
allelochemicals in marine invertebrates (Vrolijk & Targett 1992, DeBusk et al. 2000, 
Kuhajek & Schlenk 2003).  One such study (Vrolijk & Targett 1992) examined GST 
activity in the digestive gland of a generalist gastropod, Cyphoma gibbosum, which 
exclusively feeds on several families of chemically defended gorgonian corals.  The 
authors reported significantly higher GST activity in field-collected C. gibbosum feeding 
on gorgonians Gorgonia ventalina and Briareum asbestinum, suggesting that GST 
expression varies in response to different suites of gorgonian allelochemicals.  
Additionally, GST activity from C. gibbosum cytosolic preparations was among the 
highest ever reported from a molluscan digestive gland and was similar to values 
described from Papilio polyxenes, a specialist insect that feeds solely on chemically 
defended plants (Lee 1991, Lee & Berenbaum 1992).  In a subsequent study (Cronin et 
al. 1995), thin-layer chromatographic profiles of nonpolar tissue extracts from C. 
gibbosum feeding on G. ventalina did not mirror those of its octocoral prey, lending 
further support to the idea that this gastropod predator has the capacity to biotransform 
dietary compounds to readily excretable metabolites.  However, the GST isoforms 
responsible for the detoxification of gorgonian allelochemicals are not known; and in 
general GST diversity in molluscs - including gastropods - is poorly understood.  
GST cDNA sequences representing alpha, mu, pi, omega, and sigma GST classes 
have been identified in molluscs.  The majority of sequences are grouped within the pi 
class, with representatives from cephalopods (squid, octopus), and seven bivalve species 
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 (Tomarev et al. 1991, Tomarev et al. 1993, Boutet et al. 2004, Yang et al. 2004, Doyen et 
al. 2005, Hoarau et al. 2006, Munasinghe et al. 2006, Myrnes & Nilsen 2007, GenBank® 
Accession No. EF194203, EF520700, DQ530213, DQ530212).  The endogenous 
function of pi-class GSTs in molluscs has yet to be defined; however, studies in 
mammalian systems indicate that pi GSTs are more participatory than other GST classes 
in the detoxification of prostaglandins and other electrophilic α, β-unsaturated carbonyl 
compounds (Berhane et al. 1994, Bogaards et al. 1997).  Prostaglandins are potent 
signaling molecules involved in the production of pain and fever (Malan & Porreca 
2005), the regulation of blood pressure/coagulation (Egan & FitzGerald 2006) and 
reproduction (Goldberg & Ramwell 1975).  The highest concentrations of prostaglandins 
in nature have been found in Caribbean gorgonians (Weinheimer & Spraggins 1969), 
where the acetoxy acids, hydroxyl methyl esters and hydroxyl acids of prostaglandin A2 
function as feeding deterrents against generalist reef fish (Gerhart 1984, Pawlik & 
Fenical 1989).  Prostaglandins in the A series especially can significantly induce GST 
activity in mammalian cells (Uchida 2000).  I hypothesize that C. gibbosum GSTs may 
conjugate gorgonian allelochemicals, like prostaglandins, potentially alleviating their 
toxicity.     
The objective of the present study was to isolate and characterize the GSTs in C. 
gibbosum digestive gland that may protect this marine consumer from allelochemicals 
found in its prey.  Initially, I targeted pi-class GSTs because of their role in prostaglandin 
metabolism.  However, attempts to obtain pi-class GSTs from C. gibbosum using RT-
PCR with degenerate primers designed from an alignment of molluscan GST pi cDNA 
sequences (Doyen et al. 2005) failed to yield any GST sequences.  Therefore, I initiated a 
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 proteomic approach involving affinity chromatography coupled with HPLC and mass 
spectrometry to provide an unbiased assessment of GST protein diversity in the digestive 
gland of C. gibbosum.  Here I report the identification of several mu-class GST proteins 
in C. gibbosum digestive gland, the cloning and phylogenetic characterization of two 
complete mu-class GST cDNAs and partial peptide sequences of a theta-class GST, 
apparently the first member of this class identified from a mollusc.  These results 
contribute to a better understanding of GST diversity in molluscs and of the biochemical 
resistance mechanisms used by marine consumers to cope with chemical defenses in their 
prey, providing insight into patterns of predation and herbivory in the marine 
environment. 
 
Materials and Methods 
 Reagents 
CDNB, dithiothreitol (DTT), potassium phosphate, potassium chloride, EDTA, 
protease inhibitor cocktail (4-(2-aminoethyl)benzenesulfonyl fluoride, aprotinin, bestatin 
hydrochloride, E-64, leupeptin, pepstatin A), SDS, boric acid, NaCl, sodium acetate, 
GSH, GSH-agarose were purchased from Sigma (St. Louis, MO).  Bradford reagents and 
molecular weight standards for protein gels were purchased from BioRad (Hercules, CA).  
Novex® Tris-glycine gels and Sample Treatment Buffer were purchased from Invitrogen 
(Carlsbad, CA).  Silver SNAP® Stain for Mass Spectrometry was purchased from Pierce 
(Rockford, IL). 
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 Animals  
Adult Cyphoma gibbosum (ca 2-3 cm length) were collected from five shallow 
reefs (< 20m) near the Perry Institute of Marine Science (PIMS), Lee Stocking Island, 
Exuma Cays, Bahamas in January 2006 and transported to wet laboratory facilities 
provided by PIMS.  The feeding assays are described in detail in Chapter 3.  Individuals 
were allowed to feed on a control diet (e.g. alginic acid and freeze-dried squid paste 
(O'Neal & Pawlik 2002) or one of six gorgonian diets (Briareum asbestinum, Eunicea 
mammosa, Gorgonia ventalina, Pseudopterogorgia acerosa, Pseudopterogorgia 
americana, Plexaura homomalla) for four days.  The length (4 days) of the feeding assay 
was chosen based upon two previous studies that measured C. gibbosum mean residence 
time on gorgonian colonies (Harvell & Suchanek 1987, Ruesink & Harvell 1990) and the 
induction/decay kinetics of GST expression (Pickett et al. 1982).  Upon completion of the 
feeding assay the digestive glands were immediately dissected and either preserved in 
RNALater® (Ambion, Austin, TX) or frozen in liquid nitrogen and transported back to 
the Woods Hole Oceanographic Institution.  Tissues were maintained at -80°C until 
further analysis. 
 
Enzyme purification 
Individual digestive glands (n = 42) were homogenized 1:4 (w/v) in ice-cold 
homogenization buffer (0.1 M potassium phosphate, 1 mM EDTA, 1 mM DTT, 1.15% 
potassium chloride, protease inhibitor cocktail (1X); pH 7.5) with an IKA Ultra Turrax 
T8 homogenizer (Wilmington, NC) for 30 sec on ice.  All subsequent steps were carried 
out at 4°C.  Cytosol was isolated by centrifugation of the crude homogenate at 750 x g 
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 for 10 min then, without stopping, at 12,000 x g for 10 min using a Beckman J2-21 
centrifuge (Fullerton, CA).  The supernatant was carefully removed, avoiding both the 
fatty layer and the pellet and transferred to an ultracentrifuge tube and centrifuged at 
100,000 x g for 70 min using a Beckman L8-60M ultracentrifuge (Fullerton, CA).  An 
aliquot of the supernatant was taken for cytosolic protein determination using the BCA 
protein assay method (Smith et al. 1985) with BSA as the standard and the remaining 
cytosol was flash frozen in liquid nitrogen until further analysis.  Samples were stored for 
several months in this manner suffered no apparent loss of enzymatic activity. 
GSTs were purified using size exclusion chromatography, affinity 
chromatography and HPLC following a modified method from (Donham et al. 2005) .  
Cytosolic samples from individual snail digestive glands were purified separately.  
Initially, a subset of cytosol samples (n = 8) were used to determine the optimal buffer 
conditions and volumes for GST purification.  Eluted 1-mL fractions from both size-
exclusion and affinity columns were sampled for activity towards CDNB and assayed for 
protein using the Bradford assay (Bradford 1976).  These results helped streamline the 
GST purification process for the remaining cytosol samples.   
A PD-10 desalting column (bed volume 8.3 mL, bed height 5 cm, 5K NMWL) 
(GE Healthcare, Piscataway, NJ) containing Sephadex G-25 matrix was equilibrated in 
Buffer A (50 mM Tris buffer, 1 mM EDTA, 1 mM DTT; pH 6.0) and 2.5 mL of crude 
cytosol were applied to the column.  Cytosolic samples less than 2.5 mL were brought up 
to this volume with Buffer A and then applied to the column.  GST proteins were eluted 
by gravity with Buffer A and fractions containing GST activity were combined (approx. 6 
mL of elute) and then applied to a GSH-agarose affinity column (bed volume 0.5 mL, 0.8 
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 x 4 cm i.d.) equilibrated in Buffer A.  The affinity column was washed with 7 mL of 
Buffer B (Buffer A + 0.5 M NaCl) to rinse away non-specific proteins.  Retained GSTs 
were then eluted with 5 mL of Buffer C (50 mM Tris-base, 1 mM EDTA, 1 mM DTT, 
0.5 M NaCl, 50 mM glutathione; pH 9.5) and fractions containing GST activity were then 
combined, buffer exchanged to low salt concentration, and concentrated with Amicon 
Ultra-4 centrifugational filters (5K NMWL membrane; Millipore, Billerica, MA).  
Protein concentrations of Amicon concentrates were determined with the NanoOrange 
protein quantitation kit (Molecular Probes, Eugene, OR).    
 Affinity-purified GSTs from individuals feeding on the same diet were pooled 
(100 μL injection volume) and injected onto a reverse phase Vydac protein/peptide 
column (model #218 TP 52; C18 μm 250 mm x 2.1 mm) and separated on a Waters 600 
MultiSolvent Delivery System, with a flow rate of 0.5 mL/min.  Peaks were detected 
using a Waters 2487 Dual Wavelength Absorbance Detector (λ = 214 nm).  Mobile phase 
A consisted of 38% acetonitrile, 62% water and 0.1% trifluoroacetic acid (TFA).  Mobile 
phase B consisted of 80% acetonitrile, 20% water and 0.1% TFA.  The initial mobile 
phase consisted of 100% A.  GST subunits were separated using a linear gradient from 0 
to 40% B in 22 min, and 40 to 100% B in 37 min.  Peaks were hand-collected, 
centrifugally evaporated to dryness, resuspended in 1X sample treatment buffer and 
separated by 12% Novex® Tris-glycine SDS-PAGE gel electrophoresis according to 
manufacturer’s instructions (Invitrogen, Carlsbad, CA).  Bands were visualized using the 
SilverSNAP® staining kit for mass spectrometry, excised from the gel and delivered to 
the UC-Davis Proteomics Facility, Davis, CA for in-gel digestion and LC-MS/MS 
analysis. 
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 Protein in-gel digestion 
Protein bands were reduced and alkylated according to (Shevchenko et al. 1996).  
Proteins were reduced with 10 mM DTT in 100 mM NH4HCO3 (pH 8, 55°C) for 1 h, 
then alkylated with 55 mM iodoacetamide in 100mM NH4HCO3 for 45 min in the dark at 
room temperature.  Excess reagent was removed, and gel pieces were washed with 100 
mM NH4HCO3 and partially dehydrated with acetonitrile; complete dehydration was then 
performed in vacuo.  Finally, proteins were digested in 50% NH4HCO3 containing 
sequence grade trypsin (Promega, Madison, WI) at a final concentration range of 10-25 
ng μL-1 (37°C) for 17 h.  Peptides were extracted once with 0.1% TFA in water and once 
with 5% formic acid:acetonitrile (1:1).  The extraction volume was carefully controlled to 
never exceed 50 μL for mass spectrometric analysis. 
 
Nanospray LC-MS/MS and database analysis 
The trypsin-digested samples were analyzed using a Eksigent Nano LC 2-D 
system (Eksigent, Dublin, CA) coupled to an LTQ ion trap mass spectrometer (Thermo-
Fisher, San Jose, CA) interfaced with a New Objective Picoview Nano-spray ionization 
source (Woburn, MA) to identify peptide fragments.  Digested peptides were loaded on a 
reverse-phase Agilent Nano-trap (Zorbax 300SB-C18, 300Å, Agilent Technologies, 
Santa Clara, CA) at a loading flow rate of 5 μL/min for 10 min.  The buffers used for the 
reverse-phase chromatography were 0.1% formic acid in water (solvent A) and 95% 
acetonitrile in 0.1% formic acid in water (solvent B).  Peptides were eluted from the trap 
and chromatographically separated on a reverse-phase capillary column (Pico Frit, 75 μm 
x 15 cm, tip 5 μm: New Objective) packed in-house with Magic C18 AQ (3 μm, 
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 100Å:Michrom BioResources, Auburn, CA) with a 40-min linear gradient of 2-80% 
solvent B (as described below) at a flow rate of 300nL min-1.  The LTQ parameters were 
as follows: electrospray potential, 1.8 kV; source temperature, 180º; collision energy, 
35%; dynamic exclusion duration, 1min. The MS survey scan followed by ten MS/MS 
scans were consecutively acquired over the LC gradient.  Upon completion of an LC-
MS/MS run, the MS/MS spectra from each survey were charge state deconvoluted and 
searched against the non-redundant NCBI protein database using BioWorks version 3.3 
(Thermo Scientific, Waltham, MA) and MASCOT (Matrix Science, London, UK) and 
against the MSDB database (Imperial College, London, UK) using GPM software 
(http://www.thegpm.org).  Protein fragments with significant hits to eukaryotic GSTs 
were then manually validated. 
 
GST activity assay 
Enzyme activity was measured using CDNB as a substrate by the method of 
(Habig et al. 1974) optimized for C. gibbosum (Vrolijk & Targett 1992) in a microplate 
format.  The reaction mixture (in a final volume of 200 μL) contained 0.1 M potassium 
phosphate buffer, 1.0 mM EDTA, pH 7.5, 1 mM CDNB, 1 mM reduced glutathione 
(GSH) and 2μg of protein.  CDNB was solubilized in ethanol and constituted 1% of the 
final reaction mixture volume.  The reaction incubated at 25°C was initiated by the 
addition of CDNB and performed in triplicate.  The conjugation of CDNB with GSH was 
measured as the increase in absorbance at 340 nm (Δε340 0.00503 μM-1 cm-1) using a 
tunable microplate reader (Versamax, Molecular Devices, Sunnyvale, CA).  Activity was 
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 calculated using protein concentrations determined via the Bradford assay with BSA as a 
standard.   
 
RNA isolation and cDNA synthesis 
Total RNA was purified from C. gibbosum digestive glands using the RNeasy 
Maxi Kit and DNAse treated using a RNase-free DNAse Kit (Qiagen, Valencia, CA) 
following the manufacturer’s instructions.  The integrity of each RNA sample was 
checked by electrophoresis on 1% agarose-formaldehyde gel in MOPS buffer and 
visualized with ethidium bromide under UV light.  Total RNA concentration was 
determined using a Nanodrop spectrophotometer (Wilmington, DE).  Poly(A)+ RNA was 
isolated using the MicroPoly(A)Purist mRNA purification kit (Ambion, Austin, TX) 
according to the manufacturer’s instructions.  Poly(A)+ RNA was pooled from seven 
individuals feeding on either a control diet or one of six gorgonian species (0.14 μg 
poly(A) RNA/individual) to ensure representation of all GSTs expressed under various 
dietary conditions.  One microgram of pooled RNA was primed with modified oligo (dT) 
primers and used to create an adaptor-ligated ds cDNA library synthesized using the 
Marathon cDNA Amplification Kit (BD Biosciences, Palo Alto, CA) according to the 
manufacturer’s instructions.   
 
Primer design, RACE-PCR, cloning, sequencing 
Degenerate primers were designed to C. gibbosum GST peptide sequences 
identified from LC-MS/MS with homology to mu-class GSTs from abalone (Haliotis 
discus discus) and oyster (Crassostrea gigas) (GSTm_R10) (Table 1), and theta-class 
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 GSTs from sea bream (Pagrus major, Sparus aurata), plaice (Pleuronectes platessa) and 
bass (Micropterus salmoides) (primers not shown).  Primers were obtained from Sigma 
Genosys (St. Louis, MO).  PCR products were generated by rapid amplification of cDNA 
ends (RACE) using GST degenerate primers in combination with specific 
oligonucleotides designed to adaptor sequences located on the 3’ and 5’ ends of the 
cDNA.  Amplification of PCR products was carried out according to the Advantage 2 
PCR Enzyme Kit (Clontech, Mountain View, CA) and cycling parameters were as 
follows: 94°C for 30 sec; 30 cycles of 94°C for 5 sec, annealing at 55°C for 30 sec, 
extension at 68°C for 2 min.  Primers were used at the following concentrations: 10 μM 
of adaptor primer and 100 μM of degenerate primer in a 50 μL reaction.  Sequences 
obtained by RACE were then used to design specific primers (GSTm_F13 and 
GSTm_F15) to clone full-length C. gibbosum GST cDNAs.  PCR products were cloned 
into pGEM-T (Promega, Madison, WI) and sequenced in both directions using an ABI 
3730XL capillary sequencer at the Keck facility of the Josephine Bay Paul Center for 
Comparative Molecular Biology & Evolution at the Marine Biological Laboratory 
(Woods Hole, MA).  A minimum of twelve clones were sequenced for each PCR 
fragment. 
 
Sequence analysis 
Clones were grouped based on similar nucleotide sequence using Sequencher 
(Gene Codes Co., Ann Arbor, MI) and used to generate a consensus sequence that was 
compared to known GST coding sequences using BLASTX.  Multiple alignments of 
deduced amino acid sequences were performed using ClustalW (Thompson et al. 1994). 
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 Ambiguous alignment positions were excluded from further analyses. Phylogenetic 
relationships were investigated using Bayesian techniques as implemented in the 
computer program MrBayes (v 3.1.2; Ronquist & Huelsenbeck 2003). MrBayes estimates 
posterior probabilities using Metropolis-Hastings coupled Monte Carlo Markov chains 
(MC3).  MC3 estimates were performed with uninformative prior probabilities using the 
WAG model of amino acid substitution (Whelan & Goldman 2001) and prior uniform 
gamma distributions approximated with four categories (WAG+I+Γ). Four incrementally 
heated, randomly seeded Markov chains were run for 3x106 generations, and topologies 
were sampled every 100th generation. The MC3 burnin values were conservatively set at 
1x106 generations. Posterior probabilities of topologies and clades were estimated from 
the sampled topologies after removal of the initial MC3 burnin.  
 
Results 
GST purification and activity  
Cytosol was isolated from the digestive glands of individual C. gibbosum feeding for 
four days on one of six gorgonian diets (n = 4-7 snails per gorgonian diet) or a control 
diet (n = 13 snails), resulting in a mean total protein yield of 125.6 ± 52.8 mg g-1 
digestive gland wet weight.  C. gibbosum digestive glands collected for this study 
averaged 0.22 ± 0.11 g snail-1 (n = 42; mean ± SD).  Glutathione transferase activity of 
crude cytosol ranged from 0.57 to 5.82 U mg-1 protein, with an average of 2.67 ± 1.27 U 
mg protein-1 (n = 42), using CDNB as a substrate.  Following size exclusion 
chromatography and affinity purification of the GSTs from C. gibbosum digestive gland, 
an average of 25 ± 14 μg of GST protein was collected from each digestive gland (n = 
86
 36), representing approximately 0.2% of the total cytosolic protein.  A 220-fold 
purification of GST protein was obtained using size-exclusion and affinity 
chromatography (Table 2).  Representative GST elution profiles from the Sephadex G-25 
column and the GSH-agarose columns are presented in Figure 1.   
 
Gel electrophoresis and GST identification  
To provide an initial characterization of affinity-purified proteins, bound protein 
fractions obtained from GSH-agarose affinity columns from two individuals (feeding 
either on P. americana or the control diet) were concentrated, combined, and 15 μL of 
the pooled sample was analyzed on a 12% Novex® Tris-glycine SDS-PAGE gel (Figure 
2).  Three distinct bands ranging in size from 21 to 24 kDa were detected by silver 
staining and excised from the gel for identification via LC-MS/MS.  All three bands 
contained peptide sequences that closely matched those of mu-class GSTs in the database 
(Table 3).  This pooled GST affinity-purified fraction was used as standard for 
subsequent SDS-PAGE gels.   
 
HPLC and LC-MS/MS based GST identification 
Affinity-purified fractions from individual digestive glands were concentrated and 
then equal volumes of affinity-purified GSTs were pooled within each snail diet for 
further HPLC separation of GST subunits.  HPLC analysis of affinity-purified GSTs 
pooled within snail diet identified a total of fourteen unique (2 major and 12 minor) 
peaks.  The relationship between snail diet and GST subunit expression will be described 
elsewhere (Chapter 4).  Here, I present the proteomic characterization of HPLC separated 
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 GST subunits.  Figure 3 shows a representative HPLC separation of digestive gland GST 
subunits from four C. gibbosum feeding on B. asbestinum.  For peak collection purposes, 
the fourteen peaks were grouped into seven fractions (B-H; A= injection peak) (Figure 3).   
The HPLC fractions were separated on 12% Tris-glycine SDS-PAGE gels (Figure 4) 
and bands were excised for proteomic analysis.  Peptide sequences were determined for 
fractions B-H using nanospray LC-MS/MS and identified by comparison to proteins in 
the Genbank® database.  Fractions D and F, with elution times of 18 and 22 minutes, 
respectively, represent the two major GST subunits.  Both of these fractions yielded 
peptides that closely matched mu-class GSTs (Table 3; Figure 5).  Peptides in the 
remaining fractions also matched GST mu-class proteins, with the exception of fraction 
B, which yielded eight peptides that matched theta-class GSTs from fish (Table 3; Figure 
6).  Manual validation of LC-MS/MS spectra verified five of the C. gibbosum peptide 
sequences as identical to the fish GST-theta peptides (Table 3).   
 
C. gibbosum cDNA cloning and sequence analysis 
To obtain full-length cDNA sequences for C. gibbosum GSTs, polypeptides 
identified by mass spectrometry were used to design degenerate primers.  The mu-class 
GST degenerate primer (GSTm_R10), designed to the peptide sequence AYMASDK, 
yielded two 600-bp fragments that were confirmed by BLAST searches to be partial 
cDNAs encoding mu-class GSTs.  Complete cDNA sequences were generated by 3’ 
RACE, revealing open reading frames encoding predicted proteins of 215 amino acids 
each. The predicted proteins displayed 61% and 62% amino acid identity to Pacific oyster 
GST mu for transcript 1 (CgGSTM1; GenBank® Accession No. EU008563) and 
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 transcript 2 (CgGSTM2; GenBank® Accession No. EU008562), respectively.  The two 
C. gibbosum GST mu cDNAs are 78% identical and 88% similar (BLOSUM62) to each 
other at the protein level.  Translated nucleotide sequences predict a molecular mass of 
25.0 kDa for CgGSTM1 and 25.2 kDa for CgGSTM2.  Figure 5 shows an alignment of 
these two sequences with several invertebrate and vertebrate mu-class GST sequences.  
Amino acid residues involved in glutathione binding as determined using the Pfam 
database (Marchler-Bauer et al. 2007) are entirely conserved among C. gibbosum, 
vertebrate and invertebrate sequences included in the alignment, while substrate binding 
sites are poorly conserved. 
Two C. gibbosum tryptic peptides identified in the LC-MS/MS analysis (ITQSN 
AILR and AYMASDK), were found to be identical to corresponding C. gibbosum GST 
translated nucleotide sequences (nucleotides 583-603 in CgGSTM1 and CgGSTM2; and 
205-231 in CgGSTM1, respectively) (Table 3).   
 To infer relationships between C. gibbosum predicted protein sequences and other 
GST sequences, a phylogenetic tree was constructed using Bayesian techniques.  
Cyphoma GSTM1 and GSTM2 clearly group within the mu-class GST clade and appear 
most closely related to other molluscan mu GSTs, which together form a strongly 
supported subgroup within this clade (Figure 7). 
 
Discussion 
Dietary toxins present physiological challenges to marine consumers, such as 
Cyphoma gibbosum, that feed solely on chemically defended gorgonian prey.  The high 
concentration of allelochemicals in gorgonian corals (Paul 1992, O'Neal & Pawlik 2002), 
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 coupled with the findings that digestive glands of C. gibbosum – which feed exclusively 
on gorgonians - contain high levels of GST activity (Vrolijk & Targett 1992), prompted 
an investigation to identify and biochemically characterize those GST enzymes possibly 
responsible for detoxifying gorgonian allelochemicals.   
The levels of cytosolic GST activities in C. gibbosum digestive gland (Table 2 
and Vrolijk & Targett 1992) are among the highest recorded for any molluscan tissue 
(reviewed in Vrolijk & Targett 1992, Le Pennec & Le Pennec 2003). The majority of 
studies reporting GST activity from molluscs have used GST activity measurements as an 
indicator of pollutant exposure (Sheehan et al. 1995, Fitzpatrick et al. 1997, Kaaya et al. 
1999, Hoarau et al. 2006, Verlecar et al. 2006).  Although the level of GST activity in C. 
gibbosum is high even in comparison to that of molluscs exposed to pollutants known to 
induce GST expression (Boryslawskyj et al. 1988, Lee 1988, Fitzpatrick et al. 1995), this 
high activity is unlikely to be a response to anthropogenic contamination, given the 
remote site of collection.  Rather, the high GST activity may reflect an adaptation that 
facilitates consumption of allelochemical-rich prey.  Whether high GST activity is 
common among marine species that feed exclusively on chemically defended food is 
unknown, and may depend upon the specific suite of allelochemicals present in the diet.  
Regardless of its origin, the high GST activity in C. gibbosum suggested that this species 
would be a rich source of GST enzyme(s), enabling proteomic studies to further 
characterize GSTs potentially involved in allelochemical metabolism.   
 The results of the proteomic and molecular analyses in the present study clearly 
show that the predominant cytosolic GSTs expressed in C. gibbosum digestive gland are 
mu-class GSTs.  These include the major HPLC peaks (fractions D and F) as well as 
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 several minor peaks.  According to the current system of GST classification, GSTs 
sharing greater than 60% identity fall within the same class, while those with less than 
30% identity are assigned to separate classes (Sheehan et al. 2001).  The classification of 
C. gibbosum GSTs as members of the mu class is supported by both the homology 
searches of C. gibbosum tryptic peptides (Table 3) and the phylogenetic analysis of 
translated C. gibbosum GST cDNAs (Figure 7).  The presence of mu-class GSTs in 
molluscs had been predicted based on immunoblot analysis (Sheehan et al. 1995, Vidal et 
al. 2002, Hoarau et al. 2004), but only recently have molluscan GST mu nucleotide 
sequences been determined (Boutet et al. 2004, Myrnes & Nilsen 2007; Genbank® 
Accession No. ABF67506).  Our identification of two GST cDNAs in C. gibbosum 
provide the first published description of GST-mu forms from gastropods.  Phylogenetic 
analysis reveals a mollusc-specific subclass within the GST-mu clade. 
Proteomic results indicate the possibility of additional GST mu subunits beyond 
the two cDNAs identified here.  Only two of the twelve Cyphoma tryptic peptides 
identified as matching abalone and oyster mu-class GSTs were found to be encoded by 
the two cDNA clones isolated from C. gibbosum.  Not surprisingly these peptides 
corresponded to fairly conserved regions of the GST protein.  However, three peptides 
(KAAYFEALPAK; SFLGDQQFFAGSK; and 
IMQPGSLDAFPTLLAFMGRIEALPAIK) identified as matching abalone GSTM are 
quite divergent from the translated C. gibbosum sequences, indicating that at least one, 
and possibly as many as three, additional GST mu subunits are present in Cyphoma.  
HPLC analysis of affinity-purified extracts suggests that there may be additional mu-
class subunits, perhaps as many as thirteen (represented by the 13 peaks in fractions C-H, 
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 Figure 3), the majority of which are minor components.  In addition, visualization of 
hand-collected HPLC fractions by SDS-PAGE and silver staining (Figure 4) revealed the 
major peak in fraction F to be a composite of two separate GST subunits that were 
unresolvable by HPLC.  Peak F from affinity-purified extracts from each of the seven 
diets gave this similar double banding pattern (data not shown), indicating that both 
subunits are universally expressed regardless of snail diet.  Both bands were later 
confirmed to be mu-class GSTs by LC-MS/MS, thus increasing the count of potential 
mu-class subunits identified by HPLC analysis to fourteen.  Whether the HPLC peaks 
represent truly unique subunits or HPLC-resolved post-translationally modified variants 
of the same subunit remains unclear. Multiple GST mu subunits in a single species are 
not uncommon; five distinct mu-class subunits have been identified from humans 
(Sheehan et al. 2001).  Overall, our results provide conclusive evidence for at least three 
distinct GST-mu isoforms, and perhaps more, in C. gibbosum.  Interestingly, mu-class 
GST subunits are capable of forming heterodimers (Hayes & Pulford 1995).  Whether 
Cyphoma GST subunits form heterodimers is unknown, but the formation of 
heterodimeric GSTs has been suggested as a way of increasing the range of substrates 
that might be acted on by a limited set of GST isoforms (Sheehan et al. 2001). 
In this study, I identified a theta-class GST from C. gibbosum digestive gland and 
by manual validation confirmed the sequence of five peptides to be identical to theta and 
theta-class-related GSTs from fish.  The HPLC fraction B shows a single peak, 
suggesting that only one subunit is expressed.  Several attempts to amplify theta-like 
GSTs from C. gibbosum digestive gland mRNA with degenerate primers designed to 
these peptide sequences were not successful.  
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   The identification of putative a theta-class GST in C. gibbosum was unexpected.  
To the best of our knowledge, no theta-like GSTs have been identified previously in a 
molluscan species, although theta-class GSTs exist in vertebrates, arthropods, 
polychaetes, algae and bacteria (Pemble & Taylor 1992, Rhee et al. 2007).  Theta-class 
GSTs in general have been notoriously hard to identify because they normally do not 
bind to affinity matrices such as GSH-agarose (Sheehan et al. 2001).  In addition, most 
lack detectable activity toward CDNB, and thus can be missed if GST activity is the only 
means of GST isolation (Comstock et al. 1994, Lopez et al. 1994).  The unique activity of 
theta-class GSTs can be traced to the presence of the essential Ser-11, responsible for 
glutathione deprotonation and activation, in place of the tyrosine found in the alpha, mu, 
and pi class GSTs (Landi 2000).  Theta-class GSTs can be further distinguished from 
alpha/mu/pi class isoforms because of their high affinity for glutathione (high Km), but 
low affinity for glutathione-conjugates.  The diminished product retention in the active 
site of theta GSTs favors increased substrate turnover in comparison to alpha/mu/pi 
forms, which have a greater capacity to sequester conjugated products (Landi 2000).  
Generally, it is believed that the theta-class GSTs gave rise to the alpha/mu/pi classes via 
gene duplication events (Pemble & Taylor 1992); however, this has been called into 
question more recently (Blanchette et al. 2007).  In this study, I identified a theta-like 
GST from C. gibbosum digestive gland and by manual validation confirmed the sequence 
of five peptides to be identical to theta and theta-class related GSTs from fish.  The 
HPLC fraction B shows a single peak, suggesting that only one subunit is expressed.  
Attempts to amplify theta-like GSTs from C. gibbosum digestive gland mRNA with 
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 degenerate primers (not shown) designed to these peptide sequences have not yet 
succeeded.   
It is interesting to note that Cyphoma theta-like peptides matched only theta-class 
GSTs from fish rather than those from terrestrial invertebrates.  Using phylogenetic 
relationships inferred from Bayesian analyses, Lee et al. (2006) found that theta class 
GSTs formed two distinct, well-supported clades, one (“theta A”) containing only fish 
representatives, which includes the related rho-class GSTs, and the other (“theta B”) 
including theta-class GSTs from mammals, fish, birds, and invertebrates.  Recent 
evidence has confirmed the deeply rooted nature of the “theta A” clade by the 
identification of a rho-GST in a primitive cephalochordate (Fan et al. 2007) once thought 
to be a fish-specific class (Lee et al. 2006).  The Cyphoma GST theta-like peptides 
matched both rho- and theta-class fish sequences in the “theta A” clade, providing the 
first evidence for invertebrate members within group.   
Several natural compounds, including alpha-tocopherol, coumarin, and indole-3-
carbinol, have been identified as potent inducers of mammalian theta GSTs. However, it 
is the dehalogenase activity of theta-class GSTs that makes this class of enzymes so 
unique (Landi 2000).  For example, both bacterial and mammalian theta-class GSTs are 
capable of metabolizing dichloromethane (DCM) to formaldehyde (Gisi et al. 1999).  The 
oceans are the largest source of organohalogens (Gribble 2003), with representatives 
from cnidarians including briarane diterpenes (Kubota et al. 2006), bromo-, chloro- and 
indo-vulones, clavulones and punaglandins (related to mammalian prostaglandins) (Baker 
& Scheuer 1994, Rezanka & Dembitsky 2003, Rowley et al. 2005), and chlorinated 
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 sterols (Iwashima et al. 2001).  It is possible that C. gibbosum theta-like GSTs may have 
evolved to protect this consumer against halogenated compounds from its gorgonian host. 
Numerous studies have begun to identify allelochemical substrates for 
invertebrate GSTs (reviewed in Li et al. 2007).  Many plant allelochemicals and marine 
natural products contain the appropriate functional groups that can be directly conjugated 
with GSH (Schlenk & Buhler 1988, Brattsten 1992).  Cyphoma gibbosum regularly feeds 
on the gorgonian Plexaura homomalla, which contains high concentrations (up to 8% of 
the dry weight) of prostaglandins (15(R)-PGA2) (Weinheimer & Spraggins 1969, 
Dominguez et al. 1980).  Prostaglandins are known to suppress cell proliferation and 
overexpression of mu-class GSTs resulting in increased conjugation of prostaglandins 
may inhibit the antiproliferative effects of these compounds (Tsuchilda & Sato 1992).  
Naturally occurring prostaglandins (PGA2 and PGJ2) undergo enzymatic conjugation by 
purified human GSTM1a-1a (Bogaards et al. 1997).  Thus, high expression of GST mu 
isoforms may allow C. gibbosum to tolerate the chemical defenses of its host gorgonian 
and subsequently feed longer than would otherwise be possible.  Preliminary studies have 
demonstrated that prostaglandins found in gorgonians significantly inhibit Cyphoma GST 
activity in vitro (Chapter 4), consistent with the idea that gorgonian prostaglandins may 
be substrates for Cyphoma GSTs. 
In summary, a proteomic approach was successful at identifying peptides 
representing the collection of expressed GST subunits in C. gibbosum digestive gland.  
This technique is a valuable alternative to designing degenerate primers to all of the GST 
classes suspected of being expressed in the sample.  Using proteomics, I was able to 
identify several mu-class GSTs and one theta-class GST subunit(s), the latter class 
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 identified for the first time in a mollusc.  The manually validated GST peptides were used 
to design primers to amplify two full-length C. gibbosum mu-class GST cDNAs.  Future 
studies will focus on identifying gorgonian allelochemicals that are substrates for C. 
gibbosum GSTs using a bioassay-guided fractionation approach; expression of   
recombinant proteins will allow further characterization of individual GST isoforms.  The 
high GST activity and diversity of GST isoforms in C. gibbosum may protect this 
generalist predator against dietary chemicals while conferring a selective advantage over 
other consumers that avoid chemically defended prey. 
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Figure 1.  Purification of cytosolic GSTs from C. gibbosum digestive gland.  (A) The crude cytosol (2.5 
mL) from one individual was applied to a size exclusion PD-10 desalting column (bed volume 8.3 mL, 5 
cm height) containing Sephadex G-25 matrix (85 – 260 μm) equilibrated in 50 mM Tris buffer, 1mM 
EDTA, 1mM DTT at pH 6.0 (Buffer A).  Fractions were collected in 1.2 mL aliquots by gravity at a flow 
rate of 1 mL min-1.  Fractions 3 – 7 were pooled for further purification.  (B) The pooled fractions (approx. 
6 mL) from the size exclusion column were applied to the GSH-agarose (sulfur to epoxide-activiated 4% 
cross-lined beaded agarose) affinity column (bed volume 0.5 mL, 0.8 x 4 cm i.d.) equilibrated in Buffer A.  
The affinity column was first rinsed with 6 mL of Buffer A and then 7 mL of Buffer B (Buffer A + 0.5 M 
NaCl) to rinse away non-specific proteins.  GSTs were eluted with Buffer C (Buffer B + 50 mM GSH, pH 
9.5) in 1 mL aliquots at a flow rate of 0.5 mL min-1.  Fractions 18 -20 were collected and pooled for further 
separation by HPLC.  GST activity (bars) was measured as the increase in absorbance at 340 nm and 
protein concentration (●) was estimated by absorbance at 595 nm. 
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Figure 2. SDS-PAGE of affinity purified GSTs from C. gibbosum digestive gland 
SDS-PAGE of affinity-purified extract from C. gibbosum digestive gland obtained from 
size exclusion and affinity chromatography.  Lane M, Bio-Rad Kaleidoscope protein 
standards; lane Aff., affinity-purified extract.  Bands visualized by silver staining. 
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Figure 3. HPLC spectrum of GST subunits.  Representative HPLC spectrum of pooled 
affinity-purified extracts from C. gibbosum feeding on B. asbestinum.  GST subunits 
were separated on a reverse phase VYDAC protein/peptide column (C18 μm 250 mm x 
2.1 mm) with a flow rate of 0.5 mL min-1.  Mobile phase A consisted of 
acetonitrile/water/TFA (38:62:0.1, v/v) and mobile phase B consisted of 
acetonitrile/water/TFA (80:20:0.1, v/v).  GST subunits were separated using a linear 
gradient from 0 to 40% B in 22 min, and 40 to 100% B in 37 min and visualized at 214 
nm.  Fourteen unique peaks were identified (not all visible in representative HPLC 
spectrum) and grouped into fractions B-H.  Fraction A consisted of the injection peak 
(not shown); fraction B was identified as a theta-like GST; fractions C – H were 
identified as mu-class GSTs. 
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 Figure 7.  Phylogenetic tree depicting the relationship of Cyphoma gibbosum mu-
class GSTs with other invertebrate and vertebrate GSTs. 
Tree was constructed using MrBayes.  Fruitfly, Housefly and Honeybee sigma-GSTs 
were defined as an outgroup.  Values at branch points are posterior probabilities derived 
from 3e6 generations (see methods).  Note the clustering of Cyphoma GSTMs (bold) with 
other molluscan GSTMs.  The tree contains the following JGI and Genbank accession 
nos:  Apis mellifera (XP_624682), Boophilus microplus (AAD15991), Caenorhabditis 
elegans (NP_499006, NP_503889), Corbicula fluminea (AAX20374), Crassostrea gigas 
(CAD90167), Cyphoma gibbosum (EU008563 and EU008562), Danio rerio 
(XP_690427), Drosophila melanogaster (NP_725653), Fasciola hepatica (P56598), 
Haliotis discus discus (ABF67506, ABF67507), Haemaphysalis longicornis 
(AAQ74441), Homo sapiens (NP_665683, AAV38750,  NP_000840, NP_000841, 
NP_000843), Lottia gigantea (JGI scaffold_43000011), Monodelphis domestica 
(P46437), Mytilus edulis (AAS60226), Mus musculus (P13745, NP_038569, 
NP_034488), Strongylocentrotus purpuratus (XP_795664, XP_785553), Sarcoptes 
scabiei (AAO15607), Tetraodon nigroviridis (CAF91521), Unio tumidus (AAX20373), 
Xenopus tropicalis (NP_001004964). Tree construction performed by J. Goldstone. 
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Chapter III 
 
Gorgonian host-inducible cytochrome P450s from Cyphoma gibbosum: molecular 
cloning, diversity and function 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
115
 Abstract 
The production of chemical defenses by marine organisms limits predation and 
herbivory by most potential consumers.  However, there are some marine consumers that 
can tolerate allelochemicals produced by their prey/hosts seemingly without deleterious 
effects.  The induction of biochemical resistance mechanisms, such as cytochrome P450s 
(P450s), have been proposed to mediate allelochemical detoxification in these consumers, 
yet compelling evidence for these claims are generally lacking.  Here, I use the generalist 
marine gastropod Cyphoma gibbosum, which feeds exclusively on chemical defended 
gorgonians, as a model to investigate the diversity, transcriptional response and 
enzymatic activity of putative allelochemical detoxification P450s in marine consumers.  
Using an adaptor-ligated cDNA library combined with specific and degenerate primers 
targeted to cytochrome P450 (CYP) Family 4, twelve new CYP4 genes were identified 
from the digestive gland of C. gibbosum.  In controlled laboratory-based feeding studies 
with C. gibbosum, a 2.7- to 5.1-fold induction of CYP4-2 (CYP4BK) and CYP4-3 
(CYP4BL) transcripts was observed following dietary exposure to the gorgonian 
Plexaura homomalla.  This gorgonian species is known to contain high concentrations of 
ichthyodeterrent prostaglandins.  Phylogenetic analysis reveals C. gibbosum CYP4-2 and 
CYP4-3 closest vertebrate relatives include CYP4A and CYP4F genes, whose roles entail 
metabolic inactivation of pathophysiologically important fatty acid derivatives, including 
prostaglandins.  Examination of fatty acid hydroxylase activity in Cyphoma microsomes 
and allelochemically-responsive recombinant Cyphoma P450s indicates a possible role in 
eicosanoid (e.g., leukotriene B4) metabolism.  Sequence analysis further demonstrates 
that C. gibbosum CYP4s share identical amino acid residues with vertebrate 4A and 4F 
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 forms at key positions within the active site or sites responsible for maintaining the 
correct orientation of the fatty acid within the access channel, further alluding to their 
possible role in prostaglandin metabolism.  These results are the first to describe the 
differential regulation of specific P450 transcripts in a marine consumer in response to a 
diet rich in allelochemicals.  This work has important implications for understanding the 
molecular basis of the biochemical resistance strategy marine consumers use to cope with 
their chemically defended prey, and the ancestral history and evolutionary progression of 
allelochemical metabolizing genes within the P450 superfamily. 
 
Introduction 
 Gorgonian corals (Phylum: Cnidaria; Subclass: Octocorallia; Order Gorgonacea) 
are the most conspicuous group of invertebrates on Caribbean coral reefs (Goldberg 
1973, Lasker & Coffroth 1983); however, they are rarely consumed despite their 
abundance and the intense predation in these ecosystems (O'Neal & Pawlik 2002).  The 
dominance of gorgonians can be attributed, in part, to the variety of defensive secondary 
metabolites they produce, commonly referred to as allelochemicals (Pawlik et al. 1987, 
O'Neal & Pawlik 2002, Paul & Puglisi 2004).  An allelochemical is a “chemical produced 
by an organism that is toxic to, or inhibits the growth of, other organisms” (Despres et al. 
2007).  Octocorals, in particular, produce a diverse array of terpenoid derivatives that 
have been shown to have antipredatory properties (Rodriguez 1995, Katz & Adamczeski 
2000, Paul & Puglisi 2004).  Although these chemical defenses limit the predation by 
most potential consumers, the ovulid gastropod Cyphoma gibbosum thrives solely on a 
diet of allelochemically-rich octocorals and is considered the principle consumer of 
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 gorgonians on Caribbean coral reefs (Birkeland & Gregory 1975, Burkepile & Hay 
2007).  High levels of predation by this mollusc have also been shown to significantly 
increase production of the ichthyodeterrent terpenoids in in situ caging studies (Thornton 
& Kerr 2002).  The mechanisms by which C. gibbosum can tolerate these and other 
dietary allelochemicals at natural or elevated concentrations are unknown.  
A wealth of literature describes the diversity of gorgonian allelochemicals and 
their effects on consumers (Gerhart 1984, Pawlik et al. 1987, Harvell et al. 1988, Pawlik 
& Fenical 1989, Fenical & Pawlik 1991, Pawlik & Fenical 1992, Gerhart & Coll 1993, 
O'Neal & Pawlik 2002; reviewed in Harper et al. 2001); yet, relatively little is known 
about the mechanisms marine consumers have evolved to overcome the chemical 
defenses of their hosts/prey.  While avoidance of toxic prey (Gerhart 1991, Long & Hay 
2006), diet-mixing (Harvell & Suchanek 1987), sequestration (Proksch 1994, Cimino & 
Ghiselin 1999) and target-site mutation conferring insensitivity (Bricelj et al. 2005) have 
been described in marine systems, few studies have investigated allelochemical 
detoxification as a mechanism by which marine consumers may use to cope with noxious 
dietary compounds.   
In comparison to consumer-prey dynamics in marine ecosystems, insect-plant 
allelochemical interactions are better understood and provide a conceptual framework for 
investigating how marine consumers respond to toxins both on a behavioral and 
cellular/biochemical level.  In terrestrial ecosystems, metabolic resistance to host plant 
toxins is attributed, in part, to an arsenal of inducible detoxification enzymes termed 
cytochrome P450 monooxygenases (P450s), capable of protecting the consumer from 
dietary intoxication (Schuler 1996).  Furthermore, much of the apparent diversity of P450 
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 isoforms in insects may be the result of the co-evolutionary ‘arms race’ between prey 
chemical defenses and predator detoxification mechanisms (Gonzalez & Nebert 1990).  
According to this view, multiple duplication and divergence events among P450 genes 
have allowed isoforms to gain new functions and presumably to increase the pool of 
allelochemical substrates upon which they act (Li et al. 2003), while still allowing some 
isoforms to retain their ancestral metabolic capabilities (Li et al. 2002a).  A similar 
diversification of P450s genes may have occurred in marine invertebrates feeding on 
chemically-defended prey, providing consumers like C. gibbosum with protection against 
the continuous barrage of defensive compounds they may encounter.    
Vrolijk and Targett (Vrolijk & Targett 1992) were the first to measure P450 
content and activity from field-collected C. gibbosum feeding on four species of 
gorgonian corals (Briareum asbestinum, Gorgonian ventalina, Plexaura homomalla, and 
Pseudopterogorgia americana).  The specific content of cytochrome P450 in the 
digestive gland was low and only quantifiable in C. gibbosum collected from P. 
americana.  The authors suggested that the low specific content may have resulted from 
denatured P450 protein, which was confirmed by the presence of 420 nm peaks in the 
CO-difference spectra.  Additionally, two spectrofluorometric assays (methoxyresorufin 
O-deethylase (MROD) and ethoxyresorufin O-deethylase (EROD)) used to detect P450 
activity in C. gibbosum digestive gland microsomes were negative.  MROD and EROD 
assays have classically been used to detect subfamily specific P450 activity (i.e. CYP1A) 
in vertebrates exposed to pollutants (e.g. planar halogenated and polycyclic aromatic 
hydrocarbons) (Stegeman & Hahn 1994).  While evidence of deuterostome (e.g. tunicate 
and sea urchin) CYP1A-like and CYP1-like genes exists (Goldstone et al. 2007), to date  
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 no full-length CYP1-like sequences have been reported for molluscs (Rewitz et al. 2006) 
or any other protostome, further suggesting that the CYP1 family may be deuterostome 
specific.  Recent work by Grosvik et al. (2006) strengthens this argument by calling into 
question immunochemical evidence suggesting the presence of a CYP1A-like protein in 
molluscs.  Therefore, it is not entirely surprising that C. gibbosum digestive gland tissues 
lack CYP1A-like enzyme activity, which does not preclude the possibility of other 
xenobiotic detoxifying CYPs being responsible for allelochemical resistance.   
Members of the P450 (CYP) family 4 represent a substantial portion of the cDNA 
sequences identified to date in molluscan species (Snyder 1998, Chaty et al. 2004).  This 
family is considered one of the most ancient P450 families, having evolved from the 
steroid-synthesizing P450s and since diverged into an array of subfamilies whose 
substrates may be more diverse than previously realized.  In vertebrates, CYP4 genes are 
recognized as the predominant fatty acid ω-hydroxylases, preventing lipotoxicity by 
hydroxylating eicosanoids, including prostaglandins (Kikuta et al. 2002, Hsu et al. 2007).  
Prostaglandins are potent signaling molecules, known as regulators of fever, 
inflammation, and pain response in human biology.  In marine systems, prostaglandins 
are known to function as feeding deterrents and can comprise up to 8% of the dry weight 
of some gorgonian species (reviewed by Stanley 2000).  Yet the diversity of CYP4 
substrates extends beyond fatty acid derivatives.  
 The ability of P450s to metabolize terpenes is of particular interest here due to 
the predominance of both diterpenoid and sesquiterpenoid compounds across all 
members of the Octocorallia (Coll 1992).  Terpene derivatives, including the 
sesquiterpene farnesol as well as sesquiterpenoid epoxide juvenile hormone III, are 
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 substrates for the cockroach CYP4C7 (Sutherland et al. 1998, Sutherland et al. 2000).     
CYP4D10 isolated from the Sonoran Desert endemic Drosophilia mettleri was 
significantly induced in response to exposure to defensive isoquinoline alkaloids specific 
to its host the saguaro cactus, suggesting that this CYP may be responsible for their 
detoxification (Danielson et al. 1998).  Allelochemical resistance in this species of insect 
may also involve cooperative action among multiple P450 isoforms, possibility within the 
same family, allowing this generalist to exploit a broader range of plants with structurally 
similar defensive compounds.  Evidence from these and other studies of insect 
allelochemical metabolism highlight the relative importance of both P450 diversification 
and modulation of transcript expression in explaining consumer patterns of host plant 
utilization.  Whether C. gibbosum possesses a similar diversity of allelochemically 
responsive CYP4 genes is the focus of this investigation. 
Vrolijk and Targett (1992) originally hypothesized that the ability of C. gibbosum 
to tolerate dietary allelochemicals may involve biochemical resistance mechanisms, such 
as inducible cytochrome P450s.  Here, I explore this hypothesis further by using a 
molecular approach to identify CYP4 genes in C. gibbosum and examine their 
transcriptional response following exposure to variety of gorgonian allelochemicals in a 
series of feeding assays.  Once allelochemically-responsive CYP4 genes were identified, 
representative forms were heterologously expressed and their ability to metabolize 
diagnostic substrates was examined.  Evidence presented here emphasizes the role of 
P450 genes in the adaptation of marine consumers to their chemically defended prey. 
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 Materials and Methods 
 Animal collection and feeding assay design 
A total of 151 adult Cyphoma gibbosum (ca 2-3 cm length) were collected from 
five shallow reefs (< 20m) (Big Point – 23o47.383’N, 76o8.113’W; North Normans – 
23o47.383’N, 76o8.264’W; Rainbow Gardens – 23o47.792’N, 76o8.787’W; Shark Rock – 
23o45.075’N, 76o7.475’W; Sugar Blue Holes – 23o41.910’N, 76o0.23’W) near the Perry 
Institute of Marine Science (PIMS), Lee Stocking Island, Exuma Cays, Bahamas (Figure 
1) in January 2006.  Snails were immediately transported to wet laboratory facilities 
provided by PIMS where a series of feeding assays were conducted with seven gorgonian 
species (Briareum asbestinum, Eunicea mammosa, Gorgonia ventalina, 
Pseudopterogorgia acerosa, Pseudopterogorgia americana, Pseudopterogorgia 
elisabethae, Plexaura homomalla) observed to serve as hosts for C. gibbosum in the field.    
Individual snails were housed separately in 3-L polycarbonate tanks which were placed in 
a 12’ x 20” raceway supplied with filtered, continuous-flow seawater.  This design 
allowed for a common water source to feed each tank but prevented mixing between 
tanks.  Snails collected from the same reefs were housed separately in the same raceways. 
Snails collected from each reef were randomly assigned to one of nine groups: 
one of seven gorgonian diets, a control diet, or a time-zero group at the start of the 
feeding assays.  Snails in the time zero groups (n = 6 or 7 snails/reef location) were 
dissected within two hours after field collection and digestive glands were preserved in 
RNA Later® (Ambion) and stored at -80oC.  These time-zero snails provide baseline 
information about the CYPs expressed in a population of C. gibbosum on a particular reef 
at the time of collection.  The remaining snails were included in the feeding assay and 
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 maintained on their respective diet (gorgonian or control) for a total of four days.  A 
single feeding assay consisted of two raceways, each holding ten tanks - seven tanks 
containing one C. gibbosum feeding on one of seven gorgonian diets and three tanks each 
containing one C. gibbosum feeding on the control diet.  This design accommodated 20 
snails feeding at any one time.  Snails within each raceway were collected from the same 
reef and each four-day feeding assay (2 raceways) was repeated a total of six times 
(Figure  2).  Upon completion of the 4 d feeding assay, the digestive glands were 
immediately dissected, weighed, preserved in RNA Later® at -80oC for real-time 
quantitative PCR expression analysis and transported back to the Woods Hole 
Oceanographic Institution.  Tissues were maintained at -80oC until further analysis. 
Running in parallel with the first set of feeding assays was a second set of feeding 
assays.  Digestive gland tissues collected during the second feeding assays were used to 
investigate enzymatic activity of C. gibbosum digestive gland microsomes (described 
below) and cytosolic fractions (described in Chapter 2).  The design of the second 
feeding assay was exactly as described above, except one raceway with ten tanks each 
holding a single snail was used.  Snails within the raceway were collected from the same 
reef, and each 4 d assay was repeated four times (Figure 3).  A total of 39 snails were 
collected from four reefs (Big Point, Rainbow Gardens, Shark Rock and Sugar Blue 
Holes) and randomly assigned to either a control diet or one of six gorgonian diets (B. 
asbestinum, E. mammosa, G. ventalina, P. acerosa, P. americana, P. homomalla).  
Following the completion of the 4 d feeding assay digestive glands were immediately 
dissected, weighed, and frozen in liquid nitrogen and transported to the Woods Hole 
Oceanographic Institution.  Tissues were maintained at -80oC until further analysis.   
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 Table 1 provides a summary of digestive gland samples collected from both feeding 
assays and processed for RNA and protein analysis. 
A minimum of ten colonies for each gorgonian species were collected from 
shallow reefs (< 20m) surrounding PIMS and housed in separate raceways prior to 
introduction into the tanks containing C. gibbosum.  The maximum amount of time 
between gorgonian field collection and introduction into the feeding assay was 12 hours.  
Gorgonian colonies were cut into 2-3 inch pieces and allowed to ‘heal’ for four hours 
before addition to C. gibbosum tanks. The control diet, which closely approximated the 
nutritional quality of gorgonian tissue, consisted of a combination of alginic acid and 
freeze-dried squid powder prepared by the method of (O'Neal & Pawlik 2002) with some 
modification.  The squid-alginate paste was pressed into sixteen 3-mm deep wells which 
had been drilled into a 3” x 1” piece of Formica® resembling a domino.  The domino was 
then placed into a 0.25 M calcium chloride solution allowing the squid-aliginate paste to 
harden.  Theoretically, snails feeding on the control diet devoid of gorgonian compounds 
should experience no induction of allelochemically-responsive CYPs.   Both control and 
gorgonian diets were replaced each day for four days and feeding activity was monitored 
by the presence of feeding scars on their gorgonian prey and empty wells on control 
dominos. 
The length (4 d) of the feeding assay was decided based upon previous studies 
that measured C. gibbosum residence time on gorgonian colonies (Harvell & Suchanek 
1987) and known detoxification enzyme induction times in other invertebrates (DeBusk 
et al. 2000, Li et al. 2000, Li et al. 2002c, Kuhajek & Schlenk 2003, Rewitz et al. 2004) 
(David et al. 2006).  Studies examining the half lives of CYP mRNA have found that 
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 most decline rapidly within 24 hours (Daujat et al. 1991, Kloepper-Sams & Stegeman 
1994, Lekas et al. 2000) – some as little as two hours in terrestrial invertebrates 
(Sutherland et al. 2000) when the chemical stimulus is removed.  Therefore, any CYP 
mRNA induction we observe in C. gibbosum digestive glands should be attributed to the 
xenobiotics in their most recent diet. 
 
Initial RNA extraction and RT-PCR 
In 2004, a preliminary series of feeding assays with 15 adult C. gibbosum and 
four gorgonian species (Briareum asbestinum, Gorgonia ventalina, Pseudopterogorgia 
acerosa, Pseudopterogorgia americana) provided tissue for the initial cloning of CYP4 
fragments.  Digestive gland samples were stored in RNALater® at -80oC until further 
processing.  Total RNA was isolated from pooled digestive glands using RNA STAT-60 
(Tel-Test B, Inc., Friendswood, TX) according to the manufacturer’s protocol.  The 
integrity of the RNA sample was checked by electrophoresis on a 1% agarose-
formaldehyde gel in MOPS buffer and visualized with ethidium bromide under UV light.  
Total RNA concentration was determined using a Nanodrop spectrophotometer 
(Wilmington, DE).  Poly(A)+ RNA was purified using the MicroPoly(A)Purist mRNA 
purification kit (Ambion, Austin, TX) according to the manufacturer’s instructions.  First-
strand cDNA was reverse transcribed from 2 μg poly(A)+ RNA using OmniScript reverse 
transcriptase (OmniScript RT kit, Qiagen) with random hexamer primers.  PCR was 
performed using AmpliTaq Gold DNA polymerase (Applied Biosystems) under the 
following conditions: 94oC for 10 min; (94oC for 15 sec, 52oC for 30 sec) for 35 cycles; 
72oC for 7 min with pairs of degenerate primers (CYP4_F1/ CYP4_R3), (CYP4_F2/ 
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 CYP4_R3) (see Table 2) designed against the conserved CYP4 P450 fingerprint region.  
Primers were obtained from Sigma Genosys (St. Louis, MO).   PCR products were 
visualized on agarose gels, gel purified (Gene Clean II, Bio 101, Inc.), ligated into 
pGEM-T Easy© plasmid vector (Promega, Madison, WI), and transformed into JM109 
cells (Promega).  PCR products were sequenced in both directions using an ABI 3730XL 
capillary sequencer at the Keck facility of the Josephine Bay Paul Center for 
Comparative Molecular Biology & Evolution at the Marine Biological Laboratory 
(Woods Hole, MA).  A minimum of twelve clones were sequenced for each PCR 
fragment.  Clones were initially clustered based on nucleotide sequence identity (>80%) 
with Sequencher 4.6 (Gene Codes Corp., Ann Arbor, MI) and a consensus sequence was 
generated and examined by NCBI/GenBank BLASTx for gene identification (Altschul et 
al. 1997). 
 
Rapid amplification of cDNA ends (RACE) 
Digestive gland total RNA was purified from seven C. gibbosum individuals 
collected during the January 2006 feeding assays using the RNeasy Maxi Kit and DNAse 
treated using a RNase-free DNAse Kit (Qiagen, Valencia, CA) following the 
manufacturer’s instructions.  The integrity and concentration of total RNA was 
determined as described in Chapter 2, Methods.  Poly(A)+ RNA was isolated using the 
MicroPoly(A) Purist mRNA purification kit according to the manufacturer’s instructions.  
Poly(A)+ RNA was pooled from seven snails feeding either on a control diet or one of 
six gorgonian species (0.14 μg poly(A)+ RNA/individual) to ensure representation of all 
CYPs expressed under various dietary conditions.  One microgram of pooled 
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 poly(A)+RNA was primed with modified oligo (dT) primers and used to create an 
adaptor-ligated double-stranded cDNA library synthesized using the Marathon cDNA 
Amplification Kit (BD Biosciences, Palo Alto, CA) according to the manufacturer’s 
instructions.   
Gene specific primers designed to the three partial cDNA sequences (Table 2) 
obtained in the initial RT-PCR experiment were used in combination with adaptor-
specific primers to obtain full-length CYP sequences by 5’ and 3’ RACE-PCR.  Primers 
were obtained from Sigma Genosys (St. Louis, MO).  Amplification of PCR products 
was carried out according to the Advantage 2 PCR Enzyme Kit (Clontech, Mountain 
View, CA) and cycling parameters were as follows: 94oC for 30 sec; (94oC for 5 sec, 
72oC for 2.5 min) for 5 cycles; (94oC for 5 sec, 70oC for 2.5 min) for 5 cycles; (94oC for 
5 sec, 68oC for 2.5 min) for 25 cycles; 68oC for 5 min with the following specific primer 
pairs (RACE_1_F/ CYP4_A12_R ), (RACE_1_F/ CYP4_D09_F), (RACE_1_F/ 
CYP4_F11_R), (RACE_1_F/ CYP4_F1), and (AP1/ CYP4-3_R1).  Once the start and 
stop codons had been obtained, primers were designed immediately up or down stream, 
respectively, to amplify full-length cDNA.  Full-length products were amplified with 
PfuUltra™ Fusion HS DNA Polymerase (Stratagene, La Jolla, CA) and cycling 
parameters were as follows: 95oC for 1 min; (95oC for 20 sec, 63oC for 20 sec, 72oC for 
1min) for 40 cycles; 72oC for 3 min with specific primers pairs CYP4-3_F3/ CYP4-3_R6, 
and CYP4-2_F1/ CYP4-2_R1.  All PCR products were sequenced and analyzed as 
described above.   
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 Sequence analysis and structural alignments 
Partial and full-length CYP4 nucleotide sequences were clustered by Sequencher 
4.6 based on nucleotide identity (> 80% identity), aligned using ClustalX (Thompson et 
al. 1994) and this alignment was used to construct maxium parsimony trees using 
PAUP*4.0b10 (Swofford 1998) from which the number of possible distinct CYP4 loci 
were inferred. Trees were visualized and manipulated using FigTree v1.1(Rambaut 
2007). Sequences within each cluster were then grouped according to maximum 
parsimony tree results, and consensus nucleotide and deduced amino acid sequences were 
generated from these groupings in BioEdit v7.0.5.2 (Hall 1999). 
Multiple alignments of Cyphoma deduced amino acid sequences and other 
invertebrate and vertebrate full-length CYP4 gene sequences were performed by ClustalX 
for phylogenetic analysis by Bayesian and maximum likelihood methods.  Ambiguous 
alignment positions were excluded from further analyses. Bayesian phylogenetic 
relationships were investigated using the computer program MrBayes (v 3.1.2; Ronquist 
& Huelsenbeck 2003). MrBayes estimates posterior probabilities using Metropolis-
Hastings coupled Monte Carlo Markov chains (MC3). MC3 estimates with uninformative 
prior probabilities were performed using the WAG model of amino acid substitution 
(Whelan & Goldman 2001) and prior uniform gamma distributions approximated with 
four categories (WAG+I+gamma). Four incrementally heated, randomly seeded Markov 
chains were run for 3x106 generations, and topologies were sampled every 100th 
generation. The MC3 burnin values were conservatively set at 1x106 generations. 
Posterior probabilities of topologies and clades were estimated from the sampled 
topologies after removal of the initial MC3 burnin. Maximum likelihood phylogenetic 
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 relationships were calculated with the Pthreads version of RAxML v7.0.0 (Stamatakis 
2006, Ott et al. 2007) using the WAG+gamma model of amino acid substitution. Multiple 
initial ML searches were performed from random starting points and bootstrap support 
was estimated for the best ML tree. 
Identification of putative substrate recognition sites (SRSs) of Cyphoma CYPs 
was accomplished by using the bacterial CYP102 (Ravichandran et al. 1993) as a 
template to highlight (putative) active site residues.  Bacterial CYPs have often been used 
convincingly as templates for eukaryotic P450 homology modeling studies (Chang et al. 
1996).   ClustalX was used to align full-length Cyphoma deduced amino acid sequences 
with CYP102 and selective mammalian CYPs whose SRSs have previously been 
determined (Gotoh 1992, Loughran et al. 2000, Kalsotra et al. 2004).  Alignments were 
visualized in BioEdit v7.0.5.2 (Hall 1999) and structurally conserved regions (e.g., 
helices and β-structures) and SRS for Cyphoma CYPs were generated by copying the 
backbone coordinates from CYP102. 
 
Real-time quantitative RT-PCR 
 DNAse-treated poly(A)+ RNA (0.2 μg) from the digestive gland of snails 
participating in the 2006 feeding assay (n = 141, Table 1) was used to synthesize cDNA 
using a blend of oligo (dT) and random hexamers as decribed by the iScript™ cDNA 
Synthesis Kit (Bio-Rad, Hercules, CA).  The quantity of poly(A)+RNA for cDNA 
synthesis was chosen based on an experiment comparing the product yield (e.g. target 
gene expression) versus input concentration of poly(A)+RNA (Figure 4).  PCR reactions 
were performed using iQ SYBR Green Supermix (Bio-Rad) using an iCycler MyiQ Real-
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 Time PCR Detection System (Bio-Rad).  Sequence-specific primers for quantitative PCR 
analysis of CYP mRNA expression are listed in Table 3.  In addition, a representative 
group of poly(A)+ RNA samples was used to perform control cDNA synthesis 
experiments without reverse transcriptase to check for contamination by genomic DNA.  
The PCR conditions were as follows: 95oC for 3min; (95oC for 15 sec, 64oC or 62oC for 1 
min) for 40 cycles.  PCR product specificity from each primer pair was confirmed by 
melt curve analysis to ensure that only a single product was amplified.  A standard curve 
was generated for each CYP grouping by serially diluting plasmids containing the 
fragment to be amplified.  Each sample and standard was run in duplicate and the 
expression of C. gibbosum β-actin was used to control for differences in cDNA synthesis 
among samples.  The molecule number per gene in each RNA sample was calculated 
from the standard curve. 
 
Data analysis of RT-qPCR experiments 
 To test whether cytochrome P450 gene expression differed between snails feeding 
on a control diet versus each gorgonian diet, a two way multivariate analysis of variance 
(MANOVA) was used with Diet (control vs. gorgonian diet) as a fixed factor and Reef 
(snail origin) as a random factor.  The CYP4 genes were considered dependent variables.  
If Diet was found to be significant in the two-way MANOVA, univariate two-way 
ANOVAs were run for each CYP4 gene to determine which diet showed significant 
differences.  In addition, a one-way MANOVA was used to examine the variability in 
CYP4 gene expression among reefs, where Reef was considered a random factor.  This 
test was used to investigate reef-specific variation in transcript levels in time-zero snails, 
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 and to determine if any such variation persisted in snails collected from these same reefs 
after being fed a control diet for four days.  The CYP4 genes were considered dependent 
variables.   
P-values have been corrected for both MANOVA analyses using Bonferroni’s 
adjustment (Sankoh et al. 1997).  Data analysis was performed using SYSTAT® version 
11 (Systat Software, Inc., San Jose, CA).  Data reported as molecule numbers for each 
gene were log transformed to homogenize variances for MANOVA and ANOVA 
analysis. 
 
Heterologous expression of Cyphoma CYPs in yeast 
 The open reading frame (ORF) of five CYPs, representing a diversity of the 
CYP4 sequences from Cyphoma (CYP4-2a = clone 198_58; CYP4-2b = clone 198_27; 
CYP4-3a1 = clone 197_52; CYP4-3b1 = clone 197_48; CYP4-3b3 = clone 197_53), 
were amplified with custom primers (Table 4) and PCR fragments were ligated into 
pENTR/D/TOPO® according to the manufacturer’s instructions (Invitrogen, Carlsbad, 
CA).  PCR products were amplified using PfuUltra™ (Stratagene, La Jolla, CA) with the 
following conditions: 95oC for 2 min; (95oC for 20 sec, 63.2oC for 20 sec, 72oC for 30 
sec) for 30 cycles; and 72oC for 3 min for final extension.  Primers were used at 10 μM in 
a 50 μL reaction.  PCR products were separated on a 1% agarose gel and discrete bands 
were excised and extracted with the Geneclean® kit (Qbiogene, Irvine, CA) according to 
the manufacturer’s protocol. 
ORFs for all five clones were transferred from the entry vector pENTR/D/TOPO 
to the destination vector pYESDEST52/V5-His using the TOPO Cloning Kit (Invitrogen) 
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 and provided protocol.  A pYESDEST52 plasmid carrying the Arabidopsis β-
glucuronidase (gus) gene was used as a transformation and expression control.  
Expression clone plasmids were purified from overnight E. coli culture and used for yeast 
transformation.  Saccharomyces cerevisiae W(R) strain, which over-expresses the yeast 
NADPH-cytochrome P450 reductase under a galactose-inducible promoter, was a kind 
gift of Drs. D. Pompon and P. Urban (Center de Génétique Moléculaire, CNRS, Gif-sur-
Yvette, France) (Pompon et al. 1996).  The W(R) yeast was made competent using the 
S.c. EasyComp™ transformation kit according to the manufacturer’s instructions 
(Invitrogen) and separately transformed with the expression clones containing C. 
gibbosum P450s.   
To achieve higher recombinant protein expression, yeast cells were initially 
grown to high density with glucose as the main carbon source; thereafter, galactose was 
added to induce expression.  The production of recombinant CYP protein was as follows: 
a single transformed yeast colony was picked from a selective plate and used to inoculate 
30 mL of SGI medium (containing per liter, 6.7g yeast nitrogen base without amino 
acids, 1g bactocasamino acids deficient for uracil, 40 mg DL-tryptophan, 20 g glucose, 
100 mg adenine).  The SGI culture was grown at 28oC with shaking at 130 rpm 
overnight, then transferred (10 mL) to a 2-liter flask containing 500 mL of YPGE media 
(containing per liter, 10 g yeast extract, 10 g bactopeptone, 5 g glucose, 100 mg adenine, 
3% ethanol).  The YPGE culture was grown overnight at 28oC with shaking at 130rpm.  
Yeast cells were induced by the addition of 2% galactose for 8 or 15 hrs at 28oC with 
shaking at 130rpm.  Cells were harvested by centrifugation, washed with TES50 buffer 
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 (50 mM Tris-HCl, 1 mM EDTA, 0.6 M sorbitol; pH 7.4) and stored at -80oC until 
microsomal preparation. 
 
Preparation of yeast microsomes 
Yeast cells were suspended in degassed TES50 buffer containing 1.0 mM 
dithiothreitol (DTT) and protease inhibitor cocktail (1X) (Sigma) and mechanically 
disrupted using the BeadBeater (BioSpec Products, Inc., Bartlesville, OK).  A 25 mL 
chamber containing about 50% glass beads (0.5 mm diameter) and yeast cell slurry was 
cooled with an ice water/methanol (20%) cooling jacket.  Any air remaining in the 
chamber was displaced by adding TES50 buffer.  The cells were disrupted by twenty 5-s 
BeadBeater cycles with 45-s resting (cooling) periods between cycles.  This method of 
disruption has been shown to be effective at maintaining the sample temperature below 
8oC during disruption and results in greater than 90% lysis of yeast cells (Chung et al. 
2004). 
All subsequent steps were carried out at 4oC.  Cell lysate was decanted and the 
beads remaining in the chamber were washed once with 2 mL of degassed buffer and 
combined with the cell lysate.  The combined cell lysate was centrifuged at 750 x g for 10 
min then, without stopping, at 12,000 x g for 10 min using a Beckman J2-21 centrifuge 
(Fullerton, CA) to remove cell debris.  The supernatant was carefully removed and 
centrifuged at 100,000 x g for 70 min using a Beckman L8-60M ultracentrifuge 
(Fullerton, CA) to collect the microsomal fraction.  The resulting microsomal pellet was 
resuspended in 1 to 2 mL of TEG50 buffer (50 mM Tris-HCl, 1 mM EDTA, 20% 
glycerol (by vol.), 1 mM DTT; pH 7.4) by gentle hand homogenization using a Potter-
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 Elvehjem homogenizer and microsomal suspensions were stored at -80oC until use.  An 
aliquot of suspension was taken for microsomal protein determination using the Bradford 
assay method (Bradford 1976) with BSA as the standard.   
 
Preparation of Cyphoma digestive gland microsomes 
Individual digestive glands (n = 49) were homogenized 1:4 (w/v) in ice-cold 
homogenization buffer (0.1 M potassium phosphate, 1 mM EDTA, 1 mM DTT, 1.15% 
potassium chloride, protease inhibitor cocktail (1X); pH 7.5) with an IKA Ultra Turrax 
T8 homogenizer (Wilmington, NC) for 30 sec on ice.  All subsequent steps were carried 
out at 4°C.  Cytosol was isolated by centrifugation of the crude homogenate at 750 x g 
for 10 min then, without stopping, at 12,000 x g for 10 min using a Beckman J2-21 
centrifuge (Fullerton, CA).  The supernatant was carefully removed, avoiding both the 
fatty layer and the pellet and transferred to an ultracentrifuge tube and centrifuged at 
100,000 x g for 70 min using a Beckman L8-60M ultracentrifuge (Fullerton, CA).  The 
microsomal pellet was resuspended in 0.2 to 0.8 mL of microsomal buffer (0.1 M 
potassium phosphate, 1 mM EDTA, 1 mM DTT, 20% glycerol (by vol.); pH 7.5) and 
stored at -80oC until use.  An aliquot of suspension was taken for microsomal protein 
determination using the Bradford assay method (Bradford 1976) with BSA as the 
standard.   
 
P450 content and enzymatic assays 
 Cytochrome P450 specific content of yeast and digestive gland microsomal 
samples was determined by the carbon monoxide difference spectrum (ΔOD450-490) of 
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 sodium dithionite-reduced samples (1 mg/mL) using an extinction coefficient of 91 mM-
1cm-1 by the method of (Omura & Sato 1964).  P450 reductase in both yeast and digestive 
gland microsomal samples was assayed by measuring NADPH-cytochrome c reductase 
activity.  The reaction mixture (in a final volume of 200 μL) contained 0.2 M potassium 
phosphate buffer, pH 7.7, 80 μM equine heart type III Cytochrome c (Sigma), and 0.2 
mM NADPH.  NADPH was solubilized in TEG50 buffer.  The rate of Cytochrome c 
reduction was measured as the increase in absorbance at 550 nm (Δε550 21.1 mM-1 cm-1) 
using a UV-2401PC spectrophotomer (Shimadzu).  One unit of reductase activity is 
defined as the amount of enzyme which can reduce 1 nmol of Cytochrome c per min. 
 Lauric acid hydroxylase activity was determined by Discovery Labware (BD 
Biosciences, Woburn, MA) using the method described by (Crespi et al. 2005).  The 
reaction mixture (0.1 mL final volume) contained 20 μL yeast microsomal protein (1.1-
4.0 mg/mL) expressing C. gibbosum P450s, 1.3 mM NADP+, 3.3 mM glucose-6-
phosphate, 0.4 U/mL glucose-6-phosphate dehydrogenase, 3.3 mM MgCl2, 0.1 mM 
[14C]-lauric acid in 100 mM Tris buffer (pH 7.5).  Human liver microsomes (HLM) (1.0 
mg/mL) were used as a positive control.  Yeast microsomes were incubated for 80 min at 
25oC and HLM were incubated for 10 min at 37oC.  Negative control incubations 
consisting of the same reaction mixture without microsomal proteins were also 
performed.  All samples were run in single determinations.  The reactions were stopped 
by the addition of 50 μL of 94% acetonitrile/6% acetic acid, centrifuged at 10,000 x g for 
3 min, and 75 μL of supernatant was injected onto a C18 HPLC column (5 μ, 4.6 mm x 
250 mm).  The metabolites were separated at 45oC with methanol/acetonitrile/water 
(23:23:54) containing 1 mM perchloric acid adjusted to 100% methanol over 35 min with 
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 a flow rate of 1.0 mL/min.  Lauric acid and the ω-hydroxylated metabolite were detected 
by liquid scintillation counting. 
 Leukotriene B4 (LTB4) hydroxylase activity was determined by Discovery 
Labware (BD Biosciences).  The conversion of LTB4 to its hydroxylated metabolites by 
recombinant CYP4 proteins and Cyphoma microsomes was performed by incubating 1.0 
mg/mL of snail microsomes or 2.0 mg/mL of yeast microsomes with 1.3 mM NADP+, 
3.3 mM glucose-6-phosphate, 0.4 U/mL glucose-6-phosphate dehydrogenase, 3.3 mM 
magnesium chloride, 29.7 μM LTB4 in 100 mM KPO4 (0.1 mL final volume).  Human 
liver microsomes (0.5 mg/mL) were used as a positive control.  Snail microsomes were 
incubated for 60 mins at 30oC, and yeast microsomes were incubated for 120 mins at both 
23oC and 30oC.  Reactions were terminated after 120 mins by the addition of 25 μL of 
94% acetonitrile/6% glacial acetic acid.  Incubations were centrifuged at 10,000 x g for 3 
min. and 80 μL of the supernatant was injected onto a C18 HPLC column (5μ, 4.6 mm x 
250 mm) and separated with an initial mobile phase consisting of 30% acetonitrile with 1 
mM perchloric acid in water changing to 70% methanol over 20 minutes at a flow rate of 
1.0 mL/min.  Products were detected by monitoring absorbance at 270 nm and compared 
to known standards.  Control reactions without microsomal protein, without NADPH and 
without incubation were performed with a ‘global control’ sample made by separately 
pooling all of the yeast microsomal samples and the snail microsomal samples. 
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 Results 
Identification of Cyphoma CYP4 genes 
 When an RT-PCR cloning approach was used with pooled digestive gland mRNA 
samples and degenerate primers designed to the conserved I-helix and heme-binding 
region, three partial CYP4 cDNAs approximately 396 base pairs (bp) in length were 
identified.  The resultant sequences, which shared 41-54% amino acid identify, were 
separated into three clusters designated CYP4-1, CYP4-2, and CYP4-3.  Specific primers 
designed to each of the three CYP4 clusters were used in 5’ and 3’ RACE reactions to 
obtain full-length sequences.  In total, RACE and RT-PCR cloning efforts generated 352 
cDNA clones.  The cDNA clones within each cluster were aligned using ClustalX and 
used to construct three maximum parsimony trees to assist in the further identification of 
groups and subgroups of sequences within each cluster.  These analyses were used to 
help infer the number of possible distinct CYP4 genes.   
Based on current P450 Nomenclature rules, proteins that share >40% identity are 
assigned to the same family; proteins sharing >55% identity are grouped within the same 
subfamily; and allelic variants of the same gene are classified as having < 3% divergence, 
unless functional differences (catalytic activities) can be demonstrated (Nelson 2006).  
The criteria established for P450 nomenclature, based on somewhat arbitrary cut-off 
values, does not take into account the phylogenetic relationships among species, whereby 
P450s sharing the same enzymatic function may be assigned to separate subfamilies 
because they fall below the arbitrary cut-off value (Nelson et al. 2004).  Additionally, 
there are examples of distinct genes sharing greater than 97% amino acid identitiy, 
further complicating allelic variant vs. distinct loci assignment when genomic 
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 information is lacking (Nebert et al. 1989).  These caveats were considered here when 
classifying the CYP4 sequences identified from Cyphoma.  Sequence analysis revealed 
fifteen full-length CYP4 cDNAs encoding twelve distinct CYP4 proteins, (CYP4-1, 
CYP4-2a, CYP4-2b, CYP4-3a1, CYP4-3a2, CYP4-3b1, CYP4-3b2, CYP4-3b3_clone 1, 
CYP4-3b3_clone 2, CYP4-3b3_clone 3, CYP4-3b3_clone 4, CYP4-3b3_clone 5, and 
CYP4-3c).  ClustalX alignments indicate that the Cyphoma CYP4 protein sequences 
share identities ranging from 26.3% (CYP4-3a1v2 - CYP4-1v2) to 99.2% (CYP4-
3b2_clone4 – CYP4-3b3/CYP4-3b2_clone5) (Figure 5). 
CYP4-1 cluster.  Maximum parsimony analysis (Figure 6) identified one CYP4 
gene with several allelic variants.  Upon further analysis two distinct groupings of 
variants were identified designated CYP4-1v1 and CYP4-1v2, which share 98.8% amino 
acid identity.  CYP4-1v2 differ by a 15 bp insertion at 1201 bp position, resulting in an 
open reading frame of 1551 bp encoding a 517 amino acid protein rather than the 512 a.a. 
protein as seen in CYP4-1v1 (Figure 7).  In addition, five of the 65 clones within the 
CYP4-1 group contained a 68 bp deletion at nucleotide position 1066 causing a frame 
shift to occur resulting in a premature stop codon.  These clones likely represent a low 
frequency nonfunctional allele because this mutation would delete a signification portion 
of the CYP4, including the conserved cysteine residue in the P450 active site.      
CYP4-2 cluster.  This grouping is likely represented by two distinct genes, which 
share 93.5% amino acid identity and are designated here as CYP4-2a and CYP4-2b.  The 
CYP4-2a subgroup is represented by only four of 121 possible clones, yet these 
sequences clearly form a distinct group as visualized by the unrooted maximum 
parsimony cluster analysis (Figure 8).  The remaining clones grouped within the CYP4-
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 2b cluster likely represent two allelic variants within this subgroup, evidenced by a minor 
branch extending from the main CYP4-2b cluster in Figure 8.  The nucleotide sequences 
of CYP4-2a and CYP4-2b are 1527 and 1545 bp, respectively, encoding proteins of 508 
and 514 amino acids in length (Figure 9).  The difference in length between the two 
cDNAs is due to an 18 bp addition to the 3’ end of CYP4-2b.  Both the CYP4-2a and 
CYP4-2b sequences contain this additional sequence; however, in the CYP4-2a group, a 
mutation at position 1527 leads to stop codon, truncating the protein six amino acids 
upstream of CYP4-2b stop codon.  The highly similar UTRs suggest that CYP4-2a and 
CYP4-2b arose from a recent duplication event, followed by a diversification of both 
forms; however, which sequence is representative of the ancestral form is not known.   
CYP4-3 cluster.  The CYP4-3 cluster (the most diverse) includes 166 clones that 
may correspond to as many as nine distinct loci.  An alignment of deduced amino acid 
sequences indicates that these group members share sequence identities ranging from 
89.2% to 99.2% (Figure 5).  Relationships among members of the CYP4-3 cluster were 
visualized by a maximum parsimony cluster analysis (Figure 10), indicating three 
separate groups (CYP4-3a, -3b, -3c) within the CYP4-3 members.  The CYP4-3a group is 
likely represented by one gene with at least three allelic variants (CYP4-3a1v1, CYP4-
3a1v2, and CYP4-3a2) which share >99% amino acid identity when positions common to 
all three variants are compared.  The full-length CYP4-3a1v1, CYP4-3a1v2 and CYP4-
3a2 sequences are 1563, 1500 and 1602 bp in length encoding proteins of 520, 499 and 
533 amino acids, respectively (Figure 11, 12).  One variant in particular designated 
CYP4-3a1v2, contains an inframe deletion of 63 bp (21 a.a.) causing the entire F helix 
and the majority of the SRS-2 region to be removed, resulting in a protein of 499 amino 
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 acids.  With the exception of this deletion, the protein coding sequences of CYP4-3a1v1 
and CYP4-3a1v2 are identical.  CYP4-3a2, represented by two clones, is 97.3% and 
93.4% similar at the protein level to CYP4-3a1v1 and CYP4-3a1v2; however, if you 
disregard positions containing insertions/deletions, the similarity increases to 99.7% 
between all three variants.  The most obvious difference between CYP4-3a1 and CYP4-
3a2 sequences is the addition of 13 residues at the C-terminal end of CYP4-3a2, resulting 
from a single nucleotide substitution in the corresponding stop codon in CYP4-3a1.   
 Amino acid sequence identities between CYP4-3b members range from 95.0% to 
99.2% and all encode proteins of 530 amino acids in length (Figures 11, 12).  The CYP4-
3b sequences can be further subdivided into one of three additional subgroupings (CYP4-
3b1, -3b2, -3b3) supported by the maximum parsimony analysis (Figure 10).  Protein 
identities range from 95.0 to 99.2% between CYP4-3b members (Figure 5).   While 
consensus nucleotide sequences could be easily generated for CYP4-3b1 and CYP4-3b3 
members so that at least one clone matched the consensus nucleotide sequence, this 
proved impossible for sequences within the CYP4-3b2 subgroup.  Due to the extensive 
variation among CYP4-3b2 members, illustrated by the lack of clustering among clones 
in the MP analysis (Figure 10, Part B), five full-length clones (CYP4-3b2_clone 1 thru 5) 
were selected to represent the range of CYP4-3b2 diversity in lieu of generating a 
consensus nucleotide sequence with no physical representatives.  Protein identities 
among the CYP4-3b2 subgroup members range between 96.1 to 99.2%.  The greater than 
97% amino acid identity among some subgroup members would suggest multiple allelic 
variants are a possibility. 
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 The full-length CYP4-3c sequence is 1563 bp in length and encodes a protein of 
520 amino acids.  CYP4-3c sequences represent members that appear to be a hybrid1 
between CYP4-3a and CYP4-3b groups (Figures 11, 12), with amino acid identities 
ranging from 94.6% to 98.0% (CYP4-3c and CYP4-3a) and 94.2% to 96.9% (CYP4-3c 
and CYP4-3b).  Percent identities increase even further if you restrict the region of 
comparison to the N-terminal half of CYP4-3c which is nearly identical to that of CYP4-
3a, whereas the same can be said of the C-terminal half of CYP4-3c with CYP4-3b3.   
A list of putative Cyphoma CYP4 genes, described here with their corresponding 
names assigned by the P450 Nomenclature Committee, can be found in Table 5.  An 
amino acid alignment of the 15 full-length CYP4 cDNAs generated from nucleotide 
consensus sequences is shown in Figure 12. 
 
Sequence analysis 
BlastX searches with full-length cDNA sequences and phylogenetic analysis 
using both Bayesian and Maximum Likelihood methods (Figures 13, 14) confirmed that 
all of the Cyphoma sequences identified here belong to the cytochrome P450 4 clan and 
should be placed within the CYP4 family of sequences (Nelson et al. 2004).  The CYP4 
family is one of the oldest, most diverse families within the P450 superfamily (Simpson 
1997).  Because of this ancient lineage, the addition of new members in this family has 
blurred the definition of what constitutes a CYP family leading to ‘family creep’ or the 
inclusion of invertebrate members with less than 40% identity due to the reluctance to 
                                                 
1 The term hybrid refers to a cDNA sharing identical blocks of sequence with two or more distinct cDNAs 
and does not imply a specific mechanism used to generate the hybrid cDNA  
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 create new CYP families and the recognition that phylogenetic relationships need to be 
considered (Nelson et al. 2004).   
Serial duplication events appear to have occurred within both the CYP4-2 
(CYP4BK) and CYP4-3 (CYP4BL) lineages.  The paralogous CYP4-2 and CYP4-3 
Cyphoma sequences share less than 40% amino acid sequence identity with full-length 
vertebrate CYP4 members, and cluster within an apparently invertebrate-specific clade 
whose most closely related vertebrate homologs are found within CYP4 subfamilies A, 
B, F, T, X, Z (Figure 13).  Top scores from BlastX searches indicate that Cyphoma 
CYP4-2 and CYP4-3 cDNAs are more similar to mammalian CYP4F members than to 
other non-mammalian CYP4F members or other vertebrate CYP4 subfamilies, suggesting 
possible convergent evolution between Cyphoma CYP4s and mammalian CYP4F forms, 
or the retention of residues reflecting a more ancestral form and indicating possible 
shared substrates between these two groups.  A comparison of Cyphoma CYP4-2a, 
CYP4-2b to vertebrate CYP4 members found that Cyphoma cDNAs were most similar to 
mouse CYP4F13 (GenBank Accession # NP_570952.1) with amino acid identity ranging 
from 37.8 to 38.0%, compared to 32.9 to 33.0% with Dicentrarchus labrax CYP4F7 
(seabass, GenBank Accession # AAD32564).  Identities between Cyphoma CYP4-3 
sequences and mouse CYP4F39 (GenBank Accession # AA145756.1) ranged from 36.4 
to 37.3%, compared to 30.9 to 33.0% with D. labrax CYP4F7.   
Cyphoma CYP4-1 (CYP4V10) sequences, however, do share >40% protein 
identity with other vertebrate CYP4V amino acid sequences, including 47.5-47.9% with 
zebrafish CYP4V2 (GenBank Accession # AAI25969) and 45.5-45.9% with human 
CYP4V2 (GenBank Accession # Q6ZWL3).  Cyphoma CYP4-1 sequences also share 
142
 >40% identity with invertebrate sequences formally designated within the CYP4C 
subfamily that have recently been moved into the CYP4V subfamily and include 45.2-
45.6% with Carcinus maenas CYP4V16 formally CYP4C39 (green crab, GenBank 
Accession # JC8026), and 41.3-41.7% with Orconectes limosus CYP4V11 - formally 
CYP4C15 (crayfish, GenBank Accession # AAF09264). 
Several conserved domains are present within all of the Cyphoma CYP4 proteins.   
Beginning at the N-terminal portion, eukaryotic CYPs carry a sequence of amino acids 
responsible for targeting the P450 protein to the correct subcellular location in the 
membrane, which is absent in soluble bacterial P450 proteins (Figure 12).  The highly 
conserved WXXXR domain towards the N-terminus is located in the center of the C-
helix and neutralizes the charge of one of the propionate side chains of the heme group by 
the tryptophan nitrogen and the basic arginine (Graham & Peterson 2002).  The I-helix, 
or P450 fingerprint region, is one of the most highly conserved domains among P450s.  
All of the Cyphoma CYP4 sequences contain the conserved threonine residue, located 
within the I helix, which is thought to aid in the protonation of the reduced oxygen 
intermediate (Williams et al. 2000a).  The conserved EXXR domain found within the K-
helix and located on the proximal side of the heme, may assist in stabilizing the heme 
core.  Located just before the L-helix is the P450 consensus sequence (FXXGXRXCXG) 
containing the absolutely conserved cysteine serving as the fifth ligand to the heme iron 
(Werck-Reichhart & Feyereisen 2000). 
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 Quantitative RT-PCR analysis of CYP4 expression 
 Quantitative RT-PCR analysis was used to investigate the constitutive and 
inducible expression of CYP4 forms in Cyphoma after dietary exposure to several 
gorgonian species with varying allelochemical profiles.  Adult Cyphoma were allowed to 
feed ad libitum for 4 d on one of seven gorgonian diets or a control diet devoid of 
gorgonian allelochemicals.  CYP4 transcripts were measured by quantitative RT-PCR 
from mRNA extracted from the digestive glands of either control or allelochemically-
exposed snails using general and specific gene primers2.  Digestive gland expression of 
CYP4 transcripts was monitored using general-cyp4-1, general-cyp4-2, general-cyp4-3 
oligonucleotide primers and two additional primer pairs specific for a subset (A and B) of 
CYP4-3 sequences (Table 3).  Figure 15 maps the location of those CYP4-3 clones that 
would be detected by CYP4-3(sub A) and CYP4-3(sub B) primers.  Control amplifications 
were performed with cDNAs to confirm the specificity of the primers (data not shown).   
   Initially, CYP4 expression analysis was performed using only general-cyp4-1, 
general-cyp4-2, and the subset-specific CYP4-3(sub A) and CYP4-3(sub B) quantitative PCR 
primers (Figure 16).  Subsequently, it was determined that CYP4-3(subA) and CYP4-3(sub B) 
primers did not detect some transcripts and the expression analysis was repeated with 
general-cyp4-3 primers for control snails and snails consuming the gorgonian diet P. 
homomalla for which a significant induction of CYP4-3 gene subsets was seen (Figure 
17). 
                                                 
2 Three sets of general primers were designed to each of the three Cyphoma CYP4 clusters (CYP4-1, 
CYP4-2, CYP4-3) and were used to detect the expression of all sequences within the cluster.  Two sets of 
specific primers, designated CYP4-3(sub A) and CYP4-3(sub B), were designed to pick up selected subsets 
of sequences within the CYP4-3 cluster only.  
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 Significant differences in CYP4 expression between control and gorgonian diets 
were found for three gorgonian species (MANOVA, G. ventalina F4,33 = 18.99, p < 
0.001; P. americana F4, 32 = 6.653, p < 0.001; P. homomalla F5,30 = 7.479, p < 0.001; 
Table 6).  However, for two of the two gorgonian diets a significant Diet x Reef 
interaction was observed (MANOVA, G. ventalina F16, 101 = 6.392, p < 0.001; P. 
homomalla F15,66  = 2.429, p < 0.001, Table 6), indicating that CYP4 expression in snails 
inhabiting particular reefs were of high influence.  ANOVA analysis further revealed that 
the significant Diet x Reef interaction in snails feeding on G. ventalina and P. homomalla 
could be traced to significant differences in CYP4-3(subA) expression among reefs (Table 
7).  Two snails collected from N. Normans out of 13 feeding on G. ventalina and one 
snail collected from Shark Rock out of 11 feeding on P. homomalla, showed negligible 
expression of CYP4-3(subA) transcripts, accounting for the significance of the interaction 
term.  Interestingly, all three of these snails did express transcripts detected by subset-
specific CYP4-3(subB) primers at levels similar to other snails feeding on the same diet.  In 
addition, when the entire complement of CYP4-3 transcript expression was measured in 
control and P. homomalla fed snails using general-cyp4-3 primers, the single snail from 
the Shark Rock collection feeding on P. homomalla, originally showing anomalous gene 
expression for CYP4-3(sub A), displayed induced CYP4-3 transcript expression compared 
to reef controls.  This finding may indicate that sequences detected by CYP4-3(subA) 
primers represent alternative splice variants or alleles that may not be expressed within 
certain subpopulations of snails.  Sequences that are detected by CYP4-3(subA) primers are 
contained within the CYP4-3b1/CYP4-3b3/CYP4-3c groups defined by maximum 
parsimony analysis (Figure 15), all of which contain clones that are highly homologous to 
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 each other at the C-terminal end.  However, CYP4-3b1, CYP4-3b3, and CYP4-3c share 
between 94.2 and 96.9% protein identity, which falls below the 97% cut-off suggesting 
they are distinct genes.  It is possible that these distinct loci may be inducible by specific 
compounds rather than structurally similar classes of allelochemicals produced by P. 
homomalla, and natural variability in allelochemical content among gorgonian colonies 
may account for differences in transcript expression.   
In light of this information, the data were reanalyzed for both gorgonian diets 
excluding those reefs containing snails with the anomalously low CYP4-3(subA) 
expression values.  As expected, there were no significant differences in CYP4 gene 
expression among snails feeding on G. ventalina (data not shown), but gene expression 
was still significantly different in snails feeding on P. homomalla compared to controls 
(MANOVA, F5,24 = 7.606, p < 0.001, Table 6).  There was significant induction 
(ANOVA, p < 0.001, Table 7) of CYP4-2 (2.7-fold), CYP4-3 (2.7-fold), and CYP4-
3(subA) (5.1-fold) gene expression in snails fed P. homomalla compared to controls (Figure 
17) and the significant differences among P. homomalla-fed snails were limited to diet 
effects only.  In addition, significant differences in CYP4 expression in P. americana-fed 
snails (MANOVA) were found not to be significant in ANOVA comparisons after p-
values were Bonferroni adjusted (Table 7). 
CYP4 gene expression did differ significantly among time-zero group snails 
collected from different reefs (MANOVA, F20,70 = 1.739, p = 0.047, Table 8, Figure 18).  
However, CYP4 gene expression did not vary among snails from different reefs fed a 
control diet for 4 days (MANOVA, F20,80 = 1.367, p = 0.164, Table 8, Figure 18).   These 
results demonstrate that gene expression is highly variable among snails collected from 
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 different reefs, possibility reflecting the variability of gorgonian diets at each reef 
location.  If one considers the time-zero group as a proxy for the natural variation of gene 
expression in individuals on different reefs, then four days feeding on a control diet is 
enough to allow gene expression to return to some constitutive level, no matter reef 
origin, once the allelochemical stimulus is removed.  Therefore, these results support the 
use of control snail gene expression as the true baseline, representing the non-
allelochemically induced state of CYP4 gene expression in Cyphoma. 
Running in parallel to the four day feeding assays was a longer term (14d) feeding 
assay used to investigate CYP4 gene expression in individuals exposed to the same 
gorgonian host almost five times longer than would be expected based on observations of 
residence time in the field (Harvell & Suchanek 1987).  The design of the long term 
feeding assay was the same as described above, except one raceway contained ten tanks, 
each holding a single snail feeding on either a control diet (n = 2 snails) or one of seven 
gorgonian diets (n = 7 snails) for 14 d.  All nine snails were collected from the same reef 
(i.e., North Normans).  The mean CYP4 expression of two snails feeding on the control 
diet for 14d was no different from snails feeding on control diets for 4d (Figure 19).  
While the CYP4 expression results in snails feeding on a gorgonian diet are limited to 
one observation per gorgonian species, snails feeding on B. asbestinum, E. mammosa, G. 
ventalina, P. acerosa, P. americana, and P. elisabethae displayed CYP4 expression 
patterns similar to that of the paired controls (data not shown).  Based on the four day 
feeding assays we expected to see sustained induction of CYP4-2, CYP4-3 and CYP4-
3(subA) genes in the individual feeding on P. homomalla for 14d; there was higher CYP4-
3(subA) gene expression in this snail compared to the control individuals, but expression of 
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 CYP4-2 and CYP4-3 was similar to that of controls (Figure 19).  However, feeding 
records indicate that the individual feeding on P. homomalla ceased feeding six days 
prior to the end of the 14d, which may explain the lack of CYP4 induction in this 
individual.  
 
Identification of putative substrate recognition sites 
Allelochemically-responsive Cyphoma CYP4 protein sequences were compared 
with characterized vertebrate fatty acid hydroxylases to help define the possible function 
and range of substrates for Cyphoma CYP4 forms by comparing key conserved residues 
among both groups.  Cyphoma CYP4 proteins were also aligned with the crystal structure 
coordinates of bacterial fatty acid monooxygenase CYP102 (CYPBM3) (Ravichandran et 
al. 1993) and CYP2 forms described in (Gotoh 1992) to better define putative SRS 
regions and highlight differences between active site and substrate binding residues 
among Cyphoma P450 forms.  
The bacterial CYP102 was used as a template to align Cyphoma CYP4-2 and 
CYP4-3 forms.  In addition, human CYP4F3, CYP4F11 and rabbit CYP4A4, CYP4A5, 
CYP4A6, CYP4A7 were included in the alignment to aid in comparing previously 
annotated active site residues between mammalian fatty acid hydroxylases and Cyphoma 
CYP4 proteins (Figure 20).  Amino acid identity between bacterial CYP102 and 
Cyphoma CYP4-2 and CYP4-3 sequences ranged between 16.6-21.5%.  The bacterial 
CYP102 was used in place of one of the many crystallized eukaryote P450 forms (e.g., 
rabbit CYP2C5) because the CYP102 alignment with Cyphoma CYP4 genes resulted in 
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 the highest percent identity (data not shown).  Therefore, the bacterial CYP102 backbone 
was used as the template to define putative SRSs within the Cyphoma CYP4 proteins.   
Even though Cyphoma CYP4 sequences are highly similar to one another within 
the clusters defined here, variation among even one residue can have a profound effect on 
enzymatic function (Lindberg & Negishi 1989).  An alignment of the deduced amino acid 
sequences of both CYP4-2a and CYP4-2b indicates that the sequence variations are 
limited to 27 out of a possible 508 positions, not including the additional 6 residues at the 
C-terminal end of CYP4-2b.  Seven of the 27 residues fall within five of the six substrate 
recognition sites (SRSs) which are critical for defining substrate specificity and activity 
in both vertebrate and invertebrate CYPs (Gotoh 1992, Pan et al. 2004).  A similar 
deduced amino acid alignment constructed for all sequences found in the CYP4-3 group, 
indicated that sequence variation was limited to 40 out of 520 positions, with 13 
substitutions occurring within SRSs.  If we narrow our comparison to just the seven 
sequences representing the highly similar  CYP4-3b subgroup (95.0 to 99.2% a.a. 
identity), 32 out of 520 possible positions contain amino acid variations, 13 of which are 
located in one of the six SRS regions. 
The great diversity of P450 reactions stems from the structural arrangement of the 
P450 protein, allowing for the discrimination and orientation of substrates in close 
proximity to the activated oxygen species located in the heme core.  Rigorous homology 
modeling of human CYP4A11 with bacterial fatty acid hydroxylase CYP102 coupled 
with site-directed mutational analysis has highlighted key resides in the binding pocket 
and substrate access channel influencing substrate specificity and hydroxylation position 
(Chang & Loew 1999).  Table 9 contains a listing of these residues from CYP102 and 
149
 CYP4A11 with the corresponding residues from the Cyphoma CYP4-2 and CYP4-3 
group of sequences.  The order of residues listed in the table is based on their proximity 
to the heme core (upper - region nearest to the surface of the protein; middle - region 
buried in the middle located at distance from the ferryl oxygen; lower - region containing 
residues with 7 Å from the ferryl oxygen and site of metabolic activity).  Despite the low 
sequence similarity overall, half of the residues within the lower substrate channel are 
absolutely conserved between the bacterial, human, and Cyphoma proteins, including 
T260, F261, G265, T268, A328 from CYP102.  Three of the four remaining residues near 
the heme core in CYP102 (L75, A264, and A328) are replaced by bulkier residues in 
human CYP4A11 (Y120, E321, V386), which control the entrance and depth of substrate 
penetration within the active site and favor terminal carbon hydroxylation by restricting 
only the ω methyl group to come within proximity to the ferryl oxygen (Chang & Loew 
1999).  Cyphoma CYP4-2 and CYP4-3 forms also contain the same bulky residues as 
CYP4A11 within their active sites (Table 9), suggesting terminal hydroxylation would be 
favored.      
In addition, within the active site of CYP4A, CYP4B, and CYP4F forms, a 
glutamate residue (E321 in CYP4A11 in Table 9) binds to the heme positioning the fatty 
acid into a position favoring ω-hydroxylation (Stark et al. 2005).  Mutating this position 
to an alanine results in the reduction of terminal carbon hydroxylation (ω:ω-1) from 20:1 
to 5:1, or the complete elimination of ω-hydroxylation all together (Dierks et al. 1998a, 
Dierks et al. 1998b) and reduced fatty acid hydroxylation (Zheng et al. 2003).   Cyphoma 
CYP4-2b contains the less bulky alanine at the position equivalent to E321 in CYP4A11, 
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 which would predict reduced hydroxylase activity and a substrate orientation favoring 
non-terminal ω hydroxylation for this cDNA. 
Modeling studies of mammalian CYP4A (Chang & Loew 1999, Loughran et al. 
2000) indicate that residues falling outside of the prescribed SRSs regions (Gotoh 1992) 
still play critical roles in substrate binding and activity (Figure 20).  Many of these 
residues correspond to polymorphic sites within Cyphoma CYP4-2 and CYP4-3 proteins.  
For example, residues 81 and 91, forward of the first SRS region in the Cyphoma CYP4-
3 cluster, are highly polymorphic and correspond to positions located at the mouth of the 
substrate access channel in CYP4A7 (R88) and CYP102 (Y51), responsible for anchoring 
the terminal carboxylic group on the fatty acid to the protein (Loughran et al. 2000).  In 
general, Cyphoma CYP4-2 and CYP4-3 proteins seem to contain a majority of residues 
with small side chains at these positions (alanine, glycine, valine), suggesting that the 
opening of the substrate access channel may be able to accommodate larger fatty acids.   
Further work by (Loughran et al. 2000) identified two additional residues (Y204 
and F252) in rabbit CYP4A4, one of which is located outside of putative Cyphoma SRS 
sites defined here, that influence PGE1 hydroxylase activity (Figure 20).  These residues 
have been replaced by H206 and S255 in CYP4A7, which shows substantially less 
turnover of PGE1 in comparison to CYP4A4.   Cyphoma CYP4-2 proteins share the same 
residues at both corresponding positions in CYP4A4 (Y200 and F248), highlighting their 
potential role as prostaglandin (i.e., PGE1) hydroxylases.  Cyphoma CYP4-3 proteins 
share either tyrosine (Y) or histidine (H) at the first position corresponding to Y206 in 
CYP4A4, and contain a tryptophan (W) at the second position, corresponding to a 
conservative substitution from a similar aromatic phenylalanine (F) in CYP4A4. 
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 Homology models of CYP4F3 and CYP4F11 based on bacterial (CYP102) and 
eukaryotic P450 crystal structure coordinates agree, for the most part, with our putative 
SRS assignments made for Cyphoma CYP4s based on our alignment to CYP102 
(Kalsotra et al. 2004) (Figure 20).  The exception is the SRS-2 region, which is slightly 
offset in comparison to Cyphoma CYP4 SRS-2, possibly due to the highly gapped nature 
of the author’s alignment resulting from the variability seen among P450s within the F-G 
loop region (Peterson & Graham-Lorence 1995).  The positioning, length and polarity of 
the F-G loop is thought to dictate the accessibility of the substrate to the access channel 
(Peterson & Graham-Lorence 1995, Williams et al. 2000b).  The F-G loop in Cyphoma 
CYP4-2 and CYP4-3 is predicted to be substantially larger, containing 19 additional 
residues within the G helix, in comparison to CYP102.  Interestingly, almost the entire F-
helix has been removed from sequence CYP4-3a1v2, likely altering the substrate profile 
for this variant.  Additionally, the putative SRS-1, -2 sites suggested here are different 
from those defined by (Loughran et al. 2000) for CYP4A members.  It is likely that 
Cyphoma allelochemically-responsive CYPs share properties of both vertebrate 
CYP4A/F groups because of their evolutionary history and probable shared function.  To 
date, no crystal structure has been determined for any eukaryotic CYP4 protein, further 
complicating the definitive identification of key residues for this family of proteins. 
In summary, a majority of the amino acid substitution patterns among Cyphoma 
CYP4-2 (15 out of 27) and CYP4-3 (22 of 40) sequences cluster within SRS or near 
(within 2 residues) positions identified as being involved in the positioning of the 
substrate within the access channel or the active site.  Although SRS-1 and 2 sites may 
shift somewhat depending on the species and subfamily used for comparison, these 
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 patterns suggest that amino acid replacement differences are targeted within domains 
affecting substrate recognition. 
   
Results of enzymatic assays 
 P450 content and reductase activity.  The P450 content of Cyphoma microsomal 
proteins and recombinant yeast microsomes containing selected CYP4 cDNAs (Figures  
21, 22) was investigated by the method of (Omura & Sato 1964).  The characteristic P450 
spectral peak was not detected in Cyphoma digestive gland microsomal preparations nor 
was a peak at 420 nm indicating the presence of degraded protein.  Cytochrome P450 was 
consistently detected in recombinant microsomes from yeast induced for 8 hrs on 
galactose-containing media (27.4 pmol P450 mg protein-1 – 118.7 pmol P450 mg protein-
1), but not in yeast induced for 15 hrs.  No 420 nm peak was ever observed in any yeast 
microsomal preparations.  The lack of chromophore detection at 450 nm with 
spectrophotometry in some yeast samples does not preclude NADPH-dependent 
enzymatic activities in these yeast microsomes.  For example, recombinant yeast 
expression of ovine CYP4F21 yielded no P450 spectra, but yeast microsomes containing  
CYP4F21 metabolized three stable PGH2 analogues and PGE2 to their respective 20-
hydroxy metabolites, whereas control microsomes lacked such activity (Bylund 2000, 
Bylund & Oliw 2001).  NADPH-cytochrome P450 reductase activity was also confirmed 
to be strongly induced in galactose-induced yeast microsomal samples (~ 5000 nmol min-
1 mg protein-1) and highly expressed in the one snail digestive gland examined (631 nmol 
min-1 mg protein-1). 
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  Fatty acid hydroxylase activity.  Yeast microsomes containing Cyphoma CYP4-2 
and CYP4-3 (Figure 22) proteins were surveyed for both lauric acid and leukotriene B4 
(LTB4) hydoxylase activity to define a range of possible fatty acid substrates for 
Cyphoma CYP4 proteins.  Recombinant yeast microsomes, isolated from 8- and 15-hr 
induced cultures expressing either CYP4-2a, CYP4-2b, CYP4-3a1, CYP4-3b1, or CYP4-
3b3, were incubated with 0.1 mM lauric acid or 29.7 μM LTB4 and the production of 
hydroxylated metabolites was analyzed by HPLC or liquid scintillation detection.  Yeast 
microsomes containing recombinant CYP4 protein did not metabolize lauric acid to any 
detectable metabolites; however, leukotriene B4 hydroxylase activity was detected in 
recombinant yeast microsomes (Table 10, Figure 23).  LTB4 activity was present only in 
yeast expressing CYP4-3a1 and CYP4-3b3 ranging from 0.017 – 0.299 pmol mg-1 min-1 
and was greater in samples incubated at 30oC then at 23oC.  In addition, LTB4 
hydroxylase activity was detected in the digestive gland of three of the four snails feeding 
on P. homomalla, while only one of the ten snails feeding on the control diet exhibited 
detectable activity (Table 11).   Human liver microsome samples were run in parallel 
experiments and showed typical activity and metabolic profile for this enzyme source. 
 
Discussion 
 This study provides the first evidence linking the induction of specific P450 
transcripts in a marine consumer to the chemistry of its gorgonian host.  The diet of the 
generalist C. gibbosum includes a variety of gorgonian families with structurally diverse 
allelochemical profiles.  Only snails feeding on the gorgonian Plexaura homomalla 
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 displayed significant induction (2.7- to 5.1-fold) of digestive gland CYP4 transcripts in 
comparison to individuals feeding on a control diet devoid of gorgonian allelochemicals.   
The suite of allelochemicals produced by P. homomalla is unique to this genus of 
Caribbean coral and includes high tissue concentrations of prostaglandins (1 to 8% of the 
dry tissue weight) (Weinheimer & Spraggins 1969, Schneider et al. 1977a, Dominguez et 
al. 1980).  In mammalian systems, prostaglandins behave as ‘local’ (i.e., autocrine or 
paracrine) lipid mediators, acting through G-protein-coupled receptors to stimulate the 
pro-inflammatory cascade after tissue injury, sensitize neurons to pain, stimulate smooth 
muscle contraction, regulate vasodilation, regulate temperature, and control ionic balance 
in the kidney (Funk 2001, Rowley et al. 2005).  In invertebrates, prostaglandins play 
similar roles as modulators of ion transport and regulators of immune response and 
reproduction (Stanley 2000, 2006), but are most notable as prey chemical defenses in 
marine systems (Gerhart 1984, Di Marzo et al. 1991, Gerhart 1991, Marin et al. 1991).   
The most abundant prostaglandin in P. homomalla is the fully esterified PGA2 
form (averaging 1-2% of dry weight), followed by its hydroxy acid (0.2% of dry weight) 
(Weinheimer & Spraggins 1969, Schneider et al. 1977a, Dominguez et al. 1980).  
Damage to gorgonian soft tissue can stimulate the lipase-mediated enzymatic hydrolysis 
of the acetoxy methyl ester of PGA2, resulting in the accumulation of the partially 
esterified PGA2 compounds (Schneider et al. 1977a, Valmsen et al. 2001).  Palatability 
studies with a natural assemblage of reef fish have confirmed the ichthyodetterency of the 
crude extract of P. homomalla (O'Neal & Pawlik 2002), the hydroxy acids of PGA2 (both 
S and R isomers), and both the hydroxyl methyl ester and acetoxy acid of PGA2 (Gerhart 
1984, Pawlik & Fenical 1989).  Interestingly, the fully-esterified form of PGA2 did not 
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 deter consumption; however, esterified prostaglandins have been hypothesized to 
function as sources of inducible defenses, whereby damage to the coral may cause the 
innocuous acetoxy methyl esters to undergo hydrolysis to the noxious hydroxy acids over 
a period of several hours (Pawlik & Fenical 1989).  The esterification of prostaglandins 
may protect the gorgonian from self-intoxication, allowing for the high concentration of 
prostaglandin compounds to persist in gorgonian tissues.  For less mobile predators, like 
C. gibbosum, feeding stimulated formation of the hydroxy acids of PGA2 in P. 
homomalla hosts and/or acidic hydrolysis of esterified PGA2 forms in the low-pH gastric 
environment could pose a significant threat to these obligate gorgonian predators, unless 
they possess orchestrated detoxification mechanisms capable of responding to their host 
allelochemicals.     
Within the diverse P450 superfamily, family 4 monooxygenases (CYP4) contain 
the major fatty acid ω-hydroxylases capable of preventing lipotoxicity (Hsu et al. 2007).  
Phylogenetic analysis of C. gibbosum P450 sequences revealed that those transcripts 
induced in response to dietary exposure of P. homomalla are most closely related to 
vertebrate CYP4A and CYP4F forms well known for their ability to metabolize 
prostaglandins, including PGA2 (Sawamura et al. 1993, Okita & Okita 2001, Capdevila & 
Falck 2002, Kikuta et al. 2002, Kalsotra & Strobel 2006).  In some cases the snail CYP4s 
share the same amino acid residues determined to be important in prostaglandin 
metabolism by vertebrate CYP4A/F forms.  Allelochemical-responsive P450s in 
Cyphoma include both CYP4-2 and CYP4-3, which likely function in a cooperative 
fashion to mediate prostaglandin detoxification.  The induction of P450 forms by 
gorgonian diets did not extend to all Cyphoma CYP4 forms.  CYP4-1 (CYP4V10) was 
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 not induced, nor would this have been expected, since it falls within the CYP4C/V clade 
containing CYP forms whose roles have been postulated to include hormone-stimulated 
fatty acid oxidation during starvation (cockroach, CYP4C1) (Lu et al. 1996, 1999) and 
fatty acid metabolism in the retina in vertebrates (reviewed in Hsu et al. 2007).   
P450 genes, in contrast to housekeeping genes, are often transcriptionally induced 
by substrates upon which they act (Whitlock 1986).  A significant increase in mRNA for 
selected CYP4 transcripts was observed in snails following a 4 d dietary exposure to P. 
homomalla allelochemicals.  Both CYP4-2 and CYP4-3 were constitutively expressed 
and induced to the same degree (2.7-fold).  This combination of constitutive and 
inducible expression mirrors that of the CYP6B17 and related transcripts in Papilio 
glaucus, a generalist lepidopteran that feeds on a range of host plants and occasionally 
encounters toxic furanocoumarins in its diet (Li et al. 2001).  CYP6B17 is constitutively 
expressed in uninduced larvae and induced 3-fold in larvae exposed to the 
furanocoumarin xanthotoxin.  For generalist species like P. glaucus and C. gibbosum, 
where the chance of encountering an allelochemically-rich diet is high, there may be a 
selective advantage to constitutively expressing select P450 forms.  P. glaucus also 
expresses a second group of furanocoumarin metabolizing genes that are closely related 
to the CYP6B17 group.  These transcripts within the CYP6B4 group are not 
constitutively expressed in unexposed larvae, but are highly inducible upon exposure to 
furanocoumarins (Li et al. 2001).  In contrast, all of the allelochemically-responsive 
genes had some measurable level of constitutive expression in control-fed snails; 
however, additional quantitative PCR analysis of a subset of Cyphoma CYP4-3 genes 
revealed CYP4-3(sub A) transcripts exhibited a greater fold induction (5.1-fold) and lower 
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 basal expression in comparison to the CYP4-3 cluster as a whole.  This result suggests 
selective CYP4-3 forms have different patterns of inducibility, perhaps to respond to 
different suites of compounds produced by P. homomalla.   
 Since their initial discovery of prostaglandins in gorgonians by Weinheimer and 
Spraggins in 1969, the synthesis (Valmsen et al. 2001, Valmsen et al. 2004), structural 
diversity (Spraggins 1972, Schneider et al. 1977b, Agalias et al. 2000, Schneider et al. 
2002, Schneider et al. 1972, Light & Samuelsson 1972, Schneider et al. 1977a, Groweiss 
& Fenical 1990) and bioactivity of these compounds (Honda et al. 1987, Bhakuni & 
Rawat 2005, Chiang et al. 2006, Roberts et al. 2003) have been studied intensively.  
Prostaglandins in the A series (i.e., PGA2) dominate the bulk of the crude extract of 
Plexaura homomalla (Schneider et al. 1977a).  The 15(R) form of PGA2 is typically 
found in Florida Keys populations, whereas the typical mammalian 15(S) form is found 
in colonies collected in the Bahamas, Cayman Islands and Curaçao (Schneider et al. 
1977b, Ciereszko et al. 1985, Gerhart 1986, Schneider et al. 2002).  Generally, individual 
P. homomalla colonies produce either the R and S configurations, but mixtures within the 
same colony have been reported (Schneider & Morge 1971, Schneider et al. 1977a).  
Several PGA2 analogues of minor abundance have also been described; these include 5,6-
trans-PGA2 (5-15% of the PGA2 fraction) (Schneider et al. 1977a), and 13,14-dihydro- 
and 13,14-cis-PGA2 derivatives (Schneider et al. 1977b).  Bahamian P. homomalla 
populations have also been reported to contain the prostaglandin E2 (PGE2), methyl ester 
and 15-acetate methyl ester at roughly 10% of the abundance of PGA2 esters (Schneider 
et al. 1972, Prince et al. 1973, Schneider et al. 2002) and prostaglandin F2α (PGF2α) as 
both the acid and the acetate methyl ester (0.6% of the chloroform extract) (Groweiss & 
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 Fenical 1990).  It is possible that the structurally diverse pool of prostaglandins found in 
gorgonian tissues may have necessitated the evolution of multiple prostaglandin 
metabolizing P450s, resulting in the diversity of closely related CYP4-3 transcripts 
identified here.  Many of the amino acid differences (22/40) among members of the 
CYP4-3 group occur within, or near, the putative six SRS regions or residues lining the 
substrate access channel.  Based on the location of these differences and knowledge 
gained from site-directed mutagenesis studies, it is likely that these variations will confer 
differences in catalytic activity and substrate specificity among these closely related 
proteins.   
It is conceivable that ancestral Cyphoma P450s, whose function was to metabolize 
endogenous fatty acids, acquired new functions through strategic mutations allowing this 
predator to exploit prostaglandin-rich prey.  One recent study suggests that the loss of 
host plant specialization in the Papilio lineage, favoring generalists like P. glaucus, may 
have evolved from only a small number of mutational changes within the SRS-6 region, 
allowing for the acquisition of novel catalytic activities while still retaining the ancestral 
furanocoumarin-metabolizing capability (Mao et al. 2007).  This gradual accumulation of 
functionally significant replacements, often following a series of gene duplications (Wen 
et al. 2006), has been hypothesized as a means for enzymes to evolve in response to host 
selection (Mao et al. 2007).  It would be interesting to explore whether the co-occurring 
specialist Cyphoma signatum, which feeds exclusively on Plexaurella spp., known only 
to contain the eicosanoid 11-R-hydroxy-5Z,8Z,12E,14Z-eicosateraenoic acid (11-R-
HETE) (Di Marzo et al. 1996) and not prostaglandins, retains a similar diversity CYP4 
transcripts capable of responding to foreign dietary prostaglandins.  Insect studies 
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 indicate that the constitutive expression, inducibility and catalytic versatility of herbivore 
P450s generally correspond to the frequency of ecological allelochemical exposure 
(Cohen et al. 1992, Li et al. 2001, Li et al. 2007).  This theory would predict that while C. 
signatum may share similar CYP4 genes, C. gibbosum would be more efficient at 
metabolizing dietary prostaglandins.  
 The expansion of the CYP4-3 cluster relative to the other Cyphoma P450s 
identified in the present study suggests positive selection of this subfamily likely through 
repeated gene duplication events.  In addition, alternative splicing of transcripts or the 
formation of chimeric CYPs from the splicing of pre-mRNA molecules can allow for the 
generation of novel genes with divergent catalytic functions.  There is evidence for both 
of these scenarios within the P450 superfamily.  For example, the human CYP4F3 gene 
has two different inducer specific 5’ UTR transcriptional start sites capable of controlling 
the mutually exclusive splicing of either exon 3 or 4, generating the tissue-specific 
expression of catalytically distinct CYP4F3A and CYP4F3B isoforms (Christmas et al. 
1999, Christmas et al. 2001).  In addition, chimeric RNA molecules have been identified 
for both CYP2C and CYP3A members (Finta & Zaphiropoulos 2000, Finta & 
Zaphiropoulos 2002).  In this case, exons are joined together from distinct pre-mRNA 
molecules yielding chimeric mRNAs.  Formation of hybrid mRNA, especially by trans-
splicing, allows detritus or solo exons to become functional even if they are dispersed in 
the genome (Bonen 1993).  In both cases, exon shuffling or alternative splicing of distinct 
transcripts provides the opportunity for novel catalytic functions to emerge, further 
increasing the diversity of P450 genes.  However, without specific knowledge of the 
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 genomic arrangement or exon-intron structure of Cyphoma CYP4 genes, we cannot 
distinguish between these and other possibilities.   
The consensus amino acid sequence representing Cyphoma CYP4-3c (clones 
within this group share greater than 96.3% a.a. identity) is a hybrid of both the CYP4-3b 
and CYP4-3a groups, with individual clones spanning a range of identities between the 
3a and 3b nodes (Figure 10).  This suggests the CYP4-3c locus defined here could be 
made up of multiple loci resulting from repeated duplication events, one locus with 
highly polymorphic alleles, or products of alternative splicing or trans-splicing.  The 
same could also be said of the CYP4-3b2 subgroup represented by five unique clones.  
CYP4-3b2_clone 5 is a hybrid between CYP4-3b2_clone 3/CYP4-3b2_clone 4/CYP4-
3b3 (N-terminal) and CYP4-3a group (C-terminal).  Alternatively, the hybrid nature of 
CYP4 forms here may have resulted from the combination of gene duplication events 
followed by gene conversions, resulting in the homogenization present among members 
of the CYP4-3 group.  This scenario has been hypothesized to account for the nearly 
identical amino acid sequences in CYP6B gene paralogs in the moth, Helicoverpa zea (Li 
et al. 2002b).   Additional studies such as genomic PCR or the construction of a BAC 
library would help precisely identify the number of distinct loci represented by the 
CYP4-3 cluster. 
Multiple gene duplication events are common among CYP4 members, including 
human CYP4F genes (CYP4F2, CYP4F3(A/B), CYP4F8, CYP4F11, CYP4F12) (Nelson 
et al. 2004).  While these genes share greater than 77% amino acid identity with each 
other, their enzymatic activities and substrate specificities can be strikingly different 
(reviewed by Kalsotra & Strobel 2006).  A closer examination of the substrate spectrum 
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 for vertebrate fatty acid hydroxylases suggests certain isoforms have narrow substrate 
specificity, which is a significant departure from those xenobiotic CYP families (1, 2, 3) 
known for their broad substrate pool.  Consequently, the lack of lauric acid hydroxylase 
activity or substantial LTB4 hydroxylase activity in recombinant yeast microsomes 
reported here does not preclude fatty acid hydroxylase activity of Cyphoma CYP4 
proteins.  For example, recombinant rabbit CYP4A4 can metabolize long chain fatty 
acids, including prostaglandins, yet shows little if any ability to metabolize lauric acid 
(reviewed in Okita & Okita 2001).  Mouse CYP4F14 catalyzes the ω-hydroxylations of 
LTB4, lipoxin A4 and PGA1, but no activity towards lipoxin B4, lauric acid or arachidonic 
acid was detected (Kikuta et al. 2000).  Similarly, not all LTB4 ω-hydroxylases catalyze 
prostaglandin hydroxylation.  For example, human CYP4F3 shares LTB4 ω-hydroxylase 
activity with rodent CYP4F14, yet it does not catalyze the hydroxylation of PGA1, PGE1, 
or lauric acid (Kikuta et al. 1998).  It is possible that the substrate specificities of 
allelochemically-responsive Cyphoma CYP4 forms might be finely tuned toward those 
fatty acids (primarily prostaglandins) found within its gorgonian diet.  Even so, LTB4 
hydroxylase activity measurements in Cyphoma microsomes suggests those snails 
exposed to prostaglandin-rich gorgonian diets have a greater ability to metabolize fatty 
acids in comparison to snails feeding on control diets, and it is likely that this enhanced 
enzymatic activity is due to the induction of allelochemically-responsive CYP4s.   In 
vitro studies will be needed in order to directly demonstrate that ecologically relevant 
prostaglandins can serve as substrates for C. gibbosum P450s; nevertheless, this study 
provides the most compelling evidence thus far for the involvement of P450s in 
allelochemical metabolism in marine consumers.  
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Table 6.  Results of a two-way MANOVA investigating differences in digestive gland 
CYP4 gene expression in C. gibbosum feeding on control versus gorgonian diets. 
 
Factors   df  Wilks’ Λ F    p 
Control vs. B. asbestinum 
 Diet       4, 33 0.933  0.590    0.672 
 Reef   16, 101 0.536  1.435    0.140 
 Diet x Reef  16, 101 0.744  0.644    0.840 
 
Control vs. E. mammosa 
 Diet     4, 33  0.887  1.015    0.414 
 Reef   16, 98  0.598  1.127    0.341 
 Diet x Reef  16, 98  0.594  1.142    0.329 
 
Control vs. G. ventalina 
 Diet      4, 33  0.303  18.99  <0.001 
 Reef   16, 101 0.116  6.476  <0.001 
 Diet x Reef  16, 101 0.118  6.392  <0.001 
 
Control vs. P. acerosa 
 Diet     4, 30  0.816  1.682    0.180 
 Reef   16, 92  0.470  1.615    0.080 
 Diet x Reef  16, 92  0.580  1.126    0.344 
 
Control vs. P. americana 
Diet     4, 32  0.546  6.653  <0.001 
Reef   16, 98  0.574  1.227    0.261 
Diet x Reef  16, 98  0.586  1.175    0.301 
 
Control vs. P. elisabethae 
 Diet     4, 15  0.480  4.067    0.019 
 Reef     8, 30  0.381  2.328    0.045 
 Diet x Reef    8, 30  0.619  1.017    0.444 
 
Control vs. P. homomalla (All reefs included) 
 Diet      5, 30  0.445  7.479  <0.001  
 Reef   20, 100 0.279  2.355  <0.001  
 Diet x Reef  20, 100 0.270  2.429  <0.001  
 
Control vs. P. homomalla (deletion of Shark Rock individuals) 
 Diet     5, 24  0.387  7.606  <0.001  
 Reef   15, 66  0.439  1.542    0.115 
 Diet x Reef  15, 66  0.421  1.632    0.089 
 
A p < 0.002 should be accepted as significant (Bonferroni adjusted).  Significant values in bold.  
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Table 7.  Results of ANOVA comparisons (Univariate F-tests) of diet- and reef-specific mean CYP4 
gene expression in C. gibbosum feeding on control vs. gorgonian diets. 
 
Diet comparisons    df  MS    F    p 
Control vs. G. ventalina 
 Diet  CYP4-1  1, 36  0.016    0.050    0.825 
   CYP4-2  1, 36  0.030    0.550    0.464 
   CYP4-3(subA) 1, 36  6.070  46.339  <0.001 
   CYP4-3(subB) 1, 36  0.010    1.368    0.250 
 Reef  CYP4-1  4, 36  0.069    0.211    0.931 
   CYP4-2  4, 36  0.054    0.989    0.426 
   CYP4-3(subA) 4, 36  3.127  23.869  <0.001 
   CYP4-3(subB) 4, 36  0.124    1.710    0.169 
 Diet x Reef CYP4-1  4, 36  0.280    0.850    0.503 
   CYP4-2  4, 36  0.034    0.629    0.645 
   CYP4-3(subA) 4, 36  3.555  27.137  <0.001 
   CYP4-3(subB) 4, 36  0.032    0.447    0.774 
 
Control vs. P. americana 
 Diet  CYP4-1  1, 35  0.037  0.114    0.738  
   CYP4-2  1, 35  0.035  0.871    0.357 
   CYP4-3(subA) 1, 35  0.948  6.681    0.014 
   CYP4-3(subB) 1, 35  0.354  5.667    0.023 
  
Control vs. P. homomalla (All reefs included) 
 Diet  CYP4-1  1, 34  0.162  0.442    0.511 
   CYP4-2  1, 34  1.557  36.592  <0.001 
   CYP4-3(subA) 1, 34  0.394  1.316    0.259 
   CYP4-3(subB) 1, 34  0.494  8.210    0.007 
   CYP4-3  1, 34  1.678  19.924  <0.001 
 Reef  CYP4-1  4, 34  0.643  1.756    0.161 
   CYP4-2  4, 34  0.043  1.017    0.412 
   CYP4-3(subA) 4, 34  3.200  10.698  <0.001 
   CYP4-3(subB) 4, 34  0.041  0.688    0.605 
   CYP4-3  4, 34  0.078  0.925    0.461 
 Diet x Reef CYP4-1  4, 34  0.053  0.144    0.965 
   CYP4-2  4, 34  0.090  2.113    0.101 
   CYP4-3(subA) 4, 34  2.354  7.870  <0.001 
   CYP4-3(subB) 4, 34  0.036  0.592    0.670 
   CYP4-3  4, 34  0.144  1.713    0.170 
 
Control vs. P. homomalla (deletion of Shark Rock individuals) 
 Diet  CYP4-1  1, 28  0.097  0.488    0.490 
   CYP4-2  1, 28  1.530  32.658  <0.001 
   CYP4-3(subA) 1, 28  3.877  27.577  <0.001 
   CYP4-3(subB) 1, 28  0.509  7.610    0.010 
   CYP4-3  1, 28  1.765  18.754  <0.001 
 
A p < 0.007 should be accepted as significant (Bonferroni adjusted).  Significant values in bold. 
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Table 8.  Results of a one-way MANOVA investigating CYP4 gene expression 
variability among reefs for time-zero and control-fed C. gibbosum.  Reefs were 
considered random factors. 
 
Factors   df  Wilks’ Λ F    p 
Reef (Experiment 1) 
Control diet  20, 80  0.163  1.367  0.164 
 
Reef (Experiment 2) 
Time-zero group 20, 70  0.265  1.739  0.047 
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Figure 1.  Cyphoma gibbosum and gorgonian sampling location in the Exuma Keys, 
Bahamas.  Black circles indicate the locations of reefs where C. gibbosum and gorgonian 
colonies were collected for feeding assays in January of 2004 and 2006. 
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Figure 4. Quantifying relative yield of a target gene by real-time quantitative PCR 
(qPCR) versus input poly(A)+ RNA concentration.  Four concentrations of 
poly(A)+RNA isolated from a single individual were reverse transcribed to cDNA as 
described in the methods.  Quantitative PCR was performed with CYP4-3(subB) primers as 
described in the methods.  The average ΔCT was calculated from duplicate qPCR wells 
for each poly(A)+ RNA concentration and subtracted from the ΔCT obtained with 1.0 μg 
poly(A)+RNA yielding ΔΔCT.  The ΔΔCT were then backtransformed (2 –ΔΔCT) to 
calculate relative abundance of each sample.  A five-fold increase in poly(A)+RNA (0.2 
μg Æ1.0 μg) quantity affords less than a 1.25x increase in product yield.  It was decided 
to use 0.2 μg of poly(A)+RNA in subsequent qPCR experiments to maximize the yield of 
cDNA using the least amount of starting poly(A)+RNA. 
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Figure 6.  Cluster analysis of CYP4-1 clones visualized by an unrooted maximum parsimony tree. 
Nucleotide sequences were aligned using ClustalX (Thompson et al., 1997) and the alignment was used to 
construct a maximum parsimony tree using PAUP*4.0b10 (Swofford 1998).  Trees were visualized and 
manipulated using FigTree v1.1 (Rambaut 2008).  Each operational taxonomic unit (OTU) represents the 
consensus sequence of an individual clone sequenced in both directions.  Black OTUs correspond to CYP4-
1v1.  Red OTUs correspond to CYP4-1v2 and indicate clones with an insertion of 15bp at nucleotide 
position 1201.  Blue OTUs indicate clones with a 68 bp deletion at nucleotide position 1066 causing a 
frame shift resulting in a premature stop codon likely resulting in a non-functional protein; no designation 
was given.  The green OTU denotes a single clone found to have both the 15 bp insertion and 68 bp 
deletion.  Scale bar indicates the number of nucleotide base changes. 
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Figure 8. Cluster analysis of CYP4-2 clones visualized by an unrooted maximum 
parsimony tree.  Nucleotide sequences were aligned using ClustalX (Thompson et al., 
1997) and the alignment was used to construct a maximum parsimony tree using 
PAUP*4.0b10 (Swofford 1998).  Trees were visualized and manipulated using FigTree 
v1.1 (Rambaut 2008).  Each operational taxonomic unit (OTU) represents the consensus 
sequence of an individual clone sequenced in both directions.  Black OTUs correspond to 
CYP4-2b cDNAs and red OTUs (4 clones) correspond to CYP4-2a cDNAs.  Scale bar 
indicates the number of nucleotide base changes. 
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Figure 10. Cluster analysis of CYP4-3 clones visualized by an unrooted maximum parsimony tree.  
Nucleotide sequences were aligned using ClustalX (Thompson et al., 1997) and the alignment was used to 
construct a maximum parsimony tree using PAUP*4.0b10 (Swofford 1998).  Trees were visualized and 
manipulated using FigTree v1.1 (Rambaut 2008).  Each operational taxonomic unit (OTU) represents the 
consensus sequence of an individual clone sequenced in both directions.  The color of the OTU indicates 
further groupings denoting possible distinct loci. Part (A) depicts all clones within the CYP4-3 grouping; 
CYP4-3a1=orange, CYP4-3a2=black, CYP4-3b1=green, CYP4-3b2=red, CYP4-3b3=blue, CYP4-
3c=purple. Part (B) is an expanded view of the CYP4-3b node.  Clones used in yeast heterologous 
expression experiments are indicated by an asterisk.  Scale bar indicates the number of nucleotide base 
changes. 
 
195
 
Figure 11. Nucleotide alignment of eleven full-length Cyphoma gibbosum CYP4-3 cDNA sequences.  
The consensus nucleotide sequences for all eleven cDNAs, including possible allelic variants, are shown.   
Nucleotide polymorphisms are indicated according to IUPAC naming conventions.  CYP4-3a sequences 
are represented three allelic variants.  CYP4-3b2 sequences are represented by five individual clones 
because no ‘physical’ clones could be supported by the consensus sequence generated for the CYP4-3b2 
subgroup. Identical bases are indicated with a “●” and are shaded grey.  Real-time quantitative PCR primer 
locations are indicated by arrows; solid arrows correspond to all CYP4-3 sequences; dashed arrows 
correspond to CYP4-3(sub A) sequences; dotted arrows correspond to CYP4-3(sub B) sequences. GenBank 
Accession numbers: CYP4-3a1v1 (CYP4BL1v1, EU546254); CYP4-3a1v2 (CYP4BL1v2, EU546255); 
CYP4-3a2 (CYP4BL1v3, EU546256); CYP4-3b1 (CYP4BL4, EU546257); CYP4-3b2_clone1 (CYP4BL5, 
EU546258); CYP4-3b2_clone2 (CYP4BL6, EU546259); CYP4-3b2_clone3 (CYP4BL7, EU546260); 
CYP4-3b2_clone4 (CYP4BL8, EU546261); CYP4-3b2_clone5 (CYP4BL9, EU546262); CYP4-3b3 
(CYP4BL3, EU546263). 
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CYP4-3a1v1 1 ATGGATGAT ACCT TCTCTCAACTGAAAT ATRCACTGCTGCT ACCGGTGGYAGGGT TCAT TGT T T ACAAAGT TGT T T T AGCCAT ACAT AACT T T AAGT TGT ACGCAAAGAC 110
CYP4-3a1v2 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3a2 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3c 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3b1 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3b3 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . 110
CYP4-3b2_clone1 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3b2_clone2 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3b2_clone3 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3b2_clone4 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3b2_clone5 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
CYP4-3a1v1 111 CT T TGACGCCTGTCCTGGGGAGACTGAT T TCCACTGGCTCT ACGGGAAT ATGCACAAGT ATCCAGGTCCCAATGAGAAAGGCATCCAAT ATGACAT TGACTCAATGGAGA 220
CYP4-3a1v2 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
CYP4-3a2 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
CYP4-3c 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
CYP4-3b1 111 . . . . . . . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . C . . T . . . . T . . . . . . . . . . . . . . . AG . . . . . . . . . . . . T . C . A . . . . . . AT . . . . A . . . 220
CYP4-3b3 111 . . . . . . . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . C . . T . . . . T . . . . . . . . . . . . . . . AG . . . . . . . . . . . . T . C . A . . . . . . RT . . . . V . . . 220
CYP4-3b2_clone1 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . C . . T . . . . T . . . . . . . . . . . . . . . AG . . . . . . . . . . . . T . C . A . . . . . . AT . . . . A . . . 220
CYP4-3b2_clone2 111 . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . C . . T . . . . T . . . . . . . . . . . . . . . AG . . . . . . . . . . . . T . C . A . . . . . . AT . . . . A . . . 220
CYP4-3b2_clone3 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . C . . T . . . . T . . . . . . . . . . . . . . . AG . . . . . . . . . . . . T . C . A . . . . . . GT . . . . . . . . 220
CYP4-3b2_clone4 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . C . . T . . . . T . . . . . . . . . . . . . . . AG . . . . . . . . . . . . T . C . A . . . . . . GT . . . . . . . . 220
CYP4-3b2_clone5 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . C . . T . . . . T . . . . . . . . . . . . . . . AG . . . . . . . . . . . . T . C . A . . . . . . GT . . . . . . . . 220
CYP4-3a1v1 221 AACGACCACGCT TCAT TCGTSCGTGGGTGGGACCCT TCAGAGGAAT TCT T ATCCT T T ATCATCCAGACCT AGTCCGCAAGGT ACTCAAATCATCAGCACCCAAACCT AGA 330
CYP4-3a1v2 221 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330
CYP4-3a2 221 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330
CYP4-3c 221 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330
CYP4-3b1 221 . . . . . . . . . . . . . . TC . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . A . . GC . . . . AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . 330
CYP4-3b3 221 . . . . . . . . . . . . . . TC . . . . . T . . . . . . . . . . . . . . . . . S . . . . . . . Y . . G . . . . . AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330
CYP4-3b2_clone1 221 . . . . . . . . . . . . . . TC . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . A . . GC . . . . AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . 330
CYP4-3b2_clone2 221 . . . . . . . . . . . . . . TC . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . A . . GC . . . . AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . 330
CYP4-3b2_clone3 221 . . . . . . . . . . . . . . TC . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330
CYP4-3b2_clone4 221 . . . . . . . . . . . . . . TC . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330
CYP4-3b2_clone5 221 . . . . . . . . . . . . . . TC . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330
CYP4-3a1v1 331 AGYCGT T TCATGAAATCTGT AT ATGACATGGCCCTGGGCTGGYT TGGAARCGGGCT TCT TCTGGCT AACGGATCTCARTGGGCTCGGAGTCGTCGTCTRT TGACTCCAGC 440
CYP4-3a1v2 331 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3a2 331 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3c 331 . R . . R . . . . . . . . . . . . . . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3b1 331 . A . . A . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3b3 331 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3b2_clone1 331 . A . . A . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3b2_clone2 331 . A . . A . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3b2_clone3 331 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3b2_clone4 331 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3b2_clone5 331 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
CYP4-3a1v1 441 T T TCCACT T TGACAT TCTGCGCCCAT ATGTCACAGTCAAGAACCAAGCCGCTGACK TCT TGCTGGCT AAAATGAAGRCACAT TCAGAAGAGAAAAAACCCT T TGAAACAT 550
CYP4-3a1v2 441 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3a2 441 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3c 441 . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3b1 441 . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3b3 441 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3b2_clone1 441 . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3b2_clone2 441 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3b2_clone3 441 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3b2_clone4 441 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3b2_clone5 441 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550
CYP4-3a1v1 551 T T T ACAACGTCAGCRT ATGTCTGT T TGATGT YCTGCT ACAGTGCTCGT T TGCTCATGAAAGT AAT TGYCAGAAGACAGGRCAAAACGACCCAT ACT T ACAGAATGTGAAT 660
CYP4-3a1v2 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 630
CYP4-3a2 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 660
CYP4-3c 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . 660
CYP4-3b1 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . K . . . . . . . . . . . . V . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . 660
CYP4-3b3 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . 660
CYP4-3b2_clone1 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . 660
CYP4-3b2_clone2 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 660
CYP4-3b2_clone3 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . 660
CYP4-3b2_clone4 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . 660
CYP4-3b2_clone5 551 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . 660
CYP4-3a1v1 661 GAACTGGTGGAGCTGTGGGCTGAACGT AGTCTGAAGCCATGGT TGCACT T TGAATGGT TGT TCCGAT TGACATCACAAGGTCGGCGCTGGT ACAAGT TGTGTGACCAAGT 770
CYP4-3a1v2 630 ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 707
CYP4-3a2 661 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 770
CYP4-3c 661 . . . . . . K . . . . . . . . . . . . . . S . . . . . . . . M . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . W. . . . . . . . . . . . . . . . . . . 770
CYP4-3b1 661 . . . . . . K . . . . . . . . . . . . . . S . . . . . . . . M . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . W. . . . . . . . . . . . . . . . . . . 770
CYP4-3b3 661 . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . M . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 770
CYP4-3b2_clone1 661 . . . . . . T . . . . . . . . . . . . . . C . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 770
CYP4-3b2_clone2 661 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 770
CYP4-3b2_clone3 661 . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . A . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 770
CYP4-3b2_clone4 661 . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . A . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 770
CYP4-3b2_clone5 661 . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . A . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 770
CYP4-3a1v1 771 TCATGCTGTGTCAGAGGATCTCAT TGACAAACGACGGAAAGCTCTGGAGGCCAAAAAAGCTGCAGGAGAT ACRGAT AACTCBGAGGATGAAAGTCCTGGAAAGAAACGCT 880
CYP4-3a1v2 708 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 817
CYP4-3a2 771 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
CYP4-3c 771 . . . . . . . R . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
CYP4-3b1 771 . . . . . . . R . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
CYP4-3b3 771 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
CYP4-3b2_clone1 771 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
CYP4-3b2_clone2 771 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
CYP4-3b2_clone3 771 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
CYP4-3b2_clone4 771 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
CYP4-3b2_clone5 771 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880
197
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CYP4-3a1v1 881 TGATGTGT T T TGTGGACGTCT TGCTCAGCGCTCGAGATGAAGACGGAGTGGGAATGACCCCAT TGGAGATCCGCAATGAGGCTGAT ACCT T TCTGT T TGAAGGT T ATGAY 990
CYP4-3a1v2 818 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 927
CYP4-3a2 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 990
CYP4-3c 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . R . . . . . . . . . B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 990
CYP4-3b1 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . R . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 990
CYP4-3b3 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . G . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . 990
CYP4-3b2_clone1 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 990
CYP4-3b2_clone2 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 990
CYP4-3b2_clone3 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 990
CYP4-3b2_clone4 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 990
CYP4-3b2_clone5 881 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 990
CYP4-3a1v1 991 ACWACTRCCAGTGCTCTGAGCTGGACCCTGT ACAGCCTGGCGAGATGGCCAGAACACCAGACCCTGGTCCAGGAGGAGGTGGACGCYYTGT T ACAGGKCCGCAGCTCAGA 1100
CYP4-3a1v2 928 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1037
CYP4-3a2 991 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1100
CYP4-3c 991 . . R . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . YK . . . . . . . . . . . . . M . . Y . . . . . . . . 1100
CYP4-3b1 991 . . R . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . M . . Y . . . . . . . . 1100
CYP4-3b3 991 . . G . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . M . . Y . . . . . . . . 1100
CYP4-3b2_clone1 991 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1100
CYP4-3b2_clone2 991 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1100
CYP4-3b2_clone3 991 . . G . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . A . . T . . . . . . . . 1100
CYP4-3b2_clone4 991 . . G . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . A . . T . . . . . . . . 1100
CYP4-3b2_clone5 991 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1100
CYP4-3a1v1 1101 CT ACAT T ACCTGGGATGATCTGACTCAACTGCCAT AYACAACGGCATGCATCAAAGAGGCCAT T AGAAAT T AT TCCRCYGTGCCAT TMAT TS AGCGAGAAATCACAGARC 1210
CYP4-3a1v2 1038 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1147
CYP4-3a2 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . 1210
CYP4-3c 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1210
CYP4-3b1 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . . . . . . . . . . . . . . . . . . . . . 1210
CYP4-3b3 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1210
CYP4-3b2_clone1 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1210
CYP4-3b2_clone2 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1210
CYP4-3b2_clone3 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1210
CYP4-3b2_clone4 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1210
CYP4-3b2_clone5 1101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1210
CYP4-3a1v1 1211 CT T TGAACCTGGAYGGACAT AT T AT TCCCGCAGGMACAT T YAT AGCAAT AS AK AT T TGGKS YCT TCATCACAACCCCDCTGT ATGGGACAGGCCACATGACT ACCTGCCA 1320
CYP4-3a1v2 1148 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1257
CYP4-3a2 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3c 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3b1 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3b3 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3b2_clone1 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3b2_clone2 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3b2_clone3 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3b2_clone4 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3b2_clone5 1211 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1320
CYP4-3a1v1 1321 GAACGAT T T T T TGGAGAYAAYGCT T TGAACATGGAYCCCT T TCAGT ATGTRCCT T T T TCAGCAGGRTCAAGAAAT TGCATCGGTCAGAAYT T TGCCATGAATGAAT TGAA 1430
CYP4-3a1v2 1258 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1367
CYP4-3a2 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3c 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3b1 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3b3 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3b2_clone1 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3b2_clone2 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3b2_clone3 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3b2_clone4 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3b2_clone5 1321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1430
CYP4-3a1v1 1431 GGTGATGGT TGCTCGCATCT TCCACAGGT T T ACACTKGCCCT TGATCCAAATCATGAAATCCT ACGTGCTCCAT TGGCCACT T TCAAARCAGAGAAAGACAYCAAACTGT 1540
CYP4-3a1v2 1368 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1477
CYP4-3a2 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3c 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3b1 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3b3 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3b2_clone1 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3b2_clone2 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3b2_clone3 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3b2_clone4 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3b2_clone5 1431 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1540
CYP4-3a1v1 1541 TGATCACRCCACGCAAAGGCT AA                                        1563
CYP4-3a1v2 1478 . . . . . . . . . . . . . . . . . . . . . . .                                        1500
CYP4-3a2 1541 . . . . . . . . . . . . . . . . . . . . . T . CAAGTCCT TGT TGACACTGTGGGACAGCAAAATCACT AG 1602
CYP4-3c 1541 . . . . . . . . . . . . . . . . . . . . . . .                                        1563
CYP4-3b1 1541 . . . . . . . . . . . . . . . . . . . . . . .                                        1563
CYP4-3b3 1541 . . . . . . . . . . . . . . . . . . . . . . .                                        1563
CYP4-3b2_clone1 1541 . . . . . . . . . . . . . . . . . . . . . . .                                        1563
CYP4-3b2_clone2 1541 . . . . . . . . . . . . . . . . . . . . . . .                                        1563
CYP4-3b2_clone3 1541 . . . . . . . . . . . . . . . . . . . . . . .                                        1563
CYP4-3b2_clone4 1541 . . . . . . . . . . . . . . . . . . . . . . .                                        1563
CYP4-3b2_clone5 1541 . . . . . . . . . . . . . . . . . . . . . . .                                        1563
198
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.  Deduced amino acid alignment of C. gibbosum CYP4-1, CYP-4-2, and 
CYP4-3 consensus sequences.  Amino acid sequences were generated from consensus 
nucleotide sequences and aligned using ClustalX.  Grey boxes indicate areas of identical 
sequence among all cDNAs.  Amino acid residues identical to CYP4-3b2_clone 5 are 
indicated by a “●” and gaps by a “~”.  The stop codon is denoted by an asterisk.  The 
conserved WXXXR, I-helix, EXXR, PXRF, and heme-binding domains, in order, are 
indicated by black lines under the sequence alignment. 
CYP4-1v1 1 ~ ~ ~ ~ ~ ~ ~ M F V . . . . V G I V T . . G T L . WM L Q ~ ~ ~ ~ T A K F R QQ I S L I . . P P T I P L . GN V H QM T T . . GWY K Q V L KWG . E F R . QG I . R I M L I S ~ ~ K P V I G V T C AE 87
CYP4-1v2 1 ~ ~ ~ ~ ~ ~ ~ M F V . . . . V G I V T . . G T L . WM L Q ~ ~ ~ ~ T A K F R QQ I S L I . . P P T I P L . GN V H QM T T . . GWY K Q V L KWG . E F R . QG I . R I M L I S ~ ~ K P V I G V T C AE 87
CYP4-2a 1 . . L G . . S MS L T . Q A V . V L V V T T L . . GG . K R L L R Y R S . L . A MS L L . . . . . H S . I W . D L . . L R N M T S . QR . S V F GK F T . . F . K . Y . F . L . . . Q A N I . . L . . . 100
CYP4-2b 1 . . L G . . S MS L T . Q A V . V L V V T T L . . GG . K R L L R Y R S . L . A MS L L . . . . . H S . I W . D L . R L QN M T C . QR . S V Y GK F T . . F . K . Y . F . M . . . H A N I . . V . . . 100
CYP4-3a1v1 1 . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . M . . Y . . . . ~ . K . . . Y D . . S . . . . . . . I . A . . . . . . . . . I . Y . . . 96
CYP4-3a1v2 1 . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . M . . Y . . . . ~ . K . . . Y D . . S . . . . . . . I . A . . . . . . . . . I . Y . . . 96
CYP4-3a2 1 . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . M . . Y . . . . ~ . K . . . Y D . . S . . . . . . . I . A . . . . . . . . . I . Y . . . 96
CYP4-3b1 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . I . K . . . . . . . . . . . . . . . . I A . . . . . 96
CYP4-3b3 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
CYP4-3c 1 . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . M . . Y . . . . ~ . K . . . Y D . . S . . . . . . . I . A . . . . . . . . . I . Y . . . 96
CYP4-3b2_clone1 1 . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . I . K . . . . . . . . . . . . . . . . I A . . . . . 96
CYP4-3b2_clone2 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . I . K . . . . . . . . . . . . . . . . I A . . . . . 96
CYP4-3b2_clone3 1 . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y . . . 96
CYP4-3b2_clone4 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
CYP4-3b2_clone5 1 MD D T F S Q L K Y A L L L P V A G F I V YK V V L A I H ~ ~ ~ N F K L Y A K T F D A C P GE T D F HWL Y GN V H K F P GP N ~ E E G I Q F Q I D V ME K R P R F S R VWVGP F R G I L V L I H P D 96
CYP4-1v1 88 T A E V M . N . . K H I D K A Q ~ ~ ~ ~ E . G Y L H A . . . T . . . T S T . D K . R MR . K M . . . T . . . R . . H D F . E . F . . Q T C . . I E . L . H . VD K GQ ~ . N V . QD I A L . A L . I I C 182
CYP4-1v2 88 T A E V M . N . . K H I D K A Q ~ ~ ~ ~ E . G Y L H A . . . T . . . T S T . D K . R MR . K M . . . T . . . R . . H D F . E . F . . Q T C . . I E . L . H . VD K GQ ~ . N V . QD I A L . A L . I I C 182
CYP4-2a 101 T . K D L F . T A D . . . F G ~ ~ ~ ~ ~ ~ . Q F G I P . . . E . . . I . G . . K . . . . . . . . S . . . . . . . . K . . . K . G . E . S . K . . E . V . K Y AD K GE S M . M YN . I . L . T L . M I M 194
CYP4-2b 101 T . K D L F . T A D . . . F N ~ ~ ~ ~ ~ ~ . E F G I P . . . E . . . I . G . . K . . . . . . . . S . . . . . . . . K . . . K . G . E . S . K . . E . V . K Y AD K GE S I . M YN . I . L . T L . M I M 194
CYP4-3a1v1 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . 196
CYP4-3a1v2 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . 196
CYP4-3a2 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . 196
CYP4-3b1 97 . . . . . . . . . . . . . . N H . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E . . . . . . . . . . . . . . F . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . 196
CYP4-3b3 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . 196
CYP4-3c 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . 196
CYP4-3b2_clone1 97 . . . . . . . . . . . . . . N H . . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E . . . . . . . . . . . . . . F . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . 196
CYP4-3b2_clone2 97 . . . . . . . . . . . . . . N H . . . . G . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . 196
CYP4-3b2_clone3 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . 196
CYP4-3b2_clone4 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . 196
CYP4-3b2_clone5 97 L V R K V L K S S A P K P R S R F MK S V YD M A L GWL GN G L L L A N GS QWAR S R R L L T P A F H F D I L R P Y V T V K N Q A A D V L L A K MK T H S E E K K P F E T F YN V S I C L F D V L L 196
CYP4-1v1 183 E T A MGQH V . A . T K E S ~ ~ A Y V . S . Y K MC G F V E K . MR T . . H Y N K T M Y D . F G P . E V H D H H L K I L . E F T I K V . K D . MS N F N A E R A QR L L D D . N . K K DWV N C . . S 280
CYP4-1v2 183 E T A MGQH V . A . T K E S ~ ~ A Y V . S . Y K MC G F V E K . MR T . . H Y N K T M Y D . F G P . E V H D H H L K I L . E F T I K V . K D . MS N F N A E R A QR L L D D . N . K K DWV N C . . S 280
CYP4-2a 195 R . A MS . S N D I . A K . E S H . Y V V A . S . . A D . L I . . I R N . L A Y N D F V Y G . . K N . . . F K E Q . H Y . . G I . . Q I . Q E . Q . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ I . . R ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 272
CYP4-2b 195 R . A MS . S N D I . T K . E S H . Y V V A . S . . N D . L I . . I R N . L V Y N D F V Y G . . K N . . . F K E Q . H Y . . G I . . Q I . Q E . Q . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ I . . R ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 272
CYP4-3a1v1 197 . . . . . H . . . . . . . . . . . . Y . . . . . . . . . . . . E . . L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3a1v2 197 . . . . . H . . . . . . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 265
CYP4-3a2 197 . . . . . H . . . . . . . . . . . . Y . . . . . . . . . . . . E . . L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3b1 197 . . . . . . . . . . . . . . . . . . . . . . . . . . L . . . . . . . . . . . . . . . . . . Q . . . . . . . . N . . . . . . . . M . . . . . . R . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3b3 197 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3c 197 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3b2_clone1 197 . . . . . . . . . . . . . . . . . . . . . . . . . . L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3b2_clone2 197 . . . . . H . . . . . . . . . . . . Y . . . . . . . . . . . . E . . L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3b2_clone3 197 . . . . . H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3b2_clone4 197 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . 286
CYP4-3b2_clone5 197 QC S F A Y E S N C QK T GQN D P H L QN VN E L V E L WAQR S MK P WL H F E WL F R L T S QGR RWY K L C D Q V H A V S E D L I D K R R K ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ A L E AK K A A GD T D N S E D 286
CYP4-1v1 281 . T N C R . T R L A . L . M . . F MS . ~ N . K V L S I D D . . E . V . . . M . . . H . . . A A G MN . C T . L I GS D E K V . GK . C . . L . R V F GN S D R ~ MP . M . . . K E . K . L E C . . . . 378
CYP4-1v2 281 . T N C Q . T R L A . L . M . . F MS . ~ N . K V L S I D D . . E . V . . . M . . . H . . . A A G MN . C T . L I GS D E K V . GK . C . . L . R V F GN S D R ~ MP . M . . . K E . K . L E C . . . . 378
CYP4-2a 273 . G . P . . . Y L D . L . I . . T . K . D T . T . L . . . . . . S . V . . . . . . . H . . . A . . I . . I . . . . C Q H . D I . E K . . Q . I . T V . K . . D . . E . E . S . . P K F E F M . M V . . . 372
CYP4-2b 273 . G . S . . . Y L D . L . I . . T . K . D T . T . L . . . . . . S . V . . . . . A . H . . . A . . I . . I . . . . C Q H . D I . E K . . Q . I . T V . K . . D . . E . E . S . . P K F K F M . M V . . . 372
CYP4-3a1v1 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3a1v2 266 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 365
CYP4-3a2 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3b1 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3b3 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3c 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3b2_clone1 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3b2_clone2 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3b2_clone3 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3b2_clone4 287 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386
CYP4-3b2_clone5 287 E S P GK K R L MC F V D V L L S A R D E D G V GM T P L E I R N E A D T F L F E G Y D T T T S A L SWT L Y S L A RWP E H Q T L V QE E V D A L L QGR S S D Y I TWD D L T Q L P Y T T A C I K E 386
CYP4-1v1 379 . Q . L F P S . . Y F G . T T . . E A Q I S ~ ~ ~ ~ ~ S F R V . K D V T V I V F T S A I . R D T RWF P N . E H F D . D . . L P E . S V GR H . . A . I . . . . . L . . . . . . K . . . M . E . . I L S 473
CYP4-1v2 379 . Q . L F P S . . Y F G . T T . . E A Q I S K S S N C S F R V . K D V T V I V F T S A I . R D T RWF P N . E H F D . D . . L P E . S V GR H . . A . I . . . . . L . . . . . . K . . . M . E . . I L S 478
CYP4-2a 373 GM . L H C P . . . . S . V T QK . M I . E . ~ ~ ~ ~ ~ F S . . . . S V C T . H . F N I . . . . V . . P D . WE F K . . . . H P . . T K D R . S . A F . . . . . . P . . . . . . H . . . . . E . . . L S 467
CYP4-2b 373 GM . L H C P . . . . S . I S QK . M T . E . ~ ~ ~ ~ ~ F S . . . . S L C S . H M F N I . . . . V . . P D . WA F K . . . . H P . . T T D R . S . A F . . . . . . P . . . . . . H . . . D . E . . . L S 467
CYP4-3a1v1 387 . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3a1v2 366 . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 460
CYP4-3a2 387 . . . . . . . . . . . . . . T . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3b1 387 . . . . . . . . . L . Q . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . D . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3b3 387 . . . . . . . . . L . Q . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3c 387 . . . . . . . . . L . Q . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3b2_clone1 387 . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3b2_clone2 387 . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3b2_clone3 387 . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3b2_clone4 387 . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 481
CYP4-3b2_clone5 387 A I R N Y S T V P F I E R E I T E P L N L D G ~ ~ ~ ~ ~ H I I P AG T F I A I Q I WC L H H N P T VWD R P H D Y L P E R F F GD N A L N MD P F Q Y V P F S A GS R N C I GQN F A MN E L K V M V A 481
CYP4-1v1 474 S . . R N . K V K S C QS R E . L . P VGE L I L R P Q . G . F I E L S A . *                512
CYP4-1v2 479 S . . R N . K V K S C QS R E . L . P VGE L I L R P Q . G . F I E L S A . *                517
CYP4-2a 468 . L L R . Y . F R . . . K ~ Y P V V . K M T . I M . . . S GMR M F A . . . T P T V *            509
CYP4-2b 468 . L L R . Y . F R . . . K ~ . P V V . K M T I I M . . . S GMR M F A . . . T P T V Y N NWE H *      515
CYP4-3a1v1 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . *              521
CYP4-3a1v2 461 . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . *              500
CYP4-3a2 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . L Q V L V D T V G QQN H * 534
CYP4-3b1 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . A . . . . . . . . . . . . . *              521
CYP4-3b3 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . A . . . . . . . . . . . . . *              521
CYP4-3c 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . A . . . . . . . . . . . . . *              521
CYP4-3b2_clone1 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . *              521
CYP4-3b2_clone2 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . A . . . . . . . . . . . . . *              521
CYP4-3b2_clone3 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . A . . . . . . . . . . . . . *              521
CYP4-3b2_clone4 482 . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . *              521
CYP4-3b2_clone5 482 R I F H R F T L A L D P N ~ H E I L R AP L A T F K T E K D I K L L I T P R K G *              521
199
Figure 13.  Phylogenetic relationships of Cyphoma gibbosum CYP4 proteins with 
other invertebrate and vertebrate CYP4s.  Bayesian and Maximum Likelihood (ML) 
trees were constructed as described in the Methods.  Both trees resulted in the same 
topology, and the Bayesian tree is depicted here.  Sequences from C. gibbosum are 
highlighted in red.  Values at branch points represent posterior probabilities derived from 
3x106 generations and ML bootstrap values calculated with 1000 replications.  Predicted 
sequences are labeled with an asterisk.  Sequences include: Abalone CYP4V13 formally 
CYP4C17 (H. rufescens, AAC32833), Anemone (N. vectensis, JGI # 194368), Anemone 
(N. vectensis, JGI # 86714), Cockroach CYP4C7 (D. punctata, AAC69184), Crayfish 
CYP4V11 formally CYP4C15 (O. limosus, AAF09264), Fly CYP4C3 (D. melanogaster, 
FlyBase FBpp0085074), Frog CYP4F42 (X. laevis, BAD02914.1), Green crab CYP4V16 
formally CYP4C39 (C. maenas, JC8026), Hard clam CYP30 (M. mercenaria, 
AAB66556), Human CYP4A11 (NP_000769.2), Human CYP4A22 (NP_001010969.2), 
Human CYP4B1 (NP_000770.2), Human CYP4F11 (NP_067010.2), Human CYP4F12 
(NP_076433.2), Human CYP4F2 (XP_001172541.1), Human CYP4F22 (NP_775754.2), 
Human CYP4F3 (NP_000887.2), Human CYP4F8 (NP_009184.1), Human CYP4V2 
(NP_997235.2), Human CYP4X1 (NP_828847.1), Human CYP4Z1 (NP_835235.1), 
Limpet (L. gigantea, JGI# 122078), Limpet (L. gigantea, JGI# 154296), Limpet (L. 
gigantea, JGI# 178560), Limpet (L. gigantea, JGI# 206515), Limpet (L. gigantea, JGI# 
211775), Limpet (L. gigantea, JGI# 237658), Mouse CYP4A12a (NP_803125.2), Mouse 
CYP4A12b (NP_758510.2), Mouse CYP4A14 (NP_031848.1), Mouse CYP4B1 
(NP_031849.1), Mouse CYP4F13 (NP_570952.1), Mouse CYP4F14 (NP_071879.1), 
Mouse CYP4F15 (NP_598888.1), Mouse CYP4F16 (NP_077762.1), Mouse CYP4F18 
(NP_077764.1), Mouse CYP4F37 (NP_001093657.1), Mouse CYP4F39 (AAI45756), 
Mouse CYP4F40 (NP_001095058.1), Mussel CYP4Y1 (M. galloprovincialis, 
AAC32835), Polychaete worm (Capitella sp. JGI# 130691), Polychaete worm (Capitella 
sp. JGI# 144012), Polychaete worm (Capitella sp. JGI# 162759), Polychaete worm 
(Capitella sp. JGI# 181976), Polychaete worm CYP4AT1 (C. capitata, AAS87604), 
Sand worm CYP4BB1 (N. virens, AAR88241), Sea urchin (S. purpuratus, J. Goldstone 
predicted, GLEAN3_ 05931), Sea urchin (S. purpuratus, J. Goldstone predicted, 
GLEAN3_20229), Seabass (D. labrax, AAD32564), Silkworm CYP4M9 (B. mandarina, 
ABK27872.1), Tunicate (C. intestinalis, JGI# Sc78), Water flea CYP4C34 (D. pulex, 
BQ703383), Zebrafish CYP 4T (D. rerio, Ensembl ENSDART00000013654), Zebrafish 
CYP4F13 (D. rerio, Ensembl ENSDART00000063442), Zebrafish CYP4V2 (D. rerio, 
Ensembl ENSDART00000089480), Zebrafish CYP4V7(D. rerio, Ensembl 
ENSDART00000087976).  Phylogenetic tree construction by J. Goldstone. 
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Figure 14. Phylogenetic relationships among Cyphoma gibbosum CYP4-3 proteins.  
Partial tree representing an expanded view of the CYP4-3 node from Figure 13.  Values 
at branch points represent posterior probabilities derived from 3x106 generations and 
maximum likelihood bootstrap values calculated with 1000 replications.  Gene 
designations assigned by the P450 Nomenclature Committee are indicated to the right of 
the tree.  Phylogenetic tree construction by J. Goldstone. 
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Figure 15. Maximum parsimony trees depicting transcripts recognized by CYP4-3(sub A) and CYP4-
3(sub B) quantitative RT-PCR primers.  Each taxon represents the consensus sequence of an individual 
clone sequenced in both directions.  The qPCR primer set used to detect clone-specific abundance is 
indicated by operational taxonomic unit (OTU) color.  OTUs in red and orange denote those clones that are 
picked up by CYP4-3(sub A) qPCR primers.  Red OTUs indicate clones that contain no nucleotide 
mismatches with qPCR primers. Orange OTUs (n = 3) indicate clones with a one base pair mismatch in the 
forward primer, not within three base pairs of the 3’ end.  OTUs in blue and green denote those clones that 
are picked up by CYP4-3(sub B) qPCR primers.  Blue OTUs indicate clones that contain a one base pair 
mismatch in the forward primer ten base pairs from the 3’end.  Green OTUs (n = 4) indicate clones with a 
one base pair mismatch in both the forward and reverse primers not within ten base pairs of the 3’ end.   
Black OTUs denote clones that would not be picked up by either primer set.  Partial sequences not covered 
by the qPCR primer pairs described here were deleted from the above trees.  The (A) unrooted maximum 
parsimony tree (see Figure X) was proportionally transformed into a circular tree (B) using FigTree v1.1 
(Rambaut 2008).  The scale bar in (A) indicates the number of nucleotide base changes. 
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Figure 16. Mean CYP4 gene expression among C. gibbosum feeding on gorgonian 
and control diets for four days.  Bars represent the mean CYP4 gene expression (± SE) 
of snails feeding on B. asbestinum (n = 13), E. mammosa (n = 12), G. ventalina (n = 13), 
P. acerosa (n = 10), P. americana (n = 12), P. elisabethae (n = 6), P. homomalla (n = 11) 
and the control diet (n = 33).  Results from snails collected from all five reefs are shown.  
Real-time quantitative PCR was performed and the number of molecules per 0.2 μg of 
polyA+ RNA was calculated from the standard curve and normalized by a β-actin 
correction factor.  
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Figure 17. Induction of CYP4 gene expression in C. gibbosum feeding on the 
gorgonian Plexaura homomalla compared to diet controls.  Bars represent the mean 
CYP4 gene expression (± SE) of snails feeding on control diet (n = 27 snails; e.g. alginic 
acid + squid powder) or P. homomalla (n = 9 snails) for 4d.  Results shown here only 
include snails  from four reefs (Big Point, North Normans, Rainbow Gardens, and Sugar 
Blue Holes). Real-time quantitative PCR was performed and the number of molecules per 
0.2 μg of polyA+ RNA was calculated from the standard curve and normalized by a β-
actin correction factor.  Bars in the [ ] indicate molecule numbers for a subset of genes 
within group CYP4-3 (see Figure 15 for more information).  Statistically significant 
induction (p<0.001) is indicated by an asterisk. 
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Figure 18.  Comparing CYP4 expression levels among time-zero and 4 d control-fed C. gibbosum 
snails collected from five reefs.  (A) Control snails; Bars represent mean CYP4 expression (± SE) in 
snails (n = 33) collected from five reefs and fed a control diet (e.g. alginic acid + squid powder) for four 
days.  (B) Time-zero snails; Bars represent mean CYP4 expression (± SE) in snails (n = 30) collected 
from five reefs and immediately dissected to preserve reef-specific gene expression signals. Real-time 
quantitative PCR was performed and the number of molecules per 0.2 μg of polyA+ RNA was calculated 
from the standard curve and normalized by a β-actin correction factor.  Bars in the [ ] indicate molecule 
numbers for a subset of genes within group CYP4-3.   
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Figure 19. Comparison of CYP4 gene expression in snails feeding on control or P. 
homomalla diet for 4 d or greater.  Bars represent the mean CYP4 gene expression (± 
SE) of snails feeding on control diet (n = 27 snails; e.g. alginic acid + squid powder) or P. 
homomalla (n = 9 snails) for 4d.  Results shown here only include snails from four reefs 
(Big Point, North Normans, Rainbow Gardens, and Sugar Blue Holes).  Run in parallel to 
the four day feeding assays was a series of long term feeding assays used to examine the 
induction of CYP4 in C. gibbosum.  Adult C. gibbosum collected from North Normans 
were allowed to feed on control (n = 2) or P. homomalla (n = 1) for 14 d and mean CYP4 
gene expression (± SE) is shown for each 14 d diet group .  Real-time quantitative PCR 
was performed and the number of molecules per 0.2 μg of polyA+ RNA was calculated 
from the standard curve and normalized by a β-actin correction factor.  Bars in the [ ] 
indicate molecule numbers for a subset of genes within group CYP4-3.  
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Figure 20. Amino acid alignment for defining putative residues involved in substrate 
recognition and catalytic activity in allelochemically-responsive Cyphoma CYP4-2 
and CYP4-3 deduced amino acid sequences.  In order to identify key amino acid 
residues, Cyphoma CYP4s were aligned to selected human CYP4Fs and rabbit CYP4As, 
whose substrate recognition sites (SRSs) have been identified in Loughran et al. (2000) 
and Kalsotra et al. (2004).  The crystallized bacterial CYP102 provided a structural 
template and secondary structural elements (helices A-L and β-sheets 1-12) described in 
Ravichandran et al. (1993) were copied onto this alignment.  Putative SRSs were also 
identified by aligning Cyphoma CYP4 deduced amino acid sequences with mammalian 
CYP2s from Gotoh (1992) (CYP2 sequences not included here).  Residues identical to 
CYP4-3b2_clone 5 are indicated by a dot within the alignment.  Boxed regions represent 
the six SRSs.  Residues shaded in grey are identical in all 20 CYP sequences.  The N-
terminal membrane anchor region is indicated by a dotted line above the alignment.  
Residues lining the substrate binding channel as described in Chang and Lowe (1999) are 
indicated by a black dot below the alignment.  Residues affecting fatty acid hydroxylase 
activity in rabbit CYP4A isoforms as described in Loughran et al. (2000) are indicated by 
a red dot below the alignment.  The blue shaded boxes indicate SRS-1 and SRS-2 in 
rabbit CYP4A sequences defined by Loughran et al. (2000).  The yellow shaded box 
indicates SRS-2 in human CYP4F sequences defined by Kalsotra et al. (2004).  Gaps 
within the alignment are indicated by (~) and (―).  Protein sequences used in the 
alignment include: bacterial CYP102 (2HPD), CYP4A4 (rabbit, P10611), CYP4A5 
(rabbit, P14579), CYP4A6 (rabbit, P14580), CYP4A7 (rabbit, P14581), CYP4F3 
(human, Q08477), CYP4F11 (human, Q9HBI6). 
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CYP102 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - . I K E M . QP K - - - - T F . E L K N L . L L . T D K P V . A L MK I A D E L GE I F 40
Rabbit CYP4A4 1 MS V S A L S P T R L P GS . S G L . Q V A A L L G L L L L L L K . A Q L Y L H R QWL L R A L QQ F . C P P - . . . . L . - - . S R E F Q . D Q . - L E R I QK WV . . F . G A C 86
Rabbit CYP4A5 1 MS V S A L S P T R L P GS . S G L . Q V A A L L G L L L L L L K . A Q L Y L R R QWL L R A L QQ F . C P P - . . . . L . - - . S R E F QMN Q . - L . Q I L K WV . . F . . A C 86
Rabbit CYP4A6 1 MS V S A L N P T R L P GS . S G L . Q V A G L L G L L L L L L K . A Q L Y L H R QWL L R A L QQ F . C P P - . . . . L . - - . S R E F Q . GH . - L . V M L K WV . . F . S A C 86
Rabbit CYP4A7 1 MS V S A L S S T R L P GS F S G F . Q A A A L L G L L L L L L K . A Q L Y L R R QWL L R A L QQ F . C P P - S . . . L . - - . S R E F . I D S . - L . Q V L K R V . . F . S A C 86
Human CYP4F3 1 MP Q L S L S S L G L WP M A A S P W . . L L L V G A S WL L A R I L AWT Y T . Y D N C C R L R C F . QP P K R N . F L . - - . L G L I H S S . . . L L Y T QS L A C T F GD MC 88
Human CYP4F11 1 MP Q L S L S WL G L GP V A A S P W . . L L L V GGS WL L A R V L AWT Y T . Y D N C R R L QC F . QP P K QN . FW . - - . QG L V T P T . . . MK T L T Q L V T T Y . QG F 88
CYP4-2a 1 ~ ~ ~ ~ ~ ~ ~ . . L G . . S MS L T . Q A V . V L V V T T L . . GG . K R L L R Y R S . L . A MS L L . . . . . H S . I W . D L . . L R N M T S . QR . S V F GK F T . . F . K . Y 83
CYP4-2b 1 ~ ~ ~ ~ ~ ~ ~ . . L G . . S MS L T . Q A V . V L V V T T L . . GG . K R L L R Y R S . L . A MS L L . . . . . H S . I W . D L . R L QN M T C . QR . S V Y GK F T . . F . K . Y 83
CYP4-3a1v1 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . M . . Y . . . . ~ . K . . . Y D . . S . . . . . . . I 79
CYP4-3a1v2 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . M . . Y . . . . ~ . K . . . Y D . . S . . . . . . . I 79
CYP4-3a2 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . M . . Y . . . . ~ . K . . . Y D . . S . . . . . . . I 79
CYP4-3b1 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . I . K . . . . . . 79
CYP4-3b3 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . 79
CYP4-3c 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . M . . Y . . . . ~ . K . . . Y D . . S . . . . . . . I 79
CYP4-3b2_clone1 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . I . K . . . . . . 79
CYP4-3b2_clone2 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . S . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . I . K . . . . . . 79
CYP4-3b2_clone3 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . T . . . . . V . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . 79
CYP4-3b2_clone4 1 ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . 79
CYP4-3b2_clone5 1 ~ ~ ~ ~ ~ ~ ~ MD D T F S Q L K Y A L L L P V A G F I V Y K V V L A I H ~ ~ ~ N F K L Y A K T F D A C P GE T D F HWL Y GN V H K F P GP N ~ E E G I Q F Q I D V ME K R P R F S 79
CYP102 41 K F E A P G - . V T R Y . S S QR . I K E A C D E . R - - F D . N L . Q - - - - A L K F V R D F A . D . . F T S WT H E K N . K K A H N I . L . S . S QQ A MK G . H A MM V D I . 123
Rabbit CYP4A4 87 P W . L S GN K A R . L V Y D . . Y L K V I . GR . D - - - . . A P R N - - - - - . K L M T P . I . Y . . . . L D - - . Q T . F QH . . M . . . . . . Y . . . K . . . G L M V D S V 166
Rabbit CYP4A5 87 P H . I . GN K V R V Q . Y D . . Y MK V I . GR . D - - - . . S . GS - - - - - . T F V A P . I . Y . . . . L . - - . QP . F QH . . M . . . . . . Y . . . K . . . G L M V D S V 166
Rabbit CYP4A6 87 P R . L WGS . A H . L I Y D . . Y MK V I . GR . D - - - . . A QGS - - - - - . R F L A P . I . Y . . . . L . - - . Q T . F QH . . M . . . . . . Y . . . K . . . G L M A D S V 166
Rabbit CYP4A7 87 P R . L WGS E L F . I C Y D . . Y MK T I . GR . D - - - . . A . V S - - - - - . S F L A P . I . Y . . . . L E - - . Q T . F QH . . M . . . . . . Y . . . K . . . G L M V D S V 166
Human CYP4F3 89 CW . . . . WH A . V R I F . . T Y I K P . . F A P . A I V . . D K V F - - - - - . S F L K P . . . D . . . . S A - - . E K . S . H . . M . . . . . . . N . . K . . MK I F . E S V 171
Human CYP4F11 89 K L . L . . T F P L . I . C . . . I I . P I T S A . . A V A . . D M I F - - - - - . G F L K P . . . D . . . . S G - - . D K . S . H . . M . . . . . . . N . . K . . MK I F . K S V 171
CYP4-2a 84 . F . L . . . Q A N I . . L . . . T . K D L F . T A D ~ ~ ~ . . . F G ~ ~ ~ ~ ~ ~ . Q F G I P . . . E . . . I . G ~ ~ . . K . . . . . . . . S . . . . . . . . K . . . K . G . E . S 162
CYP4-2b 84 . F . M . . . H A N I . . V . . . T . K D L F . T A D ~ ~ ~ . . . F N ~ ~ ~ ~ ~ ~ . E F G I P . . . E . . . I . G ~ ~ . . K . . . . . . . . S . . . . . . . . K . . . K . G . E . S 162
CYP4-3a1v1 80 . A . . . . . . . . . I . Y . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . S . . . . . . ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
CYP4-3a1v2 80 . A . . . . . . . . . I . Y . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . S . . . . . . ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
CYP4-3a2 80 . A . . . . . . . . . I . Y . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . S . . . . . . ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
CYP4-3b1 80 . . . . . . . . . . I A . . . . . . . . . . . . . . . ~ ~ ~ . . . . N H . . . . G . . . . . . . . . . . . . . . . ~ ~ . . . . . . . . . . . . . . . . . E . . . . . . . . . . . . . 164
CYP4-3b3 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
CYP4-3c 80 . A . . . . . . . . . I . Y . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . S . . . . . . ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
CYP4-3b2_clone1 80 . . . . . . . . . . I A . . . . . . . . . . . . . . . ~ ~ ~ . . . . N H . . . . G . . . . . . . . . . . . . . . . ~ ~ . . . . . . . . . . . . . . . . . E . . . . . . . . . . . . . 164
CYP4-3b2_clone2 80 . . . . . . . . . . I A . . . . . . . . . . . . . . . ~ ~ ~ . . . . N H . . . . G . . . . . . . . . S . . . . . . ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
CYP4-3b2_clone3 80 . . . . . . . . . . . . . Y . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . S . . . . . . ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
CYP4-3b2_clone4 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
CYP4-3b2_clone5 80 R VWV GP F R G I L V L I H P D L V R K V L K S S A ~ ~ ~ P K P R S R F MK S V Y D M A L GWL GN G L L L A N ~ ~ GS QWA R S R R L L T P A F H F D I L R P Y V T V K N Q A A 164
CYP102 124 V Q . V Q . WE R L N - - A D E H I . V P E D M T R L T L . T I G L . G . N . R F . S F Y R D . - P H . F I T S M V R A L D E A MN K L QR A N P D D P A Y D - - - E N K . Q F QE 207
Rabbit CYP4A4 167 Q I M . D RWE Q L I S QD S S - L . I . QH . . L M T L . T I MK . A . S . QGS V . L D - R N S H S Y I . A I . D . N N . V F Y . A R N V F H QS D F . Y . . S P E . . L F H R 254
Rabbit CYP4A5 167 Q I M . D . WE Q L V S QD S S - L . V . QD I . L M T L . T I MK . A . S . QGS V . L D S R N S QS Y I . A . GD . N N . V F A . V R N I F H QS D T I Y . . S P E . . L S H R 255
Rabbit CYP4A6 167 Q I M . D . WE Q L V S QD S S - L . V . QD I . L M T L . T I MK . A . S H QGS V . L D - R N S QS Y I . A . GD . N N . F F S . V R N V F H QS D T I Y . . S P E . . L S H R 254
Rabbit CYP4A7 167 Q . M . D . L E K L A R K D A . - L . I Y E H . . L M T L E T I MK . A . S H QGS V . L E S R T S K S Y I . A . R . . S D . A L . . V R N V F H QS D F . Y . . S P E . . L S H R 255
Human CYP4F3 172 N I MH . . WQ L L A S . GS A R L D M . E H I . L M T L . S . QK . V . S F D . H . . E K - - - P S E Y I A A I L . . S A . V T K . H QQ I L . Y I D F . Y Y . . P D . Q . F R R 258
Human CYP4F11 172 N I MH D . WQR L A S . GS A R L D M . E H I . L M T L . S . QK . V . S F . . . . . E K - - - P S E Y I A A I L . . S A F V E K . N QQ I L . . T D F . Y Y . . P D . Q . F R R 258
CYP4-2a 163 . K . . E . V . K Y A D K GE S ~ M . M Y N . I . L . T L . M I MR . A MS . S N D I . A K . E ~ S H . Y V V A . S . . A D . L I . . I R N . L A Y N D F V Y G . . K N . . . F K E 250
CYP4-2b 163 . K . . E . V . K Y A D K GE S ~ I . M Y N . I . L . T L . M I MR . A MS . S N D I . T K . E ~ S H . Y V V A . S . . N D . L I . . I R N . L V Y N D F V Y G . . K N . . . F K E 250
CYP4-3a1v1 165 . . . . . . . . . . . . . . . . ~ . . . . . . . . V . . . . . . . . . . . . H . . . . . . . . . ~ . . . Y . . . . . . . . . . . . E . . L . . . . . . . . . . . . . . . . . . . . . 252
CYP4-3a1v2 165 . . . . . . . . . . . . . . . . ~ . . . . . . . . V . . . . . . . . . . . . H . . . . . . . . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . 231
CYP4-3a2 165 . . . . . . . . . . . . . . . . ~ . . . . . . . . V . . . . . . . . . . . . H . . . . . . . . . ~ . . . Y . . . . . . . . . . . . E . . L . . . . . . . . . . . . . . . . . . . . . 252
CYP4-3b1 165 . F . . . . . . A . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . L . . . . . . . . . . . . . . . . . . Q . . . . . . . . N . 252
CYP4-3b3 165 . F . . . . . . A . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
CYP4-3c 165 . . . . . . . . . . . . . . . . ~ . . . . . . . . V . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
CYP4-3b2_clone1 165 . F . . . . . . A . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
CYP4-3b2_clone2 165 . . . . . . . . . . . . . . . . ~ . . . . . . . . V . . . . . . . . . . . . H . . . . . . . . . ~ . . . Y . . . . . . . . . . . . E . . L . . . . . . . . . . . . . . . . . . . . . 252
CYP4-3b2_clone3 165 . . . . . . . . . . . . . . . . ~ . . . . . . . . V . . . . . . . . . . . . H . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
CYP4-3b2_clone4 165 . F . . . . . . A . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
CYP4-3b2_clone5 165 D V L L A K MK T H S E E K K P ~ F E T F Y N V S I C L F D V L L QC S F A Y E S N C QK T GQ ~ N D P H L QN V N E L V E L WA QR S MK P WL H F E WL F R L T S QGR RWY K 252
SRS-1
CYP102 208 D I K V MN D L V D K I . A D . - - - - - - - - - - - - - - - - - - - K A S GE QS D D L L T H M . N GK . P . T . E P L D D E N . . Y Q I I . . . I A . H E . . S G L . . F A . . 278
Rabbit CYP4A4 255 A . Q L A . E H T D R V . QQ . K A Q . QQE GE - - - - - - - - L . K V R R . . R L D . L . . . . F . K M - . N . S S L S D QD L . A . V . . . M . . . H . . . A . G V . . I F . 335
Rabbit CYP4A5 256 A . Q L A . E H T D R V . QQ . K A Q . QQE GE - - - - - - - - L . K V R R . . R L D . L . . . . F . K M - . N . S S L S D QD L . A . V . . . M . . . H . . . A . G V . . I F . 336
Rabbit CYP4A6 255 A . Q L A . E H T D R V . QQ . K A Q . QQE GE - - - - - - - - L . K V R R . . R L D . L . . . . F . K M - . N . S S L S D QD L . A . V . . . M . . . H . . . A . G I . . I F . 335
Rabbit CYP4A7 256 A . Q L A . E H T D R V . QQ . K A Q . QQE GE - - - - - - - - L . K V R R . . R L D . L . . . . F . K M - . N . S S L S D QD L . A . V . . . M . . . H . . . A . G I . . I F . 336
Human CYP4F3 259 A . R L . . D F T D A V . QE . . R T . P S QG V D - - - - - D F L Q A K A . S K T L D . I . . . . L S K . - . . . K K L S D E D . . A . . . . . M . . . H . . . A . G . . . V . . 342
Human CYP4F11 259 A . H L . . D F T D A V . QE . . R T . P T QG I D - - - - - D F L K N K A . S K T L D . I . . . . L S K . - . . . K E L S D E D . . A . . . . . M . . . H . . . A . G . . . V . . 342
CYP4-2a 251 Q . H Y . . G I . . Q I . QE . Q . I . . R ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . G . P . . . Y L D . L . I . . T . K . ~ D T . T . L . . . . . . S . V . . . . . . . H . . . A . . I . . I . . 327
CYP4-2b 251 Q . H Y . . G I . . Q I . QE . Q . I . . R ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . G . S . . . Y L D . L . I . . T . K . ~ D T . T . L . . . . . . S . V . . . . . A . H . . . A . . I . . I . . 327
CYP4-3a1v1 253 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 341
CYP4-3a1v2 232 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320
CYP4-3a2 253 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 341
CYP4-3b1 253 . . . . . . . M . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . V . . . . . . . . . . . . . . . . . A . . . . . . . . 341
CYP4-3b3 253 . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . 341
CYP4-3c 253 . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . 341
CYP4-3b2_clone1 253 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 341
CYP4-3b2_clone2 253 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 341
CYP4-3b2_clone3 253 . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . 341
CYP4-3b2_clone4 253 . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . 341
CYP4-3b2_clone5 253 L C D Q V H A V S E D L I D K R R K A L E A K K A A GD T D N S E D E S P GK K R L MC F V D V L L S A R D ~ E D G V GM T P L E I R N E A D T F L F E G Y D T T T S A L S WT L Y 341
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CYP102 454 P L GG I P S P S T E QS A K K V R 471
Rabbit CYP4A4 510 - - - - - - - - - - - - - - - - - - 510
Rabbit CYP4A5 511 - - - - - - - - - - - - - - - - - - 511
Rabbit CYP4A6 510 - - - - - - - - - - - - - - - - - - 510
Rabbit CYP4A7 511 - - - - - - - - - - - - - - - - - - 511
Human CYP4F3 520 - - - - - - - - - - - - - - - - - - 520
Human CYP4F11 521 A N S Q - - - - - - - - - - - - - - 524
CYP4-2a 506 P T V                508
CYP4-2b 506 P T V Y N NWE H          514
CYP4-3a1v1 520 .                  520
CYP4-3a1v2 499 .                  499
CYP4-3a2 520 . L Q V L V D T V GQQN H     533
CYP4-3b1 520 .                  520
CYP4-3b3 520 .                  520
CYP4-3c 520 .                  520
CYP4-3b2_clone1 520 .                  520
CYP4-3b2_clone2 520 .                  520
CYP4-3b2_clone3 520 .                  520
CYP4-3b2_clone4 520 .                  520
CYP4-3b2_clone5 520 G                  520
CYP102 279 F . V K N . H V L QK A A . . A A R V . V D P - - - V P S Y K Q V K . . K . V GM V L N . . L . L WP . A . A F S L Y A K . D T V . GGE Y P L E K . D E L M V L . P Q . . R D K . 365
Rabbit CYP4A4 336 A . . T H . . . . H R C R . . I QG . . GD G - - A S . . . E H . D . M . . . . M . . . . . L . L . P P . . S V T . Q L S K . V T F P . . R S L . K . V I L F L S . Y G . . Y . . K 423
Rabbit CYP4A5 337 A . . T H . . . . H R C R . . I QG . . GD G - - A S . . . E H . D . M . . . . M . . . . . M . L . P P . . A . S . D L S S . V T F P . . R S L . K . F T V T L S . Y G . . . . . N 424
Rabbit CYP4A6 336 A . . T H . . . . H R C R . . I QG . . GD G - - A S . . . E H . D . M . . . . M . . . . . L . L . P P . . G V G . Q L S S . V T F P . . R S L . K . V I V T L S . Y A . . . . . K 423
Rabbit CYP4A7 337 A . . T H . . . . H R C R . . I QG . . GD G - - A S . . . E H . D K M . . . . M . . . . . L . L . P P . . G V GS K L S S . V T F P . . R S L . K . I I . T L S . Y G . . . . . K 424
Human CYP4F3 343 H . . K H . . Y . E R C R Q . . QE . . K D . E P K E . E . . . . A . . . F L . M . . . . S L . L H P P . . A V S . C C . QD I V . P . . R V . . K . I I C L . S V F G T . . . . A 432
Human CYP4F11 343 H . . K H . . Y . E QC R Q . . QE . . K D . E P I E . E . . . . A . . . F L . M . . . . S L . L H P P . . V . S . C C . QD F V . P . . R V . . K . I V C L . N . I G I . Y . . . 432
CYP4-2a 328 . . C QH . D I . E K . . Q . I . T V . K . . D . . E . E . S . . P K F E F M . M V . . . GM . L H C P . . . . S . V T QK . M I . ~ E . F S . . . . S V C T . H . F N I . . . . V 416
CYP4-2b 328 . . C QH . D I . E K . . Q . I . T V . K . . D . . E . E . S . . P K F K F M . M V . . . GM . L H C P . . . . S . I S QK . M T . ~ E . F S . . . . S L C S . H M F N I . . . . V 416
CYP4-3a1v1 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . 430
CYP4-3a1v2 321 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . 409
CYP4-3a2 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . 430
CYP4-3b1 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L . Q . . . . . . . . . ~ . . . . . . . . . . . . . D . . A . . . . . . 430
CYP4-3b3 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L . Q . . . . . . . . . ~ . . . . . . . . . . . . . E . . . . . . . . . 430
CYP4-3c 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L . Q . . . . . . . . . ~ . . . . . . . . . . . . . E . . . . . . . . . 430
CYP4-3b2_clone1 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . 430
CYP4-3b2_clone2 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . E . . . . . . . . . 430
CYP4-3b2_clone3 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . 430
CYP4-3b2_clone4 342 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . 430
CYP4-3b2_clone5 342 S L A RWP E H Q T L V QE E V D A L L QGR S S D Y I TWD D L T Q L P Y T T A C I K E A I R N Y S T V P F I E R E I T E P L N L ~ D GH I I P A G T F I A I Q I WC L H H N P T 430
CYP102 366 I . GD D V E E F R . . . . E N P - - S A I P QH A F K . . GN . Q . A . . . . Q . . L H . A T L V L GMM L K H . D F E D H T . Y . L D I K E T L . L . P . G F V V K A K S K K I 453
Rabbit CYP4A4 424 . . QN - . E V F D . F . . A P . - - S A Y H S H A F L . . . G . A . . . . . K Q . . . R . . . . A . . L T L V . . E . L P . . T R I P I P I A R V V L . S K N G . H . R L R K L H 510
Rabbit CYP4A5 425 . . P N - . E V F D . G . . T P G - - S A R H S H A F L . . . G . A . . . . . K Q . . . . . . . . A . . L T L V . . E . L P . . T R I P K P T A R L V L . S N N G . H . R L R K L Q 511
Rabbit CYP4A6 424 . . P N - . E V F D . F P . A P G - - S A R H S H A F L . . . G . P . . . . . K Q . . . . . . . . A . . L T L V . . E . L P . . K R V P D QK . R L V L . S S N G . H . R L R K L R 510
Rabbit CYP4A7 425 . . P N - . E V F D . S . . A P G - - S A R H S H A F L . . . G . . . . . . . K Q . . . . . . . . A . . L T L V . . E . L P . . T R V P I P I T R L V L . S K N G . H . R L R K L H 511
Human CYP4F3 433 . . P D - . E V . D . F . . D P K . I K E R S . L A F I . . . . . P . . . . . . A . . . A . M . . V L G L T L L . . R V L P . H T - . P R . K . E L V L R A . GG L W . R V E . L S 520
Human CYP4F11 433 . . P D - . E V . D . F . . N QE . I K E R S . L A F I . . . . . P . . . . . . A . . . A . M . . V L . L T L L H . R I L P T H T - . P R . K . E L I L R A . GG L W . R V E . L G 520
CYP4-2a 417 . . P D ~ . WE F K . . . . H P . . T K D R . S . A F . . . . . . P . . . . . . H . . . . . E . . . L S . L L R . Y . F R . . . K Y P V V . K M T . I M . . . S GMR M F A . . . T 505
CYP4-2b 417 . . P D ~ . WA F K . . . . H P . . T T D R . S . A F . . . . . . P . . . . . . H . . . D . E . . . L S . L L R . Y . F R . . . K . P V V . K M T I I M . . . S GMR M F A . . . T 505
CYP4-3a1v1 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 519
CYP4-3a1v2 410 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 498
CYP4-3a2 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 519
CYP4-3b1 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . 519
CYP4-3b3 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . 519
CYP4-3c 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . 519
CYP4-3b2_clone1 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 519
CYP4-3b2_clone2 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . 519
CYP4-3b2_clone3 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . 519
CYP4-3b2_clone4 431 . . . . ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 519
CYP4-3b2_clone5 431 VWD R ~ P H D Y L P E R F F GD N A L N MD P F Q Y V P F S A GS R N C I GQN F A MN E L K V M V A R I F H R F T L A L D P N H E I L R A P L A T F K T E K D I K L L I T P R K 519
J J’ K β5 β6 β7 β8 K’
L β9 β10 β11 β12
SRS-5
SRS-6
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Figure 21. Cyphoma CYP4-2 and CYP4-3 clones selected for heterologous 
expression in yeast.  CYP4-2a and CYP4-2b are represented by clones 198_58 and 
198_27, respectively.  CYP4-3a1, CYP4-3b1, CYP4-3b3 are represented by clones 
197_52, 197_48, and 197_53, respectively.  Deduced amino acid sequences were aligned 
using ClustalX.  Grey boxes indicate areas of identical sequence among all clones.  
Amino acid residues identical to clone 197_52 are indicated by a “●”.  Stop codons and 
gaps are indicated by “*” and “~”, respectively. 
 
197_52 1 MD D T F S Q L K Y T L L L P V V G F I V Y K V V L A I H ~ ~ ~ N F K L Y A K T F D A C P GE T D F HWL Y GN MH K Y 57
197_48 1 . . . . . . . . . . A . . . . . A . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . S . . . . . . . . . . . . . V . . F 57
197_53 1 . . . . . . . . . . A . . . . . A . . . . . . . . . . . . ~ ~ ~ . . . . . . . . . . . . . . . . . . . . . . . . V . . F 57
198_58 1 . . L G . . S MS L . . Q A V . . L V V T T L . . GG . K R L L R Y R S . L . A MS L L . . . . . H S . I W . D L . . L 60
198_27 1 . . L G . . S MS L . . Q A V . . L V V T T L . . GG . K R L L R Y R S . L . A MS L L . . . . . H S . I W . D L . R L 60
197_52 58 P GP N ~ E K G I Q Y D I D S ME K R P R F I R AW V GP F R G I L I L Y H P D L V R K V L K S S A P K P R S R F MK S 116
197_48 58 . . . . ~ . E . . . F Q . . I . K . . . . . S . V . . . . . . . . I A . I . . . . . . . . . . . . . . . . . N H . . . . 116
197_53 58 . . . . ~ . E . . . F Q . . V . . . . . . . S . V . . . . . . . . . V . I . . . . . . . . . . . . . . . . . . . . . . . 116
198_58 61 R N M T S . QR . S V F GK F T . . F . K . Y . F . L . . . Q A N I V . L . . . T . K D L F . T A D . . . F G ~ ~ ~ ~ ~ 115
198_27 61 QN M T C . QR . S V Y GK F T . . F . K . Y . F . M . . . H A N I V . V . . . T . K D L F . T A D . . . F N ~ ~ ~ ~ ~ 115
197_52 117 V Y D M A L GWL GS G L L L A N GS QWA R S R R L L T P A F H F D I L R P Y V T V K N Q A A D V L L A K MK T H S E 176
197_48 117 G . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . E . . . . . . . . . . . . . . F . . . . . . A . . . 176
197_53 117 . . . . . . . . . . N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F . . . . . . A . . . 176
198_58 115 ~ . Q F G I P . . . E . . . I . G . . K . . . . . . . . S . . . . . . . . K . . . K . G . E . S . K . . E . V . K Y A D 174
198_27 115 ~ . E F G I P . . . E . . . I . G . . K . . . . . . . . S . . . . . . . . K . . . K . G . E . S . K . . E . V . K Y A D 174
197_52 177 E K K P F E T F Y N V S V C L F D V L L QC S F A H E S N C QK T GQN D P Y L QN V N E L V E L WA E R S L K P WL H 236
197_48 177 . . . . . . . . . . . . I . . . . . . . . . . . . Y . . . . . . . . . . . . H . . . . . . . L . . . . Q . . M . . . . . 236
197_53 177 . . . . . . . . . . . . I . . . . . . . . . . . . Y . . . . . . . . . . . . H . . . . . . . . . . . . Q . . M . . . . . 236
198_58 175 K GE S M . M Y N . I . L . T L . M I MR . A MS Y S N D I . A K . E S H . . V V A . S . . A D . L I Q . I R N . L A Y 234
198_27 175 K GE S I . M Y N . I . L . T L . M I MR . A MS Y S N D I . T K . E S H . . V V A . S . . N D . L I Q . I R N . L V Y 234
197_52 237 F E WL F R L T S QGR RWY K L C D Q V H A V S E D L I D K R R K A L E A K K A A GD T D N S E D E S P GK K R L MC 296
197_48 237 . . . . . Q . . . . . . . . N . . . . . . . . M . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
197_53 237 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
198_58 235 N D F V Y G . . K N . . . F K E Q . H Y . . G I . . Q I . QE . Q . I . . R ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . G . P . . . Y L D 282
198_27 235 N D F V Y G . . K N . . . F K E Q . H Y . . G I . . Q I . QE . Q . I . . R ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ . G . S . . . Y L D 282
197_52 297 F V D V L L S A R D E D G V GM T P L E I R N E A D T F L F E G Y D T T T S A L S WT L Y S L A RWP E H Q T L V QE E 356
197_48 297 . . . . . . . . . . . . . . . . . . V . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . 356
197_53 297 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . 356
198_58 283 . L . I . . T . K . D T . T . L . . . . . . S . V . . . . . . . H . . . A . . I . . I . . . . C QH . D I . E K . . Q . 342
198_27 283 . L . I . . T . K . D T . T . L . . . . . . S . V . . . . . A . H . . . A . . I . . I . . . . C QH . D I . E K . . Q . 342
197_52 357 V D A L L QGR S S D Y I TWD D L T Q L P Y T T A C I K E A I R N Y S T V P F I E R E I T E P L N L D GH I I P A G T 416
197_48 357 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L . Q . . . . . . . . . . . . . . . . . . 416
197_53 357 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L . Q . . . . . . . . . . . . . . . . . . 416
198_58 343 I . T V . K . . D . . E . E . S . . P K F E F M . M V . . . GM . L H C P . . . . S . V T QK . M I . E . F S . . . . S 402
198_27 343 I . T V . K . . D . . E . E . S . . P K F K F M . M V . . . GM . L H C P . . . . S . I S QK . M T . E . F S . . . . S 402
197_52 417 F I A I Q I WC L H H N P T VWD R P H D Y L P E R F F GD N A L N MD P F Q Y V P F S A GS R N C I GQN F A MN E L 476
197_48 417 . . . . D . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 476
197_53 417 . . . . E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 476
198_58 403 V C T . H . F N I . . . . V . . P D . WE F K . . . . H P . . T K D R . S . A F . . . . . . P . . . . . . H . . . . . E 462
198_27 403 L C S . H M F N I . . . . V . . P D . WA F K . . . . H P . . T T D R . S . A F . . . . . . P . . . . . . H . . . D . E 462
197_52 477 K V M V A R I F H R F T L A L D P N H E I L R A P L A T F K T E K D I K L L I T P R K G *         521
197_48 477 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . *         521
197_53 477 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . *         521
198_58 463 . . . L S . L L R . Y . F R . . . K Y P V V . K M T . I M . . . S GMR M F A . . . T P T V *       509
198_27 463 . . . L S . L L R . Y . F R . . . K . P V V . K M T I I M . . . S GMR M F A . . . T P T V Y N NWE H * 515
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Figure 22.  Recombinant expression of selected Cyphoma gibbosum CYPs in 
Saccharomyces cerevisiae.  The W(R) strain of yeast that over-expresses NADPH-
reductase was transformed with C. gibbosum CYPs under the control of a galactose 
inducible promoter.  (A) After 8 hours (B) or 15 hours of induction in YPGE media 
containing 2% galactose, CYP expression is visualized by Western blotting with anti-V5-
HRP.  Each lane contains 20 μg of protein. (lanes – Con, positive control gene expression 
(Arabidopsis β-glucuronidase); lane 1, 198_58; lane 2, 198_27; lane 3, 197_52; lane 4, 
197_48; lane 5, 197-53).   
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Figure 23. High pressure liquid chromatograms of leukotriene B4 metabolites 
formed by recombinant yeast expressing C. gibbosum CYP4 proteins.  Structure of 
metabolites formed in LTB4 hydroxylase assays are shown in (A).  Human liver 
microsomes (HLM) (0.5 mg/mL protein) (B) and yeast microsomes (2.0 mg/mL) 
containing C. gibbosum CYP4 proteins (C) and were incubated with 29.7 μM LTB4, 1.3 
mM NADP+, 3.3 mM glucose-6-phosphate, 0.4 U/mL glucose-6-phosphate 
dehydrogenase, 3.3 mM magnesium chloride in 100 mM KPO4 buffer at 23oC and 30oC 
for 120 min.  Substrate and metabolites analyzed by reverse phase HPLC and separated 
initially with 30% acetonitrile with 1 mM perchloric acid in water changing to 70% 
methanol over 20 min (flow rate = 1.0 mL/min).  LTB4 hydroxylase activity was detected 
with recombinant C. gibbosum microsomes (D), but not in three control incubations (i.e., 
no protein control incubation; a ‘global control’ pooled yeast sample incubation without 
NADPH cofactor or without incubation = time zero (E)).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
214
 
 
 
  
 
20-carboxy LTB420-hydroxy LTB4
(A)
215
 216
  
 
 
 
 
 
 
Chapter IV 
 
Influence of gorgonian diet on the activity and expression of Cyphoma gibbosum 
glutathione S-transferases (GSTs): evidence that ecologically relevant 
prostaglandins are substrates for molluscan GSTs. 
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Abstract 
 Despite the profound variation in tolerance of allelochemically-rich foods among 
marine consumers, few studies have addressed the proximate mechanisms underlying this 
variation.  Under continual exposure to naturally occurring prey toxins, associated 
predators have likely evolved glutathione S-transferases capable of metabolizing and/or 
sequestering a wide range of structurally diverse compounds.  GSTs were isolated from 
the digestive gland of the obligate gorgonian predator, Cyphoma gibbosum, and were 
studied for their sensitivity to inhibition by gorgonian extracts and commercially 
available prostaglandins that resemble known gorgonian allelochemicals.  All gorgonian 
extracts examined were potent inhibitors of GST activity, suggesting that the diet of C. 
gibbosum may contain high concentrations of GST substrates.  In particular, the 
chloroform-soluble extract from Plexaura homomalla substantially inhibited Cyphoma 
GST activity and was found to primarily contain prostaglandin A2, a known gorgonian 
feeding deterrent.  Further screening of commercially available prostaglandins in series 
A, E, and F revealed those prostaglandins most abundant in gorgonian tissues with highly 
reactive α,β-unsaturated carbonyls (PGA2) were the most potent inhibitors.  Kinetic 
studies of GST inhibition showed that PGA2 was a competitive inhibitor of 1-chloro-2,4-
dinitrobenzene (CDNB) conjugation by Cyphoma GSTs, suggesting that PGA2 is a 
substrate for Cyphoma mu-class GSTs.  In vivo estimates of PGA2 concentration in 
digestive gland tissues calculated from snail grazing rates suggest that Cyphoma GSTs 
would be saturated with respect to PGA2 and operating at or near physiological capacity.  
The high concentrations of putative substrates and inhibitors of GSTs present in all 
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gorgonian extracts may explain why Cyphoma digestive gland GSTs are highly expressed 
constitutively, i.e., regardless of the nature of the allelochemical diet.  It is likely that 
GSTs operate as ‘all-purpose’ detoxification enzymes in this marine generalist, capable 
of conjugating or sequestering a broad range of gorgonian allelochemicals, potentially 
providing a competitive dietary advantage for this species. 
 
Introduction 
 Glutathione S-transferases (GSTs, EC 2.5.1.18) comprise a large superfamily of 
enzymes whose soluble members function primarily as detoxification enzymes, 
facilitating the conjugation of a diverse array of hydrophobic electrophilic xenobiotics by 
the nucelophilic attack of glutathione (Parkinson 2001).  GSTs have long been known as 
important components of cellular defense mechanisms in mammalian systems (Hayes et 
al. 2005) and now numerous studies are revealing their significance in mediating 
allelochemical tolerance in invertebrate-host interactions (reviewed in Li et al. 2007).   
In terrestrial herbivores, both the diversity of GST forms and their allelochemical 
detoxification capabilities is likely a result of the co-evolution of these enzymes in 
response to host-plant allelochemicals (Wadleigh & Yu 1988, Bolton & Ahokas 1997).  
GST forms from polyphagous herbivores are able to metabolize a broader range of 
allelochemicals in comparison to those from specialists, consistent with the host range 
differences of these herbivores (Wadleigh & Yu 1987, 1988, Yu & Abo-Elghar 2000), 
suggesting that the evolution of generalist GST forms favors promiscuous catalytic 
activity presumably needed to cope with the breadth of dietary toxins encountered.  
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Additionally, the degree of polyphagy has also been correlated with the number of 
expressed GST isoforms.  GST isoforms purified from five lepidopterans revealed that 
specialists expressed only one major isoform, while generalists expressed multiple forms 
(Yu 1989).  In addition to the increased diversity and relaxed substrate specificity of 
generalist detoxification enzymes, the inducibility of GST forms and activity in insects 
exposed to allelochemicals and host plant foliage suggests that some consumers also have 
the ability to mount a defense against dietary toxins through changes in GST expression 
(Yu 1982, 1989, Brattsten 1992, Snyder et al. 1995, Yu 1999, Feng et al. 2001, Francis et 
al. 2001, Fang et al. 2005, Francis et al. 2005).  For generalist consumers that regularly 
encounter unpredictable host chemistry, a combination of diverse, catalytically versatile, 
allelochemically-responsive GSTs would confer a selective advantage and have 
substantial influence in determining dietary preference among herbivores.    
 Like their terrestrial counterparts, marine consumers that regularly feed on 
allelochemically-rich prey may have evolved a parallel suite of biochemical resistance 
mechanisms (reviewed in Sotka & Whalen 2008).  The induction or high constitutive 
activity of GSTs seen in several marine molluscs after exposure to allelochemical 
treatment or diet has been suggested as a protective mechanism against dietary 
intoxication (Lee et al. 1988, Vrolijk & Targett 1992, Regoli et al. 1997, DeBusk et al. 
2000, Kuhajek & Schlenk 2003, Vasconcelos et al. 2007).  For example, the generalist 
marine gastropod Cyphoma gibbosum, which feeds entirely on a diet of chemically-
defended gorgonians (O'Neal & Pawlik 2002), contains highly expressed cytosolic GST 
forms in its digestive gland (Vrolijk & Targett 1992), with activities rivaling those of 
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terrestrial invertebrates that feed solely on allelochemically-rich prey (Lee 1991, Lee & 
Berenbaum 1992).  Vrolijk & Targett (1992) noted differences in GST activity from 
field-collected C. gibbosum feeding on different gorgonian diets, suggesting that GST 
activity is induced in response to different suites of gorgonian allelochemicals.    
The gorgonian Plexaura homomalla, in particular, has been suggested to be a 
preferred diet of C. gibbosum (Harvell & Suchanek 1987, Lasker et al. 1988) even though 
this gorgonian contains impressive quantities of the cyclopentenone prostaglandins 
(PGA2) (Weinheimer & Spraggins 1969, Schneider et al. 1972, Spraggins 1972, 
Schneider et al. 1977, Ciereszko et al. 1985), known to serve as a feeding deterrent 
against generalist reef predators (Gerhart 1984, Pawlik & Fenical 1989, Gerhart 1991).  
Aside from their icythodetterent properties in marine systems, the cytotoxic effects of 
cyclopentenone prostaglandins (cyPGs) (e.g., induction of apoptosis and inhibition of cell 
growth) are believed to stem from their reactive α,β-unsaturated carbonyl group in the 
cyclopentenone ring, which can undergo nucleophilic addition with electrophilic moieties 
resulting in protein and DNA adduct formation (Noyori & Suzuki 1993, Bogaards et al. 
1997, Chen et al. 1999, Sanchez-Gomez et al. 2007).  Cyclopentenone prostaglandins of 
the A and J series have been shown to be inducers of GST activity and mRNA/protein 
expression in mammalian (Kawamoto et al. 2000, Uchida 2000) and invertebrate cell 
lines (Stanley et al. 2008).  Furthermore, select vertebrate alpha-, mu- and pi-class GSTs 
were found to enhance PGA2 conjugation with glutathione, suggesting that the 
overexpression of GST forms could modulate the cytotoxic effects of cyPGs (Bogaards et 
al. 1997).  Given that C. gibbosum neither avoids P. homomalla nor adjusts its feeding 
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rates to reduce toxin exposure (Lasker et al. 1988), this snail likely possesses effective 
detoxification mechanisms, possibility GST-mediated, to contend with the high 
concentrations of dietary prostaglandins.   
 In a previous study, proteomic analysis confirmed the expression of two major 
GST mu-class isoforms responsible for the high GST activity observed in the digestive 
gland of C. gibbosum (Chapter 2).  Here, I present the results of a controlled laboratory 
feeding study that was used to examine the influence of gorgonian diet on GST activity 
and subunit expression in C. gibbosum digestive gland.  Results indicate that GST 
subunit composition was invariant and activity was consistently high regardless of snail 
diet, suggesting that constitutive GST expression in C. gibbosum may afford this 
consumer greater protection if gorgonian diets examined were to contain GST substrates.  
To identify possible substrates for Cyphoma GSTs, gorgonian extracts were screened 
using a bioassay-guided fractionation approach.  These studies revealed that moderately 
hydrophobic fractions from all gorgonians examined inhibited GST activity, suggesting 
that the putative substrates/inhibitors for Cyphoma GSTs are ubiquitous among all 
gorgonian species.  In addition, selected prostaglandins representing a range of 
eicosanoids previously described from P. homomalla were examined for their ability to 
inhibit GST activity.  Kinetic analyses revealed cyclopentenone prostaglandins to be high 
affinity competitive inhibitors – and thus likely substrates – for C. gibbosum GSTs, with 
apparent affinity values comparable to Km values described for prostaglandin-conjugating 
vertebrate GSTs. 
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Materials and Methods 
Reagents 
1-chloro-2,4-dinitrobenzene (CDNB), dithiothreitol (DTT), potassium phosphate, 
potassium chloride, EDTA, protease inhibitor cocktail mix, glutathione (GSH), and GSH-
agarose were purchased from Sigma (St. Louis, MO).  PD-10 desalting columns were 
purchased from GE Healthcare (Piscataway, NJ).  Bradford reagents were purchased 
from BioRad (Hercules, CA).  Prostaglandins 15(S)-PGA2, 15(R)-15-methyl PGA2, 
15(S)-PGE2, 15(R)-PGE2, 15(S)-PGE2-methyl ester, 15(S)-PGF2α, 15(R)-PGF2α, 15(S)-
PGF2α-methyl ester were purchased from Cayman Chemical (Ann Arbor, MI).   
  
Animal collection and feeding assay design 
 Feeding assays with adult Cyphoma gibbosum (ca 2-3 cm length) and six species 
of gorgonian (Briareum asbestinum, Eunicea mammosa, Gorgonia ventalina, 
Pseudopterogorgia acerosa, Pseudopterogorgia americana, Plexaura homomalla) were 
performed as described in Chapter 3, Materials and Methods.  Briefly, a total of 39 snails 
were collected from four shallow reefs (Big Point – 23o47.383’N, 76o8.113’W; North 
Normans – 23o47.383’N, 76o8.264’W; Rainbow Gardens – 23o47.792’N, 76o8.787’W; 
Shark Rock – 23o45.075’N, 76o7.475’W; Sugar Blue Holes – 23o41.910’N, 76o0.23’W) 
surrounding Lee Stocking Island, Exuma Cays, Bahamas and allowed to feed ad. libum 
on either a control diet or one of six gorgonian diets for 4 d.  Following the completion of 
the feeding assay digestive glands were immediately dissected, weighed, frozen in liquid 
nitrogen and maintained at -80oC until further processing.  Table 1 and Figure 3 in 
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Chapter 3 provide a summary of the feeding assay design and summary of the digestive 
gland samples collected for protein analysis. 
 
GST purification and HPLC analysis subunits 
 Cytosolic and affinity-purified GSTs were isolated from Cyphoma digestive gland 
samples as described in Chapter 2, Materials and Methods.  Briefly, cytosolic GSTs were 
isolated by homogenizing digestive glands (n = 39) separately in buffer (0.1 M potassium 
phosphate, 1 mM EDTA, 1 mM DTT, 1.15% potassium chloride, protease inhibitor 
cocktail (1X); pH 7.5) and differentially centrifuging the homogenates to obtain the 
cytosolic fraction containing the soluble GST pool.  Individual cytosolic GST fractions 
were then applied to both a PD-10 size exclusion and GSH-agarose affinity column in 
series to obtain affinity-purified GSTs as described in Chapter 2, Materials and Methods.  
GST fractions were buffer exchanged to low salt concentration and concentrated with 
Amicon Ultra-4 centrifugational filters (5K NMWL membrane; Millipore, Billerica, 
MA).  Protein concentrations of Amicon concentrates were determined using the 
NanoOrange protein quantitation kit (Molecular Probes, Eugene, OR). 
 A 30 μL aliquot of the affinity-purified GST concentrate from each of the 39 
digestive gland samples was injected onto a reverse phase Vydac protein/peptide column 
(model #218 TP 52; C18 μm 250 mm x 2.1 mm) and separated using a Waters 600 
MultiSolvent Delivery System, with a flow rate of 0.5 mL/min.  Peaks were detected 
using a Waters 2487 Dual Wavelength Absorbance Detector (λ = 214 nm).  Mobile phase 
A consisted of 38% acetonitrile, 62% water and 0.1% trifluoroacetic acid (TFA).  Mobile 
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phase B consisted of 80% acetonitrile, 20% water and 0.1% TFA.  The initial mobile 
phase consisted of 100% A.  GST subunits were separated using a linear gradient from 0 
to 40% B in 22 min, and 40 to 100% B in 37 min.  The column was re-equilibrated with 
100% A from 37-50 mins prior to the next injection.  Integration of peak area was 
achieved using the Empower 2 Chromatography Data Software package (Waters, 
Milford, MA) and converted to GST subunit percent composition for each digestive 
gland sample.   
    
GST activity assay 
Enzyme activity was measured using CDNB as a substrate by the method of 
(Habig et al. 1974) optimized for C. gibbosum (Vrolijk & Targett 1992) in a microplate 
format.  The reaction mixture (in a final volume of 200 μL) contained 0.1 M potassium 
phosphate buffer, 1.0 mM EDTA, pH 7.5, 1 mM CDNB, 1 mM reduced glutathione 
(GSH) and 2 μg of cytosolic protein or 3.3 – 6.4 ng of affinity-purified GST sample.  
CDNB was solubilized in ethanol and constituted 1% of the final reaction mixture 
volume.  The reaction was incubated at 25°C and initiated by the addition of CDNB.  All 
reactions were performed in triplicate.  The conjugation of CDNB with GSH was 
measured as the increase in absorbance at 340 nm (Δε340 0.00503 μM-1 cm-1) using a 
tunable microplate reader (Versamax, Molecular Devices, Sunnyvale, CA).  Activity was 
calculated using protein concentrations determined via the Bradford assay with BSA as a 
standard.   
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Extraction and isolation of gorgonian compounds 
 A minimum of ten colonies for each gorgonian species were collected from 
shallow reefs (< 20 m) surrounding Lee Stocking Island, Exuma Cays, Bahamas and used 
in the feeding assays described above.  A portion of the gorgonian colonies, prior to their 
introduction into the feeding assay, was immediately removed after field collection and 
immersed in seawater to determine volumetric displacement, frozen at -80oC, and 
lyophilized for subsequent chemical extraction.  Pseudopterogoria blanquillensis was 
also collected for chemical analysis; however, this gorgonian species did not participate 
in the feeding assays.  A 50 mL equivalent pool of gorgonian tissue for each of the eight 
species was extracted twice in 250 mL reagent grade acetone overnight with agitation.  
Resulting extracts were vacuum-filtered through celite, dried down by rotary evaporation, 
and recombined into a 20 mL scintillation vial using a minimum volume of solvent.  
Extracts were then completely dried using a vacuum concentrator.  The crude extracts 
were assayed at 1/20th natural concentration by volume (i.e., the extract from 0.05 mL of 
gorgonian was diluted into 1 mL of assay buffer) for the ability to inhibit Cyphoma 
cytosolic GST activity as described above, and inhibitory fractions were subjected to 
further fractionation using a bioassay-guided fractionation approach. 
 Gorgonian crude organic extracts were separated by partition between hexane and 
methanol-water (9:1) followed by partition of the methanol-water fraction (adjusted to 
6:4) against chloroform.  All three fractions were reduced in vacuo and assayed for their 
ability to inhibit cytosolic GST activity.  The chloroform fractions from all eight 
gorgonian species showed the most inhibition and were further separated on a reverse-
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phase semi-prep Zorbax SB-C18 column (5 μm, 9.4 mm x 2.5 cm) attached to a Waters 
Breeze HPLC system (515 pump) with a Waters 2487 UV detector at 215 and 254 nm.  
Compounds were eluted over 33 mins at a flow rate of 3 mL/min with methanol/water 
(9:1) with linear ramping to 100% methanol.  HPLC fractions were hand collected at 
three minute intervals over 33 min, yielding ten fractions per gorgonian species.  Each 
fraction was assayed for GST inhibition at 1/10th natural concentration by volume.  
Fractions yielding 100% inhibition were further assayed at 1/200th natural volumetric 
concentrations. 
 
Inhibition assays 
GST activity measurements were performed as described above.  The reaction 
mixture (in a final volume of 200 μL) contained 0.1 M potassium phosphate buffer, 1.0 
mM EDTA, pH 7.5, 1 mM CDNB, 1mM reduced GSH and either 2 μg of cytosolic GST 
preparations or 3.3 – 6.4 ng of affinity-purified GSTs.  Gorgonian extracts were dissolved 
in appropriate solvents (e.g., acetone, n-propanol, or methanol), HPLC fractions were 
dissolved in methanol, and prostaglandins were dissolved in DMSO.  Solvent 
concentrations did not exceed 5% of the experimental volume and had no effect on GST 
activity when compared to non-solvent controls (data not shown).  Immediately prior to 
the start of the assay, inhibitor solutions were added to the buffer/GSH mixture and 
homogenized to ensure equal distribution of inhibitor in all microplate wells.  The data 
were corrected for the non-enzymatic reaction rates and the effect of the inhibitors on 
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catalytic activity was measured by comparing the initial rate of reaction in the presence 
and absence of the inhibitor.   
Initially, eight prostaglandins (15(S)-PGA2, 15(R)-15-methyl PGA2, 15(S)-PGE2, 
15(R)-PGE2, 15(S)-PGE2-methyl ester, 15(S)-PGF2α, 15(R)-PGF2α, 15(S)-PGF2α-methyl 
ester) were screened at 600 μM for their potential to inhibit cytosolic GST activity.  From 
this initial screening, only those prostaglandin compounds that demonstrated an ability to 
reduce GST activity by 50% or greater were further evaluated at a range of 
concentrations (0.2 – 2000 μM) in order to estimate the concentration producing 50% 
inhibition of enzyme activity (IC50).  Prostaglandin IC50 values were calculated and 95% 
confidence intervals were estimated using Prism 5.0 software (GraphPad) by fitting the 
log transformation of the response variable by nonlinear regression to the variable slope 
equation (1) and constraining the bottom to zero while allowing the Hill Slope to vary.  
The variable slope equation is: 
         (1) 
 
where Top is the maximum percent GST activity remaining, Bottom was constrained to 
zero, IC50 is the concentration of inhibitor that produces inhibition half-way between the 
Top and Bottom, and [I] is the logarithmic concentration of the inhibitor. 
 
Determining inhibition type and kinetic constants 
 In order to determine the type of inhibition, initial-rate measurements with 15(S)-
PGA2 and GSH using CDNB as the concentration-variable substrate were performed with 
Y = 
Bottom + (Top – Bottom)
1 + 10 ((LogIC50 – [I])* HillSlope)
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an affinity-purified GST sample at 25oC in 0.1 M potassium phosphate buffer, 1.0 mM 
EDTA, pH 7.5, containing 4% (v/v) DMSO.  Data were corrected for the non-enzymatic 
reaction rates and globally fitted to equations for competitive (Eq. (2)), noncompetitive 
(Eq. (3)), and uncompetitive (Eq. (4)) using a single substrate-single inhibitor model with 
Prism 5.0 software.  The equations used were:   
          (2) 
 
 
          (3) 
 
          (4)  
          
where v is the initial rate of product formation, Vmax is the maximal rate of product 
formation, Km is the Michaelis-Menten constant, [S] is the substrate concentration, [I] is 
the inhibitor concentration, Ki is the equilibrium dissociation constant for the enzyme-
inhibitor complex, and Ki’ is the equilibrium dissociation constant for the inhibitor from 
the enzyme-substrate-inhibitor complex.  
The appropriate model of inhibition was chosen based on how well the data 
supported each model (goodness-of-fit), given the number of parameters and sample size, 
using both the Akaike information criterion (AIC) (Akaike 1986) and the extra-sum-of-
squares (F-test) tests.  In paired model comparisons (i.e., Eq. (2) versus Eq. (3)) 
performed by Prism 5.0, the resulting ΔAICc values were used to calculate the probability 
Vmax [S]
Km   + [S](1 + [I]/Ki’) 
vo = 
Vmax [S]
Km(1 + [I]/Ki) + [S](1 + [I]/Ki’) 
vo = 
Vmax [S]
Km(1 + [I]/Ki) + [S]
vo = 
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that each model was correct given the available data and AIC results were compared to 
F-test results to select the most appropriate inhibition model.  In no case did the two test 
results (Akaike and extra-sum-of-squares) differ from one another.  The data were then 
fitted to the most appropriate model and used to estimate an apparent Michaelis-Menten 
constant (Km) and maximal velocity (Vmax).  Double reciprocal plots of the inhibition data 
were used to examine the inhibition patterns.   
Because the IC50 depends on the substrate concentration used in the experiment, 
this value is only useful for comparing inhibitors within experiments and not between 
laboratories unless identical assay conditions were used.  However, calculated Ki values 
(the dissociation constant of the enzyme-inhibitor complex) can be used to directly 
compare inhibitor affinity for the enzyme between studies.  Once 15(S)-PGA2 was 
confirmed to be a competitive inhibitor of C. gibbosum GST activity, the Ki was 
calculated using the IC50 values obtained for 15(S)-PGA2, 15(R)-15-methyl PGA2, 15(S)-
PGE2, 15(S)-PGF2α with the Cheng-Prusoff equation (Eq. 5), where IC50, Km, S, and Ki 
are defined above. 
         (5) 
 
Results 
Dietary influence on GST activity and protein composition 
 Cytosol was isolated from the digestive glands of 39 individual C. gibbosum 
feeding on one of six gorgonian diets (n = 27) or a control diet (n = 12) for four days.  
GST specific activity levels measured from individual crude cytosolic preparations were 
IC50 = Ki (1 +          )Km
S
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grouped by snail diet and ranged from 1930 to 2957 nmol min-1mg protein-1.  GST 
activity values were within the range reported by Vrolijk and Targett (1992) but did not 
differ significantly between snail diets (Figure 1).  Cytosolic GSTs were further purified 
(approximately 200-fold) by size-exclusion and affinity chromatography (see Chapter 2, 
Results) and separated by reverse-phase HPLC in order to quantify the relative 
abundance of GST subunits from each digestive gland sample (Figure 2).  HPLC 
separation identified fourteen unique peaks, with two major peaks (4 and 8) representing 
on average 25% and 68% of the relative composition of GST subunits among all 
digestive gland samples, respectively (Figure 3).  HPLC peak (1) and peaks (2 – 14) were 
previously identified as theta- and mu-class GSTs, respectively (Chapter 2, Results).  The 
relative amounts of each GST form did not differ significantly as a function of gorgonian 
diet when expressed either as a percent of all subunits present (Figure 3) or when 
normalized to the amount of affinity-purified GST sample injected on to the HPLC 
column (Figure 4).  These results indicate that, while GST activity is constitutively 
expressed at high levels in Cyphoma digestive gland, both GST activity and subunit 
abundance are unaffected by gorgonian diet. 
 
Inhibition of GST activity by gorgonian extracts 
 Crude organic extracts were prepared from eight species of gorgonian (B. 
asbestinum, E. mammosa, G. ventalina, P. acerosa, P. americana, P. blanquillensis, P. 
elisabethae, and P. homomalla) and tested at 1/20th natural volumetric concentrations for 
inhibition of Cyphoma GST activity (Figure 5).  Extracts from both P. acerosa and P. 
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homomalla completely inhibited GST activity, while extracts from the remaining 
gorgonian species inhibited > 70% of GST activity compared to solvent controls.  Crude 
extracts were then partitioned into three fractions (e.g., hexane, chloroform, and aqueous) 
of increasing polarity.  The chloroform soluble fractions from all gorgonian species 
consistently showed > 80% inhibition of GST activity compared to controls.  Aqueous 
fractions displayed minor inhibitory effects with the exception of fractions from P. 
acerosa and P. homomalla, which inhibited GST activity by 85 and 99%, respectively. 
Hexane fractions exhibited intermediate and wide-ranging inhibitory effects depending 
on gorgonian species.  It was decided to further separate the chloroform soluble fraction 
by HPLC because of the consistency of inhibition seen for this fraction among all 
gorgonian extracts surveyed.   
 Chloroform soluble fractions were separated using reverse-phase HPLC.  For all 
gorgonian species examined, compounds eluting between 3 to 6 min (fraction 1) 
consistently inhibited affinity-purified GST activity by > 80% at 1/10th natural volumetric 
concentrations compared to paired solvent controls (Figure 6).  Inspection of HPLC 
traces suggests that fraction 1 for all gorgonian species examined consists of a mixture of 
compounds.  HPLC fraction 1 was further diluted to 1/200th natural volumetric 
concentrations for those gorgonian species (B. asbestinum, E. mammosa, P. acerosa, P. 
homomalla) exhibiting > 93% inhibition of GST activity.  Diluting fraction 1 decreased 
the inhibitory effect of the compound(s); however, in all cases diluted fractions still 
retained the ability to inhibit > 65% GST activity compared to solvent controls. 
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 The highly inhibitory chloroform fraction 1 from P. homomalla was further 
analyzed by Amy Lane at the Georgia Institute of Technology by high-performance 
separation techniques coupled with spectroscopic methods such as mass spectrometry 
(MS) and nuclear magnetic resonance (NMR) to provide additional structurally 
informative data.  LC-MS analysis of P. homomalla chloroform-soluble fraction 1 
revealed the presence of three peaks (m/z = 271, 315, 333), which are diagnostic of the 
free hydroxy acid of PGA2 (Figure 7).  Further comparison of the 1H NMR spectra of P. 
homomalla (fraction 1) and the PGA2 standard (Figure 8) confirmed the presence of 
PGA2 in the gorgonian tissue and indicated that the free hydroxy acid of PGA2 was a 
major component of the chloroform-soluble fraction.  A dilution series of the PGA2 
standard was subjected to LC-MS analysis and used to quantify the amount of PGA2 in P. 
homomalla tissue (1.6 mM) based on an extrapolation from the standard curve.  Further 
analysis of P. homomalla HPLC fractions 1 and 2 by LC-MS and NMR also suggested 
the presence of additional prostaglandins, possibly PGA2 analogs (data not shown).  
 
Inhibition of GST activity by prostaglandins 
 Eight commercially available prostaglandins representing a diversity of forms 
present in gorgonian tissue (i.e., PGA2, PGE2, PGF2α), including both enantiomers (R and 
S) forms when possible, were screened at 600 μM for their ability to inhibit CDNB-
conjugating activity of crude cytosolic Cyphoma GSTs (Figure 9).  Prostaglandins 
containing a cyclopentenone ring (PGA2) caused the greatest inhibition of GST activity, 
while the methyl ester forms of PGE2 and PGF2α displayed little to no inhibitory activity.  
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In general, prostaglandin series with the greatest inhibitory activities (i.e., PGA2) were 
those reported to be found in the greatest abundance in gorgonian tissues.  The potencies 
of the four most inhibitory prostaglandins (15(S)-PGA2, 15(R)-15-methyl PGA2, 15(S)-
PGE2, 15(S)-PGF2α) were evaluated at a range of concentrations (0.2 – 2000 μM) (Figure 
10).  All displayed concentration-dependent inhibition of enzyme activities with IC50 
values ranging from 75.4 μM for 15(S)-PGA2 to 334.6 μM for 15(S)-PGF2α (Table 1).   
The inhibitory effect of 15(S)-PGA2 was studied in greater detail by examining 
CDNB concentration-dependent GST conjugating activity in the presence of two 
concentrations of inhibitor.  Apparent kinetic constants (Km and Vmax) for CDNB in the 
presence and absence of 15(S)-PGA2 (Table 2) were obtained by fitting the data to the 
Michaelis-Menten equation by non-linear regression.  Vmax values for CDNB in the 
presence and absence of inhibitor did not differ significantly from one another (Extra 
sum-of-squares F test, Experiment 1, F1,32 = 2.462, p = 0.13; Experiment 2, F1,31 = 2.471, 
p = 0.13); however, precise determination of this parameter proved difficult due to the 
high variability in GST activity measurements at high concentrations of CDNB (Figure 
11, part A, B), due to the limited solubility of this substrate at concentrations greater than 
3 mM. 
To determine the type of inhibition caused by PGA2, the data were fit to three 
inhibition models (competitive, noncompetitive, and uncompetitive) in a series of 
pairwise comparisons (Table 3, 4).  Both the Akaike’s information criterion and the 
extra-sum-of-square F test were in agreement that competitive inhibition was statistically 
superior for describing the data.  The competitive inhibition model was, therefore, used to 
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calculate kinetic constants for CDNB (Km = 0.25 – 0.47 mM) and 15(S)-PGA2 (Ki = 15.6 
– 24.2 μM) (Table 5).  The Cheng-Prusoff equation for competitive inhibition was also 
used to calculate the corresponding Ki values for 15(S)-PGA2, 15(R)-15-methyl PGA2, 
15(S)-PGE2, and 15(S)-PGF2α using the IC50 values listed in Table 1.  The average Ki 
value for 15(S)-PGA2 derived from the competitive inhibition equation (Ki = 19.9 μM, 
Table 5) exactly matched the calculated Ki value obtained using the IC50 values obtained 
for 15(S)-PGA2 (Ki = 19.9 μM, Table 1).   
Lineweaver-Burk plots of 1/V versus 1/[CDNB] for 15(S)-PGA2 inhibition of 
affinity-purified GSTs did not converge on the y-axis as expected for competitive 
inhibition, suggesting mixed (competitive and noncompetitive) inhibition (Figure 11, part 
C, D).  Because inhibition assays were not performed on single GST isoform preparations 
but rather on affinity-purified GST fractions containing multiple GST isoforms, it is 
possible that PGA2 could interact differently with select GST isoforms.  In addition, the 
variability of the data, likely a result of the insolubility of CDNB at concentrations above 
3 mM, could substantially influence the trajectory of the regression analysis.  In contrast 
to the Lineweaver-Burke plots, the weight of evidence from the more statistically valid 
nonlinear regression analysis suggests that PGA2 is a competitive inhibitor and putative 
substrate for Cyphoma GSTs.   
  
Discussion 
 It is likely that the exploitation of allelochemically-defended gorgonian corals by 
the co-evolved predator, Cyphoma gibbosum, is facilitated by this predator’s ability to 
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biotransform or sequester dietary allelochemicals using detoxification enzymes such as 
soluble glutathione S-transferases.  GSTs are integral components of the cellular 
xenobiotic defense system (Strange et al. 2000) and have been documented to mediate 
allelochemical tolerance in terrestrial consumers (Wadleigh & Yu 1987, 1988, Yu & 
Abo-Elghar 2000).  Here, I investigated the influence of gorgonian diet on the expression, 
activity and inhibition of Cyphoma GSTs.   
Cyphoma cytosolic digestive gland preparations contained high GST activity; 
however, contrary to previous reports (Vrolijk & Targett 1992), GST activity did not 
significantly vary with respect to gorgonian diet.  The apparent differences likely lie in 
the basic experimental design between the two studies.  Vrolijk & Targett (1992) noted 
differences in GST activity among field-collected individuals where no data were 
available on the residence time of snails on their respective hosts.  In contrast, snails in 
the present study were subject to controlled 4 d feeding assays.  It is possible that GST 
enzymes could show significant levels of induction if snails were allowed to feed on 
gorgonian diets longer than four days.  However, it seems unlikely that our design, which 
included those gorgonian species examined by Vrolijk & Targett (1992), would have 
missed significant induction of GSTs because the length of the assay should have 
provided sufficient time for protein induction based on GST induction studies in 
polyphagous insects exposed for two days to dietary allelochemicals (Wadleigh & Yu 
1988, Yu 1999).  Additionally, snails could extend their exposure to the same suite of 
allelochemicals beyond the average 3.3 day residence time predicted by (Harvell & 
Suchanek 1987), if snails migrated to another colony of the same species.  This scenario 
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would be favored if the proportion of B. asbestinum and G. ventalina, the two gorgonian 
diets eliciting increased GST activity in Vrolijk & Targett (1992), were in higher 
abundance on reefs because prey selection by C. gibbosum is in proportion to gorgonian 
species abundance (Harvell & Suchanek 1987).   Alternatively, geographical (Rodriguez 
1995) and within colony differences in allelochemical content (Harvell & Fenical 1989) 
could account for the differences between the two studies. 
Although GST activity did not vary by gorgonian diet, cytosolic digestive gland 
GSTs were further purified by affinity chromatography to investigate if GST subunit 
composition was influenced by allelochemical exposure.  Cyphoma GST subunits were 
separated by HPLC resulting in the identification of two major mu-class GST subunits 
accounting for 93% of the total GST subunit abundance.  Quantification of GST subunit 
composition indicated that the relative abundance of GST subunits did not differ among 
snails feeding on different gorgonian diets.  Interestingly, GST activity was maintained at 
a high level and subunit composition did not vary in snails fed control diets devoid of 
allelochemicals as compared to snails fed gorgonian diets.  The presence of high GST 
activity in control-fed snails could indicate that some lipophilic gorgonian compounds 
and/or their metabolites may persist in snail tissues even after feeding has ceased, causing 
the expression of GSTs to be maintained.  Alternatively, Cyphoma GSTs could be 
expressed constitutively at high levels or regulated by an allelochemical-independent 
mechanism.  Having a constant supply of ‘all-purpose’ GST enzymes may prove 
advantageous for predators that consistently feed on prey containing allelochemical GST 
substrates.  
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To determine the prevalence of gorgonian species containing putative GST 
substrates, gorgonian extracts and semi-pure fractions were screened for their ability to 
inhibit the CDNB-conjugating activity of Cyphoma GSTs.  The ability of compounds to 
inhibit GST activity was used as an indirect measure of their potential to act as GST 
substrates.  Crude extracts from all eight gorgonian species were effective at inhibiting 
GST activity by greater than 70% at 1/8th natural volumetric concentrations compared to 
controls.  In general, substrates for GST enzymes are classified as hydrophobic 
compounds able to react with the thiol moiety of glutathione (Hayes et al. 2005).  Upon 
further separation of the crude extract, the chloroform-soluble fraction was identified as 
containing the bulk of the inhibitory compounds.  Efforts are underway to determine if 
the chloroform-soluble fractions contain electrophilic compounds with internal leaving 
groups (e.g., epoxides, α,β-unsaturated ketones, halogenated hydrocarbons, etc.) (van 
Bladeren 2000) capable of serving as sites for the nucleophilic addition of glutathione.   
In addition to containing potential GST substrates, gorgonian extracts may also 
contain electrophilic compounds that could act as potent GST inhibitors, binding to free 
cysteine residues on the protein, resulting in enzyme inactivation (van Iersel et al. 1999).  
The presence of high affinity GST inhibitors in gorgonian tissues may represent specific 
counter-adaptations of prey to thwart consumer GST-mediated metabolism of co-
occurring allelochemicals (Lee 1991, Li et al. 2007).  Although the high-throughput 
screening approach of gorgonian extracts was not able to distinguish between GST 
substrates and inhibitors, this result did substantiate the hypothesis that all gorgonian 
species contained significant quantities of compounds capable of interacting with 
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Cyphoma GSTs, which could account for the high constitutive activity of digestive gland 
GSTs identified here and in (Vrolijk & Targett 1992).    
In this study, I also examined the chemistry of specific gorgonian diets that 
contain classes of compounds recognized to be substrates/inhibitors for vertebrate GSTs 
(Cagen et al. 1975, van Iersel et al. 1999, Beuckmann et al. 2000, Kawamoto et al. 2000, 
Uchida 2000, Murphy & Zarini 2002, Sanchez-Gomez et al. 2007).  The gorgonian 
Plexaura homomalla, once under intense study because of the unusually high 
concentration of prostaglandins isolated from its tissues, can account for nearly 50% of 
the biomass on some Caribbean reefs (Bayer & Weinheimer 1974) and has been 
suggested to be a favored diet of C. gibbosum (Harvell & Suchanek 1987, Lasker et al. 
1988, Chiappone et al. 2003).  The potential importance of this particular gorgonian 
species’ allelochemicals in the co-evolution of C. gibbosum detoxification enzymes 
coupled with the interesting ecological and biological activities of eicosanoids, were 
motivating factors in determining if prostaglandins could serve as substrates for C. 
gibbosum GSTs.   
P. homomalla tissues predominately contain the fully esterified form of PGA2 (~ 
2% dry weight of the gorgonian) (Weinheimer & Spraggins 1969), which is related to a 
larger group of eicosanoids that includes the coral-derived halogenated marine clavulones 
(Honda et al. 1987, Iguchi et al. 1987) and puniglandins (Fukushima & Kato 1985, Baker 
& Scheuer 1994), all of which display cytotoxic activities thought to be related to the 
presence of a reactive α,β-unsaturated ketone (Honn & Marnett 1985, Kato et al. 1986).  
While the exact mechanism of toxicity is unknown, the prostaglandins are transported 
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into the nucleus (Narumiya & Fukushima 1986, Narumiya et al. 1987, Narumiya et al. 
1988) where the electrophilic α,β-unsaturated carbonyl is free to bind with nucleophilic 
sulfhydryl residues on target proteins, unless rapidly conjugated by cytosolic GSH and 
exported out of the cell by glutathione-conjugate transporters (Atsmon et al. 1990).  In 
this study, the α,β-unsaturated carbonyl-containing prostaglandins (15(R)-15-methyl 
PGA2 and 15(S)-PGA2) were the most potent inhibitors of CDNB conjugating activity of 
Cyphoma GSTs in both the initial screening of eight prostaglandin compounds and upon 
comparison of IC50 values, establishing the order of potency of prostaglandins to be 
15(S)-PGA2 > 15(R)-15-methyl PGA2 >> 15(S)-PGE2 ≈ 15(S)-PGF2α.  The Ki values for 
cyclopentenone-containing prostaglandin A series were also 2.3- to 4-fold lower (greater 
affinities) for Cyphoma GSTs in comparison to those of either PGE2 or PGF2α.  In 
addition, subsequent structural analysis confirmed that the inhibitory P. homomalla 
chloroform-soluble fractions predominantly contained high concentrations of the potent 
PGA2 and PGA2-analogs, likely accounting for the bulk of the observed inhibition for 
these particular HPLC fractions.   
Statistical comparison of the goodness-of-fit of the data among different models 
of inhibition using both Akaike information criterion and extra-sum-of-squares test 
suggest that PGA2 is a competitive inhibitor of CDNB, and likely a substrate for C. 
gibbosum GST(s).  Because PGA2 acts as a competitive inhibitor of GST activity, likely 
binding with high affinity in the active site (H-site) once occupied by CDNB, it is 
reasonable to compare Ki values (i.e., apparent Km for PGA2) obtained here to Km values 
for PGA2 cited in other studies.  The apparent Km (~ 19.9 μM) for 15(S)-PGA2 described 
240
here is in line with the Km value identified for the conversion of PGA2 to its glutathione 
conjugate by human mu-class GST M1a-a (26 μM) (Bogaards et al. 1997) and Km values 
for PGA2 for rat alpha-class GST A4-4 (12 μM) and human mu-class GST M2-2 (7.6 
μM) (Hubatsch et al. 2002).  The similarity between kinetic constants further supports the 
conclusion that PGA2 is a substrate for Cyphoma GSTs.  The rank order of affinity of 
Cyphoma GSTs for prostaglandins (15(S)-PGA2 > 15(R)-15-methyl PGA2 > 15(S)-PGE2 
> 15(S)-PGF2α), also is positively correlated with the abundance of each prostaglandin 
series in P. homomalla tissues, suggesting that Cyphoma GSTs may have evolved to 
efficiently catalyze those prostaglandin series found in the greatest abundance in its diet 
(PGA2), yet still retain a broad enough substrate specificity to conjugate additional forms 
(PGE2, PGF2α).   
 The apparent Km values reported here indicate that dietary prostaglandins would 
be high affinity substrates of Cyphoma digestive gland GSTs in vivo.  However, the 
physiological relevance of GSTs for prostaglandin biotranformation depends on the 
concentrations of prostaglandins occurring in the digestive glands of Cyphoma feeding on 
prostaglandin-containing gorgonians.  To obtain an estimate of these concentrations, I  
first calculated the volume of P. homomalla tissue consumed per snail per day based on 
feeding scar measurements reported in (Harvell & Suchanek 1987).  Cyphoma feeding 
scars on P. homomalla colonies averaged 12 cm in length (n = 21 snails), did not exceed 
1 cm in width, and penetrated to the gorgonian skeleton 66% of the time (Harvell & 
Suchanek 1987).  Therefore, conservative estimates of scar volume averaged 1.44 cm3 
per snail (or 1.44 mL) (length x width x depth; 12 cm x 0.4 cm x 0.4 cm).  This tissue 
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volume was divided by the mean residence time of snails feeding on P. homomalla (2.9 
d, n = 50 snails) (Harvell & Suchanek 1987) to yield an estimate for the volume of P. 
homomalla tissue consumed by each snail per day (0.66 mL/snail/day).  (Pawlik & 
Fenical 1989) determined that 1 mL of wet P. homomalla tissue (excluding the gorgonian 
axial skeleton) was equal to 0.86 g of dry gorgonian tissue.  If 2% of the dry weight of 
the gorgonian is prostaglandins (Weinheimer & Spraggins 1969), then 0.66 mL of 
gorgonian tissue would contain 0.011 g of prostaglandins.  Assuming the majority of the 
prostaglandins are in the PGA2 (FW = 348.5 g/mol) form and are completely retained 
within the digestive gland upon ingestion (ave. dig. gland weight = 0.25 g (n = 96 snails) 
with a density comparable to human liver ~1 g/mL), then the upper limit of PGA2 
concentrations in digestive gland would be 0.13 M.  The single day grazing rates of P. 
homomalla colonies by C. gibbosum reported in (Lasker et al. 1988) were used to obtain 
a lower bound of tissue consumption; their average feeding rates of 0.17 mL/snail/day 
lead to an estimated PGA2 concentration of 0.03 M.  Ciereszko & Schneider (1987) 
reported the fecal pellets of C. gibbosum contain no appreciable amounts of recognizable 
prostaglandins, suggesting that the majority of prostaglandins are being metabolized or 
sequestered in the snail.  If we conservatively assume only 1% of the ingested 
prostaglandins are retained within the digestive gland during feeding (e.g., 1% 
concentration of PGA2 ~ 0.3 – 1.3 mM PGA2), the in vivo concentration of 
prostaglandins in this tissue would still be 15- to 65-fold higher than the apparent Km 
(15.6 – 24.2 μM) obtained for PGA2 (Table 5).  Even at the lower bound of in vivo PGA2 
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concentration (~ 0.3 mM), Cyphoma GSTs would be nearing their physiological capacity 
(>95%) according to fractional velocity (v/Vmax) calculations.    
The Km for CDNB calculated here (ave. 0.36 mM) was substantially lower than 
the Km value (ave. 1.49 mM) reported for Cyphoma by Vrolijk and Targett (1992), 
indicating that CDNB has a higher affinity for Cyphoma GSTs than previously thought.  
The apparent differences between kinetic constants is likely a result of measurements 
made using different protein sources – affinity-purified GSTs used in this study as 
opposed to crude cytosolic preparations used in Vrolijk and Targett (1992).  If CDNB 
readily interacts with non-GST proteins in a sample, effectively decreasing the free-
CDNB concentration, this could result in higher apparent Km values reported by Vrolijk 
and Targett (1992). 
GSTs have gained considerable attention for their conjugating ability to conjugate 
electrophilic toxicants.  However, their lesser known ability to bind non-substrate ligands 
by acting as ‘xenobiotic sponges’, capable of soaking up and sequestering excess 
intracellular xenobiotics, may be as important of a protective mechanism (Ketley et al. 
1975, Kostaropoulos et al. 2001).  Select human GST isoforms have also been shown to 
exert their protective effects through this ligandin-like behavior by binding with high 
affinity to inhibitory prostaglandins (e.g., PGJ2), effectively sequestering them in the 
cytosol away from target nuclear proteins and preventing gene regulation (Paumi et al. 
2004, Sanchez-Gomez et al. 2007).  Lineweaver-Burke plots indicate that PGA2 is a 
mixed inhibitor of Cyphoma GST activity, suggesting that this prostaglandin can bind to 
both the substrate active site and other sites on Cyphoma GSTs.  This additional binding 
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capacity of PGA2 to non-active site residues may indicate that sequestration of cyPGs by 
Cyphoma GSTs may be an important protective mechanism, and that over expression of 
GST forms could afford additional protection against prostaglandin-induced cytotoxicity.   
The potential of GST to bind non-substrates has also been hypothesized to help 
protect consumers that regularly feed on allelochemical-rich prey.  A comprehensive 
screening of allelochemicals from plants found that many inhibit the GSTs found in 
generalist lepidopterans (Yu & Abo-Elghar 2000), and over expression of GST enzymes 
in these consumers may play an important role in non-enzymatic cellular defense against 
dietary electrophilic chemical defenses.  In marine systems, the chiton Cryptochiton 
stelleri regularly feeds on a red algal diet known to contain high concentrations of the 
feeding deterrent lanosol (DeBusk et al. 2000).  Lanosol was found to be a 
noncompetitive inhibitor of C. stelleri GST activity, suggesting that while this feeding 
deterrent is not a substrate, overexpression of GSTs may serve as a detoxification strategy 
if GST enzymes can sequester the compound.  Like C. stelleri, high constitutive GST 
activity was observed in Cyphoma independent of allelochemical diet and all of the 
gorgonian extracts examined contained potent inhibitory compounds.  While the type of 
inhibition was not quantified for the gorgonian extracts, it is likely that gorgonian diets 
contain both substrates (i.e., PGA2) and non-substrate ligands.  Therefore, constitutive 
expression of GSTs may be indicative of a more general biochemical resistance strategy 
that is capable of responding to a diversity of compounds in the diet of a generalist 
consumer.  
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 The results of this study provide the first comprehensive evaluation of the 
influence of dietary allelochemicals on the expression and function of glutathione 
transferases in a generalist marine consumer.  Controlled feeding assays showed that 
Cyphoma digestive gland GST composition and activity did not vary with gorgonian diet.  
This result, in combination with evidence from in vitro inhibition studies with Cyphoma 
GSTs by gorgonian extracts, suggests the high constitutive expression of GST enzymes 
in Cyphoma digestive gland may be necessitated by the presence of numerous potent 
inhibitors/substrates in their gorgonian diets.  Furthermore, all three prostaglandin series 
(A, E, F) found in the gorgonian P. homomalla were able to inhibit Cyphoma CDNB-
conjugating GST activity, with relative potencies positively correlated with their 
abundance in gorgonian tissues.  Kinetic analysis also demonstrated that inhibition of 
Cyphoma GSTs by prostaglandin A2 was competitive toward CDNB and that its Ki 
(apparent Km) values were similar to Km values from known prostaglandin-conjugating 
vertebrate GSTs, suggesting that this allelochemical is a substrate for Cyphoma mu-class 
GSTs.  Together, these findings suggest C. gibbosum detoxification enzymes have 
evolved to enable the detoxification of a broad range of electrophilic allelochemicals 
resulting from its close association with diverse gorgonian diets.  Given the importance of 
allelochemicals in shaping patterns of predation and herbivory in marine systems, these 
findings suggest that co-evolved marine consumers have the capacity to detoxify 
allelochemicals in their prey, providing these consumers with a competitive advantage in 
ecosystems where allelochemically-rich prey species abound.  
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Figure 1.  GST activity levels from digestive gland cytosolic preparations of C. 
gibbosum feeding either on a control diet or six gorgonian diets in controlled 4 d 
feeding assays.  Bars represent the mean GST activity (± SE) of snails feeding on control 
diet (n = 12 snails; e.g., alginic acid + squid powder) or one of six gorgonian diets (B. 
asbestinum, n = 4; E. mammosa, n = 4; G. ventalina, n = 4; P. acerosa, n = 4; P. 
americana, n = 7; P. homomalla, n = 4).  The reaction mixture contained 2 μg of 
cytosolic protein in 0.1 M potassium phosphate buffer, pH 7.5, containing 1 mM GSH 
and 1 mM CDNB at 25oC.  Results indicate that GST activity did not significantly differ 
among snail diets (ANOVA, p = 0.687) or between snails collected from different reefs 
feeding on the control diet (ANOVA, p = 0.109). 
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Figure 2.  Representative HPLC separation of affinity-purified GST subunits from a 
C. gibbosum digestive gland. Representative HPLC separation of an affinity-purified 
extract from an individual C. gibbosum feeding on B. asbestinum.  GST subunits were 
separated on a reverse phase VYDAC protein/peptide column (C18 μm 250 mm x 2.1 
mm) with a flow rate of 0.5 mL min-1.  Mobile phase A consisted of 
acetonitrile/water/TFA (38:62:0.1, v/v) and mobile phase B consisted of 
acetonitrile/water/TFA (80:20:0.1, v/v).  GST subunits were separated using a linear 
gradient from 0 to 40% B in 22 min, and 40 to 100% B in 37 min and visualized at 214 
nm.  Fourteen unique peaks were identified; however, not all were visible in one HPLC 
spectrum, therefore a representative spectrum was chosen.  The position of HPLC peaks 
1-4, 7-11, 13 and 14 are labeled. 
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Figure 3. Average GST subunit percent composition as a function of snail diet.  Bars 
represent the mean percent GST subunit composition (± SD) in affinity-purified digestive 
gland preparations from snails grouped by diet; control diet (n = 12 snails) and gorgonian 
diets (B. asbestinum, n = 4; E. mammosa, n = 4; G. ventalina, n = 4; P. acerosa, n = 4; P. 
americana, n = 7; P. homomalla, n = 4).  Statistical analysis (ANOVA) indicated that 
GST subunit percent composition did not significantly differ among snail diets. 
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Figure 4.  Peak area normalized to the amount of affinity-purified GST sample 
applied to the HPLC column.  Bars represent the mean HPLC peak area normalized for 
the amount of GST protein applied to the HPLC column as a function of snail diet (± 
SE); control diet (n = 12 snails) and gorgonian diets (B. asbestinum, n = 4; E. mammosa, 
n = 4; G. ventalina, n = 4; P. acerosa, n = 4; P. americana, n = 7; P. homomalla, n = 4).  
Statistical analysis (ANOVA) indicated the amount of starting material did not 
significantly affect GST subunit abundance among snail diets. 
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Figure 5.  Inhibition of C. gibbosum GST activity by gorgonian crude and semi-
purified extracts. Bars represent the mean (± SE) percent GST activity remaining after 
exposure to gorgonian compounds compared to solvent controls.  Reaction mixture 
consisted of 2 μg cytosolic protein in 0.1 M potassium phosphate buffer, pH 7.5, 
containing 1 mM GSH, 1 mM CDNB at 25oC with <0.01% (v/v) solvent.  Reactions were 
performed in duplicate with digestive gland crude cytosolic preparations from two snails.  
Crude extracts from eight gorgonian species were tested at 1/20th natural volumetric 
concentration (NC) found in gorgonian tissues for their ability to inhibit crude cytosolic 
GST activity.  Hexane and aqueous soluble extracts were tested at 1/4 x NC.  Chloroform 
soluble fractions were tested at 1/4 x NC with the following exceptions: G. ventalina, P. 
acerosa, and P. homomalla were tested at 1/8 x NC.  A zero indicates complete inhibition 
of GST activity by the gorgonian extract or fraction.  Bars approaching the dotted line 
indicate no difference from solvent controls. 
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Figure 6.  Inhibition of C. gibbosum GST activity by the chloroform-soluble HPLC 
fractions from eight gorgonian species.  Chloroform partitions from eight gorgonian 
species ((A) B. asbestinum; (B) E. mammosa; (C) G. ventalina; (D) P. acerosa; (E) P. 
americana; (F) P. blanquillensis; (G) P. elisabethae; (H) P. homomalla) were separated 
into ten fractions (indicated by dotted lines) using a reverse-phase HPLC column (Zorbax 
SB-C18, 9.4mm x 2cm; solvent flow rate = 3 mL/min; injection volume = 500 μL).  
Mobile phase: methanol/water 9:1 from 0-5 mins; linear ramping to 100% methanol from 
5-18 min; 100% methanol from 18-25 min;  linear gradient to initial starting conditions of 
methanol/water 9:1 from 25-26 min; column flushed with methanol/water 9:1 from 26-33 
min.  Absorbance was monitored at 215 and 254 nm and fractions were collected every 
three minutes beginning at to=3min.  Overlaid on the HPLC absorbance spectra are the 
results GST inhibition assays with affinity-purified GST protein.  The reaction mixture 
consisted of 6 ng of affinity-purified GST protein in 0.1 M potassium phosphate buffer, 
pH 7.5, containing 1 mM GSH, 1 mM CDNB at 25oC with 2% (v/v) methanol.  An 
affinity-purified GST preparation from a single digestive gland was used as the protein 
source with a specific activity (mean ± SE) of 561 ± 25 μmol min-1 mg protein-1.  HPLC 
fractions were tested at 1/10th natural volumetric concentration, unless marked by an 
asterisk indicating samples were further tested at 1/200th natural volumetric 
concentration.  Each point (■) represents the mean of two technical replicates.   
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Figure 7.  LC-MS identification of PGA2 in P. homomalla chloroform extracts.  The 
fragmentation pattern of the free hydroxy acid of PGA2 is shown in (A).  The similarity 
between the full-scan mass spectrum of P. homomalla fraction 1 (B) and the PGA2 
standard (mol wt 333) (C) indicates that the P. homomalla chloroform-soluble HPLC 
fraction 1 contains PGA2. 
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Figure 8.  Comparison of 1H NMR spectra from the PGA2 standard (A) and the 
chloroform-soluble fraction 1 from P. homomalla (B). 
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Figure 9.  Effect of prostaglandin A, E, and F series on cytosolic C. gibbosum GST 
activity.  Eight commercially available prostaglandin compounds, representing a 
diversity of prostaglandin series present in gorgonian tissues, were screened for their 
ability to inhibit GST activity at 600 μM.  Bars represent the mean (± SE) percent GST 
activity remaining after prostaglandin exposure compared to solvent controls.  The 
reaction mixture consisted of 2 μg of cytosolic GST protein in 0.1 M potassium 
phosphate buffer, pH 7.5, containing 1 mM GSH, 1 mM CDNB at 25oC with 5% (v/v) 
DMSO.  Digestive gland cytosolic preparations from two snails were used as the enzyme 
source with specific activities of 5.8 and 5.1 μmol min-1 mg protein-1, respectively. 
 
15(S)-Prostaglandin A2 15(R)-15-methyl-Prostaglandin A2
15(S)-Prostaglandin F2α-methyl ester 15(R)-Prostaglandin F2α15(S)-Prostaglandin F2α
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PGE2
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Figure 10.  Inhibition of C. gibbosum affinity-purified GST activity by selected 
prostaglandins.  Points represent the mean (± SE) GST activity remaining compared to 
solvent controls after incubation with various concentrations (0.2 – 2000 μM) of 15(R)-
15-methyl PGA2 (●), 15(S)-PGE2 (■), 15(S)-PGA2 (▲), 15(S)-PGF2α (▼).  The reaction 
mixture consisted of 3.3 – 6.4 ng of affinity-purified GST protein in 0.1 M potassium 
phosphate buffer, pH 7.5, containing 1 mM GSH, 1 mM CDNB at 25oC with 5% (v/v) 
DMSO.  Affinity-purified GST preparations from five snails were used as the enzyme 
source with specific activities of ranging from 290 – 582 μmol min-1 mg protein-1.  Plots 
were used to obtain the IC50 value for each prostaglandin using Prism software and are 
listed in Table 1. 
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Figure 11.  Lineweaver-Burke plots showing mixed inhibition of Cyphoma GSTs 
toward CDNB by 15(S)-PGA2.  GST activity was measured at varying concentrations of 
CDNB in the absence (DMSO) and presence of 200 μM (A) and 60 μM (B) PGA2.  The 
reaction mixture consisted of varying concentrations of CDNB and 6 ng of affinity-
purified GST protein in 0.1 M potassium phosphate buffer, pH 7.5, containing 1 mM 
GSH at 25oC with 5% (v/v) DMSO.  An affinity-purified GST preparation from a single 
digestive gland was used as the protein source with a specific activity of 561 ± 25 μmol 
min-1 mg protein-1.  DMSO (●) and PGA2 (■) values at each CDNB concentration 
represent the mean (± SE) of two technical replicates.  Lineweaver-Burke plots (C, D) of 
1/Vmax versus CDNB concentration were constructed from data in part A and B, 
respectively.  Lineweaver-Burke plots indicated a mixed type of inhibition (i.e., 
competitive and noncompetitive inhibition). 
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Chapter V 
 
The role of multixenobiotic transporters in generalist and specialist molluscan 
predators as counter-defense mechanisms against dietary chemical stress 
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Abstract 
 Multixenobiotic transporters have been extensively studied for their ability to 
modulate the absorption, metabolism, and toxicity of pharmacological agents.  These 
transporters may also play critical roles in regulating the efflux or accumulation of 
natural dietary toxins in marine consumers, perhaps ultimately influencing dietary choice.  
This study presents functional and molecular evidence for multixenobiotic transporter-
mediated efflux activity and expression in a generalist (Cyphoma gibbosum) and 
specialist (Tritonia hamnerorum) molluscan predator, both of which are obligate 
consumers of chemically defended gorgonian corals.  Immunochemical analysis revealed 
that proteins with homology to the permeability glycoprotein (Pgp) subfamily of ABC 
transporters were not expressed in C. gibbosum digestive gland preparations or tissues, 
but were highly expressed in T. hamnerorum tissue homogenates.  Pgp expression in T. 
hamnerorum was primarily localized to the apical tips of the gut epithelium, a region 
particularly vulnerable to dietary allelochemical exposure, suggesting these transporters 
may provide an effective means of protection against ingested environmental toxins.  In 
vivo dye assays with T. hamnerorum indicated concentration-dependent inhibition of 
calcein-am efflux by specific inhibitors of Pgp and the multidrug resistance-associated 
protein (MRP), implying that both ABC protein subfamilies may facilitate allelochemical 
transport in this specialist predator.  An adaptor-ligated cDNA library with degenerate 
and specific primers was used to clone eight cDNAs encoding two partial ABCB and two 
partial ABCC proteins from both C. gibbosum and T. hamnerorum.  In addition, real-time 
quantitative PCR analysis demonstrated selected C. gibbosum MRP transcripts were 
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constitutively expressed in the digestive gland regardless of allelochemical diet.  The 
constitutive expression of C. gibbosum MRP transporters with homology to mammalian 
glutathione-conjugate transporters may be explained by previous evidence suggesting 
that gorgonian diets contain high affinity substrates for phase II detoxification enzymes, 
whose conjugates may in turn be exported by MRPs.  In summary, the foraging strategies 
of marine consumers may result in different expression patterns of related 
multixenobiotic transporters depending on diet chemistry and the requirements of the 
consumer; however, it is likely that both subfamilies of ABC transporters operate as 
effective allelochemical pumps, providing a physiological defense against environmental 
toxicants in both molluscan species. 
 
Introduction 
 Soft-bodied benthic organisms produce a vast number of structurally diverse 
secondary metabolites, many of which function as feeding deterrents in marine systems 
(Hay & Fenical 1988, Harvell & Fenical 1989, Paul 1992, Hay 1996, Stachowicz 2001).  
For marine consumers, the consequences of ingesting chemically defended prey can be 
quite severe (Targett & Arnold 2001), yet specialized consumers that solely feed on toxic 
prey can apparently tolerate these dietary compounds, and in some cases, even 
concentrate the defensive compounds for their own protection (Cimino et al. 1985, 
Cronin 2001).  Few studies have explored the physiological targets of these compounds 
in generalist consumers and progress has been slow in understanding the mechanisms by 
which more specialized predators are able to cope with their toxic prey.   
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For organisms that feed on toxin laden prey, multixenobiotic resistance 
transporters represent one mechanism by which predators may protect themselves against 
the toxicity of their prey, either by actively exporting allelochemicals out of cells or 
sequestering toxins within specialized cells or organelles, effectively compartmentalizing 
them away from vulnerable protein and DNA targets (Sorensen & Dearing 2006).  Those 
proteins involved in the transport of xenobiotics across membranes belong to the ATP 
Binding Cassette (ABC) family, and likely provide consumers with a ‘first line of 
defense’ against the accumulation of dietary allelochemicals (Epel 1998).  Several 
members of the ABCB (P-glycoprotein; Pgp or MDR) and ABCC (multidrug resistance-
associated protein or MRP) subfamilies function as highly promiscuous transporters, 
capable of trafficking a diverse array of moderately hydrophobic xenobiotics across cell 
membranes (Bodo et al. 2003).  Together, the overexpression of both Pgp and MRP in 
tumor cell lines has long been known to mediate the ATP-dependent efflux of anticancer 
agents, conferring tumor resistance to natural product chemotherapeutic compounds 
(Deeley & Cole 2006, Sarkadi et al. 2006).  Only recently has it been suggested that ABC 
transporters are responsible for regulating the absorption of allelochemicals in the guts of 
consumers, and may therefore have a significant influence on the foraging patterns and 
ultimately diet choice of these organisms (Sorensen & Dearing 2006, Sotka & Whalen 
2008). 
The ubiquity of these multixenobiotic resistance proteins (MXRs) in aquatic 
organisms has been confirmed by immunological cross-reactivity studies, in vivo 
functional assays, competitive inhibition substrate binding assays (Bard 2000, Eufemia & 
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Epel 2000), and more recently by molecular evidence (Goldstone et al. 2007).  The 
distribution of MXRs in tissues involved in absorption, secretion and barrier functions in 
aquatic invertebrates (Bard 2000) suggests that they may play a role in the prevention of 
dietary xenobiotic absorption.  Several studies have also identified marine natural 
products from algae, tunicates, sea hares and gorgonians that may be substrates for 
multixenobiotic resistance proteins (Suganuma et al. 1988, Chambers et al. 1993, 
Williams & Jacobs 1993, Aherne et al. 1996, Quesada et al. 1996, Schroder et al. 1998, 
Tanaka et al. 2002), suggesting that the pool of potential substrates in marine ecosystems 
may be extensive.  Given this evidence, the constitutive or inducible expression of MXRs 
in marine consumers may serve a protective role against a range of allelochemically-rich 
prey.   
Analogous to the reciprocal evolution of terrestrial consumer biotransformation 
enzymes in response to their toxic host plants (Li et al. 2004), marine consumers likely 
evolved multixenobiotic resistance mechanisms out of a similar need to mount a cellular 
defense against the escalating chemical attack produced by their prey/host(s).  As a result 
of this chemical ‘arms race’, it is expected that many marine allelochemicals may be 
MXR substrates or potent inhibitors (Smital et al. 2004) – the latter likely functioning as 
counter-defense strategies of chemical defended prey to thwart the detoxification 
attempts by their consumers (Sorensen & Dearing 2006).   Eufemia et al. (2002) 
examined seaweed and phytoplankton extracts co-occurring with the filter feeder, Mytilus 
californianus, for their ability to act as chemosensitizers (substrates and/or inhibitors) for 
molluscan ABC transporters using competition-based fluorescent dye assays.  Tissue 
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accumulation of the fluorescent ABC transporter substrate (e.g., rhodamine) occurred if 
the test compound was a substrate (or inhibitor) of transport activity.  Moderately 
hydrophobic fractions from five algal extracts caused the greatest accumulation of 
rhodamine dye in the gill tissue of M. californianus, suggesting the presence of P-
glycoprotein substrates in algal species.  In addition, polyphenolics (phlorotannins), 
known to be potent feeding deterrents in some marine ecosystems (Targett & Arnold 
2001), were also found to cause dye accumulation, suggesting they too are substrates or 
inhibitors for MXRs.  Recent evidence also reveals that the unpalatability of newly 
invasive seaweeds may be linked in part to the liberation of potent MXR inhibitors 
(Smital et al. 2004).  Extracts from the invasive green alga, Caulerpa taxifolia, resulted in 
the reversal of MXT activity in cell culture and in in vivo experiments with bivalves 
Dreissena polymorpha and Mytilus galloprovincialis (Smital et al. 1996, Schroder et al. 
1998, Smital et al. 2004).  Consumption of these algal species could pose severe threats 
to naïve consumers who may lack adequate adaptations to cope with the invasives.  
However, for those marine consumers that are regularly exposed to toxic allelochemicals 
in their diet, maintaining high levels of ABC transporter protein and/or activity in 
vulnerable tissues may allow these consumers to exploit an otherwise unattainable 
resource.  
The objective of this study was to characterize the multixenobiotic resistance 
proteins potentially involved in dietary allelochemical resistance in two species of 
tropical gastropods that feed exclusively on allelochemically defended gorgonian corals.  
A combination of molecular, immunological and functional approaches were used to 
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examine the expression and activity of molluscan ABC transporters in Tritonia 
hamnerorum, a specialist nudibranch that feeds on a single genus of gorgonian, and 
Cyphoma gibbosum, a generalist gastropod that includes multiple gorgonian families in 
its diet.  Evidence from terrestrial chemical ecology studies suggests that generalists have 
likely evolved a greater diversity of catalytically versatile xenobiotic resistance 
mechanisms as a result of their chemically diverse diets, compared to specialists that feed 
on a reduced spectrum of allelochemicals due to their narrow foraging range (Li et al. 
2004, Sorensen & Dearing 2006).  This study presents the initial characterization of those 
molluscan MXRs likely responsible for xenobiotic resistance, and will ultimately 
contribute to a more complete understanding of how generalists and specialists cope with 
their allelochemical diet(s).   
Expression levels of select MXR transporters were compared between the two 
molluscan species to examine the relationship between MXR expression and diet 
specificity.  Reverse transcription-polymerase chain reaction (RT-PCR) in combination 
with adaptor-specific and degenerate primers was used to perform targeted searches for 
ABC transporter genes and successfully identified two Pgp homologs and two MRP 
homologs from each molluscan species.  To determine if MXR expression was 
influenced by the different allelochemical profiles of host gorgonians, quantitative RT-
PCR was used to measure the expression of selected ABC transporter transcripts in 
digestive gland samples from C. gibbosum feeding on seven different gorgonian species.  
In addition, immunochemical analysis was used to characterize the expression and 
localization of Pgp in molluscan tissue homogenates and sections.  Finally, quantification 
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of MXR activity was measured using in vivo competitive-based fluorescent dye assays by 
examining the sensitivity of Tritonia transporters to model Pgp and MRP inhibitors.  
Together, these results indicate that both ABC protein subfamilies may play a significant 
role in defending molluscan predators against naturally occurring dietary toxins.  
 
Materials and Methods 
Animal collection 
 In January 2004, over 200 Tritonia hamnerorum, ranging in size from 3 mm to 15 
mm, were collected from shallow reefs surrounding the Perry Institute of Marine Science 
(PIMS), Lee Stocking Island, Exuma Cays, Bahamas.  The purple sea fan, Gorgonia 
ventalina, was the only species of octocoral observed to serve as host for Tritonia 
hamnerorum at our study site.  The density of Tritonia hamnerorum on individual sea 
fans ranged from two to over 500 individuals per sea fan.  Nudibranchs were collected by 
removing the portion of sea fan housing them with scissors and transporting both the 
gorgonian and nudibranchs back to wet laboratory facilities provided by PIMS where 
they were maintained in flowing filtered seawater until further use.  T. hamnerorum 
individuals used for RNA and protein isolation were removed from their host gorgonian, 
pooled, flash frozen and stored in liquid nitrogen until processing. 
 In a preliminary series of feeding assays conducted in January 2004, adult 
Cyphoma gibbosum were allowed to feed for four days on one of four gorgonian species 
(Briareum asbestinum, Gorgonia ventalina, Pseudopterogorgia acerosa, 
Pseudopterogorgia americana).  A complete description of the feeding assay 
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experimental set-up can be found in Chapter 3, Methods.  Upon completion of the assays, 
digestive glands were immediately dissected and either frozen in liquid nitrogen (n = 2 
digestive glands) or stored in RNALater® at -80oC (n = 15 digestive glands) until further 
processing.   
 
RNA isolation and RT-PCR cloning 
Both Tritonia hamnerorum and Cyphoma gibbosum collected in 2004 provided 
tissue for initial ABC transporter cloning studies.  Total RNA from a frozen, pooled 
sample of whole T. hamnerorum (267.9 mg; n > 40 individuals) was isolated with the 
RNeasy Maxi Kit (Qiagen, Valencia, CA) following the manufacturer’s instructions.  
RNA isolation from pooled C. gibbosum digestive glands was performed as described in 
Chapter 3, Methods.  The integrity of the RNA samples was checked by electrophoresis 
on a 1% agarose-formaldehyde gel in MOPS buffer and visualized with ethidium 
bromide under UV light.  Total RNA concentration was determined using a Nanodrop 
spectrophotometer (Wilmington, DE).  Poly(A)+ RNA was purified using the 
MicroPoly(A)Purist mRNA purification kit (Ambion, Austin, TX) according to the 
manufacturer’s instructions.  First-strand cDNA was reverse transcribed from 2 μg 
poly(A)+ RNA using OmniScript reverse transcriptase (OmniScript RT kit, Qiagen) with 
random hexamer primers.  
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Initial cloning of C. gibbosum and T. hamnerorum MRP fragments.   
PCR and nested PCR were performed using AmpliTaq Gold DNA polymerase 
(Applied Biosystems) under the following conditions: 94oC for 10 min; (94oC for 15 sec, 
52oC for 30 sec) for 35 cycles; 72oC for 7 min and with degenerate primers pairs 
(MRP_F/MRP_R and nestMRP_F/nestMRP_R) (Table 1) designed against the conserved 
Walker A/B domains (Allikmets & Dean 1998, Dean et al. 2001).  Primers were a 
generous gift from David Epel and Amro Hamdoun, Hopkins Marine Station.  PCR 
products were visualized on agarose gels, gel purified (Gene Clean II, Bio 101, Inc.), 
ligated into pGEM-T Easy© plasmid vector (Promega, Madison, WI), and transformed 
into JM109 cells (Promega).  PCR products were sequenced in both directions using an 
ABI 3730XL capillary sequencer at the Keck facility of the Josephine Bay Paul Center 
for Comparative Molecular Biology & Evolution at the Marine Biological Laboratory 
(Woods Hole, MA).  A minimum of twelve clones were sequenced for each PCR 
fragment.  Clones were grouped based on nucleotide sequence with Sequencher 4.6 
(Gene Codes Corp., Ann Arbor, MI) and a consensus sequence was generated and then 
examined by NCBI/GenBank BLASTx for gene identification (Altschul et al. 1997).  
BLASTx (NCBI) searches identified two partial sequences from C. gibbosum and two 
partial sequences from T. hamnerorum as having homology to MRP transporters.  Gene 
specific primers (Table 1) were then designed to these cDNA fragments in order to obtain 
additional 5’ and 3’ sequence. 
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Rapid amplification of cDNA ends (RACE) 
Cyphoma RACE-PCR.  Poly(A)+RNA isolated from the digestive glands of snails 
feeding on one of four gorgonian diets (see Chapter 3, Methods) (Briareum asbestinum, 
Gorgonia ventalina, Pseudopterogorgia acerosa, Pseudopterogorgia americana) was 
pooled and 1 μg was primed with modified oligo (dT) primers and used to create an 
adaptor-ligated, double-stranded (ds) cDNA library using the Marathon cDNA 
Amplification Kit (BD Biosciences, Palo Alto, CA) according to the manufacturer’s 
instructions.  Gene specific primers were designed to both MRP cDNA fragments 
(CgMRP-1 and CgMRP-2) (Table 1) and were used in combination with adaptor-specific 
primers in nested 5’ and 3’ RACE reactions.  All primers were obtained from Sigma 
Genosys (St. Louis, MO).  Amplification of C. gibbosum MRP specific PCR products 
was carried out according to the Advantage 2 PCR Enzyme Kit (Clontech, Mountain 
View, CA) and cycling parameters were as follows: 94oC for 30sec; (94oC for 5 sec, 72oC 
for 2.5 min) for 5 cycles; (94oC for 5 sec, 70oC for 2.5 min) for 5 cycles; (94oC for 5 sec, 
68oC for 2.5 min) for 25 cycles; 68oC for 5 min with the following specific primers pairs 
(C. gibbosum MRP-1, 5’ RACE; MRP-R1/RACE_1_F); or 94oC for 30sec; (94oC for 5 
sec, 72oC for 4 min) for 5 cycles; (94oC for 5 sec, 70oC for 4 min) for 5 cycles; (94oC for 
5 sec, 68oC for 4 min) for 25 cycles with the following specific primer pairs (C. gibbosum 
MRP-1 -- CgMRP-1_F9/AP1 then CgMRP-1_F10/AP2; Cg_MRP-1_F10/AP1 then 
CgMRP-1_F8/AP2; CgMRP-1_R9/AP1 then CgMRP-1_R8/AP2; C. gibbosum MRP-2 --
CgMRP-2_F7/AP1 then CgMRP-2_F6/AP2). 
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The C. gibbosum adaptor-ligated ds cDNA library was also used to amplify 
partial Pgp cDNA sequences by RACE using degenerate primers designed to the 
conserved nucleotide binding domains.  Nested-RACE was performed with the following 
degenerate primers pairs (Pgp_Bbox_F/RACE_1_F then Pgp_Cdomain_F/RACE_1_F) 
(Table 1) using the Advantage 2 PCR Enzyme Kit with the following cycling parameters: 
94oC for 30sec; (94oC for 5 sec, 55oC for 30 sec, 68oC for 2 min) for 30 cycles.  BLASTx 
searches identified the two partial sequences as having homology to Pgp.  Gene specific 
primers were designed to both C. gibbosum Pgp-1 and Pgp-2 fragments and used in 
combination with adaptor-specific primers in nested 5’ RACE reactions.  PCR products 
were amplified with Advantage 2 polymerase with the following cycling parameters: 
94oC for 30sec; (94oC for 5 sec, 72oC for 3 min) for 5 cycles; (94oC for 5 sec, 70oC for 3 
min) for 5 cycles; (94oC for 5 sec, 68oC for 3 min) for 25 cycles with the following 
specific primer pairs (C. gibbosum Pgp-1 -- Pgp_R4/AP1; C.gibbosum Pgp-2 – 
Pgp_R5/AP1 then Pgp_R6/AP2) (Table 1). 
Tritonia RACE PCR.  One microgram of poly(A)+RNA, isolated as described 
above, was used to created an adaptor-ligated ds cDNA library using the Marathon cDNA 
Amplification Kit according to the manufacturer’s instructions.  Gene specific primers 
were designed to both MRP cDNA fragments (ThMRP-1 and ThMRP-2) (Table 1) and 
were used in combination with adaptor-specific primers in nested 5’ and 3’ RACE 
reactions.  T. hamnerorum MRP specific PCR products were amplified using the 
Advantage 2 PCR Enzyme Kit; cycling parameters were as follows: 94oC for 30sec; 
(94oC for 5 sec, 72oC for 3 min) for 5 cycles; (94oC for 5 sec, 70oC for 3 min) for 5 
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cycles; (94oC for 5 sec, 68oC for 3 min) for 25 cycles with the following specific primer 
pairs (T. hamnerorum MRP -1 – MRP_F4/AP1 then MRP_F5/AP2; MRP_R5/AP1 then 
MRP_R4/AP2; ThMRP-1_R6/AP1 then ThMRP-1_R7/AP2; ThMRP-1_F7/AP1 then 
ThMRP-1_F6/AP1; T. hamnerorum MRP-2 – MRP_R3/AP1 then MRP_R2/AP2; 
MRP_F2/AP1 then MRP_F3/AP2; ThMRP-2_R9/AP1 then ThMRP-2_R8/AP2; 
ThMRP-2_F11/AP1 then MRP_F3/AP2; ThMRP-2_F10/AP1 then MRP_F3/AP2). 
The T. hamnerorum adaptor-ligated ds cDNA library was also used to initially 
amplify partial Pgp cDNA sequences by RACE using a combination of degenerate 
primers designed to the conserved nucleotide binding region and specific adaptor 
primers.  Nested-RACE was performed with degenerate primer pairs 
(Pgp_Bbox_F/RACE_1_F then Pgp_Cdomain_F/RACE_1_F) (Table 1) using the 
Advantage 2 PCR Enzyme Kit with the following cycling parameters: 94oC for 30sec; 
(94oC for 5 sec, 61oC for 30 sec, 68oC for 2 min) for 5 cycles; (94oC for 5 sec, 59oC for 
30 sec, 68oC for 2 min) for 5 cycles; (94oC for 5 sec, 57oC for 30 sec, 68oC for 2 min) for 
20 cycles.  BLASTx searches identified the two partial sequences as having homology to 
Pgp.  Gene specific primers were designed to both T. hamnerorum Pgp-1 and Pgp-2 
fragments and used in combination with adaptor-specific primers in nested RACE 
reactions.  PCR products were amplified with Advantage 2 polymerase with the 
following cycling parameters: 94oC for 30sec; (94oC for 5 sec, 72oC for 3 min) for 5 
cycles; (94oC for 5 sec, 70oC for 3 min) for 5 cycles; (94oC for 5 sec, 68oC for 3 min) for 
25 cycles with the following specific primer pairs (T. hamnerorum Pgp-1 – ThPgp-
1_R8/AP1 then ThPgp-1_R7/AP2; ThPgp-1_R8/AP1 then ThPgp-1_R7; T. hamnerorum 
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Pgp-2 – ThPgp-2_R10/AP1 then ThPgp-2_R9/AP2) (Table 1).  PCR products obtained 
from C. gibbosum and T. hamnerorum RACE reactions were cloned, sequenced, and 
analyzed as described below. 
 
Sequence analysis 
 Clones were initially grouped based on nucleotide sequence identity (>80%) with 
Sequencher 4.6 (Gene Codes Corp., Ann Arbor, MI), and a consensus sequence was 
generated and examined by NCBI/GenBank BLASTx for gene identification (Altschul et 
al. 1997).  Multiple alignments of molluscan deduced amino acid sequences were 
performed using ClustalW (Thompson et al. 1994).  Human ABC gene subfamilies were 
aligned using Muscle v3.7 (Edgar 2004).  In order to maintain the proper relationships 
between the incompletely sequenced ABC domains, C. gibbosum and T. hamnerorum 
Pgp and MRP sequences were aligned to each other separately and then to the human 
ABCB (containing Pgp) and ABCC (containing MRP) families using the profile-profile 
alignment settings of Muscle.  Alignments were automatically masked using the 
alignment quality scores of Muscle; (cut-off score of 20).  Maximum likelihood (ML) 
phylogenetic analyses were performed with RAxML (v7.0.0; Stamatakis 2006).  Two 
types of analyses were performed: default rapid hill-climbing ML searches, starting from 
multiple different randomized maximum parsimony (MP) trees; or 100 replicates of rapid 
MP bootstrapping to find optimal start trees followed by rapid hill-climbing ML 
optimization. The PROTMIXWAG model of amino acid substitution was used in all 
analyses, which uses a category model of the WAG amino acid substitution matrix 
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(Whelan & Goldman 2001) during the hill-climbing ML search but a gamma distribution 
of substitution rates for a final tree optimization (Stamatakis 2006).  
 
Western blot for ABC-transporters 
 Crude homogenates were prepared by homogenizing pooled C. gibbosum 
digestive glands and whole T. hamnerorum in 10 mM potassium chloride, 1.5 mM 
magnesium chloride, 10 mM Tris-HCl, (pH 7.4), containing 2 mM PMSF and 5% (by 
vol.) SDS at 4oC.  In addition, livers from Fundulus heteroclitus collected from New 
Bedford Harbor, MA, were also homogenized as described and used as a positive control 
(Bard et al. 2002).  The crude homogenate was centrifuged at 14,000 x g for 2 min at 4oC, 
and the supernatant was stored at -80oC until analysis.  Protein concentrations were 
determined using the bicinchoninic acid (BCA) assay (Smith et al. 1985).  Crude tissue 
homogenates were then diluted to 20 μg total protein with standard SDS-PAGE sample 
buffer (50 mM Tris, pH 6.8, 2% SDS, 10% sucrose, 0.2% β-mercaptoethanol, 0.001% 
bromphenol blue), denatured at 100oC for 3 min, and loaded onto a 7.5% Tris-glycine gel 
using a 4% stacking gel.  Prestained molecular markers were purchased from Amersham 
(Full-range Rainbow MW Markers, GE Healthcare, Buckinghamshire, UK).  Following 
electrophoresis, proteins were transferred onto a 0.45 μm nitrocellulose membrane 
(Schleicher & Schuell, Keene, NH) at 15 V for 54 min.  The membrane was blocked in 
5% (wt/vol) non-fat milk in Tris buffered saline-Tween 0.1% (TBST) for 1 hr and then 
hybridized overnight with rocking at 4oC in TBST containing 0.4 μg/mL of the 
monoclonal antibody C219 (Signet Laboratories, Dedham, MA).  The membrane was 
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subsequently washed (3 x 10 min) with TBST and incubated for 1 hr. with horseradish 
peroxidase-conjugated goat anti-mouse IgG (Jackson ImmunoResearch Inc., West Grove, 
PA) diluted 1:7000 in TBST.  Detection of HRP activity was by enhanced 
chemoluminescence (ECL) onto Hyperfilm ECL (Amersham).   
 
 Immunohistochemical analysis 
 Live nudibranchs and snails were transferred to a 50 mL beaker containing 
filtered seawater and were relaxed by adding a few crystals of magnesium sulfate until 
they no longer recoiled to the touch.  Digestive glands and mantle tissues from C. 
gibbosum (n = 4) and whole T. hamnerorum individuals (n = 2) were fixed for 2 hours at 
4oC in a buffered seawater solution of 2% paraformaldehyde, 2.5% glutaraldehyde 
(Karnovsky’s Fixative) obtained from Electron Microscopy Sciences (Hatfield, PA).  
Tissue samples were then transferred to PBS and kept at 4oC till embedding.  Paraffin-
embedded samples were sectioned at 5 μm and mounted on Superfrost Plus (Fisher 
Scientific, St. Louis, MO) microscope slides, deparaffined, and then hydrated with 
normal mouse serum in 10 mM phosphate buffered saline (pH 7.5).  Sections were 
incubated for 1 hr. at room temperature with the mAB C219 diluted (2 μg/mL) in Primary 
Antibody Diluent (Signet).  Antibody binding was visualized with a commercial avidin-
biotin-peroxidase kit using diaminobenzidine tetrahydrochlroide (DAB) as the 
chromogen (Vectastain® Elite ABC Kit, Vector Laboratories, Inc., Burlingame, CA) 
according to the manufacturer’s instructions.  Specific staining was evaluated by light 
microscopy by comparison of mAB C219 stained and unstained serial sections. 
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 In-vivo dye transport assays 
Fluorophores and inhibitors.  MK571 was purchased from Cayman Chemical 
(Ann Arbor, MI).  Calcein-acetoxymethylester (C-AM) was purchased from Axxora (San 
Diego, CA).  Calcein was purchased from Invitrogen (Carlsbad, CA).  Verapamil was 
purchased from MP Biomedicals (Solon, OH).  Concentrated stocks of MK571 and C-
AM were prepared in DMSO and were sufficiently concentrated so that the DMSO 
volume did not to exceed 0.5% of the experimental volume.  
ABC transporter activity was measured by the accumulation of calcein in whole 
T. hamnerorum individuals.  Calcein-AM (C-AM) is a non-fluorescent substrate for both 
MRP and Pgp.  Any C-AM entering the cell, if not transported out immediately by either 
ABC transporter, is rapidly hydrolyzed by intracellular esterases to form calcein, a 
fluorescent membrane-impermeable molecule (Essodaigui et al. 1998).  Therefore, 
exposure to inhibitors of ABC transporter activity results in high calcein accumulation 
and increased fluorescence, while reduced intracellular accumulation of calcein and 
fluorescence is observed when transporter activity is increased. 
Nudibranchs maintained in the laboratory were removed from their host, G. 
ventalina, and allowed to depurate for four hours in a beaker of sterile-filtered seawater.  
Five similarly sized T. hamnerorum were placed in each well of a 24-well plate and 
incubated for two hours in 3 mL of 500 nM C-AM resuspended in sterile-filtered 
seawater.  Incubations were performed in the presence or absence of two inhibitors at two 
concentrations.  MK571 specifically inhibits MRP transport activity, while verapamil 
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inhibits Pgp transport activity.  Nudibranchs were then rapidly washed two times with 
sterile-filtered seawater and homogenized for 30 seconds using an electric drill with a 
Teflon pestle in a 2 mL Wheaton glass homogenizer containing 125 μL of ethanol.  The 
homogenate (~ 175 μL) was transferred to a 1.5 mL tube and centrifuged at room 
temperature for 7 min at 6.1 relative centrifugal force (RCF).  Eighty-five microliters of 
supernatant was transferred to a 96-well black plate containing a clear bottom to 
minimize light scattering.  The level of calcein in the resulting supernatant was measured 
fluorimetrically (λex = 485 nm, λem = 530 nm) using a Cytofluor 2300 plate reader 
(Millepore).  A calcein standard curve was run alongside the supernatant readings to 
estimate the concentration of intracellular calcein.  The ratio of intracellular calcein 
fluorescence in the absence and presence of MK571 or verapamil was used as a measure 
of the activity of T. hamnerorum MRP and Pgp transporters.  Statistical analysis was 
performed using a two sample t test of the means with a significance level of 5%. 
 
Real-time quantitative RT-PCR and data analysis 
 Total RNA and poly(A)+ RNA (n=141) were isolated as described in Chapter 3, 
Methods from the digestive glands of Cyphoma participating in the 2006 feeding assay.  
Sequence-specific primers for quantitative PCR analysis of C. gibbosum MRP-1 mRNA 
expression are listed in Table 1.  PCR amplification conditions, control cDNA synthesis 
experiments, melt curve analysis and standard curve serial dilutions specific for the 
representative MRP-1 clone were performed as described in Chapter 3, Methods.    Each 
sample and standard was run in duplicate and the expression of C. gibbosum β-actin was 
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used to control for differences in cDNA synthesis among samples.  Molecule number for 
each RNA sample was calculated from a standard curve dilution series.   
To test whether Cyphoma MRP-1 gene expression differed between snails feeding 
on a control diet versus a gorgonian diet, a two way analysis of variance (ANOVA) was 
used with Diet (control vs. gorgonian diet) as a fixed factor and Reef (snail origin) as a 
random factor.  The MRP-1 gene was considered a dependent variable.  In addition, a 
one-way ANOVA was used to examine the variability in MRP-1 expression among reefs, 
where Reef was considered a random factor.  This test was used to investigate reef-
specific variation in transcript levels in time-zero snails, and to determine if any such 
variation persisted in snails collected from these same reefs after being fed a control diet 
for four days.  P-values were corrected for the two-way ANOVA analysis using by 
Bonferroni adjustment (Sankoh et al. 1997).  Data analysis was performed using 
SYSTAT® version 11 (Systat Software, Inc., San Jose, CA).   
 
Results  
Cloning of molluscan ABC transporter genes 
 An RT-PCR approach with pooled mRNA samples1 and degenerate 
oligonucleotide primers were used to identify initial Pgp and MRP fragments within the 
conserved nucleotide binding domain of ABC transporter genes from both Cyphoma 
gibbosum and Tritonia hamnerorum.  BlastX (NCBI) comparison of translated cDNAs 
indicated homology to mammalian ABCB and ABCC proteins.  Initial gene fragment 
                                                 
1 Molluscan mRNA samples used for the initial cloning studies were made from pooled C. gibbosum 
digestive glands and pooled T. hamnerorum individuals. 
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sizes were as follows: C. gibbosum MRP-1 and MRP-2, 168 bp; C. gibbosum Pgp-1 and 
Pgp-2, 216 bp; T. hamnerorum MRP-1 and MRP-2, 170 bp; T. hamnerorum Pgp-1 and 
Pgp-2, 71 and 182 bp respectively.  Specific oligonucleotide primers were designed to 
these initial fragments and were used in 5’ and 3’ RACE reactions to obtain the eight 
partial MXR sequences listed in Table 2 and depicted in Figures 1 thru 10.   
 
Sequence analysis 
Deduced amino acid alignments of the molluscan MRPs and Pgps generated from 
nucleotide consensus sequences are shown in Figures 5 and 10.  MRP amino acid 
alignments with human ABCC sequences revealed nearly full-length coding sequence 
was obtained for ThMRP-1 with only a minimal portion of the 3’ end missing.  The 
partial sequence obtained for CgMRP-1 included the putative start codon and covered the 
first two transmembrane spanning domains and the nucleotide binding domain.  
Substantially less sequence was obtained for both CgMRP-2 and ThMRP-2, which align 
with the first nucleotide binding domain.  An alignment of molluscan Pgp amino acid 
sequences with mouse ABCB1a revealed that both Tritonia Pgp sequences align with the 
first nucleotide binding domain, while Cyphoma Pgp sequences covered the second half 
of the protein and included the stop codon.  In addition, Kyte and Doolittle (1982) 
hydrophobicity plots of C. gibbosum and T. hamnerorum ABC transporters with mouse 
ABCB1a and human ABCC3 were nearly identical when aligned with each other (Figure 
11, 12), increasing confidence in the assignment of molluscan transmembrane and 
nucleotide binding domains. 
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Phylogenetic analysis revealed homology of the molluscan ABC transporters to 
the human ABCB and ABCC subfamilies (Figure 13).  Tritonia Pgp-1, Pgp-2 and 
Cyphoma Pgp-1, Pgp-2 were 63.5, 72.7, 55.5 and 55.9% identical, respectively, with 
overlapping portions of human ABCB1.  In addition, Tritonia MRP-1, MRP-2 and 
Cyphoma MRP-1, MRP-2 protein sequences were 34.3, 32.2, 35.8 and 24.8% identical, 
respectively, with overlapping portions of human ABCC1.  A second phylogenetic tree 
was constructed in order to better define the relationships among molluscan proteins and 
the human ABCB and ABCC subfamilies (Figure 14).  This second tree suggested that 
two sets of paralogs exist for ABCB and ABCC proteins in Tritonia as a result of 
duplication events.  The gene duplication resulting in ThMRP-1 and ThMRP-2 appears to 
have occurred prior to the Cyphoma/Tritonia speciation, while the duplication leading to 
ThPgp-1 and ThPgp-2 may have occurred after the Cyphoma/Tritonia speciation event.  
Overlapping portions of deduced amino acid sequences of Tritonia Pgp-1 and Pgp-2 are 
67.4% identical, while Tritonia MRP-1 and MRP-2 are 38.4% identical.  A similar 
comparison of Cyphoma proteins indicates that CgPgp-1 and CgPgp-2 (50.8% a.a. 
identity) arose from a more recent duplication in comparison to CgMRP-1 and CgMRP-2 
(34.5% a.a. identity), which appear to be more deeply divergent, sharing a common 
ancestor basal to the clades containing ABCC13 and ABCC4. 
Bootstrap values indicating strong support were used to assign molluscan genes to 
either a particular human ortholog, or when a strong relationship did not exist (bootstrap 
value < 80), the assignment was made to a particular clade containing multiple subfamily 
members.  Among ABCC proteins, only human ABCC5 and CgMRP-2 are indicated as 
299
possible orthologs; however, the bootstrap value on this pairing is very low (50%, see 
Figure 14), resulting in minimal confidence in this observation.  Rather, CgMRP-2 
should be considered an ortholog of all three human genes in this clade (ABCC5, 
ABCC11 and ABCC12 clade; i.e., the human genes are co-orthologs of CgMRP-2).  
CgMRP-1 and ThMRP-1 emerge as orthologs and together with ThMRP-2 appear to be 
most closely related to the human ABCC1, ABCC2, ABCC3 and ABCC6 members.  
Within the Pgp-related ABCB subfamily, significant bootstrap support exists for the 
molluscan Pgp/ABCB1/ABCB4/ABCB5/ABCB11 clade; however, more specific 
relationships can not be defined further because of low bootstrap support. 
 
Expression and localization of P-glycoproteins 
 Expression of P-glycoprotein in Cyphoma digestive gland and whole Tritonia 
homogenates was examined by Western blot using the monoclonal antibody C219, which 
recognizes a highly conserved amino acid sequence within the nucleotide binding domain 
(VQ-E/A/V-ALD) (Georges et al. 1990).  In Tritonia tissue homogenates, this antibody 
recognized a distinct band of expected size, 170 kDa (Juliano & Ling 1976), and two 
larger diffuse bands, > 200 kDa, possibility representing differentially glycosylated 
isoforms of Pgp (Schinkel et al. 1993) (Figure 15).  However, similar immunoreactivity 
was absent for Cyphoma digestive gland homogenates.  Based on deduced amino acid 
sequences, the lack of reactivity in Cyphoma homogenates is somewhat surprising 
considering that at least one of the Cyphoma proteins (CgPgp-1) contains the epitope 
VQEALD, among those recognized by C219.  Although C219 recognizes this epitope 
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containg Glu (E), it does so less strongly than the epitope containing Ala (A) (VQAALD) 
(Georges et al. 1990).  The partial Tritonia Pgp-1 sequence contains the Ala at this 
position (VQAALD), which may explain the difference in reactivity between molluscan 
species.  Alternatively, or in addition, there may be differences in Pgp expression that 
contribute to the differential recognition by C219 in these immunoblot studies. 
 The cellular localization of P-glycoprotein was examined in paraffin-embedded 
fixed tissue sections probed with C219.  P-glycoprotein expression was detected in the 
apical tips of the ciliated columnar epithelia lining the lumen of the midgut in T. 
hamnerorum individuals (Figure 16 and 17).  The midgut in nudibranchs is a centrally 
located sac anteriorly connected to the buccal cavity containing the radula and associated 
feeding organs by the esophagus and posterially connected to the tubular hindgut (Millott 
1937).  The midgut is also connected to the caecum and the surrounding digestive gland.  
Heavy ciliated cells within the anterior portion of the midgut are arranged in folds and 
contain elongated nuclei due to the compressed condition of the cells when the midgut is 
not distended (Millott 1937, Morse 1968).  Immunohistochemical staining helps to 
accentuate the folded nature of the midgut epithelia (Figure 16).  Faint staining was also 
noted in goblet-like cells found on the nudibranch’s epidermis, possibly involved in 
mucus secretion (Figure 16).  In contrast to the staining in Tritonia tissues, Pgp was not 
detected by immunohistochemistry in C. gibbosum mantle or digestive gland tissues.   
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In vivo calcein efflux transport assay 
In vivo examination of transporter activity in Tritonia was assessed using the   
calcein efflux assay.  The calcein assay is a functional diagnostic method developed to 
quantify multixenobiotic transporter-mediated efflux activity in cells and tissues.  Non-
fluorescent calcein-AM rapidly traverses cell membranes where it can be converted to 
fluorescent calcein by non-specific esterases or extruded by Pgp and MRP before 
intracellular conversion to the non-MXR substrate.  High levels of MXR transport 
activity can prevent the accumulation of free calcein in the cell, resulting in minimal 
fluorescent calcein accumulation.  Transporter-specific MXR-mediated efflux can be 
measured by the use of specific MRP (MK571) and Pgp (verapamil) inhibitors.  If 
transport activity is minimal, the transport inhibitor will have limited or no effect 
resulting in little increased cell fluorescence.  However, if transport activity is significant, 
the presence of an inhibitor will increase calcein accumulation, as indicated by 
intracellular fluorescence, compared to incubations without the inhibitor present.   
 Live Tritonia were incubated in the presence of 500 nM extracellular C-AM with 
and without varying concentrations of inhibitors.  The addition of verapamil or MK571 to 
the seawater containing Tritonia significantly increased calcein accumulation compared 
to DMSO controls (Figure 18).  These results indicate that MXR-mediated efflux activity 
prevents calcein accumulation in Tritonia tissues and that inhibiting this activity causes 
calcein-AM to be retained and hydrolyzed to calcein.  Calcein accumulation varied 
depending on the inhibitor used and its concentration.  Increasing verapamil 
concentration to 25 μM did not cause a measurable increase in calcein accumulation 
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compared to 5 μM of verapamil, suggesting that the lower concentration of verapamil is 
sufficient to block the majority of Pgp transporters.  In contrast, 30 μM MK571 resulted 
in a further 57% increase in calcein accumulation compared to that caused by 5 μM 
MK571, and the calcein accumulation was greater than the maximal level obtained in the 
presence of verapamil.  This difference in the absolute level of calcein accumulation 
suggests that MRP transporters are either more highly expressed or more efficient at 
exporting C-AM in Tritonia tissues and therefore may play a more active role in 
xenobiotic transport compared to Pgp.   
 
Quantitative RT-PCR analysis of Cyphoma MRP-1 expression 
 Quantitative RT-PCR analysis was used to investigate the constitutive and 
inducible expression of MRP-1 forms in Cyphoma after dietary exposure to several 
gorgonian species with varying allelochemical profiles.  Cyphoma MRP-1 was selected 
for expression analysis because of its homology to the human MRP1 (ABCC1), known 
for its ability to transport a range of glutathione-conjugated substrates.  This is 
particularly relevant to the present study because Cyphoma digestive gland tissues 
constitutively express high levels of the glutathione-conjugating enzyme, glutathione S-
transferase, likely necessitated by the presence of numerous potent inhibitors/substrates 
in its gorgonian diets (see Chapter 4).  Thus, efflux of glutathione-conjugated 
allelochemicals from Cyphoma digestive gland may be mediated by MRP-1.        
 Adult Cyphoma were allowed to feed ad libitum for 4 d on one of seven 
gorgonian diets or a control diet devoid of gorgonian allelochemicals, as described in 
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Chapter 3.  Digestive gland levels of CgMRP-1 transcripts were measured by quantitative 
RT-PCR.  MRP-1 transcripts were constitutively expressed in Cyphoma digestive gland 
and the expression was not affected by gorgonian diet (Table 3, Figure 19).  MRP-1 
transcript expression was also measured in time-zero individuals to determine if 
collection location could influence gene expression.  MRP-1 expression was found to 
significantly differ in time-zero snails as a function of reef location (ANOVA, F4,26 = 
2.74, p = 0.05, Table 4, Figure 20), but did not significantly differ among snails allowed 
to feed on a control diet for four days (ANOVA, F4,28 = 0.637, p = 0.640).   
 
Discussion 
In aquatic systems, much of our knowledge of the function of ABC transporters in 
marine invertebrates is limited to the response of these proteins under anthropogenic 
stress conditions (Kurelec 1992, Minier et al. 1993, Smital et al. 2000, Smital et al. 2003, 
Kingtong et al. 2007).  However, for marine consumers that regularly feed on prey/hosts 
laden with natural toxins, efflux transporters may play a critical role in regulating the 
absorption of allelochemicals, thereby dictating diet selection.  This study is the first to 
examine the expression and activity of ABC transporters from two molluscan predators 
that feed solely on chemically defended prey.    
 
Molluscan P-glycoproteins  
Using a combination of molecular approaches, four partial Pgps related to 
multixenobiotic transporters in vertebrates were identified from the digestive gland of 
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Cyphoma gibbosum (CgPgp-1, CgPgp-2) and whole Tritonia hamnerorum (ThPgp-1, 
ThPgp-2).  All four molluscan Pgps encode transporters that cluster within a highly 
supported clade containing the human ABCB1, ABCB4, ABCB5 and ABCB11 genes.  
ABCB1 (MDR1 or Pgp1) is possibly the most well studied of all the multixenobiotic 
transporters and is known for its promiscuous transport of hydrophobic substrates, 
including xenobiotics, lipids, sterols, and chemotherapeutics derived from natural 
products (Choudhuri & Klaassen 2006).  ABCB4 (MDR3) and ABCB11 are both 
expressed in the liver and are involved in the secretion of bile acids (Gerloff et al. 1998, 
Oude Elferink & Paulusma 2007), while ABCB5 is hypothesized to function as a drug 
resistance mediator, similar to ABCB1, and is primarily expressed in the epidermis 
(Frank et al. 2005).  Acquisition of complete ABCB sequences would no doubt help to 
better define the relationships of the molluscan Pgps with particular ABCB members.  
Nevertheless, the phylogenetic analysis presented here clearly groups these molluscan 
transporters with those ABCB members known to mediate xenobiotic resistance. 
Western blot analysis of molluscan tissues with the mAb C219, which recognizes 
both human MDR1 (ABCB1) and MDR3 (ABCB4) proteins (Van den Elsen et al. 1999), 
suggested that homologs of human MDR proteins are expressed in Tritonia tissues but 
not in Cyphoma digestive gland.  The disparity in Pgp expression between both 
molluscan predators may reflect differences in their foraging behavior.  Specialist 
herbivores that consume a diet rich in allelochemicals had a higher intestinal Pgp 
capacity in comparison to a sympatric generalists that are unable to tolerate the toxin-
laden diet (Green et al. 2004).  While high Pgp protein expression does not necessarily 
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translate to increased protein activity, these results do suggest that dietary toxins could be 
handled differently depending on consumer experience.       
Deduced amino acid sequences from two partial Cyphoma Pgps indicate that at 
least one of the forms (CgPgp-1) contains the correct epitope (VQEALD) in its 
nucleotide binding domain and therefore would be recognized by C219 if expressed in 
the digestive gland.  It is possible that CgPgp-1 is expressed in tissues other than the 
digestive gland; however, immunohistochemical analysis of whole Cyphoma sections 
with C219 did not detect any immunoreactive protein.  Based on sequence data, multiple 
forms of Pgp are expressed in Cyphoma digestive gland, yet their detection may be 
limited by the reactivity of the antibody used here, suggesting that western blots should 
be interpreted with caution.  In contrast, Tritonia tissue homogenates displayed a distinct 
band at 170 kDa, in agreement with human MDR proteins (Choudhuri & Klaassen 2006) 
and two diffuse bands at > 200 kDa.  Similar multiple banding patterns (i.e., 170 kDa, 
and > 200 kDa banding) have also been observed in the gill tissue of mussels Mytilus 
californianus, M. galloprovincialis, and M. edulis and oysters Crassostrea gigas and C. 
virginica (i.e., > 200 kDa) (reviewed in Bard 2000).  Protein bands > 200 kDa may 
represent post-translational modifications or differential glycosylation states, not 
uncommon among mammalian P-glycoproteins (Schinkel et al. 1993).   
Immunohistochemical staining of Tritonia tissues by C219 indicated that Pgp 
proteins were localized to the apical epithelial of the midgut and to a lesser extent in the 
epidermis.  The location of Pgp in Tritonia digestive tissues is in agreement with the 
localization of mammalian ABCB1 on the apical (or luminal) surface of polarized 
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epithelia of many tissues, such as the gastrointestinal tract, kidney proximal tubules and 
biliary heptocytes (Klein et al. 1999).  Based on the location of mammalian ABCB1 in 
barrier tissues coupled with its function as a unidirectional transporter of a range of toxic 
substrates, it is likely that the physiological role of ABCB1 and its orthologs is to protect 
cells and ultimately organisms against toxic compounds (Schinkel et al. 1994, Schinkel et 
al. 1997).  The two tissues types observed to exhibit the greatest Pgp expression in 
Tritonia, the gut epithelia and the epidermis, correspond to those tissues that would be 
exposed to the greatest concentration of gorgonian allelochemicals, due to the fact that 
Tritonia both resides on and consumes its gorgonian host.   
Interestingly, this nudibranch is able to selectively sequester a furano-germacrene 
feeding deterrent from its gorgonian host, Gorgonia ventalina, and concentrate this 
chemical defense four-fold (dry mass basis) relative to the gorgonian (Cronin et al. 1995).  
While the exact mechanism of sequestration in nudibranch tissues is unknown, recent 
studies have demonstrated that mammalian MXR transporters can reduce the intracellular 
concentration of toxins by actively sequestering them in subcellular compartments, away 
from vulnerable cellular targets (Van Luyn et al. 1998, Molinari et al. 2002, Rajagopal & 
Simon 2003, Ifergan et al. 2005).  Furthermore, MXR members can have different 
activity profiles depending on membrane location (i.e., plasma membrane versus 
lysosomal membrane), which may be linked to the lipid environment or post-translational 
modification of the transporter that can occur within subcellular compartments 
(Rajagopal & Simon 2003).  This intracellular sequestration phenomenon has also been 
observed in mussel blood cells, whereby the intracellular accumulation of the fluorescent 
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Pgp substrate Rhodamine B in lysosomes could be reversed if incubated with verapamil 
(Svensson et al. 2003).  In addition, the MXR-mediated subcellular localization is 
suspected to be responsible for the sequestration of the marine toxin, okadaic acid in the 
mussel Mytilus edulis (Svensson et al. 2003).  Transporters have also been suggested as a 
mechanism by which herbivorous insects can sequester unmetabolized host plant toxins 
in diverticular pouches, defensive glands or hemolymph (Sorensen & Dearing 2006).  
Therefore, sequestration of dietary allelochemicals by ABC transporters may function as 
a protective mechanism against cytotoxicity, with the added advantage of providing the 
marine consumer with its own chemical protection. 
The in vivo activity of MXR transporters was investigated in Tritonia using ABC 
subfamily specific transport inhibitors capable of blocking the Pgp- and MRP-mediated 
efflux of C-AM.  Both inhibitors resulted in increased dye accumulation in Tritonia 
tissues, which is consistent with previous competitive dye transport assays reporting 
MXR-mediated transport activity in a variety of marine invertebrates (grass shrimp 
(Finley et al. 1998), worm (Toomey & Epel 1993), sponge (Muller et al. 1996), oyster 
(Keppler 1997), mussel (McFadzen et al. 2000), sea urchin (Hamdoun et al. 2004)).  
Varying inhibitor concentration did not increase Pgp-mediated calcein accumulation, but 
did cause a substantial impact on MRP-mediated calcein accumulation.  The greater level 
of calcein accumulation in Tritonia exposed to MRP inhibitor suggests that MRP-
mediated efflux may contribute more to xenobiotic resistance than Pgp in Tritonia. 
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Molluscan multixenobiotic resistance-associated proteins 
While both subfamilies of transporters confer multixenobiotic resistance, the 
substrate selectivities of Pgp and MRP differ markedly.  Pgp transport neutral or mildly 
positive lipophilic compounds, while MRP substrates are lipophilic anions capable of 
transporting a range of substrates including glutathione (GSH), glucuronide, or sulfate 
conjugates of phase II detoxification reactions (Kruh & Belinsky 2003).  Phylogenetic 
analysis of molluscan MRP sequences obtained here indicate that CgMRP-1, ThMRP-1 
and ThMRP-2 fall within a well-supported clade containing the mammalian ABCC1, 
ABCC2, ABCC3 and ABCC6 proteins, known for their ability to transport a variety of 
glutathione conjugates including natural product cancer drugs and prostaglandins (Evers 
et al. 1997, de Waart et al. 2006).  The Caribbean gorgonian Plexaura homomalla is 
regularly consumed by Cyphoma despite the high concentration of prostaglandin A2 
esters (Gerhart 1986), which function as potent feeding deterrents in this coral (Gerhart 
1984, Pawlik & Fenical 1989).  Recent evidence suggests that Cyphoma may be able to 
tolerate dietary prostaglandins and other lipophilic gorgonian compounds by conjugation 
with glutathione S-transferases (GSTs).  GSTs are highly expressed in the digestive gland 
of this predator, and a screening of gorgonian lipophilic extracts suggests all gorgonian 
diets may contain substrates for Cyphoma GSTs (Chapter 4).  Therefore, the constitutive 
expression of MRP-1 in the digestive gland of Cyphoma may facilitate the efficient 
biliary excretion of putative glutathione-conjugates of prostaglandins and other lipophilic 
compounds (Evers et al. 1997, Paumi et al. 2003, de Waart et al. 2006).  MRP-1 
expression was also detected in the snails feeding on control diets devoid of gorgonian 
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allelochemicals, suggesting that these transporters may also be responsible for the export 
of physiological substrates, in addition to their roles in multixenobiotic resistance.  In 
contrast, MRP-1 expression significantly varied in time-zero snails as a function of reef 
location.  While it is difficult to conclusively pin point the cause of this reef-specific 
variation, the length of snail foraging time on a single colony or the presence of 
additional gorgonian species not tested in our feeding assays may have had an effect on 
MRP-1 expression.   
Phylogenetic analysis revealed that Cyphoma MRP-2 is significantly divergent 
from the other molluscan MRPs identified in this study and falls into the clade containing 
human ABCC5, ABCC11 and ABCC12.  All three of these transporters are at the early 
stages of investigation and their physiological functions are unknown, yet studies indicate 
that they mediate the transport of antiretroviral nucleosides and lipophilic glutathione-
conjugates (Wijnholds et al. 2000, Kruh et al. 2007). 
Mounting evidence suggests that ABC transporters likely regulate the absorption 
and subsequent distribution of natural toxins in marine organisms (Toomey & Epel 1993, 
Toomey et al. 1996, Keppler & Ringwood 2001, Eufemia et al. 2002).  The present work 
describes the first efforts to identify MXR genes that may protect marine invertebrates 
that have adapted to exclusively feed on allelochemically-rich prey.   Messenger RNA 
encoding MXR transporters is expressed in both generalist and specialist molluscan 
species and share sequence and organizational structure similar to MXRs of distantly 
related organisms, indicating the likelihood of shared function as natural product 
transporters between mammalian and molluscan orthologs.  A second piece of evidence 
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supporting the role of MXR proteins as dietary allelochemical efflux pumps comes from 
the results of immunohistochemical analyses in Tritonia tissues, where Pgp expression 
was highest in the tissues most vulnerable to allelochemical exposure.  Additionally, in 
vivo studies of MXR activity using ABC subfamily-specific inhibitors provided added 
support for the presence and function of MXR transporters in Tritonia.  However, for 
organisms where in vivo dye assays may not be permitted, real-time qPCR provided a 
highly robust and sensitive method for quantifying MXR isoform-specific expression.  
Constitutive expression of selected promiscuous MXR transporters may be advantageous 
to a generalist predator with a chemically diverse diet.  Support for this hypothesis may 
come from screening gorgonian extracts in competitive substrate inhibition assays with 
transfected cell lines or isolated membrane vesicles overexpressing molluscan MXRs of 
interest.  This initial screening approach would facilitate comparisons of substrate breadth 
between MXRs from generalist and specialist consumers and allow one to begin to test 
predictions about whether generalist MXRs possess greater structural and functional 
flexibility in their substrate specificity compared to specialists (Li et al. 2004). 
In summary, the elucidation of the molecular mechanisms underlying consumer 
tolerance is a prerequisite to understanding the foraging behavior of marine consumers.  
This study provides a much needed first step in identifying putative environmental 
chemical stress genes capable of ameliorating allelochemical-induced toxicity.  It is likely 
that both MRP and Pgp play significant roles in natural toxicant efflux in marine 
consumers.  Future work aimed at elucidating those marine natural products capable of 
311
interacting with substrate-binding sites on MXRs will provide valuable insight into the 
evolution of ABC transporter-mediated consumer counter-defense mechanisms.   
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Table 1.  Primers used in the present study 
 
Gene   Primers   Direction Sequences (5’ to 3’)       
 
Degenerate 
MRP   MRP_F   Forward CTD GTD GCD GTD GTD GG     
    MRP_R   Reverse RCT NAV NGC NSW NAR NGG NTC RCT 
    nest_MRP_F  Forward CGG GAT CCA GRG ARA AYA THC TNT TTG G 
    nest_MRP_R  Reverse CGG AAT TCN TCR TCH AGN AGR TAD ATR TC 
P-gp    Pgp_Bbox_F  Forward GGI GGI CAG AAR CAR MGI ATI GC  
    Pgp_Cdomain_F Forward GAY GAR GCI ACI TCI GCI CTI G 
 
Specific 
Cyphoma MRP-1 MRP-R1   Reverse CCG GGC TAA ACT CAC TCT CTG TTT CTG G
    CgMRP-1_R8  Reverse CAT CCA TGA CCT GAG AAG ATC TGG 
    CgMRP-1_R9  Reverse GGT TCA CAA ACT GCA ACA GGT CG 
    CgMRP-1_F8  Forward CCA GAA ACA GAG AGT GAG TTT AGC C 
    CgMRP-1_F9  Forward GAA TGG CAC CGT CAT CGT ACA GAG 
    CgMRP-1_F10  Forward ATT GAC GCC TGT GCC CTT CGC AC  
Cyphoma MRP-2 CgMRP-2_F6  Forward GAG ACA TTT GGA GCT GGG GAC CAG 
    CgMRP-2_F7  Forward GTG TCA GCA TGC TGT CTG GAC AAA G 
Cyphoma Pgp-1 P-gp_R4   Reverse CCT CTG TCA CCA CAC CAT GTC G 
Cyphoma Pgp-2 P-gp_R5   Reverse GTT GGC CAC AAA GCC AGC GTA GGC 
    P-gp_R6   Reverse CTC CAA CAC CTG ACC GTT CTC C 
 
Tritonia MRP-1 MRP_F4   Forward CAA TCG GAT ATT GAC ATT CTC CCT GGC 
    MRP_F5   Forward GCT GTG TAC AGT GAC CAA GAC 
    MRP_R4   Reverse CAG GGA GAA TGT CAA TAT CCG ATT GG 
    MRP_R5   Reverse GTC TTG GTC ACT GTA CAC AGC 
    ThMRP-1_F6  Forward AAA TGA CGT CCG CTG CTG GTG TCC 
    ThMRP-1_F7  Forward AGG CAT TTG GCT GAC GGA GTG GAC 
    ThMRP-1_R6  Reverse AAA CAT GGC CAC GCC TAG TTG GTC 
ThMRP-1_R7  Reverse GGA AGT CTC ATC GCC AAT GCT GG 
Tritonia MRP-2 MRP_F2   Forward GGT CCA GAT CTG CAA ATG CTG 
    MRP_F3   Forward GCA AAT GCT GCC AGA TGG TGA TC 
MRP_R2   Reverse CAG CAT TTG CAG ATC TGG ACC 
    MRP_R3   Reverse GAT CAC CAT CTG GCA GCA TTT GC 
    ThMRP-2_R9  Reverse GGA CTT GAC CAA ATT GCC CAG CC 
    ThMRP-2_R8  Reverse TGA CCC GTG AAG TGA AGC GCT ATC 
    ThMRP-2_F10  Forward GTG GAA GGG AGT GTT GTC ATG AGG 
    ThMRP-2_F11  Forward GAA TCA ACG TGA CGA TTC CAG ACC 
 
Adaptor primers RACE_1_F    AAT ACG ACT CAC TAT AGG   
    AP1      CCA TCC TAA TAC GAC TCA CTA TAG GGC 
    AP2      ACT CAC TAT AGG GCT CGA GCG GC 
 
Cyphoma MRP-1  136_1_F1   Forward ACG AGG AGC TGA TGT GTC ACG ATG G 
qPCR primers           136_1_R1   Reverse GTC CTC CTC ATC CAC ATC TTC ATC G 
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Table 3.  Results of a two-way ANOVA investigating differences in MRP-1 gene expression in C. 
gibbosum feeding on control versus gorgonian diets. 
 
Factors     df   MS    F   p  
Control vs. B. asbestinum 
 Diet          1    5.3x109   0.797  0.422 
 Reef      4   1.4x1010   0.423  0.791 
 Diet x Reef     4    6.6x109   0.204  0.935 
 Error    36   3.2x1010    
 
Control vs. E. mammosa 
 Diet          1    5.4x109     3.22  0.147 
 Reef      4    3.2x109   0.106  0.980 
 Diet x Reef     4   1.7x1010      0.555  0.697 
 Error    35   3.0x1010    
 
 
Control vs. G. ventalina 
 Diet          1   5.9x1010     5.91  0.072 
 Reef      4   1.4x1010   0.432  0.785 
 Diet x Reef     4   1.0x1010   0.313  0.867 
 Error    35   3.2x1010    
 
 
Control vs. P. acerosa 
 Diet          1   2.0x1010   0.948  0.385 
 Reef      4   5.5x1010     1.87  0.139 
 Diet x Reef     4   2.1x1010   0.723  0.582 
 Error    33   3.0x1010    
 
 
Control vs. P. americana 
 Diet          1   1.9x1010     1.01  0.371 
 Reef      4   2.5x1010   0.852  0.502 
 Diet x Reef     4   1.9x1010   0.651  0.629 
 Error    35   2.9x1010    
 
 
Control vs. P. elisabethae 
 Diet          1   1.7x1010     5.02  0.154 
 Reef      2   1.8x1010     1.30  0.297 
 Diet x Reef     2   3.5x1010   0.249  0.782 
 Error    18   1.4x1010    
 
Control vs. P. homomalla 
 Diet          1   6.4x1010     9.66  0.036 
 Reef      4    4.5x109   0.157  0.958 
 Diet x Reef     4    6.6x109   0.230  0.920 
 Error    34   2.9x1010    
 
 
A p < 0.007 should be accepted as significant (Bonferroni adjusted).       
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Table 4.  Results of a one-way ANOVA investigating reef-dependent MRP-1 gene 
expression in time-zero and four day control fed C. gibbosum.  Reefs considered 
random factors. 
 
 
Factors     df   MS   F   p 
Reef (Experiment 1)  
 Control diet   4, 28  2.1x1010  0.637  0.640 
 
Reef (Experiment 2) 
 Time-zero group  4, 26  3.1x1010    2.74  0.050 
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Figure 1. Partial nucleotide and deduced amino acid sequence of Cyphoma MRP-1 cDNA.  The 
Cyphoma MRP-1 nucleotide polymorphisms (boxed) are indicated according to IUPAC naming 
conventions. Arrows indicate location of quantitative PCR primers.  GenBank Accession number 
EU487192. 
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Figure 2.  Partial nucleotide and deduced amino acid sequence of Cyphoma MRP-2 
cDNA.  The Cyphoma MRP-2 nucleotide polymorphisms (boxed) are indicated 
according to IUPAC naming conventions.  GenBank Accession number EU487193. 
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Figure 3.  Partial nucleotide and deduced amino acid sequence of Tritonia MRP-1 
cDNA.  The Tritonia MRP-1 nucleotide polymorphisms (boxed) are indicated according 
to IUPAC naming conventions.  GenBank Accession number EU487194. 
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Figure 4. Partial nucleotide and deduced amino acid sequence of Tritonia MRP-2 
cDNA.  The Tritonia MRP-2 nucleotide polymorphisms (boxed) are indicated according 
to IUPAC naming conventions.  GenBank Accession number EU487195. 
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Figure 5. Alignment of deduced amino acid sequences of Cyphoma and Tritonia MRP proteins.  
Molluscan deduced amino acids sequences were aligned using ClustalX.  Identical residues in at least two 
sequences are shaded in grey.  Black and red boxes represent the putative nucleotide binding domains and 
hydrophobic transmembrane domains, respectively.  Domains were predicted using the algorithm of Kyte 
and Doolittle (1982) (window of 13 amino acids) and with NCBI Conserved Domain Database searches 
(Marchler-Bauer 2007).  Predicted start codons for Cyphoma MRP-1 and Tritonia MRP-1 are indicated by 
a downward arrow above the alignment.  A dash (-) indicates missing or gapped residues.  GenBank 
sequences in the alignment include: Cyphoma MRP-1 (EU487192); Cyphoma MRP-2 (EU487193); 
Tritonia MRP-1 (EU487194); Tritonia MRP-2 (EU487195).  
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ThMRP_2 217 S L L T F L T Y V Y V N D K H Y L D P QR A F V A I S L F N I I K F A I N F A P M V V T E A V K A V I S A R R I QR Y L N QE D L D E N S V T K D E Y A G T P I C I T N G T F S WT 306
CgMRP_2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThMRP_1 706 L D QP I S T L R N I N L E I K S GS L V A V V G T V GC GK S S L I S A A L GE ME R L GGR V T V K GS I A Y V P QE AW I QN A T L R D N I L F GK D Y R E H M Y K K I I D A 795
CgMRP_1 675 K E L P L P T L R K I N L E I P K GK L V A V V GQ V G T GK S S L L S A M L GE MQK L N G T V I V QS S T A Y V P QQ AW I QN A T L K D N I L F GK P E N E N A Y QK V I D A 764
ThMRP_2 307 S D N D QN T L QR I N V T I P D QS L T A V V GP V GS GK S S L L S A M L GE I E K V E GS V V MR GS V S Y V P QQ AW I QN N T L R N N I L F GK D Y D S E F Y N K C V E A 396
CgMRP_2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - P Y D E E K F D R V V S A 13
ThMRP_1 796 C A L QS D I D I L P GGD K T E I GE K G I N V S GGQK QR V S L A R A V Y S D QD I Y L L D D P L S A V D S H V GK H I F QE V I GQK G V L K H K T R L L V T H G I QWL P 885
CgMRP_1 765 C A L R T D L D I L P GGD M T E I GE K G I N L S GGQK QR V S L A R A V Y N D A D I Y L L D D P L S A V D S H V GK H I F QE V I GD K G L L R N K T R V L V T H G V HWL P 854
ThMRP_2 397 C A L GP D L QM L P D GD H T E I GE K G I N L S GGQK QR V S L A R A I Y S QS D I Y L L D D P L S A V D S H V GK H I F N Q V L S N A G L L A GK V C V L V T H G L HWL P 486
CgMRP_2 14 C C L D K D F E T F G A GD Q V E I GD R G L T L S GGQK QR I S L A R A I Y S D S D I Y L L D D P L S A L D I Q I GR H V F A QC L - - K I M L K D K T V L F V T H H L E Y L P 101
ThMRP_1 886 L V D N I F V V S N GE I S E K G T Y T E L L E K D GH F A Q F I K E Y A QE N K N D S D E GE A K P L F QR QE S A I S GD S S D F G T S S L R K R K L S Y A QR P S T A S R R H 975
CgMRP_1 855 M V D T I V V M V D GR I S E I GS Y E E L MC H D GD F A Q F L K A Y L L QGD E D V D E - - E D P E I QQ V K - - - - - - - - - - - - A K M L E R V D S V I S E P S A T S GE E 930
ThMRP_2 487 H T D Q V I V M V N GQ V S E I GH Y E D L L S H K GD F A R L V T S F L T QK E E QE E N E D D D E Y L E MK R S - - - - - - - - - - L L R T L S E T E N E D T D V GS D S H QD 566
CgMRP_2 102 K C D Q V M L L H E GS V S E MGC H QD L L G T S - - A GP M Y T E L F Q L Y QS K Y D K - - - - - - I QR H R - - - - - - - - - - - - - - - L L S C L GP P QD GD V K T P QR 168
ThMRP_1 976 S AWD GN S L L E K S L E A S K A A A R A G T K L T E D - - - - - - E V G L S GK V K L E I Y L K Y L R E L G V A T C V G A F I L Y GCWA GC T C F A G I WL T E WT GD S Y L 1059
CgMRP_1 931 G A A GGR - - - K MS R Q L S R QH S K P G L - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 951
ThMRP_2 567 I F L Q L S K T F E QS V E V K K K E E K D M T P V K V D GG L I E E E A V Q T GS V K WS V V K S Y GR S I G Y G Y L F I I L F F Y L I Y V GC GMGS N L WL T E WT D D D R L 656
CgMRP_2 169 G F S R MS - - - - - L H Q L S R H L S R - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 184
ThMRP_1 1060 L N L S N K D T D K Y D - - D E T D K Y L G V Y A A A S I S QG L F I M V F S F I A A F QM T S A A G V L H N R M L H N V L R T P MS F F D T T P I GR I MN R F S R D V E V L D N 1147
CgMRP_1 951 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 951
ThMRP_2 657 A N F T Q L P E D S S E R MN R N D F Y L T I Y G V F G I V K T F A V I V R A F L GN Y R A V T A S G I V H QS M L S R I L H A P MS F F D T T P MGR I V N R F S K D I S D MD E 746
CgMRP_2 184 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 184
ThMRP_1 1148 I L P L S MK Q V MN V GGQ V I I T I V N I S Y G T P I F L V A L L P L S I I Y I A I Q L V Y I P T C R Q L R R I N S I T R S P I Y V H F S E T L S G A S S I R A Y GMQE R F I 1237
CgMRP_1 951 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 951
ThMRP_2 747 S L P M T F N MWMD GML T V L S S - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 765
CgMRP_2 184 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 184
ThMRP_1 1238 E E S MR R I D H N V K F Y F S S I A A A S WL S F R L Q F L GN M V I F A A A I F A V A A S D I D P S V V G L S V S Y A S MM T N A L E Q L V S V I S E T E T N I I S V E R L QE 1327
CgMRP_1 951 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 951
ThMRP_2 765 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 765
CgMRP_2 184 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 184
ThMRP_1 1328 Y T N A P QE A AW I L D H H R P K P DWP E K GN I V F D N Y Q T R Y R P G L D L V L R D L T C S I K GGE K I G I V GR T G A GK S S M T V A L F R I I E A A D GK I I I D GE 1417
CgMRP_1 951 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 951
ThMRP_2 765 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 765
CgMRP_2 184 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 184
ThMRP_1 1418 D V A K MG I H D L R N K I T I L P QE P V I F S G T L R MN L D P F N K Y T E P D MWN A L E H S Y L K E F V E G L P GK L D Y E C GE E GS N L S V GQR Q L V C L A R T L L R 1507
CgMRP_1 951 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 951
ThMRP_2 765 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 765
CgMRP_2 184 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 184
ThMRP_1 1508 K T K I L V L D E A T A A V D ME T D D L I Q A T I R T Q F K E C T V L T I A H R L 1549
CgMRP_1 951 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 951
ThMRP_2 765 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 765
CgMRP_2 184 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 184
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Figure 6.  Partial nucleotide and deduced amino acid sequence of Cyphoma Pgp-1 
cDNA.  The Cyphoma Pgp-1 nucleotide polymorphisms (boxed) are indicated according 
to IUPAC naming conventions.  The stop codon is indicated by an asterisk.   GenBank 
Accession number EU487190. 
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Figure 7.  Partial nucleotide and deduced amino acid sequence of Cyphoma Pgp-2 
cDNA.  The Cyphoma Pgp-2 nucleotide polymorphisms (boxed) are indicated according 
to IUPAC naming conventions.  The stop codon is indicated by an asterisk.  GenBank 
Accession number EU487191. 
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Figure 8.  Partial nucleotide and deduced amino acid sequence of Tritonia Pgp-1 
cDNA.  The Tritonia Pgp-1 nucleotide polymorphisms (boxed) are indicated according to 
IUPAC naming conventions.  GenBank Accession number EU487196. 
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Figure 9.  Partial nucleotide and deduced amino acid sequence of Tritonia Pgp-2 
cDNA.  The Tritonia Pgp-2 nucleotide polymorphisms (boxed) are indicated according to 
IUPAC naming conventions.  GenBank Accession number EU487197. 
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Figure 10. Alignment of deduced amino acid sequences of Cyphoma and Tritonia Pgp proteins with 
Mouse ABCB1a.  Molluscan deduced amino acid sequences and mouse protein sequence were aligned 
using ClustalX.  Identical residues are shaded in grey.  Black and red boxes represent the putative 
nucleotide binding domains and hydrophobic transmembrane domains, respectively.  Transmembrane and 
nucleotide binding domains were predicted using the algorithm of Kyte and Doolittle (1982) (window of 13 
amino acids) and with NCBI Conserved Domain Database searches (Marchler-Bauer et al. 2007). An 
asterisk indicates a stop codon and a dash (-) indicates missing or gapped residues. GenBank sequences in 
the alignment include: mouse ABCB1a (M. musculus, NP_035206), C. gibbosum Pgp-1 (EU487190), C. 
gibbosum Pgp-2 (EU487191), T. hamnerorum Pgp-1 (EU487196), T. hamnerorum Pgp-2 (EU487197).    
 
ABCB1a 1 ME L E E D L K GR A D K N F S K MGK K S K K E K K E K K P A V S V L T M F R Y A GWL D R L Y M L V G T L A A I I H G V A L P L MML I F GD M T D S F A S V GN V S K N S T N 90
CgPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ABCB1a 91 MS E A D K R A M F A K L E E E M T T Y A Y Y Y T G I G A G V L I V A Y I Q V S FWC L A A GR Q I H K I R QK F F H A I MN QE I GWF D V H D V GE L N T R L T D D V S K I N E 180
CgPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ABCB1a 181 G I GD K I GM F F Q A M A T F F GG F I I G F T R GWK L T L V I L A I S P V L G L S A G I WA K I L S S F T D K E L H A Y A K A G A V A E E V L A A I R T V I A F GGQK K E L 270
CgPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ABCB1a 271 E R Y N N N L E E A K R L G I K K A I T A N I S MG A A F L L I Y A S Y A L A FWY G T S L V I S K E Y S I GQ V L T V F F S V L I G A F S V GQ A S P N I E A F A N A R G A A Y E 360
CgPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ABCB1a 361 V F K I I D N K P S I D S F S K S GH K P D N I QGN L E F K N I H F S Y P S R K E V Q I L K G L N L K V K S GQ T V A L V GN S GC GK S T T V Q L MQR L Y D P L D GMV S I D 450
CgPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Q V Q L D 5
ThPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - N K L N I I GQ V L L D 12
ABCB1a 451 GQD I R T I N V R Y L R E I I G V V S QE P V L F A T T I A E N I R Y GR E D V T MD E I E K A V K E A N A Y D F I MK L P H Q F D T L V GE R G A Q L S GGQK QR I A I A R A 540
CgPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 6 GE D I R D L N I QWL R S N I G I V S QE P I L F GMS I A K N I Q L GQP D I S ME E V E K A A R M A N A H D F I K S L P QG Y N T L V GE R G A Q L S GGQK QR V A I A R A 95
ThPgp-2 13 GMD V K E L N I K WL R E N I G L V S QE P V L F D T T I A E N I R Y GR D D V T MD G I I E A A K N A N A Y D F I S K L P D K F N T L V G A R G A Q L S GGQK QR I A I A R A 102
ABCB1a 541 L V R N P K I L L L D E A T S A L D T E S E A V V Q A A L D K A R E GR T T I V I A H R L S T V R N A D V I A G F D GG V I V E QGN H D E L MR E K G I Y F K L V M T Q T A GN E 630
CgPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 96 L A R D P R I L L L D E A T S A L D S E S E G I V Q A A L D K V H N - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129
ThPgp-2 103 L V R D P K I L L L D E A T S A L D T E S E S V V QD A L D K V T I - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 136
ABCB1a 631 I E L GN E A C K S K D E I D N L D MS S K D S GS S L I R R R S T R K S I C GP H D QD R K L S T K E A L D E D V P P A S FWR I L K L N S T E WP Y F V V G I F C A I I N GG L 720
CgPgp-1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - A P F T Q L MR L N A P E WK F I L MGC M A G I I N GG I 30
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 129 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129
ThPgp-2 136 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 136
ABCB1a 721 QP A F S V I F S K V V G V F T N GGP P E T QR QN S N L F S L L F L I L G I I S F I T F F L QG F T F GK A GE I L T K R L R Y M V F K S M L R QD V S WF D D P K N T T G A L 810
CgPgp-1 31 QP A F S V I F S K I I G V F A L P D L D E - QE R R I L V Y T F I L I G L G V V S F F T M F MQS Y F F A T S GE N L T V R I R D M T F R A M L Y QD I T Y F D D K R N N T G A L 119
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 129 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129
ThPgp-2 136 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 136
ABCB1a 811 T T R L A N D A A Q V K G A T GS R L A V I F QN I A N L G T G I I I S L I Y GWQ L T L L L L A I V P I I A I A G V V E MK M L S GQ A L K D K K E L E GS GK I A T E A I E N F 900
CgPgp-1 120 T T R L A T D A S L V QG V T G V R L GQ A I MN F A N I G T G L V I A F I Y GWQ L T L L I I G F L P L L V L GG F L Q I R I MS G V A GS N K T A L E E A GK T A T E A I D N I 209
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1
ThPgp-1 129 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129
ThPgp-2 136 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 136
ABCB1a 901 R T V V S L T R E QK F E T M Y A QS L Q I P Y R N A MK K A H V F G I T F S F T Q A MM Y F S Y A A C F R F G A Y L V T QQ L M T F E N V L L V F S A I V F G A M A V GQ V S S F 990
CgPgp-1 210 R T V V S L GR E I T MH D R F M T H L R GP Y N S A L K K GH I V G F A F G F S QG A I F F V Y A A S F I L G A Y L I E QS E MN F E D V F M V F S A I V F S A M A V GN A S A F 299
CgPgp-2 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - N A Q V Y S M A T A F S A S I I F F I Y A GC F R F G A Y L V GE GE MD A E E V Y R V F M A M T M A GQ V V GQ T S S I 61
ThPgp-1 129 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129
ThPgp-2 136 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 136
ABCB1a 991 A P D Y A K A T V S A S H I I R I I E K T P E I D S Y S T QG L K P - N M L E GN V Q F S G V V F N Y P T R P S I P V L QG L S L E V K K GQ T L A L V GS S GC GK S T V V Q L L 1079
CgPgp-1 300 A P D A GK A Q T S A K R I I K L L N S K P S I D S Q T K E GK T L P D G F L S E I Q F R D V E F H Y P S R P D A K I L QK L N I N V S QGQ T V A L V GS S GC GK S T T V Q L I 389
CgPgp-2 62 L P D Y GK GR L A A A Y I F R MMR T E P R I D N S S T A G I R - - K D V K GS V Q L K K V E F H Y P MR P E I K V L R G I S L E V E A GQ T A A L V G I S GC GK S T I I S L L 149
ThPgp-1 129 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129
ThPgp-2 136 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 136
ABCB1a 1080 E R F Y D P M A GS V F L D GK E I K Q L N V QWL R A Q L G I V S QE P I L F D C S I A E N I A Y GD N S R V V S Y E E I V R A A K E A N I H Q F I D S L P D K Y N T R V GD K G 1169
CgPgp-1 390 E R F Y D T E T GS V T L GD I N V K E L N V QH L R A Q I G I V S QE P V L F D R S L A E N I A Y GD N E R V V QMD E I I K A A R D A N I H E F I A S L P N G Y D T P A GD K G 479
CgPgp-2 150 QR Y Y D P V H GS L M V D G T D V R Q Y N I S V L R S M L S V V S QE P T L F D C S I R E N I V Y G L E G - D V P M A D V I E A C K T S N I H S F I S K L P N G Y D T Q V GGK G 238
ThPgp-1 129 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129
ThPgp-2 136 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 136
ABCB1a 1170 T Q L S GGQK QR I A I A R A L V R QP H I L L L D E A T S A L D T E S E K V V QE A L D K A R E GR T C I V I A H R L S T I QN A D L I V V I QN GK V K E H G T H QQ L L A Q 1259
CgPgp-1 480 A Q L S GGQK QR V A I A R A L V R N P R V L L L D E A T S A L D T E S E K V V QE A L D R A R E GR T C I V I A H R L S T I T N A D K I C V I R H G V V T E E G T H S T L MN Q 569
CgPgp-2 239 T Q L S GGQK QR V A I A R A L V R N P R I L L L D E A T S A L D T E S E K L V QQ A L D N A R E GR T C L V I A H R L S T I QN A D V I F V ME N GQ V L E K G T H QE L L A L 328
ThPgp-1 129 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129
ThPgp-2 136 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 136
ABCB1a 1260 K G I Y F S M V S V Q A G A K R S * 1277
CgPgp-1 570 QG F Y Y K L N M A Q A R QK *   585
CgPgp-2 329 QG A Y A G F V A N QK I N *    343
ThPgp-1 129 - - - - - - - - - - - - - - - - -  129
ThPgp-2 136 - - - - - - - - - - - - - - - - -  136
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Figure 11. Comparison of molluscan and human MRP hydropathy profiles.  (A) Deduced amino acid 
sequences from Cyphoma and Tritonia MRP profiles were aligned using ClustalX.  Tritonia MRP-1 plot is 
indicated by the red line and the Cyphoma MRP-1 (blue line), Tritonia MRP-2 (green line) and Cyphoma 
MRP-2 (maroon line) are layered on top. (B) Deduced amino acid sequence from Tritonia MRP-1 (blue 
line) was aligned with human ABCC3 (red line) using ClustalX.   Black bars above the plots indicate 
positions of the three transmembrane regions (TM1, TM2, TM3) and nucleotide binding domains (NB1, 
NB2) in ABCC proteins.  Values above and below the horizontal line indicate hydrophobic and hydrophilic 
regions, respectively.  Hydrophobicity plots were generated using the Kyte-Doolittle algorithm (1982) with 
a window of 13 residues by BioEdit v7.0.5.2.  GenBank sequences in the alignment include: human 
ABCC3 (NP_003777.2), C. gibbosum MRP-1 (EU487192), C. gibbosum MRP-2 (EU487193), T. 
hamnerorum MRP-1 (EU487194), T. hamnerorum MRP-2 (EU487195).    
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Figure 12. Comparison of molluscan and mouse Pgp hydropathy profiles.  Deduced amino acid 
sequences of Cyphoma and Tritonia P-glycoproteins were aligned to mouse ABCB1a using ClustalX.  The 
mouse ABCB1a plot is indicated by the red line and is overlaid by Cyphoma Pgp-1 (blue line), Cyphoma 
Pgp-2 (green line), Tritonia Pgp-1 (maroon line), and Tritonia Pgp-2 (black line).  Black bars above the 
plots indicate positions of the two transmembrane regions (TM1, TM2) and nucleotide binding domains 
(NB1, NB2) in ABCB proteins.  Values above and below the horizontal line indicate hydrophobic and 
hydrophilic regions, respectively.  Hydrophobicity plots were generated using the Kyte-Doolittle algorithm 
(1982) with a window of 13 residues by BioEdit v7.0.5.2.  GenBank sequences in the alignment include: 
mouse ABCB1a (M. musculus, NP_035206), C. gibbosum Pgp-1 (EU487190), C. gibbosum Pgp-2 
(EU487191), T. hamnerorum Pgp-1 (EU487196), T. hamnerorum Pgp-2 (EU487197).      
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Figure 13.  Phylogenetic relationships among Cyphoma, Tritonia and human ABC transporters.  
Maximum likelihood (ML) trees were constructed as described in the Methods.  Out of a possible 3450 
positions, 1821 positions (or 52.8%) were used to construct the final tree.  Molluscan sequences are 
highlighted in red.  Values at branch points represent ML bootstrap values calculated with 100 replications.  
Triangles represent portions of the tree that were collapsed due to poor resolution of the taxa within each 
clade as evidenced by bootstrap analysis.  GenBank sequences in the tree include: Human ABCA proteins 
(ABCA1, NP_005493.2; ABCA2, NP_001597.2; ABCA3, NP001080.2; ABCA4, NP_000341.2; ABCA5, 
NP_061142.2; ABCA6, NP_525023.2; ABCA7, NP_061985.2; ABCA8, NP_009099.1; ABCA9, 
NP_525022.2; ABCA10, NP_525021.3; ABCA12, NP_775099.2), human ABCB proteins (ABCB1, 
NP_000918.2; ABCB2, NP_000584.2; ABCB3, NP_000535.3; ABCB4, NP_000434.1; ABCB5, 
NP_848654.3; ABCB6, NP_005680.1; ABCB7, NP_004290.2; ABCB8, NP_009119.2; ABCB9, 
NP_982269.1; ABCB10, NP_036221.1; ABCB11, NP_003733.2), human ABCC proteins (ABCC1, 
NP_004987.2; ABCC2, NP_000383.1; ABCC3, NP_003777.2; ABCC4, NP_005836.2; ABCC5, 
NP_005679.2; ABCC6, NP_001162.3; ABCC8, NP_000343.2; ABCC9 a/b, NP_005682.2, NP_064693.2; 
ABCC10, NP_258261.2; ABCC11, NP_115972.2; ABCC12, NP_150229.2; ABCC13, EAX10058.1), 
human ABCD (ABCD1, NP_000024.2; ABCD2, NP_005155.1; ABCD3, NP_002849.1, ABCD4, 
NP_005041.1), human ABCE (ABCE1, NP_002931.2), human ABCF (ABCF1, NP_001020262.1; 
ABCF2, NP_009120.1; ABCF3, NP_060828.2), human ABCG (ABCG1, NP_997057.1; ABCG2, 
NP_004818.2; ABCG4, NP_071452.2; ABCG5, NP_071881.1; ABCG8, NP_071882.1), Cyphoma 
gibbosum MRP-1 (EU487192), MRP-2 (EU487193), Pgp-1 (EU487190), Pgp-2 (EU487191), Tritonia 
hamnerorum MRP-1 (EU487194), MRP-2 (EU487195), Pgp-1 (EU487196), Pgp-2 (EU487197).  Analysis 
performed by J. Goldstone. 
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Figure 14.  Phylogenetic relationships among Cyphoma, Tritonia and human ABCB and ABCC 
protein subfamilies.  Maximum likelihood (ML) trees were constructed as described in the Methods.  Out 
of a possible 2026 positions, 1402 positions (or 69.2%) were used to construct the final tree.   Molluscan 
sequences are highlighted in red.  Values at branch points represent ML bootstrap values calculated with 
100 replications. GenBank sequences in the tree include: Human ABCB proteins (ABCB1, NP_000918.2; 
ABCB2, NP_000584.2; ABCB3, NP_000535.3; ABCB4, NP_000434.1; ABCB5, NP_848654.3; ABCB6, 
NP_005680.1; ABCB7, NP_004290.2; ABCB8, NP_009119.2; ABCB9, NP_982269.1; ABCB10, 
NP_036221.1; ABCB11, NP_003733.2), human ABCC proteins (ABCC1, NP_004987.2; ABCC2, 
NP_000383.1; ABCC3, NP_003777.2; ABCC4, NP_005836.2; ABCC5, NP_005679.2; ABCC6, 
NP_001162.3; ABCC8, NP_000343.2; ABCC9 a/b, NP_005682.2, NP_064693.2; ABCC10, NP_258261.2; 
ABCC11, NP_115972.2; ABCC12, NP_150229.2; ABCC13, EAX10058.1),  Cyphoma gibbosum MRP-1 
(EU487192), MRP-2 (EU487193), Pgp-1 (EU487190), Pgp-2 (EU487191), Tritonia hamnerorum MRP-1 
(EU487194), MRP-2 (EU487195), Pgp-1 (EU487196), Pgp-2 (EU487197). Analysis performed by J. 
Goldstone. 
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Figure 15.  Detecting Pgp expression in molluscan tissue homogenates.  Western blots 
were probed with anti-P-glycoprotein mAb C219 which reacted with (A) one sharp band 
at 170 kDa and two diffuse bands at > 170 kDa in T. hamnerorum whole cell 
homogenates.  No immunopositive bands were detected in C. gibbosum digestive gland 
homogenates.  (B) Fundulus heteroclitus liver cell lysates were used as a positive control. 
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Figure 16.  Immunolocalization of Pgp in T. hamnerorum tissues.  Tangential sections 
of T. hamnerorum were probed with the anti-P-glycoprotein mAb C219.  Orange-brown 
staining indicates immunoreactive protein. (A) Black arrows indicate intense staining by 
C219 along the apical tips of the gut epithelium; grey arrow indicates lighter staining by 
C219 along the epidermis; bm. buccal mass; mg. midgut; oe. esophagus; ra. radula; (50x). 
(B) Magnification (100x) of esophagus and midgut. (C) Further magnification (200x) of 
the ciliated columnar epithelia in the midgut; cilia indicated by white arrow. 
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Figure 17. Immunolocalization of Pgp in T. hamnerorum tissues continued.  (A) 
Hematoxylin and eosin stained section depicting the folded nature of T. hamnerorum 
midgut tissues; mg. midgut (100x). (B) C219 probed tissue section and (C) unlabeled 
serial section showing P-glycoprotein localized to the periphery of the midgut epithelium 
(indicated by black arrows) (200x) 
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Figure 18. Change in intracellular fluorescence in T. hamnerorum incubated with 
MRP (MK571) and Pgp (verapamil) inhibitors compared to untreated controls.  
Bars represent mean fluorescence (± SE) of T. hamnerorum tissue homogenates from 
four or eight replicate wells (replicates indicated in parentheses).  All inhibitor exposures 
resulted in a significant increase in calcein accumulation.  MK571 at 30 μM exposure 
resulted in the greatest inhibition of transport activity in T. hamnerorum. (*p=0.001, 
**p<0.001, Two sample t test) 
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Figure 19. Mean MRP-1 transcript expression among C. gibbosum individuals 
feeding on a gorgonian or control diet for four days.  Bars represent the mean MRP-1 
transcript expression (± SE) of snails feeding on B. asbestinum (n = 13 snails), E. 
mammosa (n = 12), G. ventalina (n = 13), P. acerosa (n =10), P. americana (n = 12), P. 
elisabethae (n = 6), P. homomalla (n = 11) or a control diet (n = 33).  Real-time 
quantitative PCR was performed and the number of transcript molecules per 0.2 μg of 
poly(A)+ RNA was calculated from the standard curve and normalized by a β-actin 
correction factor.  Results of a two-way ANOVA indicate no significant differences in 
MRP-1 expression in snails feeding on different diets. 
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Figure 20.  Mean MRP-1 transcript expression among time-zero and four day control diet fed C. 
gibbosum collected from five reefs. (A) Time-zero snails; mean MRP-1 transcript expression (± SE) in 
snails (n = 31 snails) collected from five reefs and immediately dissected to preserve reef-specific transcript 
expression signals. (B) Control snails; mean MRP-1 transcript expression (± SE) in snails (n = 33 snails) 
collected from five reefs and fed a control diet (e.g., alginic acid + squid powder) for four days.  Values in 
parentheses indicate the number of replicate snails examined per reef. Real-time quantitative PCR was 
performed and the number of transcript molecules per 0.2 μg of poly(A)+ RNA was calculated from the 
standard curve and normalized by a β-actin correction factor.     
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 The marriage between molecular/proteomic tools and traditional methods for the 
study of marine consumer-prey interactions holds considerable promise for the field of 
chemical ecology.  Despite the tremendous progress in identifying the diversity, 
concentrations and distribution of allelochemicals and their effects on the behavior of 
marine consumers, few studies have addressed the proximate mechanisms underlying the 
profound variation in tolerance among these consumers for their chemically defended 
foods.  The work presented in this thesis demonstrates the power of emerging 
technologies available to chemical ecologists to characterize for the first time those 
biochemical innovations postulated to lead to the adaptation of marine consumers to their 
allelochemically-defended prey.  Elucidation of consumer environmental response genes 
encoding proteins involved in the detoxification and transport of natural products will 
undoubtedly ignite exciting science at the interface of pharmacology and marine ecology.  
Moreover, identifying the molecular underpinnings of organismal physiological response 
has broad implications for understanding the role of the environment in determining gene 
function in a co-evolutionary context.  What follows in this chapter is the summation of a 
multidisciplinary study investigating the expression, activity and diversity of three 
dominant families of enzymes involved in xenobiotic resistance, providing the most 
comprehensive assessment thus far of biochemical resistance mechanisms used by marine 
consumers to cope with their chemically defended prey.      
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A Proteomic Approach to Chemical Ecology 
 Glutathione S-transferases (GSTs) have long been known to play pivotal roles in 
xenobiotic resistance in insects and the high GST activity in the digestive gland of our 
model consumer, Cyphoma gibbosum (Vrolijk & Targett 1992), further indicated their 
potential importance in allelochemical detoxification.  However, information as to the 
diversity, isoform-specific expression, and relatedness of C. gibbosum GSTs to those of 
metazoans was lacking.  After a molecular approach with degenerate primers designed to 
previously cloned molluscan GSTs failed to yield any GST sequences, efforts were 
redirected toward a proteomic approach that proved to be highly successful, facilitating 
the identification of the collection of expressed GSTs in C. gibbosum digestive gland.  
Peptide fragment analysis revealed that both mu- and theta-class GSTs were expressed in 
molluscan tissues – the latter being the first theta-class GST identified from a molluscan 
source.  Mu-class GSTs are known to mediate the conjugation of electrophilic natural 
products, including prostaglandins (previously characterized as gorgonian feeding 
deterrents), while theta-class GSTs are unique in their ability to act as dehalogenases and 
may protect Cyphoma from a host of organohalogens found in its gorgonian diet.   
 RT-PCR and RACE cloning efforts with degenerate primers designed to 
homologous peptides obtained from proteomic analyses yielded two full-length mu-class 
GST cDNA sequences from C. gibbosum digestive gland.  Comparative and phylogenetic  
analysis revealed that Cyphoma GST mu homologs share 78% amino acid identity and 
form a monophyletic group with other molluscan GST mu sequences.  Attempts were 
made to further biochemically characterize individual Cyphoma mu-class GST isoforms 
349
by recombinant expression in yeast.  While immunochemical analysis confirmed the 
expression of Cyphoma mu-class GSTs in yeast systems, GST activity was never 
observed with recombinant cytosolic fractions.  It is possible the choice of expression 
system (yeast vs. E. coli) may have affected protein activity (e.g., inhibitor present), yet 
studies successfully expressing GSTs for functional characterization in both systems have 
been reported.  Additional possibilities include the prevention of GST homodimer 
formation due to the presence of the C-terminal epitope tag used to visualize protein 
expression.  Alternatively, Cyphoma GSTs may function as heterodimers, not uncommon 
among mu-class GSTs, and co-expression of both cDNAs would be necessary for GST 
activity to be restored.  The potential of GST subunits to form heterodimers would likely 
increase the pool of potential substrates available for conjugation.  Future optimization of 
recombinant Cyphoma GST expression systems will allow for further biochemical 
characterization of paralogous GST isoforms and permit the testing of hypotheses 
concerning possible subfunctionalization of specific GST isoforms following gene 
duplication and divergence events.   
   
Cyphoma GSTs: the role of constitutive biochemical defense mechanisms 
 In contrast to most housekeeping genes, genes involved in xenobiotic metabolism 
often are strongly inducible by substrates upon which they act, accelerating the 
biotransformation and elimination of the substrate.  Interestingly, Cyphoma digestive 
gland tissues constitutively express high levels of GST regardless of the diet of this 
consumer.  Further, separation of Cyphoma GST proteins by HPLC revealed that GST 
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subunits are expressed in the digestive gland in the same relative abundance in 
individuals feeding on different diets.  These findings led me to test the hypothesis that 
the constitutive expression of GSTs may be advantageous to our generalist if the majority 
of gorgonian diets contain substrates for Cyphoma GSTs.  A screen of crude extracts 
from eight species of gorgonian corals, commonly serving as hosts for Cyphoma in the 
field indicated that all extracts contained potent inhibitors of these enzymes, the most 
inhibitory of which were traced to the moderately hydrophobic, chloroform-soluble 
fractions.  The sensitivity of Cyphoma GSTs to inhibition by these extracts suggests that 
gorgonian diets contain electrophilic substrates or inhibitors.  GSTs are most notable for 
their ability to conjugate electrophilic substrates with glutathione; however, the ability of 
these enzymes to act as ‘xenobiotic sponges’ by sequestering non-substrate ligands 
(Ketley et al. 1975, Kostaropoulos et al. 2001) may serve as further protection against 
allelochemical toxicity.  Additionally, the presence of inhibitors could represent counter-
defense strategies employed by gorgonian hosts to block the GST-mediated metabolism 
of co-occurring allelochemicals by Cyphoma.  Further studies at both the biochemical 
and organismal level would be needed to determine if potent gorgonian inhibitors could 
reduce the effectiveness of Cyphoma GSTs and thereby enhance toxicity. 
 Specific gorgonian compounds known for their ecological and biological 
activities were investigated for their ability to serve as substrates for Cyphoma GSTs.  In 
mammals, prostaglandins are hormone-like fatty acids that exert their effects through G-
protein-coupled receptors and influence a variety of cellular processes including 
induction of apoptosis, inhibition of cell growth, activation of oxidative stress pathways 
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and inflammation response.  In marine systems, selected prostaglandin series (PGA2, 
PGE2 and PGF2α) are found in unusually high concentrations in gorgonian tissue, where 
they function as antipredatory compounds.  Some studies report that Cyphoma seems 
unaffected by the prostaglandins in its diet, preferring in some localities to reside on 
gorgonian species (e.g., Plexaura sp.) known to harbor high concentrations of 
prostaglandins.  A screen of commercially available prostaglandins revealed that those in 
the A series, which are most abundant in gorgonians, were the most potent inhibitors of 
Cyphoma GST activity.  Kinetic studies with affinity-purified GSTs indicated that 15(S)-
PGA2 was a competitive inhibitor, and likely a substrate for Cyphoma GSTs, with 
apparent affinity values comparable to Km constants described for vertebrate 
prostaglandin-conjugating GSTs.  Estimates of the in vivo prostaglandin concentration 
experienced by Cyphoma when foraging suggests that GSTs would be saturated with 
respect to the PGA2 and would be operating near the enzyme’s physiological limits.  
However, the prostaglandin-conjugating ability of Cyphoma GSTs will need to be 
substantiated in incubation experiments by demonstrating the formation of prostaglandin-
glutathione conjugates above non-enzymatic levels.  
The results of Chapter 4 indicate that high, constitutive activity of Cyphoma 
gibbosum GSTs is likely necessitated by the ubiquitous presence of substrates/inhibitors 
in this consumer’s gorgonian diet.  Evidence from terrestrial insect-host studies also 
indicate that generalist counter-defense enzymes often have a broader substrate 
specificity than those of comparable specialists.  The greater functional versatility of 
detoxification enzymes in generalists may facilitate the exploitation of a greater range of 
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chemically diverse diets.  Therefore, it would be interesting to compare GST expression 
and substrate metabolism profiles between the generalist Cyphoma gibbosum and the 
sympatric specialist Cyphoma signatum, which feeds solely on a single gorgonian 
species.  It is possible that the success of the polyphagous foraging strategy of C. 
gibbosum is due to the constitutive expression of catalytically versatile GSTs that allow 
this consumer to cope with its chemically unpredictable prey.   
 
Cyphoma P450s: gene specific induction in response to select suites of gorgonian 
allelochemicals 
 The majority of previous research assessing the response of marine consumer 
detoxification enzymes to allelochemical exposure has relied upon the use of enzymatic 
activity with diagnostic substrates or immunochemical detection with vertebrate-derived 
probes.  While these methods are a good first step, often the selection of probes or 
diagnostic substrates has been biased toward vertebrate gene families or subfamilies 
involved in pharmacological or pollutant response, which may have little or no ecological 
relevance to allelochemical metabolism in the organism being studied.  A more 
quantitative and sensitive approach to examine the tissue-specific level of putative 
allelochemical detoxification proteins involves quantitative PCR, which takes advantage 
of available molecular evidence and does not require first hand knowledge of protein 
function.   
Cyphoma cytochrome P450 Family 4 (CYP4) members were originally targeted 
for expression analysis based on previous evidence in other organisms suggesting that 
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classes of compounds analogous to those found in gorgonian tissues could be inducers 
and substrates of CYP4 proteins.  Using molecular techniques, I identified several distinct 
CYP4 genes from Cyphoma digestive gland.  Analysis of Cyphoma feeding on different 
diets revealed that mRNAs encoding specific CYP4 enzymes were regulated in a diet-
specific manner.  Select CYP4 transcripts were significantly induced in snails feeding on 
Plexaura homomalla, a gorgonian diet known to contain high concentrations of 
prostaglandins.  Phylogenetic analysis of allelochemically-responsive molluscan CYP4 
cDNAs indicated that the closest vertebrate relatives were those of the fatty acid 
metabolizing CYP4A and CYP4F subfamilies, both of which contain members with 
prostaglandin hydroxylase activity.  A comparison of molluscan CYP4 genes with 
vertebrate fatty acid hydroxylase members revealed that molluscan enzymes share key 
amino acid residues within their substrate access channel and active site known to 
mediate prostaglandin hydroxylase activity in vertebrates.  Heterologous expression of 
selected cDNAs indicated a possible role of Cyphoma CYP4s in eicosanoid metabolism.  
Furthermore, microsomal protein isolated from the digestive gland of snails feeding on P. 
homomlla had a greater propensity to metabolize the diagnostic fatty acid, leukotriene B4, 
in comparison to microsomes isolated from control snails.  The increased eicosanoid 
metabolism in P. homomalla fed snails is consistent with the earlier observation that 
selected CYP4 enzymes are induced in snails feeding on this particular gorgonian diet, 
likely in response to the high concentrations of dietary prostaglandins. 
 The weight of evidence for Cyphoma CYP4s as prostaglandin metabolizing genes 
is striking.  The next obvious step is to examine the metabolism of ecologically relevant 
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prostaglandins by recombinant Cyphoma CYP4s.  In addition, feeding assays with 
purified gorgonian prostaglandins incorporated into artificial diets offer a way to assess 
the rate and specificity of Cyphoma CYP4 transcript induction in response to specific 
allelochemical stressors.  These additional studies will allow for a more complete 
description of the molecular and biochemical pathways likely responsible for mediating 
dietary prostaglandin tolerance in Cyphoma. 
 The results of this chapter have built a firm foundation from which to test 
additional hypotheses about the evolution and transcriptional regulation of environmental 
response genes in marine consumers.  Molecular characterization of CYP4 transcripts 
expressed in C. gibbosum indicates that allelochemical-responsive CYP4 subfamilies 
have undergone extensive radiation in this generalist, likely driven in part by co-
evolutionary processes unique to the natural history of this consumer.  Sequence 
variations have accrued in the coding regions, including substrate recognition sites, of 
these genes and this would suggest that despite their high degree of sequence similarity, 
these proteins may have significantly different metabolic capabilities and/or substrate 
specificities.  The sequence diversity of allelochemically-responsive Cyphoma CYP4 
subfamily members may reflect the enzymatic diversity required for generalists to 
metabolize the range of prostaglandin analogs in gorgonian tissues (PGA2, PGE2 and 
PGF2α).  Heterologous expression of polymorphic transcripts and subsequent analysis of 
prostaglandin metabolism would help define the key residue(s) required for metabolism 
of specific prostaglandin classes.   
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In addition, promoter analysis of allelochemically-responsive CYP4 members is 
likely to identify a number of putative cis-acting transcriptional response elements that 
are possible targets of regulation by gorgonian allelochemicals.  Among the ligand-
activated nuclear transcription factors known to regulate both CYP4 and GST expression 
are those in the peroxisome proliferator-activated receptor (PPAR) family, known for 
their roles in homeostasis, inflammation and wound repair.  Cyclopentenone 
prostaglandins, including PGA2 series, are among the most potent of the natural PPAR 
agonists and it is likely that PPAR or related transcription factors orchestrate the 
induction of a battery of detoxification genes in Cyphoma in response to dietary 
prostaglandins.  Sequencing of the sea urchin genome revealed two PPAR paralogs are 
present in invertebrate deuterostomes (Goldstone et al. 2006); however, little information 
exists as to the true number of nuclear receptors and their functions in molluscan species.  
Future work examining the ability of ecologically relevant prostaglandins to activate 
putative Cyphoma PPARs or related orphan nuclear receptors in cell-based reporter gene 
assays will help elucidate the molecular pathways responsible for gorgonian 
allelochemical detoxification.  In sum, the work described in this chapter provides a 
framework for a more mechanistic understanding of the regulatory pathways mediating 
the expression of allelochemical metabolizing genes. 
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Possible roles of efflux transporters as consumer counter-mechanisms to prey chemical 
defenses 
 Multixenobiotic resistance transporters (MXRs) are often considered an 
organism’s first line of defense against environmental chemicals, yet they are frequently 
overlooked as possible allelochemical resistance mechanisms by many in the chemical 
ecology field.  The multixenobiotic efflux phenotype has been described in several 
aquatic organisms, and numerous natural products - including marine examples - have 
been shown to inhibit the efflux of probe substrates for these transporters.  The wide 
taxonomic distribution and broad substrate specificity of these transporters led me to 
hypothesize that MXRs may aid marine consumers in coping with dietary allelochemical 
stress.  In addition to their efflux capabilities, MXRs have also been shown to facilitate 
the intracellular concentration of substrates in subcellular vesicles or organelles as 
another possible mechanism of reducing intracellular toxicity (Van Luyn et al. 1998, 
Molinari et al. 2002, Rajagopal & Simon 2003, Ifergan et al. 2005).  Some have 
suggested that the ability of specialist consumers to concentrate the dietary chemical 
defenses of their prey or host for their own protection may be facilitated by MXR-
mediated transport (Sorensen & Dearing 2006).  However, no specific transporters have 
yet been implicated in allelochemical sequestration.  The objective of Chapter 5 was to 
improve our understanding of the diversity of putative allelochemical efflux transporters, 
their activity, and their expression in both generalist (Cyphoma gibbosum) and specialist 
(Tritonia hamnerorum) molluscan predators that are likely to process dietary 
allelochemicals in different ways based on the needs of each consumer. 
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 Molecular approaches yielded, from each molluscan species, four partial MXR 
fragments with homology to both human ABCB and ABCC subfamilies.  
Immunochemical analysis with a monoclonal antibody probe to P-glycoprotein (Pgp; 
ABCB1) detected immunoreactive proteins only in the tissue homogenates of Tritonia 
and not in the digestive gland homogenates of Cyphoma.  Tritonia Pgp proteins were 
found to be associated with the apical tips of epithelia cells lining the gut lumen, a 
location consistent with a role in mediating dietary xenobiotic efflux.  However, the lack 
of Pgp expression in Cyphoma homogenates and tissue sections was more ambiguous.  
Further inspection of partial deduced amino acid sequences of Cyphoma Pgps indicated 
that the disparity in protein expression may be due to lack of epitope recognition by the 
Pgp probe.  These findings highlight the need for caution in interpreting immunochemical 
staining when probes developed in distantly related organisms are used.   
Quantitative PCR is a more robust and sensitive approach for quantifying gene-
specific expression and, consequently, was used to investigate the influence of gorgonian 
diet on MXR expression in Cyphoma.  I initially targeted Cyphoma multidrug resistance 
protein (MRP-1) because of its putative role in the ATP-dependent export of glutathione 
(GSH) conjugates, based on homology to known GSH-X efflux transporters.  
Quantitative PCR analysis revealed that MRP-1 was constitutively expressed in snails 
feeding on all gorgonian diets.  This result coupled with the findings in Chapters 2 and 4 
suggest that Cyphoma GSTs may play a significant role in the detoxification of 
hydrophobic gorgonian allelochemicals and resultant allelochemical glutathione 
conjugates could potentially be substrates for Cyphoma MRP-1 proteins. 
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The in vivo activity of molluscan MXR transporters was assessed using a simple 
competitive dye efflux assay whereby MXR-specific inhibitors resulted in dye 
accumulation, implying the presence of MXR-mediated transport activity in Tritonia 
tissues.  One question that was not addressed in studies in Chapter 5 was the ability of 
molluscan MXRs to transport (or sequester) gorgonian compounds.  In the future, these 
same dye assays can be used to screen gorgonian extracts and pure compounds of interest 
using a bioassay-guided fractionation approach to identify substrates/inhibitors for 
molluscan MXR transporters both in in vivo and in vitro with selected heterologously 
expressed molluscan proteins.  This screening approach can also be used to test 
hypotheses about the substrate flexibility of generalist MXRs that may allow these 
consumers to export a greater diversity of compounds, reflective of the chemically 
diverse and unpredictable diets they encounter, in comparison to specialist consumers.   
 
Future work: genomic approaches to understanding allelochemical modes of action and 
consumer counter-defenses 
The field of chemical ecology has entered a new era whereby advances in 
molecular biology are set to provide physiological ecologists with the most 
comprehensive view of how cells and ultimately organisms tolerate and respond to 
allelochemical stresses.  Techniques such as transcriptome profiling using DNA 
microarrays will allow for the parallel analysis of the expression of thousands of genes, 
providing a complete picture of gene regulation occurring in response to dietary 
compounds.  This method does not limit the researcher to simple single gene hypotheses 
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rather, transcriptome profiling can be used to form a posteriori hypotheses about the 
mode of action of allelochemicals and consumer mechanisms of toxin resistance.  The 
availability of genomic data from model marine organisms (e.g., anemone, sea urchin, 
sponge, oyster, limpet, polychaete, and tunicate) is rapidly expanding, and can be 
leveraged to investigate how small molecules can tranduce their effects through the 
genotype of an organism, ultimately affecting the phenotype and organism function.  I am 
excited for the future of this field and the promise that genomic-enabled technology holds 
for rapidly advancing our understanding of allelochemical tolerance.  Knowledge of how 
consumers respond and adapt to environmental chemical stressors on the molecular level 
will add volumes to our understanding of patterns of predation and herbivory in the 
marine environment. 
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